(dp0
S'BCL2L1'
p1
(lp2
(dp3
S'source'
p4
S'http://drugbank.bio2rdf.org/sparql'
p5
sS'targetURI'
p6
Vhttp://bio2rdf.org/drugbank_target:5990
p7
sS'pharmacologicAction'
p8
NsS'drugURI'
p9
Vhttp://bio2rdf.org/drugbank:DB07108
p10
sS'targetMappingSymbol'
p11
g1
sS'targetName'
p12
S'BCL2-like 1'
p13
sS'uri'
p14
Vhttp://bio2rdf.org/drugbank_resource:DB07108_5990
p15
sS'drugGeneric'
p16
V4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID [drugbank:DB07108]
p17
sS'label'
p18
Vdrug-target interaction 4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID and Apoptosis regulator Bcl-X [drugbank_resource:DB07108_5990]
p19
sasS'SYTL4'
p20
(lp21
(dp22
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3850
p23
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p24
sg11
g20
sg12
S'synaptotagmin-like 4'
p25
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_3850
p26
sg16
VInsulin recombinant [drugbank:DB00030]
p27
sg18
Vdrug-target interaction Insulin recombinant and Synaptotagmin-like protein 4 [drugbank_resource:DB00030_3850]
p28
sa(dp29
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3850
p30
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p31
sg11
g20
sg12
g25
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_3850
p32
sg16
VInsulin, porcine [drugbank:DB00071]
p33
sg18
Vdrug-target interaction Insulin, porcine and Synaptotagmin-like protein 4 [drugbank_resource:DB00071_3850]
p34
sasS'PCK1'
p35
(lp36
(dp37
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1116
p38
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02008
p39
sg11
g35
sg12
S'phosphoenolpyruvate carboxykinase 1 (soluble)'
p40
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02008_1116
p41
sg16
V1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine [drugbank:DB02008]
p42
sg18
Vdrug-target interaction 1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine and Phosphoenolpyruvate carboxykinase, cytosolic [GTP] [drugbank_resource:DB02008_1116]
p43
sa(dp44
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1116
p45
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01819
p46
sg11
g35
sg12
g40
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01819_1116
p47
sg16
VPhosphoenolpyruvate [drugbank:DB01819]
p48
sg18
Vdrug-target interaction Phosphoenolpyruvate and Phosphoenolpyruvate carboxykinase, cytosolic [GTP] [drugbank_resource:DB01819_1116]
p49
sa(dp50
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1116
p51
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03267
p52
sg11
g35
sg12
g40
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03267_1116
p53
sg16
V1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine [drugbank:DB03267]
p54
sg18
Vdrug-target interaction 1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine and Phosphoenolpyruvate carboxykinase, cytosolic [GTP] [drugbank_resource:DB03267_1116]
p55
sa(dp56
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1116
p57
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03725
p58
sg11
g35
sg12
g40
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03725_1116
p59
sg16
VPhosphomethylphosphonic Acid-Guanylate Ester [drugbank:DB03725]
p60
sg18
Vdrug-target interaction Phosphomethylphosphonic Acid-Guanylate Ester and Phosphoenolpyruvate carboxykinase, cytosolic [GTP] [drugbank_resource:DB03725_1116]
p61
sasS'GHR'
p62
(lp63
(dp64
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:85
p65
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00052
p66
sg11
g62
sg12
S'growth hormone receptor'
p67
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00052_85
p68
sg16
VSomatropin recombinant [drugbank:DB00052]
p69
sg18
Vdrug-target interaction Somatropin recombinant and Growth hormone receptor [drugbank_resource:DB00052_85]
p70
sa(dp71
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:85
p72
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00082
p73
sg11
g62
sg12
g67
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00082_85
p74
sg16
VPegvisomant [drugbank:DB00082]
p75
sg18
Vdrug-target interaction Pegvisomant and Growth hormone receptor [drugbank_resource:DB00082_85]
p76
sasS'PTGS2'
p77
(lp78
(dp79
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p80
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00154
p81
sg11
g77
sg12
S'prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)'
p82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00154_290
p83
sg16
Vgamma-Homolinolenic acid [drugbank:DB00154]
p84
sg18
Vdrug-target interaction gamma-Homolinolenic acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB00154_290]
p85
sa(dp86
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p87
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00244
p88
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00244_290
p89
sg16
VMesalazine [drugbank:DB00244]
p90
sg18
Vdrug-target interaction Mesalazine and Prostaglandin G/H synthase 2 [drugbank_resource:DB00244_290]
p91
sa(dp92
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p93
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00233
p94
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00233_290
p95
sg16
VAminosalicylic Acid [drugbank:DB00233]
p96
sg18
Vdrug-target interaction Aminosalicylic Acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB00233_290]
p97
sa(dp98
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p99
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00159
p100
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00159_290
p101
sg16
VIcosapent [drugbank:DB00159]
p102
sg18
Vdrug-target interaction Icosapent and Prostaglandin G/H synthase 2 [drugbank_resource:DB00159_290]
p103
sa(dp104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00316
p106
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00316_290
p107
sg16
VAcetaminophen [drugbank:DB00316]
p108
sg18
Vdrug-target interaction Acetaminophen and Prostaglandin G/H synthase 2 [drugbank_resource:DB00316_290]
p109
sa(dp110
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p111
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00461
p112
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00461_290
p113
sg16
VNabumetone [drugbank:DB00461]
p114
sg18
Vdrug-target interaction Nabumetone and Prostaglandin G/H synthase 2 [drugbank_resource:DB00461_290]
p115
sa(dp116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00465
p118
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00465_290
p119
sg16
VKetorolac [drugbank:DB00465]
p120
sg18
Vdrug-target interaction Ketorolac and Prostaglandin G/H synthase 2 [drugbank_resource:DB00465_290]
p121
sa(dp122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00480
p124
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00480_290
p125
sg16
VLenalidomide [drugbank:DB00480]
p126
sg18
Vdrug-target interaction Lenalidomide and Prostaglandin G/H synthase 2 [drugbank_resource:DB00480_290]
p127
sa(dp128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00482
p130
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00482_290
p131
sg16
VCelecoxib [drugbank:DB00482]
p132
sg18
Vdrug-target interaction Celecoxib and Prostaglandin G/H synthase 2 [drugbank_resource:DB00482_290]
p133
sa(dp134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00500
p136
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00500_290
p137
sg16
VTolmetin [drugbank:DB00500]
p138
sg18
Vdrug-target interaction Tolmetin and Prostaglandin G/H synthase 2 [drugbank_resource:DB00500_290]
p139
sa(dp140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00533
p142
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00533_290
p143
sg16
VRofecoxib [drugbank:DB00533]
p144
sg18
Vdrug-target interaction Rofecoxib and Prostaglandin G/H synthase 2 [drugbank_resource:DB00533_290]
p145
sa(dp146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00554
p148
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00554_290
p149
sg16
VPiroxicam [drugbank:DB00554]
p150
sg18
Vdrug-target interaction Piroxicam and Prostaglandin G/H synthase 2 [drugbank_resource:DB00554_290]
p151
sa(dp152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00605
p154
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00605_290
p155
sg16
VSulindac [drugbank:DB00605]
p156
sg18
Vdrug-target interaction Sulindac and Prostaglandin G/H synthase 2 [drugbank_resource:DB00605_290]
p157
sa(dp158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00328
p160
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00328_290
p161
sg16
VIndomethacin [drugbank:DB00328]
p162
sg18
Vdrug-target interaction Indomethacin and Prostaglandin G/H synthase 2 [drugbank_resource:DB00328_290]
p163
sa(dp164
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p165
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00469
p166
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00469_290
p167
sg16
VTenoxicam [drugbank:DB00469]
p168
sg18
Vdrug-target interaction Tenoxicam and Prostaglandin G/H synthase 2 [drugbank_resource:DB00469_290]
p169
sa(dp170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00573
p172
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00573_290
p173
sg16
VFenoprofen [drugbank:DB00573]
p174
sg18
Vdrug-target interaction Fenoprofen and Prostaglandin G/H synthase 2 [drugbank_resource:DB00573_290]
p175
sa(dp176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00580
p178
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00580_290
p179
sg16
VValdecoxib [drugbank:DB00580]
p180
sg18
Vdrug-target interaction Valdecoxib and Prostaglandin G/H synthase 2 [drugbank_resource:DB00580_290]
p181
sa(dp182
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p183
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00586
p184
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00586_290
p185
sg16
VDiclofenac [drugbank:DB00586]
p186
sg18
Vdrug-target interaction Diclofenac and Prostaglandin G/H synthase 2 [drugbank_resource:DB00586_290]
p187
sa(dp188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00712
p190
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00712_290
p191
sg16
VFlurbiprofen [drugbank:DB00712]
p192
sg18
Vdrug-target interaction Flurbiprofen and Prostaglandin G/H synthase 2 [drugbank_resource:DB00712_290]
p193
sa(dp194
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p195
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00749
p196
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00749_290
p197
sg16
VEtodolac [drugbank:DB00749]
p198
sg18
Vdrug-target interaction Etodolac and Prostaglandin G/H synthase 2 [drugbank_resource:DB00749_290]
p199
sa(dp200
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p201
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00795
p202
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00795_290
p203
sg16
VSulfasalazine [drugbank:DB00795]
p204
sg18
Vdrug-target interaction Sulfasalazine and Prostaglandin G/H synthase 2 [drugbank_resource:DB00795_290]
p205
sa(dp206
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p207
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00814
p208
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00814_290
p209
sg16
VMeloxicam [drugbank:DB00814]
p210
sg18
Vdrug-target interaction Meloxicam and Prostaglandin G/H synthase 2 [drugbank_resource:DB00814_290]
p211
sa(dp212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00870
p214
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00870_290
p215
sg16
VSuprofen [drugbank:DB00870]
p216
sg18
Vdrug-target interaction Suprofen and Prostaglandin G/H synthase 2 [drugbank_resource:DB00870_290]
p217
sa(dp218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00991
p220
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00991_290
p221
sg16
VOxaprozin [drugbank:DB00991]
p222
sg18
Vdrug-target interaction Oxaprozin and Prostaglandin G/H synthase 2 [drugbank_resource:DB00991_290]
p223
sa(dp224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01009
p226
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01009_290
p227
sg16
VKetoprofen [drugbank:DB01009]
p228
sg18
Vdrug-target interaction Ketoprofen and Prostaglandin G/H synthase 2 [drugbank_resource:DB01009_290]
p229
sa(dp230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01041
p232
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01041_290
p233
sg16
VThalidomide [drugbank:DB01041]
p234
sg18
Vdrug-target interaction Thalidomide and Prostaglandin G/H synthase 2 [drugbank_resource:DB01041_290]
p235
sa(dp236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01041
p238
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01041_290
p239
sg16
VThalidomide [drugbank:DB01041]
p240
sg18
Vdrug-enzyme interaction Thalidomide and Prostaglandin G/H synthase 2 [drugbank_resource:DB01041_290]
p241
sa(dp242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00784
p244
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00784_290
p245
sg16
VMefenamic acid [drugbank:DB00784]
p246
sg18
Vdrug-target interaction Mefenamic acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB00784_290]
p247
sa(dp248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00788
p250
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00788_290
p251
sg16
VNaproxen [drugbank:DB00788]
p252
sg18
Vdrug-target interaction Naproxen and Prostaglandin G/H synthase 2 [drugbank_resource:DB00788_290]
p253
sa(dp254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00812
p256
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00812_290
p257
sg16
VPhenylbutazone [drugbank:DB00812]
p258
sg18
Vdrug-target interaction Phenylbutazone and Prostaglandin G/H synthase 2 [drugbank_resource:DB00812_290]
p259
sa(dp260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00821
p262
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00821_290
p263
sg16
VCarprofen [drugbank:DB00821]
p264
sg18
Vdrug-target interaction Carprofen and Prostaglandin G/H synthase 2 [drugbank_resource:DB00821_290]
p265
sa(dp266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00939
p268
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00939_290
p269
sg16
VMeclofenamic acid [drugbank:DB00939]
p270
sg18
Vdrug-target interaction Meclofenamic acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB00939_290]
p271
sa(dp272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00945
p274
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00945_290
p275
sg16
VAcetylsalicylic acid [drugbank:DB00945]
p276
sg18
Vdrug-target interaction Acetylsalicylic acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB00945_290]
p277
sa(dp278
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p279
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01014
p280
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01014_290
p281
sg16
VBalsalazide [drugbank:DB01014]
p282
sg18
Vdrug-target interaction Balsalazide and Prostaglandin G/H synthase 2 [drugbank_resource:DB01014_290]
p283
sa(dp284
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p285
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01050
p286
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01050_290
p287
sg16
VIbuprofen [drugbank:DB01050]
p288
sg18
Vdrug-target interaction Ibuprofen and Prostaglandin G/H synthase 2 [drugbank_resource:DB01050_290]
p289
sa(dp290
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p291
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00861
p292
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00861_290
p293
sg16
VDiflunisal [drugbank:DB00861]
p294
sg18
Vdrug-target interaction Diflunisal and Prostaglandin G/H synthase 2 [drugbank_resource:DB00861_290]
p295
sa(dp296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00936
p298
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00936_290
p299
sg16
VSalicyclic acid [drugbank:DB00936]
p300
sg18
Vdrug-target interaction Salicyclic acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB00936_290]
p301
sa(dp302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00963
p304
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00963_290
p305
sg16
VBromfenac [drugbank:DB00963]
p306
sg18
Vdrug-target interaction Bromfenac and Prostaglandin G/H synthase 2 [drugbank_resource:DB00963_290]
p307
sa(dp308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00963
p310
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00963_290
p311
sg16
VBromfenac [drugbank:DB00963]
p312
sg18
Vdrug-enzyme interaction Bromfenac and Prostaglandin G/H synthase 2 [drugbank_resource:DB00963_290]
p313
sa(dp314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01397
p316
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01397_290
p317
sg16
VMagnesium salicylate [drugbank:DB01397]
p318
sg18
Vdrug-target interaction Magnesium salicylate and Prostaglandin G/H synthase 2 [drugbank_resource:DB01397_290]
p319
sa(dp320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01398
p322
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01398_290
p323
sg16
VSalicylate-sodium [drugbank:DB01398]
p324
sg18
Vdrug-target interaction Salicylate-sodium and Prostaglandin G/H synthase 2 [drugbank_resource:DB01398_290]
p325
sa(dp326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01404
p328
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01404_290
p329
sg16
VGinseng [drugbank:DB01404]
p330
sg18
Vdrug-target interaction Ginseng and Prostaglandin G/H synthase 2 [drugbank_resource:DB01404_290]
p331
sa(dp332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01283
p334
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01283_290
p335
sg16
VLumiracoxib [drugbank:DB01283]
p336
sg18
Vdrug-target interaction Lumiracoxib and Prostaglandin G/H synthase 2 [drugbank_resource:DB01283_290]
p337
sa(dp338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01294
p340
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01294_290
p341
sg16
VBismuth Subsalicylate [drugbank:DB01294]
p342
sg18
Vdrug-target interaction Bismuth Subsalicylate and Prostaglandin G/H synthase 2 [drugbank_resource:DB01294_290]
p343
sa(dp344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01399
p346
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01399_290
p347
sg16
VSalsalate [drugbank:DB01399]
p348
sg18
Vdrug-target interaction Salsalate and Prostaglandin G/H synthase 2 [drugbank_resource:DB01399_290]
p349
sa(dp350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01401
p352
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01401_290
p353
sg16
VTrisalicylate-choline [drugbank:DB01401]
p354
sg18
Vdrug-target interaction Trisalicylate-choline and Prostaglandin G/H synthase 2 [drugbank_resource:DB01401_290]
p355
sa(dp356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01435
p358
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01435_290
p359
sg16
VAntipyrine [drugbank:DB01435]
p360
sg18
Vdrug-target interaction Antipyrine and Prostaglandin G/H synthase 2 [drugbank_resource:DB01435_290]
p361
sa(dp362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01600
p364
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01600_290
p365
sg16
VTiaprofenic acid [drugbank:DB01600]
p366
sg18
Vdrug-target interaction Tiaprofenic acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB01600_290]
p367
sa(dp368
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p369
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01419
p370
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01419_290
p371
sg16
VAntrafenine [drugbank:DB01419]
p372
sg18
Vdrug-target interaction Antrafenine and Prostaglandin G/H synthase 2 [drugbank_resource:DB01419_290]
p373
sa(dp374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01628
p376
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01628_290
p377
sg16
VEtoricoxib [drugbank:DB01628]
p378
sg18
Vdrug-target interaction Etoricoxib and Prostaglandin G/H synthase 2 [drugbank_resource:DB01628_290]
p379
sa(dp380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02266
p382
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02266_290
p383
sg16
VFlufenamic Acid [drugbank:DB02266]
p384
sg18
Vdrug-target interaction Flufenamic Acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB02266_290]
p385
sa(dp386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02709
p388
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02709_290
p389
sg16
VResveratrol [drugbank:DB02709]
p390
sg18
Vdrug-target interaction Resveratrol and Prostaglandin G/H synthase 2 [drugbank_resource:DB02709_290]
p391
sa(dp392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03014
p394
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03014_290
p395
sg16
VHeme [drugbank:DB03014]
p396
sg18
Vdrug-target interaction Heme and Prostaglandin G/H synthase 2 [drugbank_resource:DB03014_290]
p397
sa(dp398
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p399
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03866
p400
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03866_290
p401
sg16
VProstaglandin G2 [drugbank:DB03866]
p402
sg18
Vdrug-target interaction Prostaglandin G2 and Prostaglandin G/H synthase 2 [drugbank_resource:DB03866_290]
p403
sa(dp404
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p405
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03477
p406
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03477_290
p407
sg16
V1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole [drugbank:DB03477]
p408
sg18
Vdrug-target interaction 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole and Prostaglandin G/H synthase 2 [drugbank_resource:DB03477_290]
p409
sa(dp410
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p411
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04743
p412
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04743_290
p413
sg16
VNimesulide [drugbank:DB04743]
p414
sg18
Vdrug-target interaction Nimesulide and Prostaglandin G/H synthase 2 [drugbank_resource:DB04743_290]
p415
sa(dp416
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p417
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06802
p418
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06802_290
p419
sg16
VNepafenac [drugbank:DB06802]
p420
sg18
Vdrug-target interaction Nepafenac and Prostaglandin G/H synthase 2 [drugbank_resource:DB06802_290]
p421
sa(dp422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04552
p424
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04552_290
p425
sg16
VNiflumic Acid [drugbank:DB04552]
p426
sg18
Vdrug-target interaction Niflumic Acid and Prostaglandin G/H synthase 2 [drugbank_resource:DB04552_290]
p427
sa(dp428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:290
p429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06725
p430
sg11
g77
sg12
g82
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06725_290
p431
sg16
VLornoxicam [drugbank:DB06725]
p432
sg18
Vdrug-target interaction Lornoxicam and Prostaglandin G/H synthase 2 [drugbank_resource:DB06725_290]
p433
sasS'PLK1'
p434
(lp435
(dp436
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p437
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06897
p438
sg11
g434
sg12
S'polo-like kinase 1'
p439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06897_6246
p440
sg16
V3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol [drugbank:DB06897]
p441
sg18
Vdrug-target interaction 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB06897_6246]
p442
sa(dp443
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p444
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06963
p445
sg11
g434
sg12
g439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06963_6246
p446
sg16
V3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide [drugbank:DB06963]
p447
sg18
Vdrug-target interaction 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB06963_6246]
p448
sa(dp449
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p450
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07186
p451
sg11
g434
sg12
g439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07186_6246
p452
sg16
V4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE [drugbank:DB07186]
p453
sg18
Vdrug-target interaction 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB07186_6246]
p454
sa(dp455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07789
p457
sg11
g434
sg12
g439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07789_6246
p458
sg16
V1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea [drugbank:DB07789]
p459
sg18
Vdrug-target interaction 1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB07789_6246]
p460
sa(dp461
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p462
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08059
p463
sg11
g434
sg12
g439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08059_6246
p464
sg16
V(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE [drugbank:DB08059]
p465
sg18
Vdrug-target interaction (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB08059_6246]
p466
sasS'GSTA5'
p467
(lp468
(dp469
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:903
p470
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p471
sg11
g467
sg12
S'glutathione S-transferase alpha 5'
p472
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_903
p473
sg16
VGlutathione [drugbank:DB00143]
p474
sg18
Vdrug-target interaction Glutathione and Glutathione S-transferase A5 [drugbank_resource:DB00143_903]
p475
sasS'HSPA8'
p476
(lp477
(dp478
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6277
p479
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p480
sg11
g476
sg12
S'heat shock 70kDa protein 8'
p481
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_6277
p482
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p483
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Heat shock cognate 71 kDa protein [drugbank_resource:DB03431_6277]
p484
sa(dp485
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6277
p486
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07045
p487
sg11
g476
sg12
g481
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07045_6277
p488
sg16
V(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol [drugbank:DB07045]
p489
sg18
Vdrug-target interaction (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol and Heat shock cognate 71 kDa protein [drugbank_resource:DB07045_6277]
p490
sasS'MDM2'
p491
(lp492
(dp493
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1485
p494
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02872
p495
sg11
g491
sg12
S'MDM2 oncogene, E3 ubiquitin protein ligase'
p496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02872_1485
p497
sg16
VCis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone [drugbank:DB02872]
p498
sg18
Vdrug-target interaction Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone and Ubiquitin-protein ligase E3 Mdm2 [drugbank_resource:DB02872_1485]
p499
sa(dp500
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1485
p501
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04144
p502
sg11
g491
sg12
g496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04144_1485
p503
sg16
VCis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone [drugbank:DB04144]
p504
sg18
Vdrug-target interaction Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone and Ubiquitin-protein ligase E3 Mdm2 [drugbank_resource:DB04144_1485]
p505
sasS'CDO1'
p506
(lp507
(dp508
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:626
p509
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00151
p510
sg11
g506
sg12
S'cysteine dioxygenase, type I'
p511
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00151_626
p512
sg16
VL-Cysteine [drugbank:DB00151]
p513
sg18
Vdrug-target interaction L-Cysteine and Cysteine dioxygenase type 1 [drugbank_resource:DB00151_626]
p514
sa(dp515
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:626
p516
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p517
sg11
g506
sg12
g511
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_626
p518
sg16
VNADH [drugbank:DB00157]
p519
sg18
Vdrug-target interaction NADH and Cysteine dioxygenase type 1 [drugbank_resource:DB00157_626]
p520
sasS'GSTA2'
p521
(lp522
(dp523
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3932
p524
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p525
sg11
g521
sg12
S'glutathione S-transferase alpha 2'
p526
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_3932
p527
sg16
VGlutathione [drugbank:DB00143]
p528
sg18
Vdrug-target interaction Glutathione and Glutathione S-transferase A2 [drugbank_resource:DB00143_3932]
p529
sa(dp530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3932
p531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p532
sg11
g521
sg12
g526
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_3932
p533
sg16
VGlutathione [drugbank:DB00143]
p534
sg18
Vdrug-enzyme interaction Glutathione and Glutathione S-transferase A2 [drugbank_resource:DB00143_3932]
p535
sa(dp536
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3932
p537
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00608
p538
sg11
g521
sg12
g526
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00608_3932
p539
sg16
VChloroquine [drugbank:DB00608]
p540
sg18
Vdrug-target interaction Chloroquine and Glutathione S-transferase A2 [drugbank_resource:DB00608_3932]
p541
sasS'GSTA3'
p542
(lp543
(dp544
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:898
p545
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p546
sg11
g542
sg12
S'glutathione S-transferase alpha 3'
p547
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_898
p548
sg16
VGlutathione [drugbank:DB00143]
p549
sg18
Vdrug-target interaction Glutathione and Glutathione S-transferase A3 [drugbank_resource:DB00143_898]
p550
sa(dp551
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:898
p552
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04521
p553
sg11
g542
sg12
g547
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04521_898
p554
sg16
VGSHNA [drugbank:DB04521]
p555
sg18
Vdrug-target interaction GSHNA and Glutathione S-transferase A3 [drugbank_resource:DB04521_898]
p556
sasS'IKBKB'
p557
(lp558
(dp559
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p560
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00244
p561
sg11
g557
sg12
S'inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta'
p562
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00244_2038
p563
sg16
VMesalazine [drugbank:DB00244]
p564
sg18
Vdrug-target interaction Mesalazine and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00244_2038]
p565
sa(dp566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00795
p568
sg11
g557
sg12
g562
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00795_2038
p569
sg16
VSulfasalazine [drugbank:DB00795]
p570
sg18
Vdrug-target interaction Sulfasalazine and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00795_2038]
p571
sa(dp572
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p573
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00995
p574
sg11
g557
sg12
g562
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00995_2038
p575
sg16
VAuranofin [drugbank:DB00995]
p576
sg18
Vdrug-target interaction Auranofin and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00995_2038]
p577
sa(dp578
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p579
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p580
sg11
g557
sg12
g562
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_2038
p581
sg16
VArsenic trioxide [drugbank:DB01169]
p582
sg18
Vdrug-target interaction Arsenic trioxide and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB01169_2038]
p583
sasS'AKT1'
p584
(lp585
(dp586
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p587
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p588
sg11
g584
sg12
S'v-akt murine thymoma viral oncogene homolog 1'
p589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_476
p590
sg16
VAdenosine triphosphate [drugbank:DB00171]
p591
sg18
Vdrug-target interaction Adenosine triphosphate and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB00171_476]
p592
sa(dp593
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p594
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p595
sg11
g584
sg12
g589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_476
p596
sg16
VArsenic trioxide [drugbank:DB01169]
p597
sg18
Vdrug-target interaction Arsenic trioxide and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB01169_476]
p598
sa(dp599
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p600
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p601
sg11
g584
sg12
g589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_476
p602
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p603
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB01863_476]
p604
sa(dp605
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p606
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07584
p607
sg11
g584
sg12
g589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07584_476
p608
sg16
VN-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [drugbank:DB07584]
p609
sg18
Vdrug-target interaction N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB07584_476]
p610
sa(dp611
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p612
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07585
p613
sg11
g584
sg12
g589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07585_476
p614
sg16
V5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine [drugbank:DB07585]
p615
sg18
Vdrug-target interaction 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB07585_476]
p616
sasS'IFNAR1'
p617
(lp618
(dp619
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p620
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00011
p621
sg11
g617
sg12
S'interferon (alpha, beta and omega) receptor 1'
p622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00011_728
p623
sg16
VInterferon alfa-n1 [drugbank:DB00011]
p624
sg18
Vdrug-target interaction Interferon alfa-n1 and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00011_728]
p625
sa(dp626
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p627
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00060
p628
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00060_728
p629
sg16
VInterferon beta-1a [drugbank:DB00060]
p630
sg18
Vdrug-target interaction Interferon beta-1a and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00060_728]
p631
sa(dp632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00008
p634
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00008_728
p635
sg16
VPeginterferon alfa-2a [drugbank:DB00008]
p636
sg18
Vdrug-target interaction Peginterferon alfa-2a and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00008_728]
p637
sa(dp638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00034
p640
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00034_728
p641
sg16
VInterferon Alfa-2a, Recombinant [drugbank:DB00034]
p642
sg18
Vdrug-target interaction Interferon Alfa-2a, Recombinant and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00034_728]
p643
sa(dp644
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p645
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00069
p646
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00069_728
p647
sg16
VInterferon alfacon-1 [drugbank:DB00069]
p648
sg18
Vdrug-target interaction Interferon alfacon-1 and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00069_728]
p649
sa(dp650
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p651
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00105
p652
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00105_728
p653
sg16
VInterferon Alfa-2b, Recombinant [drugbank:DB00105]
p654
sg18
Vdrug-target interaction Interferon Alfa-2b, Recombinant and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00105_728]
p655
sa(dp656
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p657
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00018
p658
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00018_728
p659
sg16
VInterferon alfa-n3 [drugbank:DB00018]
p660
sg18
Vdrug-target interaction Interferon alfa-n3 and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00018_728]
p661
sa(dp662
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p663
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00022
p664
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00022_728
p665
sg16
VPeginterferon alfa-2b [drugbank:DB00022]
p666
sg18
Vdrug-target interaction Peginterferon alfa-2b and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00022_728]
p667
sa(dp668
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:728
p669
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00068
p670
sg11
g617
sg12
g622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00068_728
p671
sg16
VInterferon beta-1b [drugbank:DB00068]
p672
sg18
Vdrug-target interaction Interferon beta-1b and Interferon-alpha/beta receptor alpha chain [drugbank_resource:DB00068_728]
p673
sasS'ARAF'
p674
(lp675
(dp676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:483
p677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p678
sg11
g674
sg12
S'v-raf murine sarcoma 3611 viral oncogene homolog'
p679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_483
p680
sg16
VAdenosine triphosphate [drugbank:DB00171]
p681
sg18
Vdrug-target interaction Adenosine triphosphate and A-Raf proto-oncogene serine/threonine-protein kinase [drugbank_resource:DB00171_483]
p682
sasS'RB1'
p683
(lp684
(dp685
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3846
p686
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p687
sg11
g683
sg12
S'retinoblastoma 1'
p688
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_3846
p689
sg16
VInsulin recombinant [drugbank:DB00030]
p690
sg18
Vdrug-target interaction Insulin recombinant and Retinoblastoma-associated protein [drugbank_resource:DB00030_3846]
p691
sa(dp692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3846
p693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p694
sg11
g683
sg12
g688
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_3846
p695
sg16
VInsulin, porcine [drugbank:DB00071]
p696
sg18
Vdrug-target interaction Insulin, porcine and Retinoblastoma-associated protein [drugbank_resource:DB00071_3846]
p697
sasS'EPHX2'
p698
(lp699
(dp700
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p701
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02029
p702
sg11
g698
sg12
S'epoxide hydrolase 2, cytoplasmic'
p703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02029_1274
p704
sg16
VN-Cyclohexyl-N'-(4-Iodophenyl)Urea [drugbank:DB02029]
p705
sg18
Vdrug-target interaction N-Cyclohexyl-N'-(4-Iodophenyl)Urea and Epoxide hydrolase 2 [drugbank_resource:DB02029_1274]
p706
sa(dp707
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p708
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03677
p709
sg11
g698
sg12
g703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03677_1274
p710
sg16
VN-Cyclohexyl-N'-Decylurea [drugbank:DB03677]
p711
sg18
Vdrug-target interaction N-Cyclohexyl-N'-Decylurea and Epoxide hydrolase 2 [drugbank_resource:DB03677_1274]
p712
sa(dp713
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p714
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04213
p715
sg11
g698
sg12
g703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04213_1274
p716
sg16
VN-Cyclohexyl-N'-(Propyl)Phenyl Urea [drugbank:DB04213]
p717
sg18
Vdrug-target interaction N-Cyclohexyl-N'-(Propyl)Phenyl Urea and Epoxide hydrolase 2 [drugbank_resource:DB04213_1274]
p718
sa(dp719
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p720
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08258
p721
sg11
g698
sg12
g703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08258_1274
p722
sg16
V6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID [drugbank:DB08258]
p723
sg18
Vdrug-target interaction 6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID and Epoxide hydrolase 2 [drugbank_resource:DB08258_1274]
p724
sa(dp725
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p726
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08259
p727
sg11
g698
sg12
g703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08259_1274
p728
sg16
V7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID [drugbank:DB08259]
p729
sg18
Vdrug-target interaction 7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID and Epoxide hydrolase 2 [drugbank_resource:DB08259_1274]
p730
sa(dp731
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p732
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08256
p733
sg11
g698
sg12
g703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08256_1274
p734
sg16
VN-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE [drugbank:DB08256]
p735
sg18
Vdrug-target interaction N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE and Epoxide hydrolase 2 [drugbank_resource:DB08256_1274]
p736
sa(dp737
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1274
p738
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08257
p739
sg11
g698
sg12
g703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08257_1274
p740
sg16
V4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID [drugbank:DB08257]
p741
sg18
Vdrug-target interaction 4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID and Epoxide hydrolase 2 [drugbank_resource:DB08257_1274]
p742
sasS'PAN2'
p743
(lp744
(dp745
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4074
p746
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00162
p747
sg11
S'RDH14'
p748
sg12
S'retinol dehydrogenase 14 (all-trans/9-cis/11-cis)'
p749
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00162_4074
p750
sg16
VVitamin A [drugbank:DB00162]
p751
sg18
Vdrug-target interaction Vitamin A and Retinol dehydrogenase 14 [drugbank_resource:DB00162_4074]
p752
sasS'IGKC'
p753
(lp754
(dp755
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p756
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01851
p757
sg11
g753
sg12
S'immunoglobulin kappa constant'
p758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01851_6338
p759
sg16
VTetrabutylammonium Ion [drugbank:DB01851]
p760
sg18
Vdrug-target interaction Tetrabutylammonium Ion and Ig kappa chain C region [drugbank_resource:DB01851_6338]
p761
sa(dp762
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p763
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07416
p764
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07416_6338
p765
sg16
V(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE [drugbank:DB07416]
p766
sg18
Vdrug-target interaction (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE and Ig kappa chain C region [drugbank_resource:DB07416_6338]
p767
sa(dp768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04688
p770
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04688_6338
p771
sg16
VECGONINE METHYL ESTER [drugbank:DB04688]
p772
sg18
Vdrug-target interaction ECGONINE METHYL ESTER and Ig kappa chain C region [drugbank_resource:DB04688_6338]
p773
sa(dp774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07375
p776
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07375_6338
p777
sg16
V5-BETA-ANDROSTANE-3,17-DIONE [drugbank:DB07375]
p778
sg18
Vdrug-target interaction 5-BETA-ANDROSTANE-3,17-DIONE and Ig kappa chain C region [drugbank_resource:DB07375_6338]
p779
sa(dp780
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p781
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07441
p782
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07441_6338
p783
sg16
V3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID [drugbank:DB07441]
p784
sg18
Vdrug-target interaction 3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID and Ig kappa chain C region [drugbank_resource:DB07441_6338]
p785
sa(dp786
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p787
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07784
p788
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07784_6338
p789
sg16
V[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID [drugbank:DB07784]
p790
sg18
Vdrug-target interaction [4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID and Ig kappa chain C region [drugbank_resource:DB07784_6338]
p791
sa(dp792
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p793
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07882
p794
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07882_6338
p795
sg16
V4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID [drugbank:DB07882]
p796
sg18
Vdrug-target interaction 4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID and Ig kappa chain C region [drugbank_resource:DB07882_6338]
p797
sa(dp798
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p799
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07909
p800
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07909_6338
p801
sg16
V(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL [drugbank:DB07909]
p802
sg18
Vdrug-target interaction (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL and Ig kappa chain C region [drugbank_resource:DB07909_6338]
p803
sa(dp804
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p805
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08289
p806
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08289_6338
p807
sg16
VN-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE [drugbank:DB08289]
p808
sg18
Vdrug-target interaction N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE and Ig kappa chain C region [drugbank_resource:DB08289_6338]
p809
sa(dp810
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p811
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08647
p812
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08647_6338
p813
sg16
VTRAZEOLIDE [drugbank:DB08647]
p814
sg18
Vdrug-target interaction TRAZEOLIDE and Ig kappa chain C region [drugbank_resource:DB08647_6338]
p815
sa(dp816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07716
p818
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07716_6338
p819
sg16
V(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL [drugbank:DB07716]
p820
sg18
Vdrug-target interaction (4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL and Ig kappa chain C region [drugbank_resource:DB07716_6338]
p821
sa(dp822
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p823
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07893
p824
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07893_6338
p825
sg16
VPHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE [drugbank:DB07893]
p826
sg18
Vdrug-target interaction PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE and Ig kappa chain C region [drugbank_resource:DB07893_6338]
p827
sa(dp828
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p829
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08413
p830
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08413_6338
p831
sg16
VMETHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER [drugbank:DB08413]
p832
sg18
Vdrug-target interaction METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER and Ig kappa chain C region [drugbank_resource:DB08413_6338]
p833
sa(dp834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6338
p835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08562
p836
sg11
g753
sg12
g758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08562_6338
p837
sg16
V4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID [drugbank:DB08562]
p838
sg18
Vdrug-target interaction 4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID and Ig kappa chain C region [drugbank_resource:DB08562_6338]
p839
sasS'ASS1'
p840
(lp841
(dp842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:740
p843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00128
p844
sg11
g840
sg12
S'argininosuccinate synthase 1'
p845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00128_740
p846
sg16
VL-Aspartic Acid [drugbank:DB00128]
p847
sg18
Vdrug-target interaction L-Aspartic Acid and Argininosuccinate synthase [drugbank_resource:DB00128_740]
p848
sa(dp849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:740
p850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00155
p851
sg11
g840
sg12
g845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00155_740
p852
sg16
VL-Citrulline [drugbank:DB00155]
p853
sg18
Vdrug-target interaction L-Citrulline and Argininosuccinate synthase [drugbank_resource:DB00155_740]
p854
sa(dp855
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:740
p856
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00125
p857
sg11
g840
sg12
g845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00125_740
p858
sg16
VL-Arginine [drugbank:DB00125]
p859
sg18
Vdrug-target interaction L-Arginine and Argininosuccinate synthase [drugbank_resource:DB00125_740]
p860
sa(dp861
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:740
p862
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p863
sg11
g840
sg12
g845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_740
p864
sg16
VAdenosine triphosphate [drugbank:DB00171]
p865
sg18
Vdrug-target interaction Adenosine triphosphate and Argininosuccinate synthase [drugbank_resource:DB00171_740]
p866
sa(dp867
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:865
p868
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00155
p869
sg11
g840
sg12
g845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00155_865
p870
sg16
VL-Citrulline [drugbank:DB00155]
p871
sg18
Vdrug-target interaction L-Citrulline and Argininosuccinate synthase [drugbank_resource:DB00155_865]
p872
sa(dp873
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:865
p874
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00128
p875
sg11
g840
sg12
g845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00128_865
p876
sg16
VL-Aspartic Acid [drugbank:DB00128]
p877
sg18
Vdrug-target interaction L-Aspartic Acid and Argininosuccinate synthase [drugbank_resource:DB00128_865]
p878
sasS'EGF'
p879
(lp880
(dp881
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1278
p882
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00364
p883
sg11
g879
sg12
S'epidermal growth factor'
p884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00364_1278
p885
sg16
VSucralfate [drugbank:DB00364]
p886
sg18
Vdrug-target interaction Sucralfate and Pro-epidermal growth factor [drugbank_resource:DB00364_1278]
p887
sa(dp888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1278
p889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04454
p890
sg11
g879
sg12
g884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04454_1278
p891
sg16
VAlpha-Aminobutyric Acid [drugbank:DB04454]
p892
sg18
Vdrug-target interaction Alpha-Aminobutyric Acid and Pro-epidermal growth factor [drugbank_resource:DB04454_1278]
p893
sasS'KIF2C'
p894
(lp895
(dp896
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7132
p897
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p898
sg11
g894
sg12
S'kinesin family member 2C'
p899
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7132
p900
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p901
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIF2C [drugbank_resource:DB03431_7132]
p902
sa(dp903
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7132
p904
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p905
sg11
g894
sg12
g899
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_7132
p906
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p907
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Kinesin-like protein KIF2C [drugbank_resource:DB04395_7132]
p908
sasS'GSN'
p909
(lp910
(dp911
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6666
p912
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02621
p913
sg11
g909
sg12
S'gelsolin'
p914
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02621_6666
p915
sg16
VLatrunculin A [drugbank:DB02621]
p916
sg18
Vdrug-target interaction Latrunculin A and Gelsolin [drugbank_resource:DB02621_6666]
p917
sasS'DCN'
p918
(lp919
(dp920
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7020
p921
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03754
p922
sg11
g918
sg12
S'decorin'
p923
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03754_7020
p924
sg16
VTris(Hydroxymethyl)Aminomethane [drugbank:DB03754]
p925
sg18
Vdrug-target interaction Tris(Hydroxymethyl)Aminomethane and Decorin [drugbank_resource:DB03754_7020]
p926
sasS'SCN2B'
p927
(lp928
(dp929
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6133
p930
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p931
sg11
g927
sg12
S'sodium channel, voltage-gated, type II, beta subunit'
p932
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_6133
p933
sg16
VZonisamide [drugbank:DB00909]
p934
sg18
Vdrug-target interaction Zonisamide and Sodium channel subunit beta-2 [drugbank_resource:DB00909_6133]
p935
sasS'CYP3A5'
p936
(lp937
(dp938
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4118
p939
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01267
p940
sg11
g936
sg12
S'cytochrome P450, family 3, subfamily A, polypeptide 5'
p941
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01267_4118
p942
sg16
VPaliperidone [drugbank:DB01267]
p943
sg18
Vdrug-target interaction Paliperidone and Cytochrome P450 3A5 [drugbank_resource:DB01267_4118]
p944
sasS'POLQ'
p945
(lp946
(dp947
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6372
p948
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07435
p949
sg11
S'POLK'
p950
sg12
S'polymerase (DNA directed) kappa'
p951
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07435_6372
p952
sg16
V1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE [drugbank:DB07435]
p953
sg18
Vdrug-target interaction 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE and DNA polymerase kappa [drugbank_resource:DB07435_6372]
p954
sa(dp955
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6372
p956
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08237
p957
sg11
g950
sg12
g951
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08237_6372
p958
sg16
V2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate) [drugbank:DB08237]
p959
sg18
Vdrug-target interaction 2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate) and DNA polymerase kappa [drugbank_resource:DB08237_6372]
p960
sa(dp961
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6372
p962
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07652
p963
sg11
g950
sg12
g951
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07652_6372
p964
sg16
V1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE [drugbank:DB07652]
p965
sg18
Vdrug-target interaction 1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE and DNA polymerase kappa [drugbank_resource:DB07652_6372]
p966
sasS'CALM1'
p967
(lp968
(dp969
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p970
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00622
p971
sg11
g967
sg12
S'calmodulin 1 (phosphorylase kinase, delta)'
p972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00622_465
p973
sg16
VNicardipine [drugbank:DB00622]
p974
sg18
Vdrug-target interaction Nicardipine and Calmodulin [drugbank_resource:DB00622_465]
p975
sa(dp976
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p977
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00527
p978
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00527_465
p979
sg16
VDibucaine [drugbank:DB00527]
p980
sg18
Vdrug-target interaction Dibucaine and Calmodulin [drugbank_resource:DB00527_465]
p981
sa(dp982
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p983
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00623
p984
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00623_465
p985
sg16
VFluphenazine [drugbank:DB00623]
p986
sg18
Vdrug-target interaction Fluphenazine and Calmodulin [drugbank_resource:DB00623_465]
p987
sa(dp988
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p989
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00925
p990
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00925_465
p991
sg16
VPhenoxybenzamine [drugbank:DB00925]
p992
sg18
Vdrug-target interaction Phenoxybenzamine and Calmodulin [drugbank_resource:DB00925_465]
p993
sa(dp994
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p995
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00753
p996
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00753_465
p997
sg16
VIsoflurane [drugbank:DB00753]
p998
sg18
Vdrug-target interaction Isoflurane and Calmodulin [drugbank_resource:DB00753_465]
p999
sa(dp1000
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1001
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00850
p1002
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00850_465
p1003
sg16
VPerphenazine [drugbank:DB00850]
p1004
sg18
Vdrug-target interaction Perphenazine and Calmodulin [drugbank_resource:DB00850_465]
p1005
sa(dp1006
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1007
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01023
p1008
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01023_465
p1009
sg16
VFelodipine [drugbank:DB01023]
p1010
sg18
Vdrug-target interaction Felodipine and Calmodulin [drugbank_resource:DB01023_465]
p1011
sa(dp1012
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1013
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00831
p1014
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00831_465
p1015
sg16
VTrifluoperazine [drugbank:DB00831]
p1016
sg18
Vdrug-target interaction Trifluoperazine and Calmodulin [drugbank_resource:DB00831_465]
p1017
sa(dp1018
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1019
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00836
p1020
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00836_465
p1021
sg16
VLoperamide [drugbank:DB00836]
p1022
sg18
Vdrug-target interaction Loperamide and Calmodulin [drugbank_resource:DB00836_465]
p1023
sa(dp1024
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1025
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01069
p1026
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01069_465
p1027
sg16
VPromethazine [drugbank:DB01069]
p1028
sg18
Vdrug-target interaction Promethazine and Calmodulin [drugbank_resource:DB01069_465]
p1029
sa(dp1030
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1031
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01115
p1032
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01115_465
p1033
sg16
VNifedipine [drugbank:DB01115]
p1034
sg18
Vdrug-target interaction Nifedipine and Calmodulin [drugbank_resource:DB01115_465]
p1035
sa(dp1036
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1037
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01065
p1038
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01065_465
p1039
sg16
VMelatonin [drugbank:DB01065]
p1040
sg18
Vdrug-target interaction Melatonin and Calmodulin [drugbank_resource:DB01065_465]
p1041
sa(dp1042
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1043
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01100
p1044
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01100_465
p1045
sg16
VPimozide [drugbank:DB01100]
p1046
sg18
Vdrug-target interaction Pimozide and Calmodulin [drugbank_resource:DB01100_465]
p1047
sa(dp1048
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1049
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01373
p1050
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01373_465
p1051
sg16
VCalcium [drugbank:DB01373]
p1052
sg18
Vdrug-target interaction Calcium and Calmodulin [drugbank_resource:DB01373_465]
p1053
sa(dp1054
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1055
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01429
p1056
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01429_465
p1057
sg16
VAprindine [drugbank:DB01429]
p1058
sg18
Vdrug-target interaction Aprindine and Calmodulin [drugbank_resource:DB01429_465]
p1059
sa(dp1060
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1061
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01244
p1062
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01244_465
p1063
sg16
VBepridil [drugbank:DB01244]
p1064
sg18
Vdrug-target interaction Bepridil and Calmodulin [drugbank_resource:DB01244_465]
p1065
sa(dp1066
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1067
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02868
p1068
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02868_465
p1069
sg16
V3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine [drugbank:DB02868]
p1070
sg18
Vdrug-target interaction 3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine and Calmodulin [drugbank_resource:DB02868_465]
p1071
sa(dp1072
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1073
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03977
p1074
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03977_465
p1075
sg16
VN-Trimethyllysine [drugbank:DB03977]
p1076
sg18
Vdrug-target interaction N-Trimethyllysine and Calmodulin [drugbank_resource:DB03977_465]
p1077
sa(dp1078
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1079
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03900
p1080
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03900_465
p1081
sg16
V2-Methyl-2-Propanol [drugbank:DB03900]
p1082
sg18
Vdrug-target interaction 2-Methyl-2-Propanol and Calmodulin [drugbank_resource:DB03900_465]
p1083
sa(dp1084
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1085
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04513
p1086
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04513_465
p1087
sg16
VN-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide [drugbank:DB04513]
p1088
sg18
Vdrug-target interaction N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide and Calmodulin [drugbank_resource:DB04513_465]
p1089
sa(dp1090
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1091
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04841
p1092
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04841_465
p1093
sg16
VFlunarizine [drugbank:DB04841]
p1094
sg18
Vdrug-target interaction Flunarizine and Calmodulin [drugbank_resource:DB04841_465]
p1095
sa(dp1096
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1097
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04825
p1098
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04825_465
p1099
sg16
VPrenylamine [drugbank:DB04825]
p1100
sg18
Vdrug-target interaction Prenylamine and Calmodulin [drugbank_resource:DB04825_465]
p1101
sa(dp1102
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1103
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08039
p1104
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08039_465
p1105
sg16
V(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE [drugbank:DB08039]
p1106
sg18
Vdrug-target interaction (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE and Calmodulin [drugbank_resource:DB08039_465]
p1107
sa(dp1108
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:465
p1109
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p1110
sg11
g967
sg12
g972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_465
p1111
sg16
VMYRISTIC ACID [drugbank:DB08231]
p1112
sg18
Vdrug-target interaction MYRISTIC ACID and Calmodulin [drugbank_resource:DB08231_465]
p1113
sasS'PTGER4'
p1114
(lp1115
(dp1116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6002
p1117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00929
p1118
sg11
g1114
sg12
S'prostaglandin E receptor 4 (subtype EP4)'
p1119
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00929_6002
p1120
sg16
VMisoprostol [drugbank:DB00929]
p1121
sg18
Vdrug-target interaction Misoprostol and Prostaglandin E2 receptor EP4 subtype [drugbank_resource:DB00929_6002]
p1122
sa(dp1123
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6002
p1124
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00917
p1125
sg11
g1114
sg12
g1119
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00917_6002
p1126
sg16
VDinoprostone [drugbank:DB00917]
p1127
sg18
Vdrug-target interaction Dinoprostone and Prostaglandin E2 receptor EP4 subtype [drugbank_resource:DB00917_6002]
p1128
sasS'HIF1AN'
p1129
(lp1130
(dp1131
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4290
p1132
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01694
p1133
sg11
g1129
sg12
S'hypoxia inducible factor 1, alpha subunit inhibitor'
p1134
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01694_4290
p1135
sg16
VD-tartaric acid [drugbank:DB01694]
p1136
sg18
Vdrug-target interaction D-tartaric acid and Hypoxia-inducible factor 1 alpha inhibitor [drugbank_resource:DB01694_4290]
p1137
sa(dp1138
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4290
p1139
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08263
p1140
sg11
g1129
sg12
g1134
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08263_4290
p1141
sg16
VN-(CARBOXYCARBONYL)-D-PHENYLALANINE [drugbank:DB08263]
p1142
sg18
Vdrug-target interaction N-(CARBOXYCARBONYL)-D-PHENYLALANINE and Hypoxia-inducible factor 1 alpha inhibitor [drugbank_resource:DB08263_4290]
p1143
sasS'NR0B1'
p1144
(lp1145
(dp1146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:84
p1147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00755
p1148
sg11
g1144
sg12
S'nuclear receptor subfamily 0, group B, member 1'
p1149
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00755_84
p1150
sg16
VTretinoin [drugbank:DB00755]
p1151
sg18
Vdrug-target interaction Tretinoin and Nuclear receptor 0B1 [drugbank_resource:DB00755_84]
p1152
sa(dp1153
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:84
p1154
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01234
p1155
sg11
g1144
sg12
g1149
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01234_84
p1156
sg16
VDexamethasone [drugbank:DB01234]
p1157
sg18
Vdrug-target interaction Dexamethasone and Nuclear receptor 0B1 [drugbank_resource:DB01234_84]
p1158
sasS'CACNA1C'
p1159
(lp1160
(dp1161
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1162
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00308
p1163
sg11
g1159
sg12
S'calcium channel, voltage-dependent, L type, alpha 1C subunit'
p1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00308_478
p1165
sg16
VIbutilide [drugbank:DB00308]
p1166
sg18
Vdrug-target interaction Ibutilide and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00308_478]
p1167
sa(dp1168
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1169
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00270
p1170
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00270_478
p1171
sg16
VIsradipine [drugbank:DB00270]
p1172
sg18
Vdrug-target interaction Isradipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00270_478]
p1173
sa(dp1174
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1175
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00381
p1176
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00381_478
p1177
sg16
VAmlodipine [drugbank:DB00381]
p1178
sg18
Vdrug-target interaction Amlodipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00381_478]
p1179
sa(dp1180
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1181
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00401
p1182
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00401_478
p1183
sg16
VNisoldipine [drugbank:DB00401]
p1184
sg18
Vdrug-target interaction Nisoldipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00401_478]
p1185
sa(dp1186
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1187
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00568
p1188
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00568_478
p1189
sg16
VCinnarizine [drugbank:DB00568]
p1190
sg18
Vdrug-target interaction Cinnarizine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00568_478]
p1191
sa(dp1192
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1193
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00622
p1194
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00622_478
p1195
sg16
VNicardipine [drugbank:DB00622]
p1196
sg18
Vdrug-target interaction Nicardipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00622_478]
p1197
sa(dp1198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00393
p1200
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00393_478
p1201
sg16
VNimodipine [drugbank:DB00393]
p1202
sg18
Vdrug-target interaction Nimodipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00393_478]
p1203
sa(dp1204
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1205
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00661
p1206
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00661_478
p1207
sg16
VVerapamil [drugbank:DB00661]
p1208
sg18
Vdrug-target interaction Verapamil and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00661_478]
p1209
sa(dp1210
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1211
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00653
p1212
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00653_478
p1213
sg16
VMagnesium Sulfate [drugbank:DB00653]
p1214
sg18
Vdrug-target interaction Magnesium Sulfate and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB00653_478]
p1215
sa(dp1216
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1217
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01023
p1218
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01023_478
p1219
sg16
VFelodipine [drugbank:DB01023]
p1220
sg18
Vdrug-target interaction Felodipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB01023_478]
p1221
sa(dp1222
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1223
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01115
p1224
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01115_478
p1225
sg16
VNifedipine [drugbank:DB01115]
p1226
sg18
Vdrug-target interaction Nifedipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB01115_478]
p1227
sa(dp1228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01054
p1230
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01054_478
p1231
sg16
VNitrendipine [drugbank:DB01054]
p1232
sg18
Vdrug-target interaction Nitrendipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB01054_478]
p1233
sa(dp1234
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1235
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01373
p1236
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01373_478
p1237
sg16
VCalcium [drugbank:DB01373]
p1238
sg18
Vdrug-target interaction Calcium and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB01373_478]
p1239
sa(dp1240
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1241
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01388
p1242
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01388_478
p1243
sg16
VMibefradil [drugbank:DB01388]
p1244
sg18
Vdrug-target interaction Mibefradil and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB01388_478]
p1245
sa(dp1246
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1247
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06751
p1248
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06751_478
p1249
sg16
VDrotaverine [drugbank:DB06751]
p1250
sg18
Vdrug-target interaction Drotaverine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB06751_478]
p1251
sa(dp1252
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:478
p1253
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06712
p1254
sg11
g1159
sg12
g1164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06712_478
p1255
sg16
VNilvadipine [drugbank:DB06712]
p1256
sg18
Vdrug-target interaction Nilvadipine and Voltage-dependent L-type calcium channel subunit alpha-1C [drugbank_resource:DB06712_478]
p1257
sasS'THRB'
p1258
(lp1259
(dp1260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00279
p1262
sg11
g1258
sg12
S'thyroid hormone receptor, beta'
p1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00279_346
p1264
sg16
VLiothyronine [drugbank:DB00279]
p1265
sg18
Vdrug-target interaction Liothyronine and Thyroid hormone receptor beta-1 [drugbank_resource:DB00279_346]
p1266
sa(dp1267
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1268
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00451
p1269
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00451_346
p1270
sg16
VLevothyroxine [drugbank:DB00451]
p1271
sg18
Vdrug-target interaction Levothyroxine and Thyroid hormone receptor beta-1 [drugbank_resource:DB00451_346]
p1272
sa(dp1273
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1274
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00509
p1275
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00509_346
p1276
sg16
VDextrothyroxine [drugbank:DB00509]
p1277
sg18
Vdrug-target interaction Dextrothyroxine and Thyroid hormone receptor beta-1 [drugbank_resource:DB00509_346]
p1278
sa(dp1279
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1280
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01583
p1281
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01583_346
p1282
sg16
VLiotrix [drugbank:DB01583]
p1283
sg18
Vdrug-target interaction Liotrix and Thyroid hormone receptor beta-1 [drugbank_resource:DB01583_346]
p1284
sa(dp1285
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1286
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02106
p1287
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02106_346
p1288
sg16
V[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid [drugbank:DB02106]
p1289
sg18
Vdrug-target interaction [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid and Thyroid hormone receptor beta-1 [drugbank_resource:DB02106_346]
p1290
sa(dp1291
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1292
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03176
p1293
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03176_346
p1294
sg16
V3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid [drugbank:DB03176]
p1295
sg18
Vdrug-target interaction 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid and Thyroid hormone receptor beta-1 [drugbank_resource:DB03176_346]
p1296
sa(dp1297
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1298
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03181
p1299
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03181_346
p1300
sg16
V2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione [drugbank:DB03181]
p1301
sg18
Vdrug-target interaction 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione and Thyroid hormone receptor beta-1 [drugbank_resource:DB03181_346]
p1302
sa(dp1303
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1304
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03604
p1305
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03604_346
p1306
sg16
V[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid [drugbank:DB03604]
p1307
sg18
Vdrug-target interaction [4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid and Thyroid hormone receptor beta-1 [drugbank_resource:DB03604_346]
p1308
sa(dp1309
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1310
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03788
p1311
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03788_346
p1312
sg16
VGC-24 [drugbank:DB03788]
p1313
sg18
Vdrug-target interaction GC-24 and Thyroid hormone receptor beta-1 [drugbank_resource:DB03788_346]
p1314
sa(dp1315
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1316
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07425
p1317
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07425_346
p1318
sg16
V{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid [drugbank:DB07425]
p1319
sg18
Vdrug-target interaction {4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid and Thyroid hormone receptor beta-1 [drugbank_resource:DB07425_346]
p1320
sa(dp1321
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:346
p1322
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08085
p1323
sg11
g1258
sg12
g1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08085_346
p1324
sg16
V1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE [drugbank:DB08085]
p1325
sg18
Vdrug-target interaction 1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE and Thyroid hormone receptor beta-1 [drugbank_resource:DB08085_346]
p1326
sasS'NTRK1'
p1327
(lp1328
(dp1329
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1618
p1330
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p1331
sg11
g1327
sg12
S'neurotrophic tyrosine kinase, receptor, type 1'
p1332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_1618
p1333
sg16
VAmitriptyline [drugbank:DB00321]
p1334
sg18
Vdrug-target interaction Amitriptyline and High affinity nerve growth factor receptor [drugbank_resource:DB00321_1618]
p1335
sa(dp1336
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1618
p1337
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p1338
sg11
g1327
sg12
g1332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_1618
p1339
sg16
VImatinib [drugbank:DB00619]
p1340
sg18
Vdrug-target interaction Imatinib and High affinity nerve growth factor receptor [drugbank_resource:DB00619_1618]
p1341
sasS'NTRK2'
p1342
(lp1343
(dp1344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6100
p1345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p1346
sg11
g1342
sg12
S'neurotrophic tyrosine kinase, receptor, type 2'
p1347
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_6100
p1348
sg16
VAmitriptyline [drugbank:DB00321]
p1349
sg18
Vdrug-target interaction Amitriptyline and BDNF/NT-3 growth factors receptor [drugbank_resource:DB00321_6100]
p1350
sasS'PTGER3'
p1351
(lp1352
(dp1353
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4131
p1354
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00929
p1355
sg11
g1351
sg12
S'prostaglandin E receptor 3 (subtype EP3)'
p1356
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00929_4131
p1357
sg16
VMisoprostol [drugbank:DB00929]
p1358
sg18
Vdrug-target interaction Misoprostol and Prostaglandin E2 receptor, EP3 subtype [drugbank_resource:DB00929_4131]
p1359
sa(dp1360
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4131
p1361
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00905
p1362
sg11
g1351
sg12
g1356
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00905_4131
p1363
sg16
VBimatoprost [drugbank:DB00905]
p1364
sg18
Vdrug-target interaction Bimatoprost and Prostaglandin E2 receptor, EP3 subtype [drugbank_resource:DB00905_4131]
p1365
sa(dp1366
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4131
p1367
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00917
p1368
sg11
g1351
sg12
g1356
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00917_4131
p1369
sg16
VDinoprostone [drugbank:DB00917]
p1370
sg18
Vdrug-target interaction Dinoprostone and Prostaglandin E2 receptor, EP3 subtype [drugbank_resource:DB00917_4131]
p1371
sasS'OAS1'
p1372
(lp1373
(dp1374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7095
p1375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02987
p1376
sg11
g1372
sg12
S"2'-5'-oligoadenylate synthetase 1, 40/46kDa"
p1377
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02987_7095
p1378
sg16
VCysteine-S-Acetamide [drugbank:DB02987]
p1379
sg18
Vdrug-target interaction Cysteine-S-Acetamide and 2'-5'-oligoadenylate synthase 1 [drugbank_resource:DB02987_7095]
p1380
sasS'ACAN'
p1381
(lp1382
(dp1383
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6607
p1384
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02255
p1385
sg11
g1381
sg12
S'aggrecan'
p1386
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02255_6607
p1387
sg16
VGM6001 [drugbank:DB02255]
p1388
sg18
Vdrug-target interaction GM6001 and Aggrecan core protein [drugbank_resource:DB02255_6607]
p1389
sasS'HDAC2'
p1390
(lp1391
(dp1392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4122
p1393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00227
p1394
sg11
g1390
sg12
S'histone deacetylase 2'
p1395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00227_4122
p1396
sg16
VLovastatin [drugbank:DB00227]
p1397
sg18
Vdrug-target interaction Lovastatin and Histone deacetylase 2 [drugbank_resource:DB00227_4122]
p1398
sa(dp1399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4122
p1400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p1401
sg11
g1390
sg12
g1395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4122
p1402
sg16
VVorinostat [drugbank:DB02546]
p1403
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 2 [drugbank_resource:DB02546_4122]
p1404
sasS'HTR2A'
p1405
(lp1406
(dp1407
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1408
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00248
p1409
sg11
g1405
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00248_502
p1411
sg16
VCabergoline [drugbank:DB00248]
p1412
sg18
Vdrug-target interaction Cabergoline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00248_502]
p1413
sa(dp1414
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1415
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p1416
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_502
p1417
sg16
VZiprasidone [drugbank:DB00246]
p1418
sg18
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00246_502]
p1419
sa(dp1420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00247
p1422
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00247_502
p1423
sg16
VMethysergide [drugbank:DB00247]
p1424
sg18
Vdrug-target interaction Methysergide and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00247_502]
p1425
sa(dp1426
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1427
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00268
p1428
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00268_502
p1429
sg16
VRopinirole [drugbank:DB00268]
p1430
sg18
Vdrug-target interaction Ropinirole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00268_502]
p1431
sa(dp1432
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1433
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00363
p1434
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00363_502
p1435
sg16
VClozapine [drugbank:DB00363]
p1436
sg18
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00363_502]
p1437
sa(dp1438
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1439
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00413
p1440
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00413_502
p1441
sg16
VPramipexole [drugbank:DB00413]
p1442
sg18
Vdrug-target interaction Pramipexole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00413_502]
p1443
sa(dp1444
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1445
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00420
p1446
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00420_502
p1447
sg16
VPromazine [drugbank:DB00420]
p1448
sg18
Vdrug-target interaction Promazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00420_502]
p1449
sa(dp1450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00477
p1452
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00477_502
p1453
sg16
VChlorpromazine [drugbank:DB00477]
p1454
sg18
Vdrug-target interaction Chlorpromazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00477_502]
p1455
sa(dp1456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p1458
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_502
p1459
sg16
VAmitriptyline [drugbank:DB00321]
p1460
sg18
Vdrug-target interaction Amitriptyline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00321_502]
p1461
sa(dp1462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p1464
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_502
p1465
sg16
VOlanzapine [drugbank:DB00334]
p1466
sg18
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00334_502]
p1467
sa(dp1468
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1469
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00370
p1470
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00370_502
p1471
sg16
VMirtazapine [drugbank:DB00370]
p1472
sg18
Vdrug-target interaction Mirtazapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00370_502]
p1473
sa(dp1474
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1475
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00408
p1476
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00408_502
p1477
sg16
VLoxapine [drugbank:DB00408]
p1478
sg18
Vdrug-target interaction Loxapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00408_502]
p1479
sa(dp1480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00409
p1482
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00409_502
p1483
sg16
VRemoxipride [drugbank:DB00409]
p1484
sg18
Vdrug-target interaction Remoxipride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00409_502]
p1485
sa(dp1486
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1487
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00458
p1488
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00458_502
p1489
sg16
VImipramine [drugbank:DB00458]
p1490
sg18
Vdrug-target interaction Imipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00458_502]
p1491
sa(dp1492
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1493
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00472
p1494
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00472_502
p1495
sg16
VFluoxetine [drugbank:DB00472]
p1496
sg18
Vdrug-target interaction Fluoxetine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00472_502]
p1497
sa(dp1498
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1499
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00540
p1500
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00540_502
p1501
sg16
VNortriptyline [drugbank:DB00540]
p1502
sg18
Vdrug-target interaction Nortriptyline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00540_502]
p1503
sa(dp1504
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1505
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00589
p1506
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00589_502
p1507
sg16
VLisuride [drugbank:DB00589]
p1508
sg18
Vdrug-target interaction Lisuride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00589_502]
p1509
sa(dp1510
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1511
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00604
p1512
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00604_502
p1513
sg16
VCisapride [drugbank:DB00604]
p1514
sg18
Vdrug-target interaction Cisapride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00604_502]
p1515
sa(dp1516
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1517
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00656
p1518
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00656_502
p1519
sg16
VTrazodone [drugbank:DB00656]
p1520
sg18
Vdrug-target interaction Trazodone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00656_502]
p1521
sa(dp1522
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1523
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00434
p1524
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00434_502
p1525
sg16
VCyproheptadine [drugbank:DB00434]
p1526
sg18
Vdrug-target interaction Cyproheptadine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00434_502]
p1527
sa(dp1528
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1529
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00502
p1530
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00502_502
p1531
sg16
VHaloperidol [drugbank:DB00502]
p1532
sg18
Vdrug-target interaction Haloperidol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00502_502]
p1533
sa(dp1534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00679
p1536
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00679_502
p1537
sg16
VThioridazine [drugbank:DB00679]
p1538
sg18
Vdrug-target interaction Thioridazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00679_502]
p1539
sa(dp1540
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1541
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00696
p1542
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00696_502
p1543
sg16
VErgotamine [drugbank:DB00696]
p1544
sg18
Vdrug-target interaction Ergotamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00696_502]
p1545
sa(dp1546
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1547
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00714
p1548
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00714_502
p1549
sg16
VApomorphine [drugbank:DB00714]
p1550
sg18
Vdrug-target interaction Apomorphine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00714_502]
p1551
sa(dp1552
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1553
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00715
p1554
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00715_502
p1555
sg16
VParoxetine [drugbank:DB00715]
p1556
sg18
Vdrug-target interaction Paroxetine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00715_502]
p1557
sa(dp1558
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1559
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00726
p1560
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00726_502
p1561
sg16
VTrimipramine [drugbank:DB00726]
p1562
sg18
Vdrug-target interaction Trimipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00726_502]
p1563
sa(dp1564
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1565
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00751
p1566
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00751_502
p1567
sg16
VEpinastine [drugbank:DB00751]
p1568
sg18
Vdrug-target interaction Epinastine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00751_502]
p1569
sa(dp1570
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1571
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00805
p1572
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00805_502
p1573
sg16
VMinaprine [drugbank:DB00805]
p1574
sg18
Vdrug-target interaction Minaprine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00805_502]
p1575
sa(dp1576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00875
p1578
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00875_502
p1579
sg16
VFlupenthixol [drugbank:DB00875]
p1580
sg18
Vdrug-target interaction Flupenthixol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00875_502]
p1581
sa(dp1582
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1583
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00924
p1584
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00924_502
p1585
sg16
VCyclobenzaprine [drugbank:DB00924]
p1586
sg18
Vdrug-target interaction Cyclobenzaprine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00924_502]
p1587
sa(dp1588
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1589
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00933
p1590
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00933_502
p1591
sg16
VMesoridazine [drugbank:DB00933]
p1592
sg18
Vdrug-target interaction Mesoridazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00933_502]
p1593
sa(dp1594
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1595
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00734
p1596
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00734_502
p1597
sg16
VRisperidone [drugbank:DB00734]
p1598
sg18
Vdrug-target interaction Risperidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00734_502]
p1599
sa(dp1600
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1601
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00843
p1602
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00843_502
p1603
sg16
VDonepezil [drugbank:DB00843]
p1604
sg18
Vdrug-target interaction Donepezil and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00843_502]
p1605
sa(dp1606
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1607
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01069
p1608
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01069_502
p1609
sg16
VPromethazine [drugbank:DB01069]
p1610
sg18
Vdrug-target interaction Promethazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01069_502]
p1611
sa(dp1612
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1613
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01079
p1614
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01079_502
p1615
sg16
VTegaserod [drugbank:DB01079]
p1616
sg18
Vdrug-target interaction Tegaserod and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01079_502]
p1617
sa(dp1618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00777
p1620
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00777_502
p1621
sg16
VPropiomazine [drugbank:DB00777]
p1622
sg18
Vdrug-target interaction Propiomazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00777_502]
p1623
sa(dp1624
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1625
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01149
p1626
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01149_502
p1627
sg16
VNefazodone [drugbank:DB01149]
p1628
sg18
Vdrug-target interaction Nefazodone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01149_502]
p1629
sa(dp1630
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1631
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01151
p1632
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01151_502
p1633
sg16
VDesipramine [drugbank:DB01151]
p1634
sg18
Vdrug-target interaction Desipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01151_502]
p1635
sa(dp1636
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1637
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01142
p1638
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01142_502
p1639
sg16
VDoxepin [drugbank:DB01142]
p1640
sg18
Vdrug-target interaction Doxepin and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01142_502]
p1641
sa(dp1642
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1643
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01614
p1644
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01614_502
p1645
sg16
VAcepromazine [drugbank:DB01614]
p1646
sg18
Vdrug-target interaction Acepromazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01614_502]
p1647
sa(dp1648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01618
p1650
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01618_502
p1651
sg16
VMolindone [drugbank:DB01618]
p1652
sg18
Vdrug-target interaction Molindone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01618_502]
p1653
sa(dp1654
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1655
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01287
p1656
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01287_502
p1657
sg16
VDihydroergotoxine [drugbank:DB01287]
p1658
sg18
Vdrug-target interaction Dihydroergotoxine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01287_502]
p1659
sa(dp1660
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1661
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01403
p1662
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01403_502
p1663
sg16
VMethotrimeprazine [drugbank:DB01403]
p1664
sg18
Vdrug-target interaction Methotrimeprazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01403_502]
p1665
sa(dp1666
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1667
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01454
p1668
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01454_502
p1669
sg16
V3,4-Methylenedioxymethamphetamine [drugbank:DB01454]
p1670
sg18
Vdrug-target interaction 3,4-Methylenedioxymethamphetamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01454_502]
p1671
sa(dp1672
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1673
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01621
p1674
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01621_502
p1675
sg16
VPipotiazine [drugbank:DB01621]
p1676
sg18
Vdrug-target interaction Pipotiazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01621_502]
p1677
sa(dp1678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01623
p1680
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01623_502
p1681
sg16
VThiothixene [drugbank:DB01623]
p1682
sg18
Vdrug-target interaction Thiothixene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01623_502]
p1683
sa(dp1684
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1685
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01186
p1686
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01186_502
p1687
sg16
VPergolide [drugbank:DB01186]
p1688
sg18
Vdrug-target interaction Pergolide and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01186_502]
p1689
sa(dp1690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01200
p1692
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01200_502
p1693
sg16
VBromocriptine [drugbank:DB01200]
p1694
sg18
Vdrug-target interaction Bromocriptine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01200_502]
p1695
sa(dp1696
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1697
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p1698
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_502
p1699
sg16
VQuetiapine [drugbank:DB01224]
p1700
sg18
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01224_502]
p1701
sa(dp1702
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1703
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p1704
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_502
p1705
sg16
VAripiprazole [drugbank:DB01238]
p1706
sg18
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01238_502]
p1707
sa(dp1708
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1709
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01239
p1710
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01239_502
p1711
sg16
VChlorprothixene [drugbank:DB01239]
p1712
sg18
Vdrug-target interaction Chlorprothixene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01239_502]
p1713
sa(dp1714
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1715
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01242
p1716
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01242_502
p1717
sg16
VClomipramine [drugbank:DB01242]
p1718
sg18
Vdrug-target interaction Clomipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01242_502]
p1719
sa(dp1720
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1721
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01267
p1722
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01267_502
p1723
sg16
VPaliperidone [drugbank:DB01267]
p1724
sg18
Vdrug-target interaction Paliperidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01267_502]
p1725
sa(dp1726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01392
p1728
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01392_502
p1729
sg16
VYohimbine [drugbank:DB01392]
p1730
sg18
Vdrug-target interaction Yohimbine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01392_502]
p1731
sa(dp1732
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1733
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01442
p1734
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01442_502
p1735
sg16
VMMDA [drugbank:DB01442]
p1736
sg18
Vdrug-target interaction MMDA and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01442_502]
p1737
sa(dp1738
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1739
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01488
p1740
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01488_502
p1741
sg16
VDimethyltryptamine [drugbank:DB01488]
p1742
sg18
Vdrug-target interaction Dimethyltryptamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01488_502]
p1743
sa(dp1744
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1745
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01622
p1746
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01622_502
p1747
sg16
VThioproperazine [drugbank:DB01622]
p1748
sg18
Vdrug-target interaction Thioproperazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01622_502]
p1749
sa(dp1750
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1751
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01624
p1752
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01624_502
p1753
sg16
VZuclopenthixol [drugbank:DB01624]
p1754
sg18
Vdrug-target interaction Zuclopenthixol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01624_502]
p1755
sa(dp1756
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1757
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04842
p1758
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04842_502
p1759
sg16
VFluspirilene [drugbank:DB04842]
p1760
sg18
Vdrug-target interaction Fluspirilene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB04842_502]
p1761
sa(dp1762
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1763
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06288
p1764
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06288_502
p1765
sg16
VAmisulpride [drugbank:DB06288]
p1766
sg18
Vdrug-target interaction Amisulpride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06288_502]
p1767
sa(dp1768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06144
p1770
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06144_502
p1771
sg16
VSertindole [drugbank:DB06144]
p1772
sg18
Vdrug-target interaction Sertindole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06144_502]
p1773
sa(dp1774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04599
p1776
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04599_502
p1777
sg16
VAniracetam [drugbank:DB04599]
p1778
sg18
Vdrug-target interaction Aniracetam and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB04599_502]
p1779
sa(dp1780
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1781
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06148
p1782
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06148_502
p1783
sg16
VMianserin [drugbank:DB06148]
p1784
sg18
Vdrug-target interaction Mianserin and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06148_502]
p1785
sa(dp1786
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p1787
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08810
p1788
sg11
g1405
sg12
g1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08810_502
p1789
sg16
VCinitapride [drugbank:DB08810]
p1790
sg18
Vdrug-target interaction Cinitapride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB08810_502]
p1791
sasS'LYN'
p1792
(lp1793
(dp1794
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6824
p1795
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03023
p1796
sg11
g1792
sg12
S'v-yes-1 Yamaguchi sarcoma viral related oncogene homolog'
p1797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03023_6824
p1798
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p1799
sg18
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Tyrosine-protein kinase Lyn [drugbank_resource:DB03023_6824]
p1800
sasS'SCN4B'
p1801
(lp1802
(dp1803
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6135
p1804
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p1805
sg11
g1801
sg12
S'sodium channel, voltage-gated, type IV, beta subunit'
p1806
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_6135
p1807
sg16
VZonisamide [drugbank:DB00909]
p1808
sg18
Vdrug-target interaction Zonisamide and Sodium channel subunit beta-4 [drugbank_resource:DB00909_6135]
p1809
sasS'ERBB2'
p1810
(lp1811
(dp1812
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:567
p1813
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p1814
sg11
g1810
sg12
S'v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)'
p1815
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_567
p1816
sg16
VTrastuzumab [drugbank:DB00072]
p1817
sg18
Vdrug-target interaction Trastuzumab and Receptor tyrosine-protein kinase erbB-2 [drugbank_resource:DB00072_567]
p1818
sa(dp1819
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:567
p1820
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01259
p1821
sg11
g1810
sg12
g1815
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01259_567
p1822
sg16
VLapatinib [drugbank:DB01259]
p1823
sg18
Vdrug-target interaction Lapatinib and Receptor tyrosine-protein kinase erbB-2 [drugbank_resource:DB01259_567]
p1824
sasS'NPR1'
p1825
(lp1826
(dp1827
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:613
p1828
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00325
p1829
sg11
g1825
sg12
S'natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A)'
p1830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00325_613
p1831
sg16
VNitroprusside [drugbank:DB00325]
p1832
sg18
Vdrug-target interaction Nitroprusside and Atrial natriuretic peptide receptor A [drugbank_resource:DB00325_613]
p1833
sa(dp1834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:613
p1835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00727
p1836
sg11
g1825
sg12
g1830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00727_613
p1837
sg16
VNitroglycerin [drugbank:DB00727]
p1838
sg18
Vdrug-target interaction Nitroglycerin and Atrial natriuretic peptide receptor A [drugbank_resource:DB00727_613]
p1839
sa(dp1840
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:613
p1841
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00883
p1842
sg11
g1825
sg12
g1830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00883_613
p1843
sg16
VIsosorbide Dinitrate [drugbank:DB00883]
p1844
sg18
Vdrug-target interaction Isosorbide Dinitrate and Atrial natriuretic peptide receptor A [drugbank_resource:DB00883_613]
p1845
sa(dp1846
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:613
p1847
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01613
p1848
sg11
g1825
sg12
g1830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01613_613
p1849
sg16
VErythrityl Tetranitrate [drugbank:DB01613]
p1850
sg18
Vdrug-target interaction Erythrityl Tetranitrate and Atrial natriuretic peptide receptor A [drugbank_resource:DB01613_613]
p1851
sa(dp1852
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:613
p1853
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01612
p1854
sg11
g1825
sg12
g1830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01612_613
p1855
sg16
VAmyl Nitrite [drugbank:DB01612]
p1856
sg18
Vdrug-target interaction Amyl Nitrite and Atrial natriuretic peptide receptor A [drugbank_resource:DB01612_613]
p1857
sa(dp1858
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:613
p1859
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04899
p1860
sg11
g1825
sg12
g1830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04899_613
p1861
sg16
VNesiritide [drugbank:DB04899]
p1862
sg18
Vdrug-target interaction Nesiritide and Atrial natriuretic peptide receptor A [drugbank_resource:DB04899_613]
p1863
sasS'NPR2'
p1864
(lp1865
(dp1866
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1465
p1867
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01613
p1868
sg11
g1864
sg12
S'natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B)'
p1869
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01613_1465
p1870
sg16
VErythrityl Tetranitrate [drugbank:DB01613]
p1871
sg18
Vdrug-target interaction Erythrityl Tetranitrate and Atrial natriuretic peptide receptor B [drugbank_resource:DB01613_1465]
p1872
sa(dp1873
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1465
p1874
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04899
p1875
sg11
g1864
sg12
g1869
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04899_1465
p1876
sg16
VNesiritide [drugbank:DB04899]
p1877
sg18
Vdrug-target interaction Nesiritide and Atrial natriuretic peptide receptor B [drugbank_resource:DB04899_1465]
p1878
sasS'NPR3'
p1879
(lp1880
(dp1881
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4193
p1882
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p1883
sg11
g1879
sg12
S'natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)'
p1884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_4193
p1885
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p1886
sg18
Vdrug-target interaction Alpha-D-Mannose and Atrial natriuretic peptide clearance receptor [drugbank_resource:DB02944_4193]
p1887
sa(dp1888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4193
p1889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04899
p1890
sg11
g1879
sg12
g1884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04899_4193
p1891
sg16
VNesiritide [drugbank:DB04899]
p1892
sg18
Vdrug-target interaction Nesiritide and Atrial natriuretic peptide clearance receptor [drugbank_resource:DB04899_4193]
p1893
sasS'SOD1'
p1894
(lp1895
(dp1896
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4152
p1897
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03382
p1898
sg11
g1894
sg12
S'superoxide dismutase 1, soluble'
p1899
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03382_4152
p1900
sg16
VS-Oxy Cysteine [drugbank:DB03382]
p1901
sg18
Vdrug-target interaction S-Oxy Cysteine and Superoxide dismutase [Cu-Zn] [drugbank_resource:DB03382_4152]
p1902
sasS'IFNG'
p1903
(lp1904
(dp1905
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1253
p1906
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01250
p1907
sg11
g1903
sg12
S'interferon, gamma'
p1908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01250_1253
p1909
sg16
VOlsalazine [drugbank:DB01250]
p1910
sg18
Vdrug-target interaction Olsalazine and Interferon gamma [drugbank_resource:DB01250_1253]
p1911
sa(dp1912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1253
p1913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01296
p1914
sg11
g1903
sg12
g1908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01296_1253
p1915
sg16
VGlucosamine [drugbank:DB01296]
p1916
sg18
Vdrug-target interaction Glucosamine and Interferon gamma [drugbank_resource:DB01296_1253]
p1917
sasS'PRMT1'
p1918
(lp1919
(dp1920
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7107
p1921
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01752
p1922
sg11
g1918
sg12
S'protein arginine methyltransferase 1'
p1923
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01752_7107
p1924
sg16
VS-Adenosyl-L-Homocysteine [drugbank:DB01752]
p1925
sg18
Vdrug-target interaction S-Adenosyl-L-Homocysteine and Protein arginine N-methyltransferase 1 [drugbank_resource:DB01752_7107]
p1926
sasS'CPE'
p1927
(lp1928
(dp1929
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1949
p1930
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p1931
sg11
g1927
sg12
S'carboxypeptidase E'
p1932
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_1949
p1933
sg16
VInsulin recombinant [drugbank:DB00030]
p1934
sg18
Vdrug-target interaction Insulin recombinant and Carboxypeptidase E [drugbank_resource:DB00030_1949]
p1935
sa(dp1936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1949
p1937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p1938
sg11
g1927
sg12
g1932
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_1949
p1939
sg16
VInsulin, porcine [drugbank:DB00071]
p1940
sg18
Vdrug-target interaction Insulin, porcine and Carboxypeptidase E [drugbank_resource:DB00071_1949]
p1941
sasS'CREB1'
p1942
(lp1943
(dp1944
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1291
p1945
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00131
p1946
sg11
g1942
sg12
S'cAMP responsive element binding protein 1'
p1947
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00131_1291
p1948
sg16
VAdenosine monophosphate [drugbank:DB00131]
p1949
sg18
Vdrug-target interaction Adenosine monophosphate and cAMP response element-binding protein [drugbank_resource:DB00131_1291]
p1950
sa(dp1951
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1291
p1952
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01183
p1953
sg11
g1942
sg12
g1947
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01183_1291
p1954
sg16
VNaloxone [drugbank:DB01183]
p1955
sg18
Vdrug-target interaction Naloxone and cAMP response element-binding protein [drugbank_resource:DB01183_1291]
p1956
sasS'CRB2'
p1957
(lp1958
(dp1959
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6516
p1960
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07608
p1961
sg11
g1957
sg12
S'crumbs homolog 2 (Drosophila)'
p1962
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07608_6516
p1963
sg16
VN-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide [drugbank:DB07608]
p1964
sg18
Vdrug-target interaction N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide and Crumbs-like protein 2 [drugbank_resource:DB07608_6516]
p1965
sasS'IMPA1'
p1966
(lp1967
(dp1968
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2026
p1969
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01356
p1970
sg11
g1966
sg12
S'inositol(myo)-1(or 4)-monophosphatase 1'
p1971
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01356_2026
p1972
sg16
VLithium [drugbank:DB01356]
p1973
sg18
Vdrug-target interaction Lithium and Inositol monophosphatase [drugbank_resource:DB01356_2026]
p1974
sa(dp1975
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2026
p1976
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03542
p1977
sg11
g1966
sg12
g1971
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03542_2026
p1978
sg16
VL-Myo-Inositol-1-Phosphate [drugbank:DB03542]
p1979
sg18
Vdrug-target interaction L-Myo-Inositol-1-Phosphate and Inositol monophosphatase [drugbank_resource:DB03542_2026]
p1980
sasS'LPL'
p1981
(lp1982
(dp1983
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:266
p1984
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06439
p1985
sg11
g1981
sg12
S'lipoprotein lipase'
p1986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06439_266
p1987
sg16
VTyloxapol [drugbank:DB06439]
p1988
sg18
Vdrug-target interaction Tyloxapol and Lipoprotein lipase [drugbank_resource:DB06439_266]
p1989
sasS'ITGB1'
p1990
(lp1991
(dp1992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6065
p1993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p1994
sg11
g1990
sg12
S'integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)'
p1995
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_6065
p1996
sg16
VAntithymocyte globulin [drugbank:DB00098]
p1997
sg18
Vdrug-target interaction Antithymocyte globulin and Integrin beta-1 [drugbank_resource:DB00098_6065]
p1998
sasS'RET'
p1999
(lp2000
(dp2001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1864
p2002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p2003
sg11
g1999
sg12
S'ret proto-oncogene'
p2004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_1864
p2005
sg16
VImatinib [drugbank:DB00619]
p2006
sg18
Vdrug-target interaction Imatinib and RET proto-oncogene [drugbank_resource:DB00619_1864]
p2007
sa(dp2008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4177
p2009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01809
p2010
sg11
g1999
sg12
g2004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01809_4177
p2011
sg16
V1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB01809]
p2012
sg18
Vdrug-target interaction 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase receptor ret [drugbank_resource:DB01809_4177]
p2013
sa(dp2014
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4177
p2015
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08764
p2016
sg11
g1999
sg12
g2004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08764_4177
p2017
sg16
V4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE [drugbank:DB08764]
p2018
sg18
Vdrug-target interaction 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE and Proto-oncogene tyrosine-protein kinase receptor ret [drugbank_resource:DB08764_4177]
p2019
sasS'KLK6'
p2020
(lp2021
(dp2022
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2889
p2023
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p2024
sg11
g2020
sg12
S'kallikrein-related peptidase 6'
p2025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2889
p2026
sg16
VBenzamidine [drugbank:DB03127]
p2027
sg18
Vdrug-target interaction Benzamidine and Kallikrein-6 [drugbank_resource:DB03127_2889]
p2028
sasS'KLK7'
p2029
(lp2030
(dp2031
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6655
p2032
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08038
p2033
sg11
g2029
sg12
S'kallikrein-related peptidase 7'
p2034
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08038_6655
p2035
sg16
VL-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide [drugbank:DB08038]
p2036
sg18
Vdrug-target interaction L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide and Kallikrein-7 [drugbank_resource:DB08038_6655]
p2037
sasS'KIT'
p2038
(lp2039
(dp2040
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2041
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00398
p2042
sg11
g2038
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00398_504
p2044
sg16
VSorafenib [drugbank:DB00398]
p2045
sg18
Vdrug-target interaction Sorafenib and Mast/stem cell growth factor receptor [drugbank_resource:DB00398_504]
p2046
sa(dp2047
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2048
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p2049
sg11
g2038
sg12
g2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_504
p2050
sg16
VImatinib [drugbank:DB00619]
p2051
sg18
Vdrug-target interaction Imatinib and Mast/stem cell growth factor receptor [drugbank_resource:DB00619_504]
p2052
sa(dp2053
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2054
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p2055
sg11
g2038
sg12
g2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_504
p2056
sg16
VDasatinib [drugbank:DB01254]
p2057
sg18
Vdrug-target interaction Dasatinib and Mast/stem cell growth factor receptor [drugbank_resource:DB01254_504]
p2058
sa(dp2059
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2060
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01268
p2061
sg11
g2038
sg12
g2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01268_504
p2062
sg16
VSunitinib [drugbank:DB01268]
p2063
sg18
Vdrug-target interaction Sunitinib and Mast/stem cell growth factor receptor [drugbank_resource:DB01268_504]
p2064
sa(dp2065
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2066
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01962
p2067
sg11
g2038
sg12
g2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01962_504
p2068
sg16
VPhosphonotyrosine [drugbank:DB01962]
p2069
sg18
Vdrug-target interaction Phosphonotyrosine and Mast/stem cell growth factor receptor [drugbank_resource:DB01962_504]
p2070
sa(dp2071
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2072
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2073
sg11
g2038
sg12
g2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_504
p2074
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2075
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Mast/stem cell growth factor receptor [drugbank_resource:DB03431_504]
p2076
sa(dp2077
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p2078
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04868
p2079
sg11
g2038
sg12
g2043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04868_504
p2080
sg16
VNilotinib [drugbank:DB04868]
p2081
sg18
Vdrug-target interaction Nilotinib and Mast/stem cell growth factor receptor [drugbank_resource:DB04868_504]
p2082
sasS'CXCL10'
p2083
(lp2084
(dp2085
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1209
p2086
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04487
p2087
sg11
g2083
sg12
S'chemokine (C-X-C motif) ligand 10'
p2088
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04487_1209
p2089
sg16
VN-Methylleucine [drugbank:DB04487]
p2090
sg18
Vdrug-target interaction N-Methylleucine and Small inducible cytokine B10 [drugbank_resource:DB04487_1209]
p2091
sasS'PMS2'
p2092
(lp2093
(dp2094
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4838
p2095
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02930
p2096
sg11
g2092
sg12
S'PMS2 postmeiotic segregation increased 2 (S. cerevisiae)'
p2097
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02930_4838
p2098
sg16
VPhosphothiophosphoric Acid-Adenylate Ester [drugbank:DB02930]
p2099
sg18
Vdrug-target interaction Phosphothiophosphoric Acid-Adenylate Ester and PMS1 protein homolog 2 [drugbank_resource:DB02930_4838]
p2100
sa(dp2101
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4838
p2102
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2103
sg11
g2092
sg12
g2097
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_4838
p2104
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2105
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and PMS1 protein homolog 2 [drugbank_resource:DB03431_4838]
p2106
sasS'CXCL12'
p2107
(lp2108
(dp2109
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2020
p2110
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06822
p2111
sg11
g2107
sg12
S'chemokine (C-X-C motif) ligand 12'
p2112
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06822_2020
p2113
sg16
VTinzaparin [drugbank:DB06822]
p2114
sg18
Vdrug-target interaction Tinzaparin and Stromal cell-derived factor 1 [drugbank_resource:DB06822_2020]
p2115
sasS'SERPINB5'
p2116
(lp2117
(dp2118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3361
p2119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04530
p2120
sg11
g2116
sg12
S'serpin peptidase inhibitor, clade B (ovalbumin), member 5'
p2121
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04530_3361
p2122
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p2123
sg18
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and Serpin B5 [drugbank_resource:DB04530_3361]
p2124
sasS'FGFR3'
p2125
(lp2126
(dp2127
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3856
p2128
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00039
p2129
sg11
g2125
sg12
S'fibroblast growth factor receptor 3'
p2130
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00039_3856
p2131
sg16
VPalifermin [drugbank:DB00039]
p2132
sg18
Vdrug-target interaction Palifermin and Fibroblast growth factor receptor 3 [drugbank_resource:DB00039_3856]
p2133
sasS'CSNK2A1'
p2134
(lp2135
(dp2136
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2137
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01765
p2138
sg11
g2134
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01765_2236
p2140
sg16
V(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid [drugbank:DB01765]
p2141
sg18
Vdrug-target interaction (5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid and Casein kinase II subunit alpha [drugbank_resource:DB01765_2236]
p2142
sa(dp2143
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2144
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02709
p2145
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02709_2236
p2146
sg16
VResveratrol [drugbank:DB02709]
p2147
sg18
Vdrug-target interaction Resveratrol and Casein kinase II subunit alpha [drugbank_resource:DB02709_2236]
p2148
sa(dp2149
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2150
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02170
p2151
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02170_2236
p2152
sg16
V1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One [drugbank:DB02170]
p2153
sg18
Vdrug-target interaction 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One and Casein kinase II subunit alpha [drugbank_resource:DB02170_2236]
p2154
sa(dp2155
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2156
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03035
p2157
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03035_2236
p2158
sg16
V1,8-Di-Hydroxy-4-Nitro-Anthraquinone [drugbank:DB03035]
p2159
sg18
Vdrug-target interaction 1,8-Di-Hydroxy-4-Nitro-Anthraquinone and Casein kinase II subunit alpha [drugbank_resource:DB03035_2236]
p2160
sa(dp2161
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2162
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p2163
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2236
p2164
sg16
VBenzamidine [drugbank:DB03127]
p2165
sg18
Vdrug-target interaction Benzamidine and Casein kinase II subunit alpha [drugbank_resource:DB03127_2236]
p2166
sa(dp2167
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2168
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03924
p2169
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03924_2236
p2170
sg16
V5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone [drugbank:DB03924]
p2171
sg18
Vdrug-target interaction 5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone and Casein kinase II subunit alpha [drugbank_resource:DB03924_2236]
p2172
sa(dp2173
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2174
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p2175
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2236
p2176
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2177
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Casein kinase II subunit alpha [drugbank_resource:DB04395_2236]
p2178
sa(dp2179
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2180
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04462
p2181
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04462_2236
p2182
sg16
VTetrabromo-2-Benzotriazole [drugbank:DB04462]
p2183
sg18
Vdrug-target interaction Tetrabromo-2-Benzotriazole and Casein kinase II subunit alpha [drugbank_resource:DB04462_2236]
p2184
sa(dp2185
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2186
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04719
p2187
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04719_2236
p2188
sg16
VDIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE [drugbank:DB04719]
p2189
sg18
Vdrug-target interaction DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE and Casein kinase II subunit alpha [drugbank_resource:DB04719_2236]
p2190
sa(dp2191
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2192
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04721
p2193
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04721_2236
p2194
sg16
VN1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE [drugbank:DB04721]
p2195
sg18
Vdrug-target interaction N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE and Casein kinase II subunit alpha [drugbank_resource:DB04721_2236]
p2196
sa(dp2197
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2198
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04720
p2199
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04720_2236
p2200
sg16
VS-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE [drugbank:DB04720]
p2201
sg18
Vdrug-target interaction S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE and Casein kinase II subunit alpha [drugbank_resource:DB04720_2236]
p2202
sa(dp2203
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2204
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07802
p2205
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07802_2236
p2206
sg16
V3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE [drugbank:DB07802]
p2207
sg18
Vdrug-target interaction 3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE and Casein kinase II subunit alpha [drugbank_resource:DB07802_2236]
p2208
sa(dp2209
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2210
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08354
p2211
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08354_2236
p2212
sg16
V2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08354]
p2213
sg18
Vdrug-target interaction 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08354_2236]
p2214
sa(dp2215
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2216
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08360
p2217
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08360_2236
p2218
sg16
V2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08360]
p2219
sg18
Vdrug-target interaction 2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08360_2236]
p2220
sa(dp2221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08362
p2223
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08362_2236
p2224
sg16
VN-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE [drugbank:DB08362]
p2225
sg18
Vdrug-target interaction N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE and Casein kinase II subunit alpha [drugbank_resource:DB08362_2236]
p2226
sa(dp2227
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2228
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07715
p2229
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07715_2236
p2230
sg16
V3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE [drugbank:DB07715]
p2231
sg18
Vdrug-target interaction 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE and Casein kinase II subunit alpha [drugbank_resource:DB07715_2236]
p2232
sa(dp2233
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2234
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08340
p2235
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08340_2236
p2236
sg16
VN,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE [drugbank:DB08340]
p2237
sg18
Vdrug-target interaction N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE and Casein kinase II subunit alpha [drugbank_resource:DB08340_2236]
p2238
sa(dp2239
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2240
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08345
p2241
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08345_2236
p2242
sg16
V4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08345]
p2243
sg18
Vdrug-target interaction 4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08345_2236]
p2244
sa(dp2245
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2246
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08468
p2247
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08468_2236
p2248
sg16
V2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione [drugbank:DB08468]
p2249
sg18
Vdrug-target interaction 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione and Casein kinase II subunit alpha [drugbank_resource:DB08468_2236]
p2250
sa(dp2251
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2252
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08473
p2253
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08473_2236
p2254
sg16
V5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole [drugbank:DB08473]
p2255
sg18
Vdrug-target interaction 5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole and Casein kinase II subunit alpha [drugbank_resource:DB08473_2236]
p2256
sa(dp2257
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2258
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08660
p2259
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08660_2236
p2260
sg16
V1,2,5,8-tetrahydroxyanthracene-9,10-dione [drugbank:DB08660]
p2261
sg18
Vdrug-target interaction 1,2,5,8-tetrahydroxyanthracene-9,10-dione and Casein kinase II subunit alpha [drugbank_resource:DB08660_2236]
p2262
sa(dp2263
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2264
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08338
p2265
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08338_2236
p2266
sg16
V19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one [drugbank:DB08338]
p2267
sg18
Vdrug-target interaction 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one and Casein kinase II subunit alpha [drugbank_resource:DB08338_2236]
p2268
sa(dp2269
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2270
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08353
p2271
sg11
g2134
sg12
g2139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08353_2236
p2272
sg16
V2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08353]
p2273
sg18
Vdrug-target interaction 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08353_2236]
p2274
sasS'FGFR1'
p2275
(lp2276
(dp2277
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3854
p2278
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00039
p2279
sg11
g2275
sg12
S'fibroblast growth factor receptor 1'
p2280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00039_3854
p2281
sg16
VPalifermin [drugbank:DB00039]
p2282
sg18
Vdrug-target interaction Palifermin and Basic fibroblast growth factor receptor 1 [drugbank_resource:DB00039_3854]
p2283
sa(dp2284
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3854
p2285
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02058
p2286
sg11
g2275
sg12
g2280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02058_3854
p2287
sg16
VSU4984 [drugbank:DB02058]
p2288
sg18
Vdrug-target interaction SU4984 and Basic fibroblast growth factor receptor 1 [drugbank_resource:DB02058_3854]
p2289
sa(dp2290
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3854
p2291
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07525
p2292
sg11
g2275
sg12
g2280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07525_3854
p2293
sg16
V3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine [drugbank:DB07525]
p2294
sg18
Vdrug-target interaction 3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine and Basic fibroblast growth factor receptor 1 [drugbank_resource:DB07525_3854]
p2295
sa(dp2296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3854
p2297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07840
p2298
sg11
g2275
sg12
g2280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07840_3854
p2299
sg16
V(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol [drugbank:DB07840]
p2300
sg18
Vdrug-target interaction (E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol and Basic fibroblast growth factor receptor 1 [drugbank_resource:DB07840_3854]
p2301
sa(dp2302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3854
p2303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08577
p2304
sg11
g2275
sg12
g2280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08577_3854
p2305
sg16
V3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE [drugbank:DB08577]
p2306
sg18
Vdrug-target interaction 3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE and Basic fibroblast growth factor receptor 1 [drugbank_resource:DB08577_3854]
p2307
sasS'ADCY5'
p2308
(lp2309
(dp2310
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6234
p2311
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02587
p2312
sg11
g2308
sg12
S'adenylate cyclase 5'
p2313
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02587_6234
p2314
sg16
VForskolin [drugbank:DB02587]
p2315
sg18
Vdrug-target interaction Forskolin and Adenylate cyclase type 5 [drugbank_resource:DB02587_6234]
p2316
sa(dp2317
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6234
p2318
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06843
p2319
sg11
g2308
sg12
g2313
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06843_6234
p2320
sg16
V2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE [drugbank:DB06843]
p2321
sg18
Vdrug-target interaction 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE and Adenylate cyclase type 5 [drugbank_resource:DB06843_6234]
p2322
sasS'CCR5'
p2323
(lp2324
(dp2325
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1129
p2326
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04835
p2327
sg11
g2323
sg12
S'chemokine (C-C motif) receptor 5 (gene/pseudogene)'
p2328
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04835_1129
p2329
sg16
VMaraviroc [drugbank:DB04835]
p2330
sg18
Vdrug-target interaction Maraviroc and C-C chemokine receptor type 5 [drugbank_resource:DB04835_1129]
p2331
sasS'NME1'
p2332
(lp2333
(dp2334
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2335
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02181
p2336
sg11
g2332
sg12
S'NME/NM23 nucleoside diphosphate kinase 1'
p2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02181_5294
p2338
sg16
V2'-Deoxyguanosine-5'-Triphosphate [drugbank:DB02181]
p2339
sg18
Vdrug-target interaction 2'-Deoxyguanosine-5'-Triphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB02181_5294]
p2340
sa(dp2341
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2342
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02212
p2343
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02212_5294
p2344
sg16
VPyrophosphate 2- [drugbank:DB02212]
p2345
sg18
Vdrug-target interaction Pyrophosphate 2- and Nucleoside diphosphate kinase A [drugbank_resource:DB02212_5294]
p2346
sa(dp2347
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2348
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02607
p2349
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02607_5294
p2350
sg16
VAdenosine Phosphonoacetic Acid [drugbank:DB02607]
p2351
sg18
Vdrug-target interaction Adenosine Phosphonoacetic Acid and Nucleoside diphosphate kinase A [drugbank_resource:DB02607_5294]
p2352
sa(dp2353
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2354
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02345
p2355
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02345_5294
p2356
sg16
VSelenocysteine [drugbank:DB02345]
p2357
sg18
Vdrug-target interaction Selenocysteine and Nucleoside diphosphate kinase A [drugbank_resource:DB02345_5294]
p2358
sa(dp2359
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2360
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02569
p2361
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02569_5294
p2362
sg16
V2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate [drugbank:DB02569]
p2363
sg18
Vdrug-target interaction 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB02569_5294]
p2364
sa(dp2365
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2366
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02887
p2367
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02887_5294
p2368
sg16
V2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate [drugbank:DB02887]
p2369
sg18
Vdrug-target interaction 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB02887_5294]
p2370
sa(dp2371
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2372
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03103
p2373
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03103_5294
p2374
sg16
VThymidine-5'- Diphosphate [drugbank:DB03103]
p2375
sg18
Vdrug-target interaction Thymidine-5'- Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB03103_5294]
p2376
sa(dp2377
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2378
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2379
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_5294
p2380
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2381
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB03431_5294]
p2382
sa(dp2383
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2384
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2385
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_5294
p2386
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2387
sg18
Vdrug-enzyme interaction Adenosine-5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB03431_5294]
p2388
sa(dp2389
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2390
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03491
p2391
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03491_5294
p2392
sg16
V2'-Deoxyguanosine-5'-Diphosphate [drugbank:DB03491]
p2393
sg18
Vdrug-target interaction 2'-Deoxyguanosine-5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB03491_5294]
p2394
sa(dp2395
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2396
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04366
p2397
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04366_5294
p2398
sg16
V3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate [drugbank:DB04366]
p2399
sg18
Vdrug-target interaction 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB04366_5294]
p2400
sa(dp2401
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2402
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04068
p2403
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04068_5294
p2404
sg16
VFudp [drugbank:DB04068]
p2405
sg18
Vdrug-target interaction Fudp and Nucleoside diphosphate kinase A [drugbank_resource:DB04068_5294]
p2406
sa(dp2407
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2408
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p2409
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_5294
p2410
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p2411
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB04315_5294]
p2412
sa(dp2413
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5294
p2414
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04542
p2415
sg11
g2332
sg12
g2337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04542_5294
p2416
sg16
V3'-Azido-3'-Deoxythymidine-5'-Diphosphate [drugbank:DB04542]
p2417
sg18
Vdrug-target interaction 3'-Azido-3'-Deoxythymidine-5'-Diphosphate and Nucleoside diphosphate kinase A [drugbank_resource:DB04542_5294]
p2418
sasS'PPP2CA'
p2419
(lp2420
(dp2421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4078
p2422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00163
p2423
sg11
g2419
sg12
S'protein phosphatase 2, catalytic subunit, alpha isozyme'
p2424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00163_4078
p2425
sg16
VVitamin E [drugbank:DB00163]
p2426
sg18
Vdrug-target interaction Vitamin E and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB00163_4078]
p2427
sa(dp2428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4078
p2429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02506
p2430
sg11
g2419
sg12
g2424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02506_4078
p2431
sg16
V2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid [drugbank:DB02506]
p2432
sg18
Vdrug-target interaction 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB02506_4078]
p2433
sa(dp2434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4078
p2435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06905
p2436
sg11
g2419
sg12
g2424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06905_4078
p2437
sg16
V(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid [drugbank:DB06905]
p2438
sg18
Vdrug-target interaction (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB06905_4078]
p2439
sasS'KIF5B'
p2440
(lp2441
(dp2442
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5285
p2443
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2444
sg11
g2440
sg12
S'kinesin family member 5B'
p2445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_5285
p2446
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2447
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin heavy chain [drugbank_resource:DB03431_5285]
p2448
sasS'ACSL1'
p2449
(lp2450
(dp2451
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:704
p2452
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00131
p2453
sg11
g2449
sg12
S'acyl-CoA synthetase long-chain family member 1'
p2454
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00131_704
p2455
sg16
VAdenosine monophosphate [drugbank:DB00131]
p2456
sg18
Vdrug-target interaction Adenosine monophosphate and Long-chain-fatty-acid--CoA ligase 1 [drugbank_resource:DB00131_704]
p2457
sa(dp2458
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:704
p2459
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p2460
sg11
g2449
sg12
g2454
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_704
p2461
sg16
VAdenosine triphosphate [drugbank:DB00171]
p2462
sg18
Vdrug-target interaction Adenosine triphosphate and Long-chain-fatty-acid--CoA ligase 1 [drugbank_resource:DB00171_704]
p2463
sasS'KAT5'
p2464
(lp2465
(dp2466
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7088
p2467
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02039
p2468
sg11
g2464
sg12
S'K(lysine) acetyltransferase 5'
p2469
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02039_7088
p2470
sg16
VS-Acetyl-Cysteine [drugbank:DB02039]
p2471
sg18
Vdrug-target interaction S-Acetyl-Cysteine and Histone acetyltransferase KAT5 [drugbank_resource:DB02039_7088]
p2472
sa(dp2473
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7088
p2474
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01992
p2475
sg11
g2464
sg12
g2469
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01992_7088
p2476
sg16
VCoenzyme A [drugbank:DB01992]
p2477
sg18
Vdrug-target interaction Coenzyme A and Histone acetyltransferase KAT5 [drugbank_resource:DB01992_7088]
p2478
sasS'GSK3B'
p2479
(lp2480
(dp2481
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2482
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01356
p2483
sg11
g2479
sg12
S'glycogen synthase kinase 3 beta'
p2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01356_1721
p2485
sg16
VLithium [drugbank:DB01356]
p2486
sg18
Vdrug-target interaction Lithium and Glycogen synthase kinase-3 beta [drugbank_resource:DB01356_1721]
p2487
sa(dp2488
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2489
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01950
p2490
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01950_1721
p2491
sg16
VN-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea [drugbank:DB01950]
p2492
sg18
Vdrug-target interaction N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea and Glycogen synthase kinase-3 beta [drugbank_resource:DB01950_1721]
p2493
sa(dp2494
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2495
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01793
p2496
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01793_1721
p2497
sg16
VI-5 [drugbank:DB01793]
p2498
sg18
Vdrug-target interaction I-5 and Glycogen synthase kinase-3 beta [drugbank_resource:DB01793_1721]
p2499
sa(dp2500
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2501
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p2502
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_1721
p2503
sg16
VStaurosporine [drugbank:DB02010]
p2504
sg18
Vdrug-target interaction Staurosporine and Glycogen synthase kinase-3 beta [drugbank_resource:DB02010_1721]
p2505
sa(dp2506
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2507
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01772
p2508
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01772_1721
p2509
sg16
V3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione [drugbank:DB01772]
p2510
sg18
Vdrug-target interaction 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione and Glycogen synthase kinase-3 beta [drugbank_resource:DB01772_1721]
p2511
sa(dp2512
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2513
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p2514
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_1721
p2515
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p2516
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Glycogen synthase kinase-3 beta [drugbank_resource:DB02052_1721]
p2517
sa(dp2518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03444
p2520
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03444_1721
p2521
sg16
V(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime [drugbank:DB03444]
p2522
sg18
Vdrug-target interaction (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime and Glycogen synthase kinase-3 beta [drugbank_resource:DB03444_1721]
p2523
sa(dp2524
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2525
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2526
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1721
p2527
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2528
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Glycogen synthase kinase-3 beta [drugbank_resource:DB03431_1721]
p2529
sa(dp2530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04014
p2532
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04014_1721
p2533
sg16
VAlsterpaullone [drugbank:DB04014]
p2534
sg18
Vdrug-target interaction Alsterpaullone and Glycogen synthase kinase-3 beta [drugbank_resource:DB04014_1721]
p2535
sa(dp2536
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2537
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p2538
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_1721
p2539
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2540
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Glycogen synthase kinase-3 beta [drugbank_resource:DB04395_1721]
p2541
sa(dp2542
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2543
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07149
p2544
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07149_1721
p2545
sg16
V(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one [drugbank:DB07149]
p2546
sg18
Vdrug-target interaction (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one and Glycogen synthase kinase-3 beta [drugbank_resource:DB07149_1721]
p2547
sa(dp2548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07058
p2550
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07058_1721
p2551
sg16
V5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione [drugbank:DB07058]
p2552
sg18
Vdrug-target interaction 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione and Glycogen synthase kinase-3 beta [drugbank_resource:DB07058_1721]
p2553
sa(dp2554
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2555
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07014
p2556
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07014_1721
p2557
sg16
V2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole [drugbank:DB07014]
p2558
sg18
Vdrug-target interaction 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole and Glycogen synthase kinase-3 beta [drugbank_resource:DB07014_1721]
p2559
sa(dp2560
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2561
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07584
p2562
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07584_1721
p2563
sg16
VN-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [drugbank:DB07584]
p2564
sg18
Vdrug-target interaction N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine and Glycogen synthase kinase-3 beta [drugbank_resource:DB07584_1721]
p2565
sa(dp2566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07585
p2568
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07585_1721
p2569
sg16
V5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine [drugbank:DB07585]
p2570
sg18
Vdrug-target interaction 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and Glycogen synthase kinase-3 beta [drugbank_resource:DB07585_1721]
p2571
sa(dp2572
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2573
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08073
p2574
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08073_1721
p2575
sg16
V(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB08073]
p2576
sg18
Vdrug-target interaction (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and Glycogen synthase kinase-3 beta [drugbank_resource:DB08073_1721]
p2577
sa(dp2578
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2579
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07859
p2580
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07859_1721
p2581
sg16
V4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE [drugbank:DB07859]
p2582
sg18
Vdrug-target interaction 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE and Glycogen synthase kinase-3 beta [drugbank_resource:DB07859_1721]
p2583
sa(dp2584
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2585
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07676
p2586
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07676_1721
p2587
sg16
V3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one [drugbank:DB07676]
p2588
sg18
Vdrug-target interaction 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one and Glycogen synthase kinase-3 beta [drugbank_resource:DB07676_1721]
p2589
sa(dp2590
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2591
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07812
p2592
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07812_1721
p2593
sg16
VN-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide [drugbank:DB07812]
p2594
sg18
Vdrug-target interaction N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide and Glycogen synthase kinase-3 beta [drugbank_resource:DB07812_1721]
p2595
sa(dp2596
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2597
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07947
p2598
sg11
g2479
sg12
g2484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07947_1721
p2599
sg16
VISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE [drugbank:DB07947]
p2600
sg18
Vdrug-target interaction ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE and Glycogen synthase kinase-3 beta [drugbank_resource:DB07947_1721]
p2601
sasS'AHR'
p2602
(lp2603
(dp2604
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p2605
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00393
p2606
sg11
g2602
sg12
S'aryl hydrocarbon receptor'
p2607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00393_6220
p2608
sg16
VNimodipine [drugbank:DB00393]
p2609
sg18
Vdrug-target interaction Nimodipine and Aryl hydrocarbon receptor [drugbank_resource:DB00393_6220]
p2610
sa(dp2611
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p2612
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00379
p2613
sg11
g2602
sg12
g2607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00379_6220
p2614
sg16
VMexiletine [drugbank:DB00379]
p2615
sg18
Vdrug-target interaction Mexiletine and Aryl hydrocarbon receptor [drugbank_resource:DB00379_6220]
p2616
sa(dp2617
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p2618
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00499
p2619
sg11
g2602
sg12
g2607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00499_6220
p2620
sg16
VFlutamide [drugbank:DB00499]
p2621
sg18
Vdrug-target interaction Flutamide and Aryl hydrocarbon receptor [drugbank_resource:DB00499_6220]
p2622
sa(dp2623
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p2624
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01076
p2625
sg11
g2602
sg12
g2607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01076_6220
p2626
sg16
VAtorvastatin [drugbank:DB01076]
p2627
sg18
Vdrug-target interaction Atorvastatin and Aryl hydrocarbon receptor [drugbank_resource:DB01076_6220]
p2628
sa(dp2629
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p2630
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01097
p2631
sg11
g2602
sg12
g2607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01097_6220
p2632
sg16
VLeflunomide [drugbank:DB01097]
p2633
sg18
Vdrug-target interaction Leflunomide and Aryl hydrocarbon receptor [drugbank_resource:DB01097_6220]
p2634
sa(dp2635
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p2636
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01404
p2637
sg11
g2602
sg12
g2607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01404_6220
p2638
sg16
VGinseng [drugbank:DB01404]
p2639
sg18
Vdrug-target interaction Ginseng and Aryl hydrocarbon receptor [drugbank_resource:DB01404_6220]
p2640
sasS'CCND1'
p2641
(lp2642
(dp2643
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1569
p2644
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p2645
sg11
g2641
sg12
S'cyclin D1'
p2646
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1569
p2647
sg16
VArsenic trioxide [drugbank:DB01169]
p2648
sg18
Vdrug-target interaction Arsenic trioxide and G1/S-specific cyclin-D1 [drugbank_resource:DB01169_1569]
p2649
sasS'GRB2'
p2650
(lp2651
(dp2652
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1157
p2653
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00061
p2654
sg11
g2650
sg12
S'growth factor receptor-bound protein 2'
p2655
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00061_1157
p2656
sg16
VPegademase bovine [drugbank:DB00061]
p2657
sg18
Vdrug-target interaction Pegademase bovine and Growth factor receptor-bound protein 2 [drugbank_resource:DB00061_1157]
p2658
sa(dp2659
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1157
p2660
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03276
p2661
sg11
g2650
sg12
g2655
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03276_1157
p2662
sg16
V4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid [drugbank:DB03276]
p2663
sg18
Vdrug-target interaction 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid and Growth factor receptor-bound protein 2 [drugbank_resource:DB03276_1157]
p2664
sasS'GNG2'
p2665
(lp2666
(dp2667
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1768
p2668
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01159
p2669
sg11
g2665
sg12
S'guanine nucleotide binding protein (G protein), gamma 2'
p2670
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01159_1768
p2671
sg16
VHalothane [drugbank:DB01159]
p2672
sg18
Vdrug-target interaction Halothane and Guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-2 subunit [drugbank_resource:DB01159_1768]
p2673
sasS'LDHB'
p2674
(lp2675
(dp2676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:77
p2677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p2678
sg11
g2674
sg12
S'lactate dehydrogenase B'
p2679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_77
p2680
sg16
VNADH [drugbank:DB00157]
p2681
sg18
Vdrug-target interaction NADH and L-lactate dehydrogenase B chain [drugbank_resource:DB00157_77]
p2682
sa(dp2683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:77
p2684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p2685
sg11
g2674
sg12
g2679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_77
p2686
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p2687
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and L-lactate dehydrogenase B chain [drugbank_resource:DB01907_77]
p2688
sa(dp2689
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:77
p2690
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02401
p2691
sg11
g2674
sg12
g2679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02401_77
p2692
sg16
V4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid [drugbank:DB02401]
p2693
sg18
Vdrug-target interaction 4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid and L-lactate dehydrogenase B chain [drugbank_resource:DB02401_77]
p2694
sa(dp2695
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:77
p2696
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03940
p2697
sg11
g2674
sg12
g2679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03940_77
p2698
sg16
VOxamic Acid [drugbank:DB03940]
p2699
sg18
Vdrug-target interaction Oxamic Acid and L-lactate dehydrogenase B chain [drugbank_resource:DB03940_77]
p2700
sasS'TLR4'
p2701
(lp2702
(dp2703
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4210
p2704
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02767
p2705
sg11
g2701
sg12
S'toll-like receptor 4'
p2706
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02767_4210
p2707
sg16
V3-Hydroxy-Myristic Acid [drugbank:DB02767]
p2708
sg18
Vdrug-target interaction 3-Hydroxy-Myristic Acid and Toll-like receptor 4 [drugbank_resource:DB02767_4210]
p2709
sa(dp2710
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4210
p2711
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p2712
sg11
g2701
sg12
g2706
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_4210
p2713
sg16
VMYRISTIC ACID [drugbank:DB08231]
p2714
sg18
Vdrug-target interaction MYRISTIC ACID and Toll-like receptor 4 [drugbank_resource:DB08231_4210]
p2715
sasS'UBC'
p2716
(lp2717
(dp2718
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6590
p2719
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04464
p2720
sg11
g2716
sg12
S'ubiquitin C'
p2721
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6590
p2722
sg16
VN-Formylmethionine [drugbank:DB04464]
p2723
sg18
Vdrug-target interaction N-Formylmethionine and Polyubiquitin-C [drugbank_resource:DB04464_6590]
p2724
sasS'GRIP1'
p2725
(lp2726
(dp2727
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2728
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p2729
sg11
S'NCOA2'
p2730
sg12
S'nuclear receptor coactivator 2'
p2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_6241
p2732
sg16
VGenistein [drugbank:DB01645]
p2733
sg18
Vdrug-target interaction Genistein and Nuclear receptor coactivator 2 [drugbank_resource:DB01645_6241]
p2734
sa(dp2735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02998
p2737
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02998_6241
p2738
sg16
VMethyltrienolone [drugbank:DB02998]
p2739
sg18
Vdrug-target interaction Methyltrienolone and Nuclear receptor coactivator 2 [drugbank_resource:DB02998_6241]
p2740
sa(dp2741
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2742
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06871
p2743
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06871_6241
p2744
sg16
V17-METHYL-17-ALPHA-DIHYDROEQUILENIN [drugbank:DB06871]
p2745
sg18
Vdrug-target interaction 17-METHYL-17-ALPHA-DIHYDROEQUILENIN and Nuclear receptor coactivator 2 [drugbank_resource:DB06871_6241]
p2746
sa(dp2747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06898
p2749
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06898_6241
p2750
sg16
V4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol [drugbank:DB06898]
p2751
sg18
Vdrug-target interaction 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol and Nuclear receptor coactivator 2 [drugbank_resource:DB06898_6241]
p2752
sa(dp2753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07086
p2755
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07086_6241
p2756
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07086]
p2757
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07086_6241]
p2758
sa(dp2759
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2760
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07080
p2761
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07080_6241
p2762
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p2763
sg18
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Nuclear receptor coactivator 2 [drugbank_resource:DB07080_6241]
p2764
sa(dp2765
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2766
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07087
p2767
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07087_6241
p2768
sg16
V4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07087]
p2769
sg18
Vdrug-target interaction 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07087_6241]
p2770
sa(dp2771
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2772
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07195
p2773
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07195_6241
p2774
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07195]
p2775
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07195_6241]
p2776
sa(dp2777
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2778
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07708
p2779
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07708_6241
p2780
sg16
V3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07708]
p2781
sg18
Vdrug-target interaction 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Nuclear receptor coactivator 2 [drugbank_resource:DB07708_6241]
p2782
sa(dp2783
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2784
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07863
p2785
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07863_6241
p2786
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p2787
sg18
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Nuclear receptor coactivator 2 [drugbank_resource:DB07863_6241]
p2788
sa(dp2789
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2790
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07932
p2791
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07932_6241
p2792
sg16
Vdimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate [drugbank:DB07932]
p2793
sg18
Vdrug-target interaction dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate and Nuclear receptor coactivator 2 [drugbank_resource:DB07932_6241]
p2794
sa(dp2795
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2796
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08175
p2797
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08175_6241
p2798
sg16
V(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID [drugbank:DB08175]
p2799
sg18
Vdrug-target interaction (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID and Nuclear receptor coactivator 2 [drugbank_resource:DB08175_6241]
p2800
sa(dp2801
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2802
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08402
p2803
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08402_6241
p2804
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p2805
sg18
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Nuclear receptor coactivator 2 [drugbank_resource:DB08402_6241]
p2806
sa(dp2807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08601
p2809
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08601_6241
p2810
sg16
Vtributylstannanyl [drugbank:DB08601]
p2811
sg18
Vdrug-target interaction tributylstannanyl and Nuclear receptor coactivator 2 [drugbank_resource:DB08601_6241]
p2812
sa(dp2813
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2814
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07678
p2815
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07678_6241
p2816
sg16
V(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL [drugbank:DB07678]
p2817
sg18
Vdrug-target interaction (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07678_6241]
p2818
sa(dp2819
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2820
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07707
p2821
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07707_6241
p2822
sg16
V(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL [drugbank:DB07707]
p2823
sg18
Vdrug-target interaction (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07707_6241]
p2824
sa(dp2825
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2826
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08047
p2827
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08047_6241
p2828
sg16
V4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol [drugbank:DB08047]
p2829
sg18
Vdrug-target interaction 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol and Nuclear receptor coactivator 2 [drugbank_resource:DB08047_6241]
p2830
sa(dp2831
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2832
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08048
p2833
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08048_6241
p2834
sg16
V4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB08048]
p2835
sg18
Vdrug-target interaction 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL and Nuclear receptor coactivator 2 [drugbank_resource:DB08048_6241]
p2836
sa(dp2837
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2838
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08320
p2839
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08320_6241
p2840
sg16
VDIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE [drugbank:DB08320]
p2841
sg18
Vdrug-target interaction DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE and Nuclear receptor coactivator 2 [drugbank_resource:DB08320_6241]
p2842
sa(dp2843
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2844
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08398
p2845
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08398_6241
p2846
sg16
V2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE [drugbank:DB08398]
p2847
sg18
Vdrug-target interaction 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE and Nuclear receptor coactivator 2 [drugbank_resource:DB08398_6241]
p2848
sa(dp2849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07712
p2851
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07712_6241
p2852
sg16
V3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07712]
p2853
sg18
Vdrug-target interaction 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Nuclear receptor coactivator 2 [drugbank_resource:DB07712_6241]
p2854
sa(dp2855
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2856
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08595
p2857
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08595_6241
p2858
sg16
V4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB08595]
p2859
sg18
Vdrug-target interaction 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB08595_6241]
p2860
sa(dp2861
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p2862
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08773
p2863
sg11
g2730
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08773_6241
p2864
sg16
VRALOXIFENE CORE [drugbank:DB08773]
p2865
sg18
Vdrug-target interaction RALOXIFENE CORE and Nuclear receptor coactivator 2 [drugbank_resource:DB08773_6241]
p2866
sasS'ACE2'
p2867
(lp2868
(dp2869
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1385
p2870
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00722
p2871
sg11
g2867
sg12
S'angiotensin I converting enzyme (peptidyl-dipeptidase A) 2'
p2872
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00722_1385
p2873
sg16
VLisinopril [drugbank:DB00722]
p2874
sg18
Vdrug-target interaction Lisinopril and Angiotensin-converting enzyme 2 [drugbank_resource:DB00722_1385]
p2875
sa(dp2876
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1385
p2877
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00691
p2878
sg11
g2867
sg12
g2872
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00691_1385
p2879
sg16
VMoexipril [drugbank:DB00691]
p2880
sg18
Vdrug-target interaction Moexipril and Angiotensin-converting enzyme 2 [drugbank_resource:DB00691_1385]
p2881
sasS'TLR8'
p2882
(lp2883
(dp2884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5998
p2885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00724
p2886
sg11
g2882
sg12
S'toll-like receptor 8'
p2887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00724_5998
p2888
sg16
VImiquimod [drugbank:DB00724]
p2889
sg18
Vdrug-target interaction Imiquimod and Toll-like receptor 8 [drugbank_resource:DB00724_5998]
p2890
sasS'TOP2A'
p2891
(lp2892
(dp2893
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2894
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00218
p2895
sg11
g2891
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00218_817
p2897
sg16
VMoxifloxacin [drugbank:DB00218]
p2898
sg18
Vdrug-target interaction Moxifloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00218_817]
p2899
sa(dp2900
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2901
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00276
p2902
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00276_817
p2903
sg16
VAmsacrine [drugbank:DB00276]
p2904
sg18
Vdrug-target interaction Amsacrine and DNA topoisomerase 2-alpha [drugbank_resource:DB00276_817]
p2905
sa(dp2906
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2907
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00467
p2908
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00467_817
p2909
sg16
VEnoxacin [drugbank:DB00467]
p2910
sg18
Vdrug-target interaction Enoxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00467_817]
p2911
sa(dp2912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00487
p2914
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00487_817
p2915
sg16
VPefloxacin [drugbank:DB00487]
p2916
sg18
Vdrug-target interaction Pefloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00487_817]
p2917
sa(dp2918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00380
p2920
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00380_817
p2921
sg16
VDexrazoxane [drugbank:DB00380]
p2922
sg18
Vdrug-target interaction Dexrazoxane and DNA topoisomerase 2-alpha [drugbank_resource:DB00380_817]
p2923
sa(dp2924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00385
p2926
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00385_817
p2927
sg16
VValrubicin [drugbank:DB00385]
p2928
sg18
Vdrug-target interaction Valrubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00385_817]
p2929
sa(dp2930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00444
p2932
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00444_817
p2933
sg16
VTeniposide [drugbank:DB00444]
p2934
sg18
Vdrug-target interaction Teniposide and DNA topoisomerase 2-alpha [drugbank_resource:DB00444_817]
p2935
sa(dp2936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00445
p2938
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00445_817
p2939
sg16
VEpirubicin [drugbank:DB00445]
p2940
sg18
Vdrug-target interaction Epirubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00445_817]
p2941
sa(dp2942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00537
p2944
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00537_817
p2945
sg16
VCiprofloxacin [drugbank:DB00537]
p2946
sg18
Vdrug-target interaction Ciprofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00537_817]
p2947
sa(dp2948
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2949
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00773
p2950
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00773_817
p2951
sg16
VEtoposide [drugbank:DB00773]
p2952
sg18
Vdrug-target interaction Etoposide and DNA topoisomerase 2-alpha [drugbank_resource:DB00773_817]
p2953
sa(dp2954
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2955
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00685
p2956
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00685_817
p2957
sg16
VTrovafloxacin [drugbank:DB00685]
p2958
sg18
Vdrug-target interaction Trovafloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00685_817]
p2959
sa(dp2960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00694
p2962
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00694_817
p2963
sg16
VDaunorubicin [drugbank:DB00694]
p2964
sg18
Vdrug-target interaction Daunorubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00694_817]
p2965
sa(dp2966
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2967
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00997
p2968
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00997_817
p2969
sg16
VDoxorubicin [drugbank:DB00997]
p2970
sg18
Vdrug-target interaction Doxorubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00997_817]
p2971
sa(dp2972
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2973
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01137
p2974
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01137_817
p2975
sg16
VLevofloxacin [drugbank:DB01137]
p2976
sg18
Vdrug-target interaction Levofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01137_817]
p2977
sa(dp2978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00978
p2980
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00978_817
p2981
sg16
VLomefloxacin [drugbank:DB00978]
p2982
sg18
Vdrug-target interaction Lomefloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00978_817]
p2983
sa(dp2984
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2985
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01059
p2986
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01059_817
p2987
sg16
VNorfloxacin [drugbank:DB01059]
p2988
sg18
Vdrug-target interaction Norfloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01059_817]
p2989
sa(dp2990
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2991
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01165
p2992
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01165_817
p2993
sg16
VOfloxacin [drugbank:DB01165]
p2994
sg18
Vdrug-target interaction Ofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01165_817]
p2995
sa(dp2996
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p2997
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p2998
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_817
p2999
sg16
VGenistein [drugbank:DB01645]
p3000
sg18
Vdrug-target interaction Genistein and DNA topoisomerase 2-alpha [drugbank_resource:DB01645_817]
p3001
sa(dp3002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p3003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01177
p3004
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01177_817
p3005
sg16
VIdarubicin [drugbank:DB01177]
p3006
sg18
Vdrug-target interaction Idarubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB01177_817]
p3007
sa(dp3008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p3009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01179
p3010
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01179_817
p3011
sg16
VPodofilox [drugbank:DB01179]
p3012
sg18
Vdrug-target interaction Podofilox and DNA topoisomerase 2-alpha [drugbank_resource:DB01179_817]
p3013
sa(dp3014
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p3015
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01208
p3016
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01208_817
p3017
sg16
VSparfloxacin [drugbank:DB01208]
p3018
sg18
Vdrug-target interaction Sparfloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01208_817]
p3019
sa(dp3020
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p3021
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01204
p3022
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01204_817
p3023
sg16
VMitoxantrone [drugbank:DB01204]
p3024
sg18
Vdrug-target interaction Mitoxantrone and DNA topoisomerase 2-alpha [drugbank_resource:DB01204_817]
p3025
sa(dp3026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p3027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04576
p3028
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04576_817
p3029
sg16
VFleroxacin [drugbank:DB04576]
p3030
sg18
Vdrug-target interaction Fleroxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB04576_817]
p3031
sa(dp3032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p3033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04967
p3034
sg11
g2891
sg12
g2896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04967_817
p3035
sg16
VLucanthone [drugbank:DB04967]
p3036
sg18
Vdrug-target interaction Lucanthone and DNA topoisomerase 2-alpha [drugbank_resource:DB04967_817]
p3037
sasS'APP'
p3038
(lp3039
(dp3040
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5800
p3041
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02235
p3042
sg11
g3038
sg12
S'amyloid beta (A4) precursor protein'
p3043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02235_5800
p3044
sg16
VMethionine Sulfoxide [drugbank:DB02235]
p3045
sg18
Vdrug-target interaction Methionine Sulfoxide and Amyloid beta A4 protein [drugbank_resource:DB02235_5800]
p3046
sasS'KIF11'
p3047
(lp3048
(dp3049
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3050
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p3051
sg11
g3047
sg12
S'kinesin family member 11'
p3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3379
p3053
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p3054
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIF11 [drugbank_resource:DB03431_3379]
p3055
sa(dp3056
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3057
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04331
p3058
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04331_3379
p3059
sg16
VMonastrol [drugbank:DB04331]
p3060
sg18
Vdrug-target interaction Monastrol and Kinesin-like protein KIF11 [drugbank_resource:DB04331_3379]
p3061
sa(dp3062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03996
p3064
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03996_3379
p3065
sg16
V3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol [drugbank:DB03996]
p3066
sg18
Vdrug-target interaction 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol and Kinesin-like protein KIF11 [drugbank_resource:DB03996_3379]
p3067
sa(dp3068
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3069
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07064
p3070
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07064_3379
p3071
sg16
V(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE [drugbank:DB07064]
p3072
sg18
Vdrug-target interaction (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB07064_3379]
p3073
sa(dp3074
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3075
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08033
p3076
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08033_3379
p3077
sg16
V(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE [drugbank:DB08033]
p3078
sg18
Vdrug-target interaction (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08033_3379]
p3079
sa(dp3080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08037
p3082
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08037_3379
p3083
sg16
V(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide [drugbank:DB08037]
p3084
sg18
Vdrug-target interaction (2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide and Kinesin-like protein KIF11 [drugbank_resource:DB08037_3379]
p3085
sa(dp3086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08246
p3088
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08246_3379
p3089
sg16
V(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE [drugbank:DB08246]
p3090
sg18
Vdrug-target interaction (2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08246_3379]
p3091
sa(dp3092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08032
p3094
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08032_3379
p3095
sg16
VN,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE [drugbank:DB08032]
p3096
sg18
Vdrug-target interaction N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08032_3379]
p3097
sa(dp3098
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3099
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08198
p3100
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08198_3379
p3101
sg16
V[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE [drugbank:DB08198]
p3102
sg18
Vdrug-target interaction [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE and Kinesin-like protein KIF11 [drugbank_resource:DB08198_3379]
p3103
sa(dp3104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08244
p3106
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08244_3379
p3107
sg16
V(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE [drugbank:DB08244]
p3108
sg18
Vdrug-target interaction (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE and Kinesin-like protein KIF11 [drugbank_resource:DB08244_3379]
p3109
sa(dp3110
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3111
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08239
p3112
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08239_3379
p3113
sg16
V(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE [drugbank:DB08239]
p3114
sg18
Vdrug-target interaction (2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08239_3379]
p3115
sa(dp3116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p3117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08250
p3118
sg11
g3047
sg12
g3052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08250_3379
p3119
sg16
V(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE [drugbank:DB08250]
p3120
sg18
Vdrug-target interaction (5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08250_3379]
p3121
sasS'CCL2'
p3122
(lp3123
(dp3124
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1649
p3125
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01055
p3126
sg11
g3122
sg12
S'chemokine (C-C motif) ligand 2'
p3127
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01055_1649
p3128
sg16
VMimosine [drugbank:DB01055]
p3129
sg18
Vdrug-target interaction Mimosine and Small inducible cytokine A2 [drugbank_resource:DB01055_1649]
p3130
sa(dp3131
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1649
p3132
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p3133
sg11
g3122
sg12
g3127
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_1649
p3134
sg16
VDanazol [drugbank:DB01406]
p3135
sg18
Vdrug-target interaction Danazol and Small inducible cytokine A2 [drugbank_resource:DB01406_1649]
p3136
sasS'ANXA1'
p3137
(lp3138
(dp3139
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:469
p3140
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00288
p3141
sg11
g3137
sg12
S'annexin A1'
p3142
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00288_469
p3143
sg16
VAmcinonide [drugbank:DB00288]
p3144
sg18
Vdrug-target interaction Amcinonide and Annexin A1 [drugbank_resource:DB00288_469]
p3145
sa(dp3146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:469
p3147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00741
p3148
sg11
g3137
sg12
g3142
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00741_469
p3149
sg16
VHydrocortisone [drugbank:DB00741]
p3150
sg18
Vdrug-target interaction Hydrocortisone and Annexin A1 [drugbank_resource:DB00741_469]
p3151
sa(dp3152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:469
p3153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01234
p3154
sg11
g3137
sg12
g3142
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01234_469
p3155
sg16
VDexamethasone [drugbank:DB01234]
p3156
sg18
Vdrug-target interaction Dexamethasone and Annexin A1 [drugbank_resource:DB01234_469]
p3157
sasS'ACTA1'
p3158
(lp3159
(dp3160
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3161
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02621
p3162
sg11
g3158
sg12
S'actin, alpha 1, skeletal muscle'
p3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02621_3822
p3164
sg16
VLatrunculin A [drugbank:DB02621]
p3165
sg18
Vdrug-target interaction Latrunculin A and Actin, alpha skeletal muscle [drugbank_resource:DB02621_3822]
p3166
sa(dp3167
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3168
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02772
p3169
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02772_3822
p3170
sg16
VSucrose [drugbank:DB02772]
p3171
sg18
Vdrug-target interaction Sucrose and Actin, alpha skeletal muscle [drugbank_resource:DB02772_3822]
p3172
sa(dp3173
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3174
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03021
p3175
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03021_3822
p3176
sg16
VUlapualide A [drugbank:DB03021]
p3177
sg18
Vdrug-target interaction Ulapualide A and Actin, alpha skeletal muscle [drugbank_resource:DB03021_3822]
p3178
sa(dp3179
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3180
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03850
p3181
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03850_3822
p3182
sg16
VJaspisamide A [drugbank:DB03850]
p3183
sg18
Vdrug-target interaction Jaspisamide A and Actin, alpha skeletal muscle [drugbank_resource:DB03850_3822]
p3184
sa(dp3185
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3186
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03616
p3187
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03616_3822
p3188
sg16
VKabiramide C [drugbank:DB03616]
p3189
sg18
Vdrug-target interaction Kabiramide C and Actin, alpha skeletal muscle [drugbank_resource:DB03616_3822]
p3190
sa(dp3191
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3192
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p3193
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3822
p3194
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p3195
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Actin, alpha skeletal muscle [drugbank_resource:DB03431_3822]
p3196
sa(dp3197
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3198
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03903
p3199
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03903_3822
p3200
sg16
VTmr [drugbank:DB03903]
p3201
sg18
Vdrug-target interaction Tmr and Actin, alpha skeletal muscle [drugbank_resource:DB03903_3822]
p3202
sa(dp3203
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3204
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04151
p3205
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04151_3822
p3206
sg16
V4-Methyl-Histidine [drugbank:DB04151]
p3207
sg18
Vdrug-target interaction 4-Methyl-Histidine and Actin, alpha skeletal muscle [drugbank_resource:DB04151_3822]
p3208
sa(dp3209
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3210
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p3211
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_3822
p3212
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p3213
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Actin, alpha skeletal muscle [drugbank_resource:DB04395_3822]
p3214
sa(dp3215
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3216
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04629
p3217
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04629_3822
p3218
sg16
VAplyronine A [drugbank:DB04629]
p3219
sg18
Vdrug-target interaction Aplyronine A and Actin, alpha skeletal muscle [drugbank_resource:DB04629_3822]
p3220
sa(dp3221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04774
p3223
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04774_3822
p3224
sg16
VReidispongiolide A [drugbank:DB04774]
p3225
sg18
Vdrug-target interaction Reidispongiolide A and Actin, alpha skeletal muscle [drugbank_resource:DB04774_3822]
p3226
sa(dp3227
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3228
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04775
p3229
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04775_3822
p3230
sg16
VReidispongiolide C [drugbank:DB04775]
p3231
sg18
Vdrug-target interaction Reidispongiolide C and Actin, alpha skeletal muscle [drugbank_resource:DB04775_3822]
p3232
sa(dp3233
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3234
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04783
p3235
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04783_3822
p3236
sg16
VSphinxolide B [drugbank:DB04783]
p3237
sg18
Vdrug-target interaction Sphinxolide B and Actin, alpha skeletal muscle [drugbank_resource:DB04783_3822]
p3238
sa(dp3239
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3240
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08080
p3241
sg11
g3158
sg12
g3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08080_3822
p3242
sg16
VLATRUNCULIN B [drugbank:DB08080]
p3243
sg18
Vdrug-target interaction LATRUNCULIN B and Actin, alpha skeletal muscle [drugbank_resource:DB08080_3822]
p3244
sasS'MMP10'
p3245
(lp3246
(dp3247
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6188
p3248
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00786
p3249
sg11
g3245
sg12
S'matrix metallopeptidase 10 (stromelysin 2)'
p3250
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00786_6188
p3251
sg16
VMarimastat [drugbank:DB00786]
p3252
sg18
Vdrug-target interaction Marimastat and Stromelysin-2 [drugbank_resource:DB00786_6188]
p3253
sa(dp3254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6188
p3255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08271
p3256
sg11
g3245
sg12
g3250
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08271_6188
p3257
sg16
VN-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID [drugbank:DB08271]
p3258
sg18
Vdrug-target interaction N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID and Stromelysin-2 [drugbank_resource:DB08271_6188]
p3259
sasS'MMP11'
p3260
(lp3261
(dp3262
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6190
p3263
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00786
p3264
sg11
g3260
sg12
S'matrix metallopeptidase 11 (stromelysin 3)'
p3265
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00786_6190
p3266
sg16
VMarimastat [drugbank:DB00786]
p3267
sg18
Vdrug-target interaction Marimastat and Stromelysin-3 [drugbank_resource:DB00786_6190]
p3268
sa(dp3269
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6190
p3270
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04318
p3271
sg11
g3260
sg12
g3265
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04318_6190
p3272
sg16
V1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid [drugbank:DB04318]
p3273
sg18
Vdrug-target interaction 1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid and Stromelysin-3 [drugbank_resource:DB04318_6190]
p3274
sasS'MMP13'
p3275
(lp3276
(dp3277
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3278
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00786
p3279
sg11
g3275
sg12
S'matrix metallopeptidase 13 (collagenase 3)'
p3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00786_1330
p3281
sg16
VMarimastat [drugbank:DB00786]
p3282
sg18
Vdrug-target interaction Marimastat and Collagenase 3 [drugbank_resource:DB00786_1330]
p3283
sa(dp3284
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3285
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01996
p3286
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01996_1330
p3287
sg16
V3-Methylpyridine [drugbank:DB01996]
p3288
sg18
Vdrug-target interaction 3-Methylpyridine and Collagenase 3 [drugbank_resource:DB01996_1330]
p3289
sa(dp3290
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3291
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02049
p3292
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02049_1330
p3293
sg16
V2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide [drugbank:DB02049]
p3294
sg18
Vdrug-target interaction 2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide and Collagenase 3 [drugbank_resource:DB02049_1330]
p3295
sa(dp3296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02071
p3298
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02071_1330
p3299
sg16
VWAY-151693 [drugbank:DB02071]
p3300
sg18
Vdrug-target interaction WAY-151693 and Collagenase 3 [drugbank_resource:DB02071_1330]
p3301
sa(dp3302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02697
p3304
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02697_1330
p3305
sg16
VHydroxyaminovaline [drugbank:DB02697]
p3306
sg18
Vdrug-target interaction Hydroxyaminovaline and Collagenase 3 [drugbank_resource:DB02697_1330]
p3307
sa(dp3308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03033
p3310
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03033_1330
p3311
sg16
V1-Methyloxy-4-Sulfone-Benzene [drugbank:DB03033]
p3312
sg18
Vdrug-target interaction 1-Methyloxy-4-Sulfone-Benzene and Collagenase 3 [drugbank_resource:DB03033_1330]
p3313
sa(dp3314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04759
p3316
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04759_1330
p3317
sg16
VPYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE) [drugbank:DB04759]
p3318
sg18
Vdrug-target interaction PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE) and Collagenase 3 [drugbank_resource:DB04759_1330]
p3319
sa(dp3320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04760
p3322
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04760_1330
p3323
sg16
VPYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE) [drugbank:DB04760]
p3324
sg18
Vdrug-target interaction PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE) and Collagenase 3 [drugbank_resource:DB04760_1330]
p3325
sa(dp3326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07013
p3328
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07013_1330
p3329
sg16
VTERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE [drugbank:DB07013]
p3330
sg18
Vdrug-target interaction TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE and Collagenase 3 [drugbank_resource:DB07013_1330]
p3331
sa(dp3332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04761
p3334
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04761_1330
p3335
sg16
VPYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE] [drugbank:DB04761]
p3336
sg18
Vdrug-target interaction PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE] and Collagenase 3 [drugbank_resource:DB04761_1330]
p3337
sa(dp3338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08388
p3340
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08388_1330
p3341
sg16
V5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE [drugbank:DB08388]
p3342
sg18
Vdrug-target interaction 5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE and Collagenase 3 [drugbank_resource:DB08388_1330]
p3343
sa(dp3344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07827
p3346
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07827_1330
p3347
sg16
V4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID [drugbank:DB07827]
p3348
sg18
Vdrug-target interaction 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID and Collagenase 3 [drugbank_resource:DB07827_1330]
p3349
sa(dp3350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08561
p3352
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08561_1330
p3353
sg16
VBENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE [drugbank:DB08561]
p3354
sg18
Vdrug-target interaction BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE and Collagenase 3 [drugbank_resource:DB08561_1330]
p3355
sa(dp3356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1330
p3357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08490
p3358
sg11
g3275
sg12
g3280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08490_1330
p3359
sg16
V4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE [drugbank:DB08490]
p3360
sg18
Vdrug-target interaction 4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE and Collagenase 3 [drugbank_resource:DB08490_1330]
p3361
sasS'PLD1'
p3362
(lp3363
(dp3364
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3924
p3365
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00122
p3366
sg11
g3362
sg12
S'phospholipase D1, phosphatidylcholine-specific'
p3367
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00122_3924
p3368
sg16
VCholine [drugbank:DB00122]
p3369
sg18
Vdrug-target interaction Choline and Phospholipase D1 [drugbank_resource:DB00122_3924]
p3370
sasS'HRAS'
p3371
(lp3372
(dp3373
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1758
p3374
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02210
p3375
sg11
g3371
sg12
S'v-Ha-ras Harvey rat sarcoma viral oncogene homolog'
p3376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02210_1758
p3377
sg16
VHexane-1,6-Diol [drugbank:DB02210]
p3378
sg18
Vdrug-target interaction Hexane-1,6-Diol and GTPase HRas [drugbank_resource:DB02210_1758]
p3379
sa(dp3380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1758
p3381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03226
p3382
sg11
g3371
sg12
g3376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03226_1758
p3383
sg16
VTrifluoroethanol [drugbank:DB03226]
p3384
sg18
Vdrug-target interaction Trifluoroethanol and GTPase HRas [drugbank_resource:DB03226_1758]
p3385
sa(dp3386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1758
p3387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04137
p3388
sg11
g3371
sg12
g3376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04137_1758
p3389
sg16
VGuanosine-5'-Triphosphate [drugbank:DB04137]
p3390
sg18
Vdrug-target interaction Guanosine-5'-Triphosphate and GTPase HRas [drugbank_resource:DB04137_1758]
p3391
sa(dp3392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1758
p3393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p3394
sg11
g3371
sg12
g3376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_1758
p3395
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p3396
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and GTPase HRas [drugbank_resource:DB04315_1758]
p3397
sa(dp3398
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1758
p3399
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08751
p3400
sg11
g3371
sg12
g3376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08751_1758
p3401
sg16
VN,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE [drugbank:DB08751]
p3402
sg18
Vdrug-target interaction N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE and GTPase HRas [drugbank_resource:DB08751_1758]
p3403
sasS'UBE2D2'
p3404
(lp3405
(dp3406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7040
p3407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02418
p3408
sg11
g3404
sg12
S'ubiquitin-conjugating enzyme E2D 2'
p3409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02418_7040
p3410
sg16
V(R,R)-2,3-Butanediol [drugbank:DB02418]
p3411
sg18
Vdrug-target interaction (R,R)-2,3-Butanediol and Ubiquitin-conjugating enzyme E2 D2 [drugbank_resource:DB02418_7040]
p3412
sasS'GAPDH'
p3413
(lp3414
(dp3415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p3417
sg11
g3413
sg12
S'glyceraldehyde-3-phosphate dehydrogenase'
p3418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_599
p3419
sg16
VNADH [drugbank:DB00157]
p3420
sg18
Vdrug-target interaction NADH and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB00157_599]
p3421
sa(dp3422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02059
p3424
sg11
g3413
sg12
g3418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02059_599
p3425
sg16
VAdenosine-5-Diphosphoribose [drugbank:DB02059]
p3426
sg18
Vdrug-target interaction Adenosine-5-Diphosphoribose and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB02059_599]
p3427
sa(dp3428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p3430
sg11
g3413
sg12
g3418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_599
p3431
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p3432
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB01907_599]
p3433
sa(dp3434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03893
p3436
sg11
g3413
sg12
g3418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03893_599
p3437
sg16
VThionicotinamide-Adenine-Dinucleotide [drugbank:DB03893]
p3438
sg18
Vdrug-target interaction Thionicotinamide-Adenine-Dinucleotide and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB03893_599]
p3439
sa(dp3440
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3441
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07347
p3442
sg11
g3413
sg12
g3418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07347_599
p3443
sg16
V4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE [drugbank:DB07347]
p3444
sg18
Vdrug-target interaction 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB07347_599]
p3445
sasS'SAA1'
p3446
(lp3447
(dp3448
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3866
p3449
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00064
p3450
sg11
g3446
sg12
S'serum amyloid A1'
p3451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00064_3866
p3452
sg16
VSerum albumin iodonated [drugbank:DB00064]
p3453
sg18
Vdrug-target interaction Serum albumin iodonated and Serum amyloid A protein [drugbank_resource:DB00064_3866]
p3454
sa(dp3455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3866
p3456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00062
p3457
sg11
g3446
sg12
g3451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00062_3866
p3458
sg16
VHuman Serum Albumin [drugbank:DB00062]
p3459
sg18
Vdrug-target interaction Human Serum Albumin and Serum amyloid A protein [drugbank_resource:DB00062_3866]
p3460
sasS'PPOX'
p3461
(lp3462
(dp3463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6949
p3464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03088
p3465
sg11
S'HCRT'
p3466
sg12
S'hypocretin (orexin) neuropeptide precursor'
p3467
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03088_6949
p3468
sg16
VPyroglutamic Acid [drugbank:DB03088]
p3469
sg18
Vdrug-target interaction Pyroglutamic Acid and Orexin [drugbank_resource:DB03088_6949]
p3470
sasS'MED1'
p3471
(lp3472
(dp3473
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6891
p3474
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08696
p3475
sg11
g3471
sg12
S'mediator complex subunit 1'
p3476
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08696_6891
p3477
sg16
V5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL [drugbank:DB08696]
p3478
sg18
Vdrug-target interaction 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL and Mediator of RNA polymerase II transcription subunit 1 [drugbank_resource:DB08696_6891]
p3479
sasS'BCHE'
p3480
(lp3481
(dp3482
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3483
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00122
p3484
sg11
g3480
sg12
S'butyrylcholinesterase'
p3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00122_3923
p3486
sg16
VCholine [drugbank:DB00122]
p3487
sg18
Vdrug-target interaction Choline and Cholinesterase [drugbank_resource:DB00122_3923]
p3488
sa(dp3489
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3490
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00382
p3491
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00382_3923
p3492
sg16
VTacrine [drugbank:DB00382]
p3493
sg18
Vdrug-target interaction Tacrine and Cholinesterase [drugbank_resource:DB00382_3923]
p3494
sa(dp3495
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3496
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00449
p3497
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00449_3923
p3498
sg16
VDipivefrin [drugbank:DB00449]
p3499
sg18
Vdrug-target interaction Dipivefrin and Cholinesterase [drugbank_resource:DB00449_3923]
p3500
sa(dp3501
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3502
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00545
p3503
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00545_3923
p3504
sg16
VPyridostigmine [drugbank:DB00545]
p3505
sg18
Vdrug-target interaction Pyridostigmine and Cholinesterase [drugbank_resource:DB00545_3923]
p3506
sa(dp3507
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3508
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00674
p3509
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00674_3923
p3510
sg16
VGalantamine [drugbank:DB00674]
p3511
sg18
Vdrug-target interaction Galantamine and Cholinesterase [drugbank_resource:DB00674_3923]
p3512
sa(dp3513
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3514
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00772
p3515
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00772_3923
p3516
sg16
VMalathion [drugbank:DB00772]
p3517
sg18
Vdrug-target interaction Malathion and Cholinesterase [drugbank_resource:DB00772_3923]
p3518
sa(dp3519
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3520
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00989
p3521
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00989_3923
p3522
sg16
VRivastigmine [drugbank:DB00989]
p3523
sg18
Vdrug-target interaction Rivastigmine and Cholinesterase [drugbank_resource:DB00989_3923]
p3524
sa(dp3525
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3526
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01010
p3527
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01010_3923
p3528
sg16
VEdrophonium [drugbank:DB01010]
p3529
sg18
Vdrug-target interaction Edrophonium and Cholinesterase [drugbank_resource:DB01010_3923]
p3530
sa(dp3531
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3532
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00677
p3533
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00677_3923
p3534
sg16
VIsoflurophate [drugbank:DB00677]
p3535
sg18
Vdrug-target interaction Isoflurophate and Cholinesterase [drugbank_resource:DB00677_3923]
p3536
sa(dp3537
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3538
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00677
p3539
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00677_3923
p3540
sg16
VIsoflurophate [drugbank:DB00677]
p3541
sg18
Vdrug-enzyme interaction Isoflurophate and Cholinesterase [drugbank_resource:DB00677_3923]
p3542
sa(dp3543
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3544
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00733
p3545
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00733_3923
p3546
sg16
VPralidoxime [drugbank:DB00733]
p3547
sg18
Vdrug-target interaction Pralidoxime and Cholinesterase [drugbank_resource:DB00733_3923]
p3548
sa(dp3549
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3550
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01057
p3551
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01057_3923
p3552
sg16
VEchothiophate [drugbank:DB01057]
p3553
sg18
Vdrug-target interaction Echothiophate and Cholinesterase [drugbank_resource:DB01057_3923]
p3554
sa(dp3555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00941
p3557
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00941_3923
p3558
sg16
VHexafluronium [drugbank:DB00941]
p3559
sg18
Vdrug-target interaction Hexafluronium and Cholinesterase [drugbank_resource:DB00941_3923]
p3560
sa(dp3561
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3562
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00944
p3563
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00944_3923
p3564
sg16
VDemecarium [drugbank:DB00944]
p3565
sg18
Vdrug-target interaction Demecarium and Cholinesterase [drugbank_resource:DB00944_3923]
p3566
sa(dp3567
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3568
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01226
p3569
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01226_3923
p3570
sg16
VMivacurium [drugbank:DB01226]
p3571
sg18
Vdrug-target interaction Mivacurium and Cholinesterase [drugbank_resource:DB01226_3923]
p3572
sa(dp3573
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3574
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p3575
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_3923
p3576
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p3577
sg18
Vdrug-target interaction Alpha-D-Mannose and Cholinesterase [drugbank_resource:DB02944_3923]
p3578
sa(dp3579
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3580
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02687
p3581
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02687_3923
p3582
sg16
VBeta-D-Mannose [drugbank:DB02687]
p3583
sg18
Vdrug-target interaction Beta-D-Mannose and Cholinesterase [drugbank_resource:DB02687_3923]
p3584
sa(dp3585
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3586
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02845
p3587
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02845_3923
p3588
sg16
VMethylphosphinic Acid [drugbank:DB02845]
p3589
sg18
Vdrug-target interaction Methylphosphinic Acid and Cholinesterase [drugbank_resource:DB02845_3923]
p3590
sa(dp3591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02845
p3593
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02845_3923
p3594
sg16
VMethylphosphinic Acid [drugbank:DB02845]
p3595
sg18
Vdrug-enzyme interaction Methylphosphinic Acid and Cholinesterase [drugbank_resource:DB02845_3923]
p3596
sa(dp3597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02811
p3599
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02811_3923
p3600
sg16
VDiethylphosphono Group [drugbank:DB02811]
p3601
sg18
Vdrug-target interaction Diethylphosphono Group and Cholinesterase [drugbank_resource:DB02811_3923]
p3602
sa(dp3603
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3604
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02811
p3605
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02811_3923
p3606
sg16
VDiethylphosphono Group [drugbank:DB02811]
p3607
sg18
Vdrug-enzyme interaction Diethylphosphono Group and Cholinesterase [drugbank_resource:DB02811_3923]
p3608
sa(dp3609
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3610
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03568
p3611
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03568_3923
p3612
sg16
VButanoic Acid [drugbank:DB03568]
p3613
sg18
Vdrug-target interaction Butanoic Acid and Cholinesterase [drugbank_resource:DB03568_3923]
p3614
sa(dp3615
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3616
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03568
p3617
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03568_3923
p3618
sg16
VButanoic Acid [drugbank:DB03568]
p3619
sg18
Vdrug-enzyme interaction Butanoic Acid and Cholinesterase [drugbank_resource:DB03568_3923]
p3620
sa(dp3621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03814
p3623
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03814_3923
p3624
sg16
V2-(N-Morpholino)-Ethanesulfonic Acid [drugbank:DB03814]
p3625
sg18
Vdrug-target interaction 2-(N-Morpholino)-Ethanesulfonic Acid and Cholinesterase [drugbank_resource:DB03814_3923]
p3626
sa(dp3627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03814
p3629
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03814_3923
p3630
sg16
V2-(N-Morpholino)-Ethanesulfonic Acid [drugbank:DB03814]
p3631
sg18
Vdrug-enzyme interaction 2-(N-Morpholino)-Ethanesulfonic Acid and Cholinesterase [drugbank_resource:DB03814_3923]
p3632
sa(dp3633
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3634
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03672
p3635
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03672_3923
p3636
sg16
V9-N-Phenylmethylamino-Tacrine [drugbank:DB03672]
p3637
sg18
Vdrug-target interaction 9-N-Phenylmethylamino-Tacrine and Cholinesterase [drugbank_resource:DB03672_3923]
p3638
sa(dp3639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03822
p3641
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03822_3923
p3642
sg16
VEthyl Dihydrogen Phosphate [drugbank:DB03822]
p3643
sg18
Vdrug-target interaction Ethyl Dihydrogen Phosphate and Cholinesterase [drugbank_resource:DB03822_3923]
p3644
sa(dp3645
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3646
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03822
p3647
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03822_3923
p3648
sg16
VEthyl Dihydrogen Phosphate [drugbank:DB03822]
p3649
sg18
Vdrug-enzyme interaction Ethyl Dihydrogen Phosphate and Cholinesterase [drugbank_resource:DB03822_3923]
p3650
sa(dp3651
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3652
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04250
p3653
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04250_3923
p3654
sg16
VButyrylthiocholine [drugbank:DB04250]
p3655
sg18
Vdrug-target interaction Butyrylthiocholine and Cholinesterase [drugbank_resource:DB04250_3923]
p3656
sa(dp3657
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3658
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04250
p3659
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04250_3923
p3660
sg16
VButyrylthiocholine [drugbank:DB04250]
p3661
sg18
Vdrug-enzyme interaction Butyrylthiocholine and Cholinesterase [drugbank_resource:DB04250_3923]
p3662
sa(dp3663
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3664
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04251
p3665
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04251_3923
p3666
sg16
VMonoisopropyl Ester Phosphonic Acid Group [drugbank:DB04251]
p3667
sg18
Vdrug-target interaction Monoisopropyl Ester Phosphonic Acid Group and Cholinesterase [drugbank_resource:DB04251_3923]
p3668
sa(dp3669
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3670
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04251
p3671
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04251_3923
p3672
sg16
VMonoisopropyl Ester Phosphonic Acid Group [drugbank:DB04251]
p3673
sg18
Vdrug-enzyme interaction Monoisopropyl Ester Phosphonic Acid Group and Cholinesterase [drugbank_resource:DB04251_3923]
p3674
sa(dp3675
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3676
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07681
p3677
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07681_3923
p3678
sg16
VDODECANESULFONATE ION [drugbank:DB07681]
p3679
sg18
Vdrug-target interaction DODECANESULFONATE ION and Cholinesterase [drugbank_resource:DB07681_3923]
p3680
sa(dp3681
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3682
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08200
p3683
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08200_3923
p3684
sg16
V(1R)-MENTHYL HEXYL PHOSPHONATE GROUP [drugbank:DB08200]
p3685
sg18
Vdrug-target interaction (1R)-MENTHYL HEXYL PHOSPHONATE GROUP and Cholinesterase [drugbank_resource:DB08200_3923]
p3686
sa(dp3687
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3688
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08658
p3689
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08658_3923
p3690
sg16
VETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE [drugbank:DB08658]
p3691
sg18
Vdrug-target interaction ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE and Cholinesterase [drugbank_resource:DB08658_3923]
p3692
sa(dp3693
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3694
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07940
p3695
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07940_3923
p3696
sg16
V9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE [drugbank:DB07940]
p3697
sg18
Vdrug-target interaction 9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE and Cholinesterase [drugbank_resource:DB07940_3923]
p3698
sa(dp3699
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3923
p3700
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08201
p3701
sg11
g3480
sg12
g3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08201_3923
p3702
sg16
V(1S)-MENTHYL HEXYL PHOSPHONATE GROUP [drugbank:DB08201]
p3703
sg18
Vdrug-target interaction (1S)-MENTHYL HEXYL PHOSPHONATE GROUP and Cholinesterase [drugbank_resource:DB08201_3923]
p3704
sasS'PFKFB1'
p3705
(lp3706
(dp3707
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1750
p3708
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02515
p3709
sg11
g3705
sg12
S'6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1'
p3710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02515_1750
p3711
sg16
V3-Phosphoglycerol [drugbank:DB02515]
p3712
sg18
Vdrug-target interaction 3-Phosphoglycerol and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [drugbank_resource:DB02515_1750]
p3713
sa(dp3714
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1750
p3715
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02393
p3716
sg11
g3705
sg12
g3710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02393_1750
p3717
sg16
VD-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate [drugbank:DB02393]
p3718
sg18
Vdrug-target interaction D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [drugbank_resource:DB02393_1750]
p3719
sa(dp3720
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1750
p3721
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02930
p3722
sg11
g3705
sg12
g3710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02930_1750
p3723
sg16
VPhosphothiophosphoric Acid-Adenylate Ester [drugbank:DB02930]
p3724
sg18
Vdrug-target interaction Phosphothiophosphoric Acid-Adenylate Ester and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [drugbank_resource:DB02930_1750]
p3725
sa(dp3726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1750
p3727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04137
p3728
sg11
g3705
sg12
g3710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04137_1750
p3729
sg16
VGuanosine-5'-Triphosphate [drugbank:DB04137]
p3730
sg18
Vdrug-target interaction Guanosine-5'-Triphosphate and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [drugbank_resource:DB04137_1750]
p3731
sa(dp3732
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1750
p3733
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04493
p3734
sg11
g3705
sg12
g3710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04493_1750
p3735
sg16
VFructose-6-Phosphate [drugbank:DB04493]
p3736
sg18
Vdrug-target interaction Fructose-6-Phosphate and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [drugbank_resource:DB04493_1750]
p3737
sasS'EDNRB'
p3738
(lp3739
(dp3740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:49
p3741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00559
p3742
sg11
g3738
sg12
S'endothelin receptor type B'
p3743
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00559_49
p3744
sg16
VBosentan [drugbank:DB00559]
p3745
sg18
Vdrug-target interaction Bosentan and Endothelin B receptor [drugbank_resource:DB00559_49]
p3746
sa(dp3747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:49
p3748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06268
p3749
sg11
g3738
sg12
g3743
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06268_49
p3750
sg16
VSitaxentan [drugbank:DB06268]
p3751
sg18
Vdrug-target interaction Sitaxentan and Endothelin B receptor [drugbank_resource:DB06268_49]
p3752
sasS'ADH1B'
p3753
(lp3754
(dp3755
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3756
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p3757
sg11
g3753
sg12
S'alcohol dehydrogenase 1B (class I), beta polypeptide'
p3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_444
p3759
sg16
VNADH [drugbank:DB00157]
p3760
sg18
Vdrug-target interaction NADH and Alcohol dehydrogenase 1B [drugbank_resource:DB00157_444]
p3761
sa(dp3762
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3763
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p3764
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_444
p3765
sg16
VNADH [drugbank:DB00157]
p3766
sg18
Vdrug-enzyme interaction NADH and Alcohol dehydrogenase 1B [drugbank_resource:DB00157_444]
p3767
sa(dp3768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00898
p3770
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00898_444
p3771
sg16
VEthanol [drugbank:DB00898]
p3772
sg18
Vdrug-target interaction Ethanol and Alcohol dehydrogenase 1B [drugbank_resource:DB00898_444]
p3773
sa(dp3774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01213
p3776
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01213_444
p3777
sg16
VFomepizole [drugbank:DB01213]
p3778
sg18
Vdrug-target interaction Fomepizole and Alcohol dehydrogenase 1B [drugbank_resource:DB01213_444]
p3779
sa(dp3780
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3781
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p3782
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_444
p3783
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p3784
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Alcohol dehydrogenase 1B [drugbank_resource:DB01907_444]
p3785
sa(dp3786
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3787
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02481
p3788
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02481_444
p3789
sg16
VN-Benzylformamide [drugbank:DB02481]
p3790
sg18
Vdrug-target interaction N-Benzylformamide and Alcohol dehydrogenase 1B [drugbank_resource:DB02481_444]
p3791
sa(dp3792
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3793
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02721
p3794
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02721_444
p3795
sg16
V4-Iodopyrazole [drugbank:DB02721]
p3796
sg18
Vdrug-target interaction 4-Iodopyrazole and Alcohol dehydrogenase 1B [drugbank_resource:DB02721_444]
p3797
sa(dp3798
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3799
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03461
p3800
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03461_444
p3801
sg16
V2'-Monophosphoadenosine 5'-Diphosphoribose [drugbank:DB03461]
p3802
sg18
Vdrug-target interaction 2'-Monophosphoadenosine 5'-Diphosphoribose and Alcohol dehydrogenase 1B [drugbank_resource:DB03461_444]
p3803
sa(dp3804
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3805
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04077
p3806
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04077_444
p3807
sg16
VGlycerol [drugbank:DB04077]
p3808
sg18
Vdrug-target interaction Glycerol and Alcohol dehydrogenase 1B [drugbank_resource:DB04077_444]
p3809
sa(dp3810
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3811
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03703
p3812
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03703_444
p3813
sg16
VCyclohexanol [drugbank:DB03703]
p3814
sg18
Vdrug-target interaction Cyclohexanol and Alcohol dehydrogenase 1B [drugbank_resource:DB03703_444]
p3815
sa(dp3816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:444
p3817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04105
p3818
sg11
g3753
sg12
g3758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04105_444
p3819
sg16
VN-Heptylformamide [drugbank:DB04105]
p3820
sg18
Vdrug-target interaction N-Heptylformamide and Alcohol dehydrogenase 1B [drugbank_resource:DB04105_444]
p3821
sasS'HSD17B2'
p3822
(lp3823
(dp3824
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:9
p3825
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p3826
sg11
g3822
sg12
S'hydroxysteroid (17-beta) dehydrogenase 2'
p3827
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_9
p3828
sg16
VNADH [drugbank:DB00157]
p3829
sg18
Vdrug-target interaction NADH and Estradiol 17-beta-dehydrogenase 2 [drugbank_resource:DB00157_9]
p3830
sasS'SSTR1'
p3831
(lp3832
(dp3833
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:503
p3834
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00104
p3835
sg11
g3831
sg12
S'somatostatin receptor 1'
p3836
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00104_503
p3837
sg16
VOctreotide [drugbank:DB00104]
p3838
sg18
Vdrug-target interaction Octreotide and Somatostatin receptor type 1 [drugbank_resource:DB00104_503]
p3839
sasS'ABCC9'
p3840
(lp3841
(dp3842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:521
p3843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p3844
sg11
g3840
sg12
S'ATP-binding cassette, sub-family C (CFTR/MRP), member 9'
p3845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_521
p3846
sg16
VAdenosine triphosphate [drugbank:DB00171]
p3847
sg18
Vdrug-target interaction Adenosine triphosphate and ATP-binding cassette transporter sub-family C member 9 [drugbank_resource:DB00171_521]
p3848
sa(dp3849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:521
p3850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01016
p3851
sg11
g3840
sg12
g3845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01016_521
p3852
sg16
VGlyburide [drugbank:DB01016]
p3853
sg18
Vdrug-target interaction Glyburide and ATP-binding cassette transporter sub-family C member 9 [drugbank_resource:DB01016_521]
p3854
sasS'CLEC3B'
p3855
(lp3856
(dp3857
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3825
p3858
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00031
p3859
sg11
g3855
sg12
S'C-type lectin domain family 3, member B'
p3860
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00031_3825
p3861
sg16
VTenecteplase [drugbank:DB00031]
p3862
sg18
Vdrug-target interaction Tenecteplase and Tetranectin [drugbank_resource:DB00031_3825]
p3863
sasS'NEK2'
p3864
(lp3865
(dp3866
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6298
p3867
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07180
p3868
sg11
g3864
sg12
S'NIMA-related kinase 2'
p3869
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07180_6298
p3870
sg16
V5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE [drugbank:DB07180]
p3871
sg18
Vdrug-target interaction 5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE and Serine/threonine-protein kinase Nek2 [drugbank_resource:DB07180_6298]
p3872
sasS'MET'
p3873
(lp3874
(dp3875
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3876
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02152
p3877
sg11
g3873
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02152_1144
p3879
sg16
VK-252a [drugbank:DB02152]
p3880
sg18
Vdrug-target interaction K-252a and Hepatocyte growth factor receptor [drugbank_resource:DB02152_1144]
p3881
sa(dp3882
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3883
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06896
p3884
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06896_1144
p3885
sg16
V1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide [drugbank:DB06896]
p3886
sg18
Vdrug-target interaction 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide and Hepatocyte growth factor receptor [drugbank_resource:DB06896_1144]
p3887
sa(dp3888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06995
p3890
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06995_1144
p3891
sg16
VN-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide [drugbank:DB06995]
p3892
sg18
Vdrug-target interaction N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide and Hepatocyte growth factor receptor [drugbank_resource:DB06995_1144]
p3893
sa(dp3894
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3895
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06997
p3896
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06997_1144
p3897
sg16
V2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide [drugbank:DB06997]
p3898
sg18
Vdrug-target interaction 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide and Hepatocyte growth factor receptor [drugbank_resource:DB06997_1144]
p3899
sa(dp3900
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3901
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07369
p3902
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07369_1144
p3903
sg16
VN-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide [drugbank:DB07369]
p3904
sg18
Vdrug-target interaction N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide and Hepatocyte growth factor receptor [drugbank_resource:DB07369_1144]
p3905
sa(dp3906
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3907
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07969
p3908
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07969_1144
p3909
sg16
V3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol [drugbank:DB07969]
p3910
sg18
Vdrug-target interaction 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol and Hepatocyte growth factor receptor [drugbank_resource:DB07969_1144]
p3911
sa(dp3912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08584
p3914
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08584_1144
p3915
sg16
V6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline [drugbank:DB08584]
p3916
sg18
Vdrug-target interaction 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline and Hepatocyte growth factor receptor [drugbank_resource:DB08584_1144]
p3917
sa(dp3918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08700
p3920
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08700_1144
p3921
sg16
V3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine [drugbank:DB08700]
p3922
sg18
Vdrug-target interaction 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine and Hepatocyte growth factor receptor [drugbank_resource:DB08700_1144]
p3923
sa(dp3924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p3925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08791
p3926
sg11
g3873
sg12
g3878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08791_1144
p3927
sg16
V1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE [drugbank:DB08791]
p3928
sg18
Vdrug-target interaction 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE and Hepatocyte growth factor receptor [drugbank_resource:DB08791_1144]
p3929
sasS'PRLR'
p3930
(lp3931
(dp3932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:381
p3933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00052
p3934
sg11
g3930
sg12
S'prolactin receptor'
p3935
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00052_381
p3936
sg16
VSomatropin recombinant [drugbank:DB00052]
p3937
sg18
Vdrug-target interaction Somatropin recombinant and Prolactin receptor [drugbank_resource:DB00052_381]
p3938
sa(dp3939
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:381
p3940
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p3941
sg11
g3930
sg12
g3935
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_381
p3942
sg16
VFluoxymesterone [drugbank:DB01185]
p3943
sg18
Vdrug-target interaction Fluoxymesterone and Prolactin receptor [drugbank_resource:DB01185_381]
p3944
sasS'MS4A2'
p3945
(lp3946
(dp3947
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3862
p3948
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00043
p3949
sg11
g3945
sg12
S'membrane-spanning 4-domains, subfamily A, member 2'
p3950
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00043_3862
p3951
sg16
VOmalizumab [drugbank:DB00043]
p3952
sg18
Vdrug-target interaction Omalizumab and High affinity immunoglobulin epsilon receptor subunit beta [drugbank_resource:DB00043_3862]
p3953
sasS'MGMT'
p3954
(lp3955
(dp3956
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1999
p3957
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00151
p3958
sg11
g3954
sg12
S'O-6-methylguanine-DNA methyltransferase'
p3959
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00151_1999
p3960
sg16
VL-Cysteine [drugbank:DB00151]
p3961
sg18
Vdrug-target interaction L-Cysteine and Methylated-DNA--protein-cysteine methyltransferase [drugbank_resource:DB00151_1999]
p3962
sa(dp3963
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1999
p3964
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02216
p3965
sg11
g3954
sg12
g3959
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02216_1999
p3966
sg16
VS-Methylcysteine [drugbank:DB02216]
p3967
sg18
Vdrug-target interaction S-Methylcysteine and Methylated-DNA--protein-cysteine methyltransferase [drugbank_resource:DB02216_1999]
p3968
sa(dp3969
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1999
p3970
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04531
p3971
sg11
g3954
sg12
g3959
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04531_1999
p3972
sg16
VBenzylcysteine [drugbank:DB04531]
p3973
sg18
Vdrug-target interaction Benzylcysteine and Methylated-DNA--protein-cysteine methyltransferase [drugbank_resource:DB04531_1999]
p3974
sasS'PIM1'
p3975
(lp3976
(dp3977
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p3978
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00131
p3979
sg11
g3975
sg12
S'pim-1 oncogene'
p3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00131_2347
p3981
sg16
VAdenosine monophosphate [drugbank:DB00131]
p3982
sg18
Vdrug-target interaction Adenosine monophosphate and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB00131_2347]
p3983
sa(dp3984
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p3985
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p3986
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2347
p3987
sg16
VStaurosporine [drugbank:DB02010]
p3988
sg18
Vdrug-target interaction Staurosporine and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB02010_2347]
p3989
sa(dp3990
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p3991
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01754
p3992
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01754_2347
p3993
sg16
V3,4-Dihydroxy-1-Methylquinolin-2(1h)-One [drugbank:DB01754]
p3994
sg18
Vdrug-target interaction 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB01754_2347]
p3995
sa(dp3996
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p3997
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02656
p3998
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02656_2347
p3999
sg16
V2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One [drugbank:DB02656]
p4000
sg18
Vdrug-target interaction 2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB02656_2347]
p4001
sa(dp4002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04216
p4004
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04216_2347
p4005
sg16
VQuercetin [drugbank:DB04216]
p4006
sg18
Vdrug-target interaction Quercetin and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB04216_2347]
p4007
sa(dp4008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03650
p4010
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03650_2347
p4011
sg16
V(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One [drugbank:DB03650]
p4012
sg18
Vdrug-target interaction (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB03650_2347]
p4013
sa(dp4014
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4015
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03777
p4016
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03777_2347
p4017
sg16
VRbt205 Inhibitor [drugbank:DB03777]
p4018
sg18
Vdrug-target interaction Rbt205 Inhibitor and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB03777_2347]
p4019
sa(dp4020
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4021
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p4022
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2347
p4023
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p4024
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB04395_2347]
p4025
sa(dp4026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04530
p4028
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04530_2347
p4029
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p4030
sg18
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB04530_2347]
p4031
sa(dp4032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p4034
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_2347
p4035
sg16
VPhosphonoserine [drugbank:DB04522]
p4036
sg18
Vdrug-target interaction Phosphonoserine and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB04522_2347]
p4037
sa(dp4038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07151
p4040
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07151_2347
p4041
sg16
V4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one [drugbank:DB07151]
p4042
sg18
Vdrug-target interaction 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB07151_2347]
p4043
sa(dp4044
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4045
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07242
p4046
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07242_2347
p4047
sg16
V(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile [drugbank:DB07242]
p4048
sg18
Vdrug-target interaction (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB07242_2347]
p4049
sa(dp4050
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4051
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04715
p4052
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04715_2347
p4053
sg16
VIMIDAZOPYRIDAZIN 1 [drugbank:DB04715]
p4054
sg18
Vdrug-target interaction IMIDAZOPYRIDAZIN 1 and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB04715_2347]
p4055
sa(dp4056
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4057
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07524
p4058
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07524_2347
p4059
sg16
VN-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine [drugbank:DB07524]
p4060
sg18
Vdrug-target interaction N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB07524_2347]
p4061
sa(dp4062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08022
p4064
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08022_2347
p4065
sg16
V(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile [drugbank:DB08022]
p4066
sg18
Vdrug-target interaction (2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08022_2347]
p4067
sa(dp4068
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4069
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08166
p4070
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08166_2347
p4071
sg16
V(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile [drugbank:DB08166]
p4072
sg18
Vdrug-target interaction (4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08166_2347]
p4073
sa(dp4074
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4075
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08707
p4076
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08707_2347
p4077
sg16
V4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine [drugbank:DB08707]
p4078
sg18
Vdrug-target interaction 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08707_2347]
p4079
sa(dp4080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08705
p4082
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08705_2347
p4083
sg16
V6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE [drugbank:DB08705]
p4084
sg18
Vdrug-target interaction 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08705_2347]
p4085
sa(dp4086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08709
p4088
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08709_2347
p4089
sg16
V2,3-diphenyl-1H-indole-7-carboxylic acid [drugbank:DB08709]
p4090
sg18
Vdrug-target interaction 2,3-diphenyl-1H-indole-7-carboxylic acid and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08709_2347]
p4091
sa(dp4092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08230
p4094
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08230_2347
p4095
sg16
V5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE [drugbank:DB08230]
p4096
sg18
Vdrug-target interaction 5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08230_2347]
p4097
sa(dp4098
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2347
p4099
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08708
p4100
sg11
g3975
sg12
g3980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08708_2347
p4101
sg16
VN-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine [drugbank:DB08708]
p4102
sg18
Vdrug-target interaction N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine and Proto-oncogene serine/threonine-protein kinase Pim-1 [drugbank_resource:DB08708_2347]
p4103
sasS'NT5E'
p4104
(lp4105
(dp4106
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1830
p4107
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00806
p4108
sg11
g4104
sg12
S"5'-nucleotidase, ecto (CD73)"
p4109
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00806_1830
p4110
sg16
VPentoxifylline [drugbank:DB00806]
p4111
sg18
Vdrug-target interaction Pentoxifylline and 5'-nucleotidase [drugbank_resource:DB00806_1830]
p4112
sasS'CDK2'
p4113
(lp4114
(dp4115
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4116
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01769
p4117
sg11
g4113
sg12
S'cyclin-dependent kinase 2'
p4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01769_2240
p4119
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p4120
sg18
Vdrug-target interaction Double Oxidized Cysteine and Cell division protein kinase 2 [drugbank_resource:DB01769_2240]
p4121
sa(dp4122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01888
p4124
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01888_2240
p4125
sg16
V4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide [drugbank:DB01888]
p4126
sg18
Vdrug-target interaction 4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB01888_2240]
p4127
sa(dp4128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02091
p4130
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02091_2240
p4131
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [drugbank:DB02091]
p4132
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine and Cell division protein kinase 2 [drugbank_resource:DB02091_2240]
p4133
sa(dp4134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02116
p4136
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02116_2240
p4137
sg16
VOlomoucine [drugbank:DB02116]
p4138
sg18
Vdrug-target interaction Olomoucine and Cell division protein kinase 2 [drugbank_resource:DB02116_2240]
p4139
sa(dp4140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02197
p4142
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02197_2240
p4143
sg16
V4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide [drugbank:DB02197]
p4144
sg18
Vdrug-target interaction 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB02197_2240]
p4145
sa(dp4146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p4148
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2240
p4149
sg16
VStaurosporine [drugbank:DB02010]
p4150
sg18
Vdrug-target interaction Staurosporine and Cell division protein kinase 2 [drugbank_resource:DB02010_2240]
p4151
sa(dp4152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p4154
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_2240
p4155
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p4156
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Cell division protein kinase 2 [drugbank_resource:DB02052_2240]
p4157
sa(dp4158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02538
p4160
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02538_2240
p4161
sg16
VN-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide [drugbank:DB02538]
p4162
sg18
Vdrug-target interaction N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide and Cell division protein kinase 2 [drugbank_resource:DB02538_2240]
p4163
sa(dp4164
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4165
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02297
p4166
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02297_2240
p4167
sg16
V2-Amino-6-Chloropyrazine [drugbank:DB02297]
p4168
sg18
Vdrug-target interaction 2-Amino-6-Chloropyrazine and Cell division protein kinase 2 [drugbank_resource:DB02297_2240]
p4169
sa(dp4170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02407
p4172
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02407_2240
p4173
sg16
V6-O-Cyclohexylmethyl Guanine [drugbank:DB02407]
p4174
sg18
Vdrug-target interaction 6-O-Cyclohexylmethyl Guanine and Cell division protein kinase 2 [drugbank_resource:DB02407_2240]
p4175
sa(dp4176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02833
p4178
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02833_2240
p4179
sg16
V[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine [drugbank:DB02833]
p4180
sg18
Vdrug-target interaction [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine and Cell division protein kinase 2 [drugbank_resource:DB02833_2240]
p4181
sa(dp4182
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4183
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02898
p4184
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02898_2240
p4185
sg16
V5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone [drugbank:DB02898]
p4186
sg18
Vdrug-target interaction 5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone and Cell division protein kinase 2 [drugbank_resource:DB02898_2240]
p4187
sa(dp4188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02915
p4190
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02915_2240
p4191
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine [drugbank:DB02915]
p4192
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine and Cell division protein kinase 2 [drugbank_resource:DB02915_2240]
p4193
sa(dp4194
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4195
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02950
p4196
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02950_2240
p4197
sg16
VHymenialdisine [drugbank:DB02950]
p4198
sg18
Vdrug-target interaction Hymenialdisine and Cell division protein kinase 2 [drugbank_resource:DB02950_2240]
p4199
sa(dp4200
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4201
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03019
p4202
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03019_2240
p4203
sg16
V4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine [drugbank:DB03019]
p4204
sg18
Vdrug-target interaction 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine and Cell division protein kinase 2 [drugbank_resource:DB03019_2240]
p4205
sa(dp4206
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4207
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02603
p4208
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02603_2240
p4209
sg16
V1-Amino-6-Cyclohex-3-Enylmethyloxypurine [drugbank:DB02603]
p4210
sg18
Vdrug-target interaction 1-Amino-6-Cyclohex-3-Enylmethyloxypurine and Cell division protein kinase 2 [drugbank_resource:DB02603_2240]
p4211
sa(dp4212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02647
p4214
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02647_2240
p4215
sg16
VN-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide [drugbank:DB02647]
p4216
sg18
Vdrug-target interaction N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide and Cell division protein kinase 2 [drugbank_resource:DB02647_2240]
p4217
sa(dp4218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p4220
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_2240
p4221
sg16
VPurvalanol [drugbank:DB02733]
p4222
sg18
Vdrug-target interaction Purvalanol and Cell division protein kinase 2 [drugbank_resource:DB02733_2240]
p4223
sa(dp4224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03307
p4226
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03307_2240
p4227
sg16
V4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide [drugbank:DB03307]
p4228
sg18
Vdrug-target interaction 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB03307_2240]
p4229
sa(dp4230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02963
p4232
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02963_2240
p4233
sg16
V(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine [drugbank:DB02963]
p4234
sg18
Vdrug-target interaction (5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine and Cell division protein kinase 2 [drugbank_resource:DB02963_2240]
p4235
sa(dp4236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02973
p4238
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02973_2240
p4239
sg16
V4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide [drugbank:DB02973]
p4240
sg18
Vdrug-target interaction 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB02973_2240]
p4241
sa(dp4242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03428
p4244
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03428_2240
p4245
sg16
VSU9516 [drugbank:DB03428]
p4246
sg18
Vdrug-target interaction SU9516 and Cell division protein kinase 2 [drugbank_resource:DB03428_2240]
p4247
sa(dp4248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03737
p4250
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03737_2240
p4251
sg16
V4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One [drugbank:DB03737]
p4252
sg18
Vdrug-target interaction 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One and Cell division protein kinase 2 [drugbank_resource:DB03737_2240]
p4253
sa(dp4254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03365
p4256
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03365_2240
p4257
sg16
V4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline [drugbank:DB03365]
p4258
sg18
Vdrug-target interaction 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline and Cell division protein kinase 2 [drugbank_resource:DB03365_2240]
p4259
sa(dp4260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p4262
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_2240
p4263
sg16
VFlavopiridol [drugbank:DB03496]
p4264
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 2 [drugbank_resource:DB03496_2240]
p4265
sa(dp4266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03583
p4268
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03583_2240
p4269
sg16
V(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One [drugbank:DB03583]
p4270
sg18
Vdrug-target interaction (2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One and Cell division protein kinase 2 [drugbank_resource:DB03583_2240]
p4271
sa(dp4272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03801
p4274
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03801_2240
p4275
sg16
VLysine Nz-Carboxylic Acid [drugbank:DB03801]
p4276
sg18
Vdrug-target interaction Lysine Nz-Carboxylic Acid and Cell division protein kinase 2 [drugbank_resource:DB03801_2240]
p4277
sa(dp4278
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4279
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04006
p4280
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04006_2240
p4281
sg16
V[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone [drugbank:DB04006]
p4282
sg18
Vdrug-target interaction [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone and Cell division protein kinase 2 [drugbank_resource:DB04006_2240]
p4283
sa(dp4284
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4285
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03490
p4286
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03490_2240
p4287
sg16
V3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole [drugbank:DB03490]
p4288
sg18
Vdrug-target interaction 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole and Cell division protein kinase 2 [drugbank_resource:DB03490_2240]
p4289
sa(dp4290
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4291
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03663
p4292
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03663_2240
p4293
sg16
V1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol [drugbank:DB03663]
p4294
sg18
Vdrug-target interaction 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol and Cell division protein kinase 2 [drugbank_resource:DB03663_2240]
p4295
sa(dp4296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04186
p4298
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04186_2240
p4299
sg16
VN'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea [drugbank:DB04186]
p4300
sg18
Vdrug-target interaction N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea and Cell division protein kinase 2 [drugbank_resource:DB04186_2240]
p4301
sa(dp4302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04288
p4304
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04288_2240
p4305
sg16
V2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine [drugbank:DB04288]
p4306
sg18
Vdrug-target interaction 2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine and Cell division protein kinase 2 [drugbank_resource:DB04288_2240]
p4307
sa(dp4308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04407
p4310
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04407_2240
p4311
sg16
V4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol [drugbank:DB04407]
p4312
sg18
Vdrug-target interaction 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol and Cell division protein kinase 2 [drugbank_resource:DB04407_2240]
p4313
sa(dp4314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04101
p4316
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04101_2240
p4317
sg16
VN-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide [drugbank:DB04101]
p4318
sg18
Vdrug-target interaction N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide and Cell division protein kinase 2 [drugbank_resource:DB04101_2240]
p4319
sa(dp4320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04662
p4322
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04662_2240
p4323
sg16
VOLOMOUCINE II [drugbank:DB04662]
p4324
sg18
Vdrug-target interaction OLOMOUCINE II and Cell division protein kinase 2 [drugbank_resource:DB04662_2240]
p4325
sa(dp4326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04669
p4328
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04669_2240
p4329
sg16
VTRIAZOLOPYRIMIDINE [drugbank:DB04669]
p4330
sg18
Vdrug-target interaction TRIAZOLOPYRIMIDINE and Cell division protein kinase 2 [drugbank_resource:DB04669_2240]
p4331
sa(dp4332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06844
p4334
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06844_2240
p4335
sg16
V4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE [drugbank:DB06844]
p4336
sg18
Vdrug-target interaction 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB06844_2240]
p4337
sa(dp4338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06976
p4340
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06976_2240
p4341
sg16
V1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA [drugbank:DB06976]
p4342
sg18
Vdrug-target interaction 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA and Cell division protein kinase 2 [drugbank_resource:DB06976_2240]
p4343
sa(dp4344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06983
p4346
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06983_2240
p4347
sg16
V(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol [drugbank:DB06983]
p4348
sg18
Vdrug-target interaction (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol and Cell division protein kinase 2 [drugbank_resource:DB06983_2240]
p4349
sa(dp4350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07065
p4352
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07065_2240
p4353
sg16
V5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB07065]
p4354
sg18
Vdrug-target interaction 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB07065_2240]
p4355
sa(dp4356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07203
p4358
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07203_2240
p4359
sg16
V6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE [drugbank:DB07203]
p4360
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE and Cell division protein kinase 2 [drugbank_resource:DB07203_2240]
p4361
sa(dp4362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04518
p4364
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04518_2240
p4365
sg16
V3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol [drugbank:DB04518]
p4366
sg18
Vdrug-target interaction 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol and Cell division protein kinase 2 [drugbank_resource:DB04518_2240]
p4367
sa(dp4368
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4369
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04607
p4370
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04607_2240
p4371
sg16
VPHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE [drugbank:DB04607]
p4372
sg18
Vdrug-target interaction PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE and Cell division protein kinase 2 [drugbank_resource:DB04607_2240]
p4373
sa(dp4374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06888
p4376
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06888_2240
p4377
sg16
V(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE [drugbank:DB06888]
p4378
sg18
Vdrug-target interaction (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE and Cell division protein kinase 2 [drugbank_resource:DB06888_2240]
p4379
sa(dp4380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07024
p4382
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07024_2240
p4383
sg16
V2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE [drugbank:DB07024]
p4384
sg18
Vdrug-target interaction 2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE and Cell division protein kinase 2 [drugbank_resource:DB07024_2240]
p4385
sa(dp4386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07054
p4388
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07054_2240
p4389
sg16
V(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL [drugbank:DB07054]
p4390
sg18
Vdrug-target interaction (2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07054_2240]
p4391
sa(dp4392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07137
p4394
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07137_2240
p4395
sg16
V(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE [drugbank:DB07137]
p4396
sg18
Vdrug-target interaction (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07137_2240]
p4397
sa(dp4398
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4399
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07163
p4400
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07163_2240
p4401
sg16
V5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE [drugbank:DB07163]
p4402
sg18
Vdrug-target interaction 5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE and Cell division protein kinase 2 [drugbank_resource:DB07163_2240]
p4403
sa(dp4404
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4405
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07164
p4406
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07164_2240
p4407
sg16
VN-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine [drugbank:DB07164]
p4408
sg18
Vdrug-target interaction N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB07164_2240]
p4409
sa(dp4410
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4411
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07179
p4412
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07179_2240
p4413
sg16
V3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide [drugbank:DB07179]
p4414
sg18
Vdrug-target interaction 3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide and Cell division protein kinase 2 [drugbank_resource:DB07179_2240]
p4415
sa(dp4416
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4417
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07210
p4418
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07210_2240
p4419
sg16
V3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB07210]
p4420
sg18
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB07210_2240]
p4421
sa(dp4422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07220
p4424
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07220_2240
p4425
sg16
VN-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE [drugbank:DB07220]
p4426
sg18
Vdrug-target interaction N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07220_2240]
p4427
sa(dp4428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07431
p4430
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07431_2240
p4431
sg16
V(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one [drugbank:DB07431]
p4432
sg18
Vdrug-target interaction (3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one and Cell division protein kinase 2 [drugbank_resource:DB07431_2240]
p4433
sa(dp4434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06944
p4436
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06944_2240
p4437
sg16
VN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE [drugbank:DB06944]
p4438
sg18
Vdrug-target interaction N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB06944_2240]
p4439
sa(dp4440
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4441
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06948
p4442
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06948_2240
p4443
sg16
V2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE [drugbank:DB06948]
p4444
sg18
Vdrug-target interaction 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE and Cell division protein kinase 2 [drugbank_resource:DB06948_2240]
p4445
sa(dp4446
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4447
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07126
p4448
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07126_2240
p4449
sg16
VO6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE [drugbank:DB07126]
p4450
sg18
Vdrug-target interaction O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE and Cell division protein kinase 2 [drugbank_resource:DB07126_2240]
p4451
sa(dp4452
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4453
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07493
p4454
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07493_2240
p4455
sg16
V(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE [drugbank:DB07493]
p4456
sg18
Vdrug-target interaction (2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE and Cell division protein kinase 2 [drugbank_resource:DB07493_2240]
p4457
sa(dp4458
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4459
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07504
p4460
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07504_2240
p4461
sg16
V(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07504]
p4462
sg18
Vdrug-target interaction (2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07504_2240]
p4463
sa(dp4464
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4465
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07529
p4466
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07529_2240
p4467
sg16
V2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE [drugbank:DB07529]
p4468
sg18
Vdrug-target interaction 2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE and Cell division protein kinase 2 [drugbank_resource:DB07529_2240]
p4469
sa(dp4470
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4471
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07471
p4472
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07471_2240
p4473
sg16
V5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE [drugbank:DB07471]
p4474
sg18
Vdrug-target interaction 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07471_2240]
p4475
sa(dp4476
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4477
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07501
p4478
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07501_2240
p4479
sg16
V(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07501]
p4480
sg18
Vdrug-target interaction (2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07501_2240]
p4481
sa(dp4482
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4483
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07531
p4484
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07531_2240
p4485
sg16
V4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07531]
p4486
sg18
Vdrug-target interaction 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07531_2240]
p4487
sa(dp4488
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4489
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07538
p4490
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07538_2240
p4491
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE [drugbank:DB07538]
p4492
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07538_2240]
p4493
sa(dp4494
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4495
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07540
p4496
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07540_2240
p4497
sg16
V4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE [drugbank:DB07540]
p4498
sg18
Vdrug-target interaction 4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07540_2240]
p4499
sa(dp4500
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4501
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07562
p4502
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07562_2240
p4503
sg16
VN-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE [drugbank:DB07562]
p4504
sg18
Vdrug-target interaction N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE and Cell division protein kinase 2 [drugbank_resource:DB07562_2240]
p4505
sa(dp4506
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4507
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07612
p4508
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07612_2240
p4509
sg16
V6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE [drugbank:DB07612]
p4510
sg18
Vdrug-target interaction 6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE and Cell division protein kinase 2 [drugbank_resource:DB07612_2240]
p4511
sa(dp4512
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4513
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07618
p4514
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07618_2240
p4515
sg16
V2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE [drugbank:DB07618]
p4516
sg18
Vdrug-target interaction 2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07618_2240]
p4517
sa(dp4518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07685
p4520
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07685_2240
p4521
sg16
V4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07685]
p4522
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07685_2240]
p4523
sa(dp4524
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4525
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07687
p4526
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07687_2240
p4527
sg16
V4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07687]
p4528
sg18
Vdrug-target interaction 4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07687_2240]
p4529
sa(dp4530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07688
p4532
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07688_2240
p4533
sg16
V4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07688]
p4534
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07688_2240]
p4535
sa(dp4536
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4537
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07750
p4538
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07750_2240
p4539
sg16
V(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07750]
p4540
sg18
Vdrug-target interaction (2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07750_2240]
p4541
sa(dp4542
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4543
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07755
p4544
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07755_2240
p4545
sg16
V(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07755]
p4546
sg18
Vdrug-target interaction (2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07755_2240]
p4547
sa(dp4548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07761
p4550
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07761_2240
p4551
sg16
V(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07761]
p4552
sg18
Vdrug-target interaction (2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07761_2240]
p4553
sa(dp4554
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4555
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07790
p4556
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07790_2240
p4557
sg16
VN-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07790]
p4558
sg18
Vdrug-target interaction N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07790_2240]
p4559
sa(dp4560
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4561
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08132
p4562
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08132_2240
p4563
sg16
V5-hydroxynaphthalene-1-sulfonamide [drugbank:DB08132]
p4564
sg18
Vdrug-target interaction 5-hydroxynaphthalene-1-sulfonamide and Cell division protein kinase 2 [drugbank_resource:DB08132_2240]
p4565
sa(dp4566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08133
p4568
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08133_2240
p4569
sg16
VN-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide [drugbank:DB08133]
p4570
sg18
Vdrug-target interaction N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08133_2240]
p4571
sa(dp4572
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4573
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08139
p4574
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08139_2240
p4575
sg16
V5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile [drugbank:DB08139]
p4576
sg18
Vdrug-target interaction 5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile and Cell division protein kinase 2 [drugbank_resource:DB08139_2240]
p4577
sa(dp4578
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4579
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08141
p4580
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08141_2240
p4581
sg16
V4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide [drugbank:DB08141]
p4582
sg18
Vdrug-target interaction 4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08141_2240]
p4583
sa(dp4584
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4585
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08247
p4586
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08247_2240
p4587
sg16
V6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE [drugbank:DB08247]
p4588
sg18
Vdrug-target interaction 6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08247_2240]
p4589
sa(dp4590
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4591
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08248
p4592
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08248_2240
p4593
sg16
V3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE [drugbank:DB08248]
p4594
sg18
Vdrug-target interaction 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08248_2240]
p4595
sa(dp4596
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4597
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08312
p4598
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08312_2240
p4599
sg16
V6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE [drugbank:DB08312]
p4600
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE and Cell division protein kinase 2 [drugbank_resource:DB08312_2240]
p4601
sa(dp4602
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4603
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08355
p4604
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08355_2240
p4605
sg16
V1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid [drugbank:DB08355]
p4606
sg18
Vdrug-target interaction 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid and Cell division protein kinase 2 [drugbank_resource:DB08355_2240]
p4607
sa(dp4608
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4609
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08533
p4610
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08533_2240
p4611
sg16
V3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine [drugbank:DB08533]
p4612
sg18
Vdrug-target interaction 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08533_2240]
p4613
sa(dp4614
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4615
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08534
p4616
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08534_2240
p4617
sg16
V5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08534]
p4618
sg18
Vdrug-target interaction 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08534_2240]
p4619
sa(dp4620
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4621
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08539
p4622
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08539_2240
p4623
sg16
V3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08539]
p4624
sg18
Vdrug-target interaction 3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08539_2240]
p4625
sa(dp4626
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4627
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08572
p4628
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08572_2240
p4629
sg16
V4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE [drugbank:DB08572]
p4630
sg18
Vdrug-target interaction 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08572_2240]
p4631
sa(dp4632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08673
p4634
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08673_2240
p4635
sg16
V4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE [drugbank:DB08673]
p4636
sg18
Vdrug-target interaction 4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08673_2240]
p4637
sa(dp4638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08677
p4640
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08677_2240
p4641
sg16
VN-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE [drugbank:DB08677]
p4642
sg18
Vdrug-target interaction N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08677_2240]
p4643
sa(dp4644
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4645
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08694
p4646
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08694_2240
p4647
sg16
V9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol [drugbank:DB08694]
p4648
sg18
Vdrug-target interaction 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol and Cell division protein kinase 2 [drugbank_resource:DB08694_2240]
p4649
sa(dp4650
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4651
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07533
p4652
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07533_2240
p4653
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07533]
p4654
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07533_2240]
p4655
sa(dp4656
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4657
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07534
p4658
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07534_2240
p4659
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07534]
p4660
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07534_2240]
p4661
sa(dp4662
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4663
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07539
p4664
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07539_2240
p4665
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID [drugbank:DB07539]
p4666
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID and Cell division protein kinase 2 [drugbank_resource:DB07539_2240]
p4667
sa(dp4668
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4669
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07606
p4670
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07606_2240
p4671
sg16
V6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE [drugbank:DB07606]
p4672
sg18
Vdrug-target interaction 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE and Cell division protein kinase 2 [drugbank_resource:DB07606_2240]
p4673
sa(dp4674
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4675
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07622
p4676
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07622_2240
p4677
sg16
V1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA [drugbank:DB07622]
p4678
sg18
Vdrug-target interaction 1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA and Cell division protein kinase 2 [drugbank_resource:DB07622_2240]
p4679
sa(dp4680
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4681
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07751
p4682
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07751_2240
p4683
sg16
V(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07751]
p4684
sg18
Vdrug-target interaction (2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07751_2240]
p4685
sa(dp4686
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4687
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07791
p4688
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07791_2240
p4689
sg16
V4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07791]
p4690
sg18
Vdrug-target interaction 4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07791_2240]
p4691
sa(dp4692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07852
p4694
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07852_2240
p4695
sg16
V1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID [drugbank:DB07852]
p4696
sg18
Vdrug-target interaction 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID and Cell division protein kinase 2 [drugbank_resource:DB07852_2240]
p4697
sa(dp4698
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4699
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07982
p4700
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07982_2240
p4701
sg16
V2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol [drugbank:DB07982]
p4702
sg18
Vdrug-target interaction 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol and Cell division protein kinase 2 [drugbank_resource:DB07982_2240]
p4703
sa(dp4704
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4705
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08094
p4706
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08094_2240
p4707
sg16
V(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE [drugbank:DB08094]
p4708
sg18
Vdrug-target interaction (4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE and Cell division protein kinase 2 [drugbank_resource:DB08094_2240]
p4709
sa(dp4710
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4711
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08122
p4712
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08122_2240
p4713
sg16
VN-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE [drugbank:DB08122]
p4714
sg18
Vdrug-target interaction N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08122_2240]
p4715
sa(dp4716
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4717
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08123
p4718
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08123_2240
p4719
sg16
VN-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE [drugbank:DB08123]
p4720
sg18
Vdrug-target interaction N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08123_2240]
p4721
sa(dp4722
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4723
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08125
p4724
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08125_2240
p4725
sg16
V4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE [drugbank:DB08125]
p4726
sg18
Vdrug-target interaction 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08125_2240]
p4727
sa(dp4728
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4729
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08126
p4730
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08126_2240
p4731
sg16
V3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE [drugbank:DB08126]
p4732
sg18
Vdrug-target interaction 3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE and Cell division protein kinase 2 [drugbank_resource:DB08126_2240]
p4733
sa(dp4734
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4735
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08134
p4736
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08134_2240
p4737
sg16
V4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide [drugbank:DB08134]
p4738
sg18
Vdrug-target interaction 4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB08134_2240]
p4739
sa(dp4740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08135
p4742
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08135_2240
p4743
sg16
VN-phenyl-1H-pyrazole-3-carboxamide [drugbank:DB08135]
p4744
sg18
Vdrug-target interaction N-phenyl-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08135_2240]
p4745
sa(dp4746
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4747
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08137
p4748
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08137_2240
p4749
sg16
V(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide [drugbank:DB08137]
p4750
sg18
Vdrug-target interaction (4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08137_2240]
p4751
sa(dp4752
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4753
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08178
p4754
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08178_2240
p4755
sg16
V4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08178]
p4756
sg18
Vdrug-target interaction 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB08178_2240]
p4757
sa(dp4758
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4759
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08309
p4760
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08309_2240
p4761
sg16
V3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL [drugbank:DB08309]
p4762
sg18
Vdrug-target interaction 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL and Cell division protein kinase 2 [drugbank_resource:DB08309_2240]
p4763
sa(dp4764
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4765
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08441
p4766
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08441_2240
p4767
sg16
V6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE [drugbank:DB08441]
p4768
sg18
Vdrug-target interaction 6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE and Cell division protein kinase 2 [drugbank_resource:DB08441_2240]
p4769
sa(dp4770
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4771
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08532
p4772
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08532_2240
p4773
sg16
V6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine [drugbank:DB08532]
p4774
sg18
Vdrug-target interaction 6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08532_2240]
p4775
sa(dp4776
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4777
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08536
p4778
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08536_2240
p4779
sg16
V3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine [drugbank:DB08536]
p4780
sg18
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08536_2240]
p4781
sa(dp4782
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4783
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08537
p4784
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08537_2240
p4785
sg16
V3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine [drugbank:DB08537]
p4786
sg18
Vdrug-target interaction 3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08537_2240]
p4787
sa(dp4788
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4789
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08768
p4790
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08768_2240
p4791
sg16
VN-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE [drugbank:DB08768]
p4792
sg18
Vdrug-target interaction N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08768_2240]
p4793
sa(dp4794
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4795
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07595
p4796
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07595_2240
p4797
sg16
V(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE [drugbank:DB07595]
p4798
sg18
Vdrug-target interaction (5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE and Cell division protein kinase 2 [drugbank_resource:DB07595_2240]
p4799
sa(dp4800
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4801
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07686
p4802
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07686_2240
p4803
sg16
V4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07686]
p4804
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07686_2240]
p4805
sa(dp4806
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4807
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07731
p4808
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07731_2240
p4809
sg16
V4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL [drugbank:DB07731]
p4810
sg18
Vdrug-target interaction 4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL and Cell division protein kinase 2 [drugbank_resource:DB07731_2240]
p4811
sa(dp4812
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4813
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07889
p4814
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07889_2240
p4815
sg16
V1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL [drugbank:DB07889]
p4816
sg18
Vdrug-target interaction 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07889_2240]
p4817
sa(dp4818
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4819
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07936
p4820
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07936_2240
p4821
sg16
VN-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine [drugbank:DB07936]
p4822
sg18
Vdrug-target interaction N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB07936_2240]
p4823
sa(dp4824
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4825
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08066
p4826
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08066_2240
p4827
sg16
VN-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE [drugbank:DB08066]
p4828
sg18
Vdrug-target interaction N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08066_2240]
p4829
sa(dp4830
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4831
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08124
p4832
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08124_2240
p4833
sg16
V3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE [drugbank:DB08124]
p4834
sg18
Vdrug-target interaction 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE and Cell division protein kinase 2 [drugbank_resource:DB08124_2240]
p4835
sa(dp4836
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4837
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08136
p4838
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08136_2240
p4839
sg16
V4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide [drugbank:DB08136]
p4840
sg18
Vdrug-target interaction 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08136_2240]
p4841
sa(dp4842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08138
p4844
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08138_2240
p4845
sg16
V{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide [drugbank:DB08138]
p4846
sg18
Vdrug-target interaction {[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08138_2240]
p4847
sa(dp4848
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4849
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08140
p4850
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08140_2240
p4851
sg16
V5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE [drugbank:DB08140]
p4852
sg18
Vdrug-target interaction 5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE and Cell division protein kinase 2 [drugbank_resource:DB08140_2240]
p4853
sa(dp4854
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4855
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08142
p4856
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08142_2240
p4857
sg16
V4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide [drugbank:DB08142]
p4858
sg18
Vdrug-target interaction 4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08142_2240]
p4859
sa(dp4860
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4861
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08182
p4862
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08182_2240
p4863
sg16
V4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08182]
p4864
sg18
Vdrug-target interaction 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB08182_2240]
p4865
sa(dp4866
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4867
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08218
p4868
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08218_2240
p4869
sg16
VHYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM [drugbank:DB08218]
p4870
sg18
Vdrug-target interaction HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM and Cell division protein kinase 2 [drugbank_resource:DB08218_2240]
p4871
sa(dp4872
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4873
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08219
p4874
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08219_2240
p4875
sg16
V4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE [drugbank:DB08219]
p4876
sg18
Vdrug-target interaction 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08219_2240]
p4877
sa(dp4878
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4879
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08233
p4880
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08233_2240
p4881
sg16
V6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE [drugbank:DB08233]
p4882
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE and Cell division protein kinase 2 [drugbank_resource:DB08233_2240]
p4883
sa(dp4884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08241
p4886
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08241_2240
p4887
sg16
V4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE [drugbank:DB08241]
p4888
sg18
Vdrug-target interaction 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08241_2240]
p4889
sa(dp4890
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4891
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08285
p4892
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08285_2240
p4893
sg16
V(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol [drugbank:DB08285]
p4894
sg18
Vdrug-target interaction (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol and Cell division protein kinase 2 [drugbank_resource:DB08285_2240]
p4895
sa(dp4896
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4897
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08463
p4898
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08463_2240
p4899
sg16
V(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol [drugbank:DB08463]
p4900
sg18
Vdrug-target interaction (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol and Cell division protein kinase 2 [drugbank_resource:DB08463_2240]
p4901
sa(dp4902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08527
p4904
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08527_2240
p4905
sg16
V1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE [drugbank:DB08527]
p4906
sg18
Vdrug-target interaction 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08527_2240]
p4907
sa(dp4908
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4909
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08531
p4910
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08531_2240
p4911
sg16
V5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08531]
p4912
sg18
Vdrug-target interaction 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08531_2240]
p4913
sa(dp4914
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4915
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08535
p4916
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08535_2240
p4917
sg16
V3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08535]
p4918
sg18
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08535_2240]
p4919
sa(dp4920
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p4921
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08538
p4922
sg11
g4113
sg12
g4118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08538_2240
p4923
sg16
VN-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08538]
p4924
sg18
Vdrug-target interaction N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08538_2240]
p4925
sasS'IGSF10'
p4926
(lp4927
(dp4928
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7122
p4929
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00114
p4930
sg11
g4926
sg12
S'immunoglobulin superfamily, member 10'
p4931
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00114_7122
p4932
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p4933
sg18
Vdrug-target interaction Pyridoxal Phosphate and Immunoglobulin superfamily member 10 [drugbank_resource:DB00114_7122]
p4934
sasS'FLT3'
p4935
(lp4936
(dp4937
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:165
p4938
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00398
p4939
sg11
g4935
sg12
S'fms-related tyrosine kinase 3'
p4940
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00398_165
p4941
sg16
VSorafenib [drugbank:DB00398]
p4942
sg18
Vdrug-target interaction Sorafenib and FL cytokine receptor [drugbank_resource:DB00398_165]
p4943
sa(dp4944
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:165
p4945
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01268
p4946
sg11
g4935
sg12
g4940
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01268_165
p4947
sg16
VSunitinib [drugbank:DB01268]
p4948
sg18
Vdrug-target interaction Sunitinib and FL cytokine receptor [drugbank_resource:DB01268_165]
p4949
sasS'TTK'
p4950
(lp4951
(dp4952
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6293
p4953
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01782
p4954
sg11
g4950
sg12
S'TTK protein kinase'
p4955
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01782_6293
p4956
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p4957
sg18
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Dual specificity protein kinase TTK [drugbank_resource:DB01782_6293]
p4958
sasS'GUCY1A2'
p4959
(lp4960
(dp4961
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6068
p4962
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00435
p4963
sg11
g4959
sg12
S'guanylate cyclase 1, soluble, alpha 2'
p4964
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00435_6068
p4965
sg16
VNitric Oxide [drugbank:DB00435]
p4966
sg18
Vdrug-target interaction Nitric Oxide and Guanylate cyclase soluble subunit alpha-2 [drugbank_resource:DB00435_6068]
p4967
sa(dp4968
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6068
p4969
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01020
p4970
sg11
g4959
sg12
g4964
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01020_6068
p4971
sg16
VIsosorbide Mononitrate [drugbank:DB01020]
p4972
sg18
Vdrug-target interaction Isosorbide Mononitrate and Guanylate cyclase soluble subunit alpha-2 [drugbank_resource:DB01020_6068]
p4973
sasS'RRM2B'
p4974
(lp4975
(dp4976
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6108
p4977
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00242
p4978
sg11
g4974
sg12
S'ribonucleotide reductase M2 B (TP53 inducible)'
p4979
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00242_6108
p4980
sg16
VCladribine [drugbank:DB00242]
p4981
sg18
Vdrug-target interaction Cladribine and Ribonucleoside-diphosphate reductase subunit M2 B [drugbank_resource:DB00242_6108]
p4982
sasS'PIK3R1'
p4983
(lp4984
(dp4985
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1281
p4986
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01064
p4987
sg11
g4983
sg12
S'phosphoinositide-3-kinase, regulatory subunit 1 (alpha)'
p4988
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01064_1281
p4989
sg16
VIsoproterenol [drugbank:DB01064]
p4990
sg18
Vdrug-target interaction Isoproterenol and Phosphatidylinositol 3-kinase regulatory subunit alpha [drugbank_resource:DB01064_1281]
p4991
sa(dp4992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1281
p4993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08059
p4994
sg11
g4983
sg12
g4988
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08059_1281
p4995
sg16
V(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE [drugbank:DB08059]
p4996
sg18
Vdrug-target interaction (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE and Phosphatidylinositol 3-kinase regulatory subunit alpha [drugbank_resource:DB08059_1281]
p4997
sasS'JAK1'
p4998
(lp4999
(dp5000
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6649
p5001
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04716
p5002
sg11
g4998
sg12
S'Janus kinase 1'
p5003
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04716_6649
p5004
sg16
V2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE [drugbank:DB04716]
p5005
sg18
Vdrug-target interaction 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE and Tyrosine-protein kinase JAK1 [drugbank_resource:DB04716_6649]
p5006
sa(dp5007
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6649
p5008
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08183
p5009
sg11
g4998
sg12
g5003
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08183_6649
p5010
sg16
V3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile [drugbank:DB08183]
p5011
sg18
Vdrug-target interaction 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile and Tyrosine-protein kinase JAK1 [drugbank_resource:DB08183_6649]
p5012
sasS'PRKACA'
p5013
(lp5014
(dp5015
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5016
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01940
p5017
sg11
g5013
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01940_6263
p5019
sg16
VBalanol Analog 2 [drugbank:DB01940]
p5020
sg18
Vdrug-target interaction Balanol Analog 2 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB01940_6263]
p5021
sa(dp5022
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5023
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01919
p5024
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01919_6263
p5025
sg16
VPentanal [drugbank:DB01919]
p5026
sg18
Vdrug-target interaction Pentanal and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB01919_6263]
p5027
sa(dp5028
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5029
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02440
p5030
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02440_6263
p5031
sg16
VN-Octane [drugbank:DB02440]
p5032
sg18
Vdrug-target interaction N-Octane and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02440_6263]
p5033
sa(dp5034
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5035
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02155
p5036
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02155_6263
p5037
sg16
VBalanol Analog 8 [drugbank:DB02155]
p5038
sg18
Vdrug-target interaction Balanol Analog 8 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02155_6263]
p5039
sa(dp5040
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5041
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p5042
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_6263
p5043
sg16
VPhosphonothreonine [drugbank:DB02482]
p5044
sg18
Vdrug-target interaction Phosphonothreonine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02482_6263]
p5045
sa(dp5046
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5047
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02611
p5048
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02611_6263
p5049
sg16
VBalanol Analog 1 [drugbank:DB02611]
p5050
sg18
Vdrug-target interaction Balanol Analog 1 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02611_6263]
p5051
sa(dp5052
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5053
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03374
p5054
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03374_6263
p5055
sg16
V3,5-Diiodotyrosine [drugbank:DB03374]
p5056
sg18
Vdrug-target interaction 3,5-Diiodotyrosine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB03374_6263]
p5057
sa(dp5058
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5059
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04098
p5060
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04098_6263
p5061
sg16
VBalanol [drugbank:DB04098]
p5062
sg18
Vdrug-target interaction Balanol and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04098_6263]
p5063
sa(dp5064
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5065
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04707
p5066
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04707_6263
p5067
sg16
VHYDROXYFASUDIL [drugbank:DB04707]
p5068
sg18
Vdrug-target interaction HYDROXYFASUDIL and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04707_6263]
p5069
sa(dp5070
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5071
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06959
p5072
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06959_6263
p5073
sg16
V(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE [drugbank:DB06959]
p5074
sg18
Vdrug-target interaction (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB06959_6263]
p5075
sa(dp5076
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5077
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06977
p5078
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06977_6263
p5079
sg16
V(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE [drugbank:DB06977]
p5080
sg18
Vdrug-target interaction (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB06977_6263]
p5081
sa(dp5082
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5083
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07124
p5084
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07124_6263
p5085
sg16
V(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB07124]
p5086
sg18
Vdrug-target interaction (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07124_6263]
p5087
sa(dp5088
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5089
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p5090
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_6263
p5091
sg16
VPhosphonoserine [drugbank:DB04522]
p5092
sg18
Vdrug-target interaction Phosphonoserine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04522_6263]
p5093
sa(dp5094
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5095
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07107
p5096
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07107_6263
p5097
sg16
V(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE [drugbank:DB07107]
p5098
sg18
Vdrug-target interaction (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07107_6263]
p5099
sa(dp5100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07458
p5102
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07458_6263
p5103
sg16
V3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE [drugbank:DB07458]
p5104
sg18
Vdrug-target interaction 3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07458_6263]
p5105
sa(dp5106
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5107
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04530
p5108
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04530_6263
p5109
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p5110
sg18
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04530_6263]
p5111
sa(dp5112
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5113
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07204
p5114
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07204_6263
p5115
sg16
V(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE [drugbank:DB07204]
p5116
sg18
Vdrug-target interaction (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07204_6263]
p5117
sa(dp5118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07235
p5120
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07235_6263
p5121
sg16
VN-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE [drugbank:DB07235]
p5122
sg18
Vdrug-target interaction N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07235_6263]
p5123
sa(dp5124
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5125
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07857
p5126
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07857_6263
p5127
sg16
V(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB07857]
p5128
sg18
Vdrug-target interaction (2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07857_6263]
p5129
sa(dp5130
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5131
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07858
p5132
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07858_6263
p5133
sg16
V(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB07858]
p5134
sg18
Vdrug-target interaction (2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07858_6263]
p5135
sa(dp5136
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5137
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07947
p5138
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07947_6263
p5139
sg16
VISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE [drugbank:DB07947]
p5140
sg18
Vdrug-target interaction ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07947_6263]
p5141
sa(dp5142
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5143
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08070
p5144
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08070_6263
p5145
sg16
V2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB08070]
p5146
sg18
Vdrug-target interaction 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08070_6263]
p5147
sa(dp5148
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5149
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08162
p5150
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08162_6263
p5151
sg16
V5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE [drugbank:DB08162]
p5152
sg18
Vdrug-target interaction 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08162_6263]
p5153
sa(dp5154
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5155
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08568
p5156
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08568_6263
p5157
sg16
V(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE [drugbank:DB08568]
p5158
sg18
Vdrug-target interaction (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08568_6263]
p5159
sa(dp5160
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5161
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07855
p5162
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07855_6263
p5163
sg16
V(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE [drugbank:DB07855]
p5164
sg18
Vdrug-target interaction (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07855_6263]
p5165
sa(dp5166
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5167
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07996
p5168
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07996_6263
p5169
sg16
V1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE [drugbank:DB07996]
p5170
sg18
Vdrug-target interaction 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07996_6263]
p5171
sa(dp5172
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5173
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08073
p5174
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08073_6263
p5175
sg16
V(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB08073]
p5176
sg18
Vdrug-target interaction (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08073_6263]
p5177
sa(dp5178
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5179
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08114
p5180
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08114_6263
p5181
sg16
V5-benzyl-1,3-thiazol-2-amine [drugbank:DB08114]
p5182
sg18
Vdrug-target interaction 5-benzyl-1,3-thiazol-2-amine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08114_6263]
p5183
sa(dp5184
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5185
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08149
p5186
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08149_6263
p5187
sg16
V1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine [drugbank:DB08149]
p5188
sg18
Vdrug-target interaction 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08149_6263]
p5189
sa(dp5190
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5191
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08150
p5192
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08150_6263
p5193
sg16
V4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium [drugbank:DB08150]
p5194
sg18
Vdrug-target interaction 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08150_6263]
p5195
sa(dp5196
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5197
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08569
p5198
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08569_6263
p5199
sg16
V3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE [drugbank:DB08569]
p5200
sg18
Vdrug-target interaction 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08569_6263]
p5201
sa(dp5202
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5203
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07583
p5204
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07583_6263
p5205
sg16
V(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE [drugbank:DB07583]
p5206
sg18
Vdrug-target interaction (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07583_6263]
p5207
sa(dp5208
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5209
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07854
p5210
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07854_6263
p5211
sg16
VN-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE [drugbank:DB07854]
p5212
sg18
Vdrug-target interaction N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07854_6263]
p5213
sa(dp5214
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5215
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07856
p5216
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07856_6263
p5217
sg16
V6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE [drugbank:DB07856]
p5218
sg18
Vdrug-target interaction 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07856_6263]
p5219
sa(dp5220
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5221
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07859
p5222
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07859_6263
p5223
sg16
V4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE [drugbank:DB07859]
p5224
sg18
Vdrug-target interaction 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07859_6263]
p5225
sa(dp5226
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5227
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07860
p5228
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07860_6263
p5229
sg16
V(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE [drugbank:DB07860]
p5230
sg18
Vdrug-target interaction (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07860_6263]
p5231
sa(dp5232
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5233
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07876
p5234
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07876_6263
p5235
sg16
V(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE [drugbank:DB07876]
p5236
sg18
Vdrug-target interaction (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07876_6263]
p5237
sa(dp5238
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5239
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07995
p5240
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07995_6263
p5241
sg16
VN-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE [drugbank:DB07995]
p5242
sg18
Vdrug-target interaction N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07995_6263]
p5243
sa(dp5244
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5245
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07997
p5246
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07997_6263
p5247
sg16
VN-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE [drugbank:DB07997]
p5248
sg18
Vdrug-target interaction N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07997_6263]
p5249
sa(dp5250
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5251
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08113
p5252
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08113_6263
p5253
sg16
V3-pyridin-4-yl-1H-indazole [drugbank:DB08113]
p5254
sg18
Vdrug-target interaction 3-pyridin-4-yl-1H-indazole and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08113_6263]
p5255
sa(dp5256
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5257
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08148
p5258
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08148_6263
p5259
sg16
V1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine [drugbank:DB08148]
p5260
sg18
Vdrug-target interaction 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08148_6263]
p5261
sa(dp5262
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5263
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p5264
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6263
p5265
sg16
VMYRISTIC ACID [drugbank:DB08231]
p5266
sg18
Vdrug-target interaction MYRISTIC ACID and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08231_6263]
p5267
sa(dp5268
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p5269
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08756
p5270
sg11
g5013
sg12
g5018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08756_6263
p5271
sg16
V(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE [drugbank:DB08756]
p5272
sg18
Vdrug-target interaction (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08756_6263]
p5273
sasS'KIFC1'
p5274
(lp5275
(dp5276
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7015
p5277
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p5278
sg11
g5274
sg12
S'kinesin family member C1'
p5279
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7015
p5280
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p5281
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIFC1 [drugbank_resource:DB03431_7015]
p5282
sasS'AKR1C3'
p5283
(lp5284
(dp5285
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5286
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p5287
sg11
g5283
sg12
S'aldo-keto reductase family 1, member C3'
p5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_650
p5289
sg16
VNADH [drugbank:DB00157]
p5290
sg18
Vdrug-target interaction NADH and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB00157_650]
p5291
sa(dp5292
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5293
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00905
p5294
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00905_650
p5295
sg16
VBimatoprost [drugbank:DB00905]
p5296
sg18
Vdrug-target interaction Bimatoprost and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB00905_650]
p5297
sa(dp5298
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5299
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01536
p5300
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01536_650
p5301
sg16
V4-Androstenedione [drugbank:DB01536]
p5302
sg18
Vdrug-target interaction 4-Androstenedione and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB01536_650]
p5303
sa(dp5304
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5305
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01698
p5306
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01698_650
p5307
sg16
VRutin [drugbank:DB01698]
p5308
sg18
Vdrug-target interaction Rutin and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB01698_650]
p5309
sa(dp5310
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5311
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02056
p5312
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02056_650
p5313
sg16
V(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid [drugbank:DB02056]
p5314
sg18
Vdrug-target interaction (5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB02056_650]
p5315
sa(dp5316
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5317
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02266
p5318
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02266_650
p5319
sg16
VFlufenamic Acid [drugbank:DB02266]
p5320
sg18
Vdrug-target interaction Flufenamic Acid and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB02266_650]
p5321
sa(dp5322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03461
p5324
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03461_650
p5325
sg16
V2'-Monophosphoadenosine 5'-Diphosphoribose [drugbank:DB03461]
p5326
sg18
Vdrug-target interaction 2'-Monophosphoadenosine 5'-Diphosphoribose and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB03461_650]
p5327
sa(dp5328
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:650
p5329
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07700
p5330
sg11
g5283
sg12
g5288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07700_650
p5331
sg16
V3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN [drugbank:DB07700]
p5332
sg18
Vdrug-target interaction 3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN and Aldo-keto reductase family 1 member C3 [drugbank_resource:DB07700_650]
p5333
sasS'CHEK1'
p5334
(lp5335
(dp5336
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5337
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06876
p5338
sg11
g5334
sg12
S'checkpoint kinase 1'
p5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06876_5790
p5340
sg16
VN-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE [drugbank:DB06876]
p5341
sg18
Vdrug-target interaction N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB06876_5790]
p5342
sa(dp5343
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5344
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07037
p5345
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07037_5790
p5346
sg16
V(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL [drugbank:DB07037]
p5347
sg18
Vdrug-target interaction (2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07037_5790]
p5348
sa(dp5349
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5350
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07038
p5351
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07038_5790
p5352
sg16
V2-(cyclohexylamino)benzoic acid [drugbank:DB07038]
p5353
sg18
Vdrug-target interaction 2-(cyclohexylamino)benzoic acid and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07038_5790]
p5354
sa(dp5355
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5356
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07228
p5357
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07228_5790
p5358
sg16
V1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA [drugbank:DB07228]
p5359
sg18
Vdrug-target interaction 1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07228_5790]
p5360
sa(dp5361
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5362
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07025
p5363
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07025_5790
p5364
sg16
V3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE [drugbank:DB07025]
p5365
sg18
Vdrug-target interaction 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07025_5790]
p5366
sa(dp5367
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5368
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07213
p5369
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07213_5790
p5370
sg16
V(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL [drugbank:DB07213]
p5371
sg18
Vdrug-target interaction (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07213_5790]
p5372
sa(dp5373
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5374
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07243
p5375
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07243_5790
p5376
sg16
V(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE [drugbank:DB07243]
p5377
sg18
Vdrug-target interaction (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07243_5790]
p5378
sa(dp5379
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5380
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07314
p5381
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07314_5790
p5382
sg16
V1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA [drugbank:DB07314]
p5383
sg18
Vdrug-target interaction 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07314_5790]
p5384
sa(dp5385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06852
p5387
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06852_5790
p5388
sg16
V4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE [drugbank:DB06852]
p5389
sg18
Vdrug-target interaction 4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB06852_5790]
p5390
sa(dp5391
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5392
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07034
p5393
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07034_5790
p5394
sg16
V2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID [drugbank:DB07034]
p5395
sg18
Vdrug-target interaction 2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07034_5790]
p5396
sa(dp5397
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5398
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07075
p5399
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07075_5790
p5400
sg16
V3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE [drugbank:DB07075]
p5401
sg18
Vdrug-target interaction 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07075_5790]
p5402
sa(dp5403
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5404
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07078
p5405
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07078_5790
p5406
sg16
V(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE [drugbank:DB07078]
p5407
sg18
Vdrug-target interaction (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07078_5790]
p5408
sa(dp5409
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5410
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07158
p5411
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07158_5790
p5412
sg16
V5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE [drugbank:DB07158]
p5413
sg18
Vdrug-target interaction 5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07158_5790]
p5414
sa(dp5415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07311
p5417
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07311_5790
p5418
sg16
V18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE [drugbank:DB07311]
p5419
sg18
Vdrug-target interaction 18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07311_5790]
p5420
sa(dp5421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07320
p5423
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07320_5790
p5424
sg16
V4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID [drugbank:DB07320]
p5425
sg18
Vdrug-target interaction 4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07320_5790]
p5426
sa(dp5427
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5428
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07336
p5429
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07336_5790
p5430
sg16
V4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL [drugbank:DB07336]
p5431
sg18
Vdrug-target interaction 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07336_5790]
p5432
sa(dp5433
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5434
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07653
p5435
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07653_5790
p5436
sg16
VN-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE [drugbank:DB07653]
p5437
sg18
Vdrug-target interaction N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07653_5790]
p5438
sa(dp5439
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5440
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08392
p5441
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08392_5790
p5442
sg16
V2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL [drugbank:DB08392]
p5443
sg18
Vdrug-target interaction 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08392_5790]
p5444
sa(dp5445
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5446
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08393
p5447
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08393_5790
p5448
sg16
V2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL [drugbank:DB08393]
p5449
sg18
Vdrug-target interaction 2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08393_5790]
p5450
sa(dp5451
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5452
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07647
p5453
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07647_5790
p5454
sg16
V(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL [drugbank:DB07647]
p5455
sg18
Vdrug-target interaction (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07647_5790]
p5456
sa(dp5457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07648
p5459
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07648_5790
p5460
sg16
V(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL [drugbank:DB07648]
p5461
sg18
Vdrug-target interaction (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07648_5790]
p5462
sa(dp5463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07654
p5465
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07654_5790
p5466
sg16
V(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC [drugbank:DB07654]
p5467
sg18
Vdrug-target interaction (5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07654_5790]
p5468
sa(dp5469
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5470
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08774
p5471
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08774_5790
p5472
sg16
V1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine [drugbank:DB08774]
p5473
sg18
Vdrug-target interaction 1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08774_5790]
p5474
sa(dp5475
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5476
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07655
p5477
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07655_5790
p5478
sg16
V3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE [drugbank:DB07655]
p5479
sg18
Vdrug-target interaction 3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07655_5790]
p5480
sa(dp5481
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5482
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07959
p5483
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07959_5790
p5484
sg16
V3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE [drugbank:DB07959]
p5485
sg18
Vdrug-target interaction 3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07959_5790]
p5486
sa(dp5487
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5488
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08683
p5489
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08683_5790
p5490
sg16
VREL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE [drugbank:DB08683]
p5491
sg18
Vdrug-target interaction REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08683_5790]
p5492
sa(dp5493
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5494
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08776
p5495
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08776_5790
p5496
sg16
VN-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE [drugbank:DB08776]
p5497
sg18
Vdrug-target interaction N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08776_5790]
p5498
sa(dp5499
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5500
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08777
p5501
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08777_5790
p5502
sg16
V5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE [drugbank:DB08777]
p5503
sg18
Vdrug-target interaction 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08777_5790]
p5504
sa(dp5505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08780
p5507
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08780_5790
p5508
sg16
V6-MORPHOLIN-4-YL-9H-PURINE [drugbank:DB08780]
p5509
sg18
Vdrug-target interaction 6-MORPHOLIN-4-YL-9H-PURINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08780_5790]
p5510
sa(dp5511
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5512
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08778
p5513
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08778_5790
p5514
sg16
V[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone [drugbank:DB08778]
p5515
sg18
Vdrug-target interaction [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08778_5790]
p5516
sa(dp5517
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5518
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08779
p5519
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08779_5790
p5520
sg16
V2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol [drugbank:DB08779]
p5521
sg18
Vdrug-target interaction 2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08779_5790]
p5522
sa(dp5523
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p5524
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08781
p5525
sg11
g5334
sg12
g5339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08781_5790
p5526
sg16
V1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE [drugbank:DB08781]
p5527
sg18
Vdrug-target interaction 1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08781_5790]
p5528
sasS'CNR1'
p5529
(lp5530
(dp5531
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:68
p5532
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00470
p5533
sg11
g5529
sg12
S'cannabinoid receptor 1 (brain)'
p5534
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00470_68
p5535
sg16
VDronabinol [drugbank:DB00470]
p5536
sg18
Vdrug-target interaction Dronabinol and Cannabinoid receptor 1 [drugbank_resource:DB00470_68]
p5537
sa(dp5538
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:68
p5539
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00486
p5540
sg11
g5529
sg12
g5534
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00486_68
p5541
sg16
VNabilone [drugbank:DB00486]
p5542
sg18
Vdrug-target interaction Nabilone and Cannabinoid receptor 1 [drugbank_resource:DB00486_68]
p5543
sa(dp5544
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:68
p5545
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06155
p5546
sg11
g5529
sg12
g5534
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06155_68
p5547
sg16
VRimonabant [drugbank:DB06155]
p5548
sg18
Vdrug-target interaction Rimonabant and Cannabinoid receptor 1 [drugbank_resource:DB06155_68]
p5549
sasS'GSPT1'
p5550
(lp5551
(dp5552
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6958
p5553
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p5554
sg11
g5550
sg12
S'G1 to S phase transition 1'
p5555
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_6958
p5556
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p5557
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Eukaryotic peptide chain release factor GTP-binding subunit ERF3A [drugbank_resource:DB04315_6958]
p5558
sasS'IGF1'
p5559
(lp5560
(dp5561
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5841
p5562
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01890
p5563
sg11
g5559
sg12
S'insulin-like growth factor 1 (somatomedin C)'
p5564
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01890_5841
p5565
sg16
VDeoxy-Bigchap [drugbank:DB01890]
p5566
sg18
Vdrug-target interaction Deoxy-Bigchap and Insulin-like growth factor IB [drugbank_resource:DB01890_5841]
p5567
sa(dp5568
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5841
p5569
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02643
p5570
sg11
g5559
sg12
g5564
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02643_5841
p5571
sg16
VN-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate [drugbank:DB02643]
p5572
sg18
Vdrug-target interaction N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate and Insulin-like growth factor IB [drugbank_resource:DB02643_5841]
p5573
sasS'CA3'
p5574
(lp5575
(dp5576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6122
p5577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00819
p5578
sg11
g5574
sg12
S'carbonic anhydrase III, muscle specific'
p5579
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00819_6122
p5580
sg16
VAcetazolamide [drugbank:DB00819]
p5581
sg18
Vdrug-target interaction Acetazolamide and Carbonic anhydrase 3 [drugbank_resource:DB00819_6122]
p5582
sa(dp5583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6122
p5584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p5585
sg11
g5574
sg12
g5579
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_6122
p5586
sg16
VZonisamide [drugbank:DB00909]
p5587
sg18
Vdrug-target interaction Zonisamide and Carbonic anhydrase 3 [drugbank_resource:DB00909_6122]
p5588
sasS'FOS'
p5589
(lp5590
(dp5591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1953
p5592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08813
p5593
sg11
g5589
sg12
S'FBJ murine osteosarcoma viral oncogene homolog'
p5594
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08813_1953
p5595
sg16
VNadroparin [drugbank:DB08813]
p5596
sg18
Vdrug-target interaction Nadroparin and Proto-oncogene protein c-fos [drugbank_resource:DB08813_1953]
p5597
sasS'CDC25B'
p5598
(lp5599
(dp5600
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3105
p5601
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01769
p5602
sg11
g5598
sg12
S'cell division cycle 25B'
p5603
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01769_3105
p5604
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p5605
sg18
Vdrug-target interaction Double Oxidized Cysteine and M-phase inducer phosphatase 2 [drugbank_resource:DB01769_3105]
p5606
sa(dp5607
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3105
p5608
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03661
p5609
sg11
g5598
sg12
g5603
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03661_3105
p5610
sg16
VCysteinesulfonic Acid [drugbank:DB03661]
p5611
sg18
Vdrug-target interaction Cysteinesulfonic Acid and M-phase inducer phosphatase 2 [drugbank_resource:DB03661_3105]
p5612
sa(dp5613
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3105
p5614
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03674
p5615
sg11
g5598
sg12
g5603
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03674_3105
p5616
sg16
VMethyl Mercury Ion [drugbank:DB03674]
p5617
sg18
Vdrug-target interaction Methyl Mercury Ion and M-phase inducer phosphatase 2 [drugbank_resource:DB03674_3105]
p5618
sasS'CDK7'
p5619
(lp5620
(dp5621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3482
p5622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p5623
sg11
g5619
sg12
S'cyclin-dependent kinase 7'
p5624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_3482
p5625
sg16
VPhosphonothreonine [drugbank:DB02482]
p5626
sg18
Vdrug-target interaction Phosphonothreonine and Cell division protein kinase 7 [drugbank_resource:DB02482_3482]
p5627
sa(dp5628
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3482
p5629
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p5630
sg11
g5619
sg12
g5624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3482
p5631
sg16
VFlavopiridol [drugbank:DB03496]
p5632
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 7 [drugbank_resource:DB03496_3482]
p5633
sasS'EPN1'
p5634
(lp5635
(dp5636
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6962
p5637
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03316
p5638
sg11
g5634
sg12
S'epsin 1'
p5639
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03316_6962
p5640
sg16
V1,4-Diethylene Dioxide [drugbank:DB03316]
p5641
sg18
Vdrug-target interaction 1,4-Diethylene Dioxide and Epsin-1 [drugbank_resource:DB03316_6962]
p5642
sa(dp5643
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6962
p5644
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03401
p5645
sg11
g5634
sg12
g5639
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03401_6962
p5646
sg16
VD-Myo-Inositol-1,4,5-Triphosphate [drugbank:DB03401]
p5647
sg18
Vdrug-target interaction D-Myo-Inositol-1,4,5-Triphosphate and Epsin-1 [drugbank_resource:DB03401_6962]
p5648
sasS'PARP1'
p5649
(lp5650
(dp5651
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5652
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02690
p5653
sg11
g5649
sg12
S'poly (ADP-ribose) polymerase 1'
p5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02690_3126
p5655
sg16
VNU1025 [drugbank:DB02690]
p5656
sg18
Vdrug-target interaction NU1025 and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02690_3126]
p5657
sa(dp5658
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5659
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02498
p5660
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02498_3126
p5661
sg16
VCarba-Nicotinamide-Adenine-Dinucleotide [drugbank:DB02498]
p5662
sg18
Vdrug-target interaction Carba-Nicotinamide-Adenine-Dinucleotide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02498_3126]
p5663
sa(dp5664
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5665
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02701
p5666
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02701_3126
p5667
sg16
VNicotinamide [drugbank:DB02701]
p5668
sg18
Vdrug-target interaction Nicotinamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02701_3126]
p5669
sa(dp5670
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5671
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03072
p5672
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03072_3126
p5673
sg16
V2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone [drugbank:DB03072]
p5674
sg18
Vdrug-target interaction 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03072_3126]
p5675
sa(dp5676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03073
p5678
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03073_3126
p5679
sg16
V3-Methoxybenzamide [drugbank:DB03073]
p5680
sg18
Vdrug-target interaction 3-Methoxybenzamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03073_3126]
p5681
sa(dp5682
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5683
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03722
p5684
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03722_3126
p5685
sg16
V3,4-Dihydro-5-Methyl-Isoquinolinone [drugbank:DB03722]
p5686
sg18
Vdrug-target interaction 3,4-Dihydro-5-Methyl-Isoquinolinone and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03722_3126]
p5687
sa(dp5688
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5689
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03509
p5690
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03509_3126
p5691
sg16
V2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide [drugbank:DB03509]
p5692
sg18
Vdrug-target interaction 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03509_3126]
p5693
sa(dp5694
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5695
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04010
p5696
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04010_3126
p5697
sg16
V2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide [drugbank:DB04010]
p5698
sg18
Vdrug-target interaction 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB04010_3126]
p5699
sa(dp5700
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5701
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07096
p5702
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07096_3126
p5703
sg16
V6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE [drugbank:DB07096]
p5704
sg18
Vdrug-target interaction 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07096_3126]
p5705
sa(dp5706
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5707
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07232
p5708
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07232_3126
p5709
sg16
V(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium [drugbank:DB07232]
p5710
sg18
Vdrug-target interaction (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07232_3126]
p5711
sa(dp5712
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5713
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07330
p5714
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07330_3126
p5715
sg16
Vtrans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium [drugbank:DB07330]
p5716
sg18
Vdrug-target interaction trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07330_3126]
p5717
sa(dp5718
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p5719
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07787
p5720
sg11
g5649
sg12
g5654
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07787_3126
p5721
sg16
V5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE [drugbank:DB07787]
p5722
sg18
Vdrug-target interaction 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07787_3126]
p5723
sasS'HIF1A'
p5724
(lp5725
(dp5726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4130
p5727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08687
p5728
sg11
g5724
sg12
S'hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)'
p5729
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08687_4130
p5730
sg16
VN-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE [drugbank:DB08687]
p5731
sg18
Vdrug-target interaction N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE and Hypoxia-inducible factor 1 alpha [drugbank_resource:DB08687_4130]
p5732
sasS'PPARG'
p5733
(lp5734
(dp5735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00244
p5737
sg11
g5733
sg12
S'peroxisome proliferator-activated receptor gamma'
p5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00244_238
p5739
sg16
VMesalazine [drugbank:DB00244]
p5740
sg18
Vdrug-target interaction Mesalazine and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00244_238]
p5741
sa(dp5742
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5743
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00159
p5744
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00159_238
p5745
sg16
VIcosapent [drugbank:DB00159]
p5746
sg18
Vdrug-target interaction Icosapent and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00159_238]
p5747
sa(dp5748
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5749
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00197
p5750
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00197_238
p5751
sg16
VTroglitazone [drugbank:DB00197]
p5752
sg18
Vdrug-target interaction Troglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00197_238]
p5753
sa(dp5754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00328
p5756
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00328_238
p5757
sg16
VIndomethacin [drugbank:DB00328]
p5758
sg18
Vdrug-target interaction Indomethacin and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00328_238]
p5759
sa(dp5760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00412
p5762
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00412_238
p5763
sg16
VRosiglitazone [drugbank:DB00412]
p5764
sg18
Vdrug-target interaction Rosiglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00412_238]
p5765
sa(dp5766
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5767
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00795
p5768
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00795_238
p5769
sg16
VSulfasalazine [drugbank:DB00795]
p5770
sg18
Vdrug-target interaction Sulfasalazine and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00795_238]
p5771
sa(dp5772
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5773
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00912
p5774
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00912_238
p5775
sg16
VRepaglinide [drugbank:DB00912]
p5776
sg18
Vdrug-target interaction Repaglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00912_238]
p5777
sa(dp5778
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5779
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00731
p5780
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00731_238
p5781
sg16
VNateglinide [drugbank:DB00731]
p5782
sg18
Vdrug-target interaction Nateglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00731_238]
p5783
sa(dp5784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01014
p5786
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01014_238
p5787
sg16
VBalsalazide [drugbank:DB01014]
p5788
sg18
Vdrug-target interaction Balsalazide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01014_238]
p5789
sa(dp5790
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5791
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00966
p5792
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00966_238
p5793
sg16
VTelmisartan [drugbank:DB00966]
p5794
sg18
Vdrug-target interaction Telmisartan and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00966_238]
p5795
sa(dp5796
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5797
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01067
p5798
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01067_238
p5799
sg16
VGlipizide [drugbank:DB01067]
p5800
sg18
Vdrug-target interaction Glipizide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01067_238]
p5801
sa(dp5802
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5803
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01132
p5804
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01132_238
p5805
sg16
VPioglitazone [drugbank:DB01132]
p5806
sg18
Vdrug-target interaction Pioglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01132_238]
p5807
sa(dp5808
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5809
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01252
p5810
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01252_238
p5811
sg16
VMitiglinide [drugbank:DB01252]
p5812
sg18
Vdrug-target interaction Mitiglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01252_238]
p5813
sa(dp5814
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5815
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01393
p5816
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01393_238
p5817
sg16
VBezafibrate [drugbank:DB01393]
p5818
sg18
Vdrug-target interaction Bezafibrate and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01393_238]
p5819
sa(dp5820
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5821
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04270
p5822
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04270_238
p5823
sg16
V(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid [drugbank:DB04270]
p5824
sg18
Vdrug-target interaction (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB04270_238]
p5825
sa(dp5826
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5827
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06926
p5828
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06926_238
p5829
sg16
V(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid [drugbank:DB06926]
p5830
sg18
Vdrug-target interaction (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB06926_238]
p5831
sa(dp5832
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5833
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07111
p5834
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07111_238
p5835
sg16
V(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid [drugbank:DB07111]
p5836
sg18
Vdrug-target interaction (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07111_238]
p5837
sa(dp5838
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5839
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07172
p5840
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07172_238
p5841
sg16
V(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid [drugbank:DB07172]
p5842
sg18
Vdrug-target interaction (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07172_238]
p5843
sa(dp5844
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5845
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07208
p5846
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07208_238
p5847
sg16
V(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid [drugbank:DB07208]
p5848
sg18
Vdrug-target interaction (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07208_238]
p5849
sa(dp5850
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5851
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07209
p5852
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07209_238
p5853
sg16
V(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid [drugbank:DB07209]
p5854
sg18
Vdrug-target interaction (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07209_238]
p5855
sa(dp5856
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5857
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06908
p5858
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06908_238
p5859
sg16
V(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID [drugbank:DB06908]
p5860
sg18
Vdrug-target interaction (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB06908_238]
p5861
sa(dp5862
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5863
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04689
p5864
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04689_238
p5865
sg16
V2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID [drugbank:DB04689]
p5866
sg18
Vdrug-target interaction 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB04689_238]
p5867
sa(dp5868
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5869
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07053
p5870
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07053_238
p5871
sg16
V2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID [drugbank:DB07053]
p5872
sg18
Vdrug-target interaction 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07053_238]
p5873
sa(dp5874
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5875
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07302
p5876
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07302_238
p5877
sg16
V(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid [drugbank:DB07302]
p5878
sg18
Vdrug-target interaction (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07302_238]
p5879
sa(dp5880
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5881
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07509
p5882
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07509_238
p5883
sg16
Vdifluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron [drugbank:DB07509]
p5884
sg18
Vdrug-target interaction difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07509_238]
p5885
sa(dp5886
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5887
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07723
p5888
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07723_238
p5889
sg16
V3-(5-methoxy-1H-indol-3-yl)propanoic acid [drugbank:DB07723]
p5890
sg18
Vdrug-target interaction 3-(5-methoxy-1H-indol-3-yl)propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07723_238]
p5891
sa(dp5892
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5893
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07724
p5894
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07724_238
p5895
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p5896
sg18
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07724_238]
p5897
sa(dp5898
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5899
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08302
p5900
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08302_238
p5901
sg16
V3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid [drugbank:DB08302]
p5902
sg18
Vdrug-target interaction 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08302_238]
p5903
sa(dp5904
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5905
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07842
p5906
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07842_238
p5907
sg16
V(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid [drugbank:DB07842]
p5908
sg18
Vdrug-target interaction (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07842_238]
p5909
sa(dp5910
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5911
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07863
p5912
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07863_238
p5913
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p5914
sg18
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07863_238]
p5915
sa(dp5916
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5917
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08402
p5918
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08402_238
p5919
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p5920
sg18
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08402_238]
p5921
sa(dp5922
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5923
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08435
p5924
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08435_238
p5925
sg16
V(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid [drugbank:DB08435]
p5926
sg18
Vdrug-target interaction (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08435_238]
p5927
sa(dp5928
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5929
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08560
p5930
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08560_238
p5931
sg16
V3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE [drugbank:DB08560]
p5932
sg18
Vdrug-target interaction 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08560_238]
p5933
sa(dp5934
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5935
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08760
p5936
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08760_238
p5937
sg16
V(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid [drugbank:DB08760]
p5938
sg18
Vdrug-target interaction (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08760_238]
p5939
sa(dp5940
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5941
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07675
p5942
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07675_238
p5943
sg16
V(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID [drugbank:DB07675]
p5944
sg18
Vdrug-target interaction (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07675_238]
p5945
sa(dp5946
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5947
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08121
p5948
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08121_238
p5949
sg16
V(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid [drugbank:DB08121]
p5950
sg18
Vdrug-target interaction (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08121_238]
p5951
sa(dp5952
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5953
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08483
p5954
sg11
g5733
sg12
g5738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08483_238
p5955
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p5956
sg18
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08483_238]
p5957
sasS'PLAU'
p5958
(lp5959
(dp5960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p5962
sg11
g5958
sg12
S'plasminogen activator, urokinase'
p5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1074
p5964
sg16
VUrokinase [drugbank:DB00013]
p5965
sg18
Vdrug-target interaction Urokinase and Urokinase-type plasminogen activator [drugbank_resource:DB00013_1074]
p5966
sa(dp5967
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5968
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00594
p5969
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00594_1074
p5970
sg16
VAmiloride [drugbank:DB00594]
p5971
sg18
Vdrug-target interaction Amiloride and Urokinase-type plasminogen activator [drugbank_resource:DB00594_1074]
p5972
sa(dp5973
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5974
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01905
p5975
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01905_1074
p5976
sg16
V2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine [drugbank:DB01905]
p5977
sg18
Vdrug-target interaction 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB01905_1074]
p5978
sa(dp5979
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5980
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01977
p5981
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01977_1074
p5982
sg16
V6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine [drugbank:DB01977]
p5983
sg18
Vdrug-target interaction 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB01977_1074]
p5984
sa(dp5985
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5986
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02526
p5987
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02526_1074
p5988
sg16
VCRA_10655 [drugbank:DB02526]
p5989
sg18
Vdrug-target interaction CRA_10655 and Urokinase-type plasminogen activator [drugbank_resource:DB02526_1074]
p5990
sa(dp5991
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5992
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02551
p5993
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02551_1074
p5994
sg16
V6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02551]
p5995
sg18
Vdrug-target interaction 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02551_1074]
p5996
sa(dp5997
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p5998
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02193
p5999
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02193_1074
p6000
sg16
V2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine [drugbank:DB02193]
p6001
sg18
Vdrug-target interaction 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02193_1074]
p6002
sa(dp6003
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6004
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02705
p6005
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02705_1074
p6006
sg16
V6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02705]
p6007
sg18
Vdrug-target interaction 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02705_1074]
p6008
sa(dp6009
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6010
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03046
p6011
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03046_1074
p6012
sg16
V7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide [drugbank:DB03046]
p6013
sg18
Vdrug-target interaction 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide and Urokinase-type plasminogen activator [drugbank_resource:DB03046_1074]
p6014
sa(dp6015
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6016
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p6017
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_1074
p6018
sg16
VBenzamidine [drugbank:DB03127]
p6019
sg18
Vdrug-target interaction Benzamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03127_1074]
p6020
sa(dp6021
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6022
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03136
p6023
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03136_1074
p6024
sg16
V4-Iodobenzo[B]Thiophene-2-Carboxamidine [drugbank:DB03136]
p6025
sg18
Vdrug-target interaction 4-Iodobenzo[B]Thiophene-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03136_1074]
p6026
sa(dp6027
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6028
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03159
p6029
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03159_1074
p6030
sg16
VCRA_8696 [drugbank:DB03159]
p6031
sg18
Vdrug-target interaction CRA_8696 and Urokinase-type plasminogen activator [drugbank_resource:DB03159_1074]
p6032
sa(dp6033
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6034
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02398
p6035
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02398_1074
p6036
sg16
V6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02398]
p6037
sg18
Vdrug-target interaction 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02398_1074]
p6038
sa(dp6039
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6040
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02473
p6041
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02473_1074
p6042
sg16
V6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02473]
p6043
sg18
Vdrug-target interaction 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02473_1074]
p6044
sa(dp6045
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6046
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03082
p6047
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03082_1074
p6048
sg16
V6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide [drugbank:DB03082]
p6049
sg18
Vdrug-target interaction 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide and Urokinase-type plasminogen activator [drugbank_resource:DB03082_1074]
p6050
sa(dp6051
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6052
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03476
p6053
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03476_1074
p6054
sg16
VTrans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine [drugbank:DB03476]
p6055
sg18
Vdrug-target interaction Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03476_1074]
p6056
sa(dp6057
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6058
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03782
p6059
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03782_1074
p6060
sg16
VN-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea [drugbank:DB03782]
p6061
sg18
Vdrug-target interaction N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea and Urokinase-type plasminogen activator [drugbank_resource:DB03782_1074]
p6062
sa(dp6063
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6064
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03876
p6065
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03876_1074
p6066
sg16
VThieno[2,3-B]Pyridine-2-Carboxamidine [drugbank:DB03876]
p6067
sg18
Vdrug-target interaction Thieno[2,3-B]Pyridine-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03876_1074]
p6068
sa(dp6069
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6070
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03865
p6071
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03865_1074
p6072
sg16
V6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine [drugbank:DB03865]
p6073
sg18
Vdrug-target interaction 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03865_1074]
p6074
sa(dp6075
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6076
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04059
p6077
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04059_1074
p6078
sg16
V8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide [drugbank:DB04059]
p6079
sg18
Vdrug-target interaction 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide and Urokinase-type plasminogen activator [drugbank_resource:DB04059_1074]
p6080
sa(dp6081
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6082
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03729
p6083
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03729_1074
p6084
sg16
V2-Amino-5-Hydroxy-Benzimidazole [drugbank:DB03729]
p6085
sg18
Vdrug-target interaction 2-Amino-5-Hydroxy-Benzimidazole and Urokinase-type plasminogen activator [drugbank_resource:DB03729_1074]
p6086
sa(dp6087
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6088
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04172
p6089
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04172_1074
p6090
sg16
V[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine [drugbank:DB04172]
p6091
sg18
Vdrug-target interaction [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine and Urokinase-type plasminogen activator [drugbank_resource:DB04172_1074]
p6092
sa(dp6093
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6094
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06857
p6095
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06857_1074
p6096
sg16
VN-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE [drugbank:DB06857]
p6097
sg18
Vdrug-target interaction N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB06857_1074]
p6098
sa(dp6099
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6100
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07122
p6101
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07122_1074
p6102
sg16
V1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine [drugbank:DB07122]
p6103
sg18
Vdrug-target interaction 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine and Urokinase-type plasminogen activator [drugbank_resource:DB07122_1074]
p6104
sa(dp6105
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6106
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06855
p6107
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06855_1074
p6108
sg16
V6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB06855]
p6109
sg18
Vdrug-target interaction 6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06855_1074]
p6110
sa(dp6111
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6112
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06856
p6113
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06856_1074
p6114
sg16
V6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE [drugbank:DB06856]
p6115
sg18
Vdrug-target interaction 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06856_1074]
p6116
sa(dp6117
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6118
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07076
p6119
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07076_1074
p6120
sg16
V6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE [drugbank:DB07076]
p6121
sg18
Vdrug-target interaction 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB07076_1074]
p6122
sa(dp6123
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6124
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06854
p6125
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06854_1074
p6126
sg16
V2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB06854]
p6127
sg18
Vdrug-target interaction 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06854_1074]
p6128
sa(dp6129
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6130
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07129
p6131
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07129_1074
p6132
sg16
V(2R)-1-(2,6-dimethylphenoxy)propan-2-amine [drugbank:DB07129]
p6133
sg18
Vdrug-target interaction (2R)-1-(2,6-dimethylphenoxy)propan-2-amine and Urokinase-type plasminogen activator [drugbank_resource:DB07129_1074]
p6134
sa(dp6135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07625
p6137
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07625_1074
p6138
sg16
V4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide [drugbank:DB07625]
p6139
sg18
Vdrug-target interaction 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB07625_1074]
p6140
sa(dp6141
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6142
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07626
p6143
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07626_1074
p6144
sg16
V4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide [drugbank:DB07626]
p6145
sg18
Vdrug-target interaction 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB07626_1074]
p6146
sa(dp6147
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6148
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08072
p6149
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08072_1074
p6150
sg16
V4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE [drugbank:DB08072]
p6151
sg18
Vdrug-target interaction 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB08072_1074]
p6152
sa(dp6153
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p6154
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08697
p6155
sg11
g5958
sg12
g5963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08697_1074
p6156
sg16
V4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide [drugbank:DB08697]
p6157
sg18
Vdrug-target interaction 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB08697_1074]
p6158
sasS'TK1'
p6159
(lp6160
(dp6161
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2320
p6162
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01692
p6163
sg11
g6159
sg12
S'thymidine kinase 1, soluble'
p6164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01692_2320
p6165
sg16
VDithioerythritol [drugbank:DB01692]
p6166
sg18
Vdrug-target interaction Dithioerythritol and Thymidine kinase, cytosolic [drugbank_resource:DB01692_2320]
p6167
sa(dp6168
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2320
p6169
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02452
p6170
sg11
g6159
sg12
g6164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02452_2320
p6171
sg16
VThymidine-5'-Triphosphate [drugbank:DB02452]
p6172
sg18
Vdrug-target interaction Thymidine-5'-Triphosphate and Thymidine kinase, cytosolic [drugbank_resource:DB02452_2320]
p6173
sasS'KCNE1'
p6174
(lp6175
(dp6176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:544
p6177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00808
p6178
sg11
g6174
sg12
S'potassium voltage-gated channel, Isk-related family, member 1'
p6179
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00808_544
p6180
sg16
VIndapamide [drugbank:DB00808]
p6181
sg18
Vdrug-target interaction Indapamide and Potassium voltage-gated channel subfamily E member 1 [drugbank_resource:DB00808_544]
p6182
sasS'HCK'
p6183
(lp6184
(dp6185
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2599
p6186
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01809
p6187
sg11
g6183
sg12
S'hemopoietic cell kinase'
p6188
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01809_2599
p6189
sg16
V1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB01809]
p6190
sg18
Vdrug-target interaction 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Tyrosine-protein kinase HCK [drugbank_resource:DB01809_2599]
p6191
sa(dp6192
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2599
p6193
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01962
p6194
sg11
g6183
sg12
g6188
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01962_2599
p6195
sg16
VPhosphonotyrosine [drugbank:DB01962]
p6196
sg18
Vdrug-target interaction Phosphonotyrosine and Tyrosine-protein kinase HCK [drugbank_resource:DB01962_2599]
p6197
sa(dp6198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2599
p6199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04216
p6200
sg11
g6183
sg12
g6188
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04216_2599
p6201
sg16
VQuercetin [drugbank:DB04216]
p6202
sg18
Vdrug-target interaction Quercetin and Tyrosine-protein kinase HCK [drugbank_resource:DB04216_2599]
p6203
sasS'RHOA'
p6204
(lp6205
(dp6206
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2170
p6207
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p6208
sg11
g6204
sg12
S'ras homolog family member A'
p6209
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_2170
p6210
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p6211
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Transforming protein RhoA [drugbank_resource:DB04315_2170]
p6212
sasS'ITPR1'
p6213
(lp6214
(dp6215
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7032
p6216
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03401
p6217
sg11
g6213
sg12
S'inositol 1,4,5-trisphosphate receptor, type 1'
p6218
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03401_7032
p6219
sg16
VD-Myo-Inositol-1,4,5-Triphosphate [drugbank:DB03401]
p6220
sg18
Vdrug-target interaction D-Myo-Inositol-1,4,5-Triphosphate and Inositol 1,4,5-trisphosphate receptor type 1 [drugbank_resource:DB03401_7032]
p6221
sa(dp6222
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7032
p6223
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04077
p6224
sg11
g6213
sg12
g6218
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04077_7032
p6225
sg16
VGlycerol [drugbank:DB04077]
p6226
sg18
Vdrug-target interaction Glycerol and Inositol 1,4,5-trisphosphate receptor type 1 [drugbank_resource:DB04077_7032]
p6227
sasS'ARL5A'
p6228
(lp6229
(dp6230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5630
p6231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p6232
sg11
g6228
sg12
S'ADP-ribosylation factor-like 5A'
p6233
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_5630
p6234
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p6235
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and ADP-ribosylation factor-like protein 5A [drugbank_resource:DB04315_5630]
p6236
sasS'FGF2'
p6237
(lp6238
(dp6239
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1525
p6240
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00364
p6241
sg11
g6237
sg12
S'fibroblast growth factor 2 (basic)'
p6242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00364_1525
p6243
sg16
VSucralfate [drugbank:DB00364]
p6244
sg18
Vdrug-target interaction Sucralfate and Heparin-binding growth factor 2 [drugbank_resource:DB00364_1525]
p6245
sa(dp6246
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1525
p6247
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00686
p6248
sg11
g6237
sg12
g6242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00686_1525
p6249
sg16
VPentosan Polysulfate [drugbank:DB00686]
p6250
sg18
Vdrug-target interaction Pentosan Polysulfate and Heparin-binding growth factor 2 [drugbank_resource:DB00686_1525]
p6251
sa(dp6252
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1525
p6253
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00877
p6254
sg11
g6237
sg12
g6242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00877_1525
p6255
sg16
VSirolimus [drugbank:DB00877]
p6256
sg18
Vdrug-target interaction Sirolimus and Heparin-binding growth factor 2 [drugbank_resource:DB00877_1525]
p6257
sa(dp6258
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1525
p6259
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03935
p6260
sg11
g6237
sg12
g6242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03935_1525
p6261
sg16
V1,4-Dideoxy-O2-Sulfo-Glucuronic Acid [drugbank:DB03935]
p6262
sg18
Vdrug-target interaction 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid and Heparin-binding growth factor 2 [drugbank_resource:DB03935_1525]
p6263
sa(dp6264
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1525
p6265
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03959
p6266
sg11
g6237
sg12
g6242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03959_1525
p6267
sg16
VN,O6-Disulfo-Glucosamine [drugbank:DB03959]
p6268
sg18
Vdrug-target interaction N,O6-Disulfo-Glucosamine and Heparin-binding growth factor 2 [drugbank_resource:DB03959_1525]
p6269
sa(dp6270
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1525
p6271
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03981
p6272
sg11
g6237
sg12
g6242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03981_1525
p6273
sg16
V1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid [drugbank:DB03981]
p6274
sg18
Vdrug-target interaction 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid and Heparin-binding growth factor 2 [drugbank_resource:DB03981_1525]
p6275
sasS'FGF1'
p6276
(lp6277
(dp6278
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6279
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01025
p6280
sg11
g6276
sg12
S'fibroblast growth factor 1 (acidic)'
p6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01025_760
p6282
sg16
VAmlexanox [drugbank:DB01025]
p6283
sg18
Vdrug-target interaction Amlexanox and Heparin-binding growth factor 1 [drugbank_resource:DB01025_760]
p6284
sa(dp6285
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6286
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00686
p6287
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00686_760
p6288
sg16
VPentosan Polysulfate [drugbank:DB00686]
p6289
sg18
Vdrug-target interaction Pentosan Polysulfate and Heparin-binding growth factor 1 [drugbank_resource:DB00686_760]
p6290
sa(dp6291
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6292
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01942
p6293
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01942_760
p6294
sg16
VFormic Acid [drugbank:DB01942]
p6295
sg18
Vdrug-target interaction Formic Acid and Heparin-binding growth factor 1 [drugbank_resource:DB01942_760]
p6296
sa(dp6297
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6298
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01901
p6299
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01901_760
p6300
sg16
VSucrose Octasulfate [drugbank:DB01901]
p6301
sg18
Vdrug-target interaction Sucrose Octasulfate and Heparin-binding growth factor 1 [drugbank_resource:DB01901_760]
p6302
sa(dp6303
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6304
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02264
p6305
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02264_760
p6306
sg16
VO2-Sulfo-Glucuronic Acid [drugbank:DB02264]
p6307
sg18
Vdrug-target interaction O2-Sulfo-Glucuronic Acid and Heparin-binding growth factor 1 [drugbank_resource:DB02264_760]
p6308
sa(dp6309
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6310
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03959
p6311
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03959_760
p6312
sg16
VN,O6-Disulfo-Glucosamine [drugbank:DB03959]
p6313
sg18
Vdrug-target interaction N,O6-Disulfo-Glucosamine and Heparin-binding growth factor 1 [drugbank_resource:DB03959_760]
p6314
sa(dp6315
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6316
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04409
p6317
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04409_760
p6318
sg16
VNaphthalene Trisulfonate [drugbank:DB04409]
p6319
sg18
Vdrug-target interaction Naphthalene Trisulfonate and Heparin-binding growth factor 1 [drugbank_resource:DB04409_760]
p6320
sa(dp6321
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:760
p6322
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08238
p6323
sg11
g6276
sg12
g6281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08238_760
p6324
sg16
V5-AMINO-NAPHTALENE-2-MONOSULFONATE [drugbank:DB08238]
p6325
sg18
Vdrug-target interaction 5-AMINO-NAPHTALENE-2-MONOSULFONATE and Heparin-binding growth factor 1 [drugbank_resource:DB08238_760]
p6326
sasS'TUBB2B'
p6327
(lp6328
(dp6329
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5812
p6330
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07574
p6331
sg11
g6327
sg12
S'tubulin, beta 2B class IIb'
p6332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07574_5812
p6333
sg16
V2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE [drugbank:DB07574]
p6334
sg18
Vdrug-target interaction 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE and Tubulin beta-2B chain [drugbank_resource:DB07574_5812]
p6335
sasS'TNFRSF1A'
p6336
(lp6337
(dp6338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1984
p6339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03507
p6340
sg11
g6336
sg12
S'tumor necrosis factor receptor superfamily, member 1A'
p6341
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03507_1984
p6342
sg16
V6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One [drugbank:DB03507]
p6343
sg18
Vdrug-target interaction 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One and Tumor necrosis factor receptor superfamily member 1A [drugbank_resource:DB03507_1984]
p6344
sasS'TP53'
p6345
(lp6346
(dp6347
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5788
p6348
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08363
p6349
sg11
g6345
sg12
S'tumor protein p53'
p6350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08363_5788
p6351
sg16
V1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine [drugbank:DB08363]
p6352
sg18
Vdrug-target interaction 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine and Cellular tumor antigen p53 [drugbank_resource:DB08363_5788]
p6353
sasS'SGK1'
p6354
(lp6355
(dp6356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6608
p6357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03247
p6358
sg11
g6354
sg12
S'serum/glucocorticoid regulated kinase 1'
p6359
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03247_6608
p6360
sg16
VRiboflavin Monophosphate [drugbank:DB03247]
p6361
sg18
Vdrug-target interaction Riboflavin Monophosphate and Serine/threonine-protein kinase Sgk1 [drugbank_resource:DB03247_6608]
p6362
sa(dp6363
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6608
p6364
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07837
p6365
sg11
g6354
sg12
g6359
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07837_6608
p6366
sg16
V[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid [drugbank:DB07837]
p6367
sg18
Vdrug-target interaction [4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid and Serine/threonine-protein kinase Sgk1 [drugbank_resource:DB07837_6608]
p6368
sa(dp6369
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6608
p6370
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08191
p6371
sg11
g6354
sg12
g6359
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08191_6608
p6372
sg16
V4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid [drugbank:DB08191]
p6373
sg18
Vdrug-target interaction 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid and Serine/threonine-protein kinase Sgk1 [drugbank_resource:DB08191_6608]
p6374
sasS'ESR1'
p6375
(lp6376
(dp6377
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6378
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00255
p6379
sg11
g6375
sg12
S'estrogen receptor 1'
p6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00255_136
p6381
sg16
VDiethylstilbestrol [drugbank:DB00255]
p6382
sg18
Vdrug-target interaction Diethylstilbestrol and Estrogen receptor [drugbank_resource:DB00255_136]
p6383
sa(dp6384
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6385
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00269
p6386
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00269_136
p6387
sg16
VChlorotrianisene [drugbank:DB00269]
p6388
sg18
Vdrug-target interaction Chlorotrianisene and Estrogen receptor [drugbank_resource:DB00269_136]
p6389
sa(dp6390
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6391
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00304
p6392
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00304_136
p6393
sg16
VDesogestrel [drugbank:DB00304]
p6394
sg18
Vdrug-target interaction Desogestrel and Estrogen receptor [drugbank_resource:DB00304_136]
p6395
sa(dp6396
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6397
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00286
p6398
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00286_136
p6399
sg16
VConjugated Estrogens [drugbank:DB00286]
p6400
sg18
Vdrug-target interaction Conjugated Estrogens and Estrogen receptor [drugbank_resource:DB00286_136]
p6401
sa(dp6402
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6403
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00294
p6404
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00294_136
p6405
sg16
VEtonogestrel [drugbank:DB00294]
p6406
sg18
Vdrug-target interaction Etonogestrel and Estrogen receptor [drugbank_resource:DB00294_136]
p6407
sa(dp6408
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6409
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00396
p6410
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00396_136
p6411
sg16
VProgesterone [drugbank:DB00396]
p6412
sg18
Vdrug-target interaction Progesterone and Estrogen receptor [drugbank_resource:DB00396_136]
p6413
sa(dp6414
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6415
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00481
p6416
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00481_136
p6417
sg16
VRaloxifene [drugbank:DB00481]
p6418
sg18
Vdrug-target interaction Raloxifene and Estrogen receptor [drugbank_resource:DB00481_136]
p6419
sa(dp6420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00539
p6422
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00539_136
p6423
sg16
VToremifene [drugbank:DB00539]
p6424
sg18
Vdrug-target interaction Toremifene and Estrogen receptor [drugbank_resource:DB00539_136]
p6425
sa(dp6426
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6427
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00603
p6428
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00603_136
p6429
sg16
VMedroxyprogesterone [drugbank:DB00603]
p6430
sg18
Vdrug-target interaction Medroxyprogesterone and Estrogen receptor [drugbank_resource:DB00603_136]
p6431
sa(dp6432
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6433
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00367
p6434
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00367_136
p6435
sg16
VLevonorgestrel [drugbank:DB00367]
p6436
sg18
Vdrug-target interaction Levonorgestrel and Estrogen receptor [drugbank_resource:DB00367_136]
p6437
sa(dp6438
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6439
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00655
p6440
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00655_136
p6441
sg16
VEstrone [drugbank:DB00655]
p6442
sg18
Vdrug-target interaction Estrone and Estrogen receptor [drugbank_resource:DB00655_136]
p6443
sa(dp6444
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6445
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00783
p6446
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00783_136
p6447
sg16
VEstradiol [drugbank:DB00783]
p6448
sg18
Vdrug-target interaction Estradiol and Estrogen receptor [drugbank_resource:DB00783_136]
p6449
sa(dp6450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00823
p6452
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00823_136
p6453
sg16
VEthynodiol Diacetate [drugbank:DB00823]
p6454
sg18
Vdrug-target interaction Ethynodiol Diacetate and Estrogen receptor [drugbank_resource:DB00823_136]
p6455
sa(dp6456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00957
p6458
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00957_136
p6459
sg16
VNorgestimate [drugbank:DB00957]
p6460
sg18
Vdrug-target interaction Norgestimate and Estrogen receptor [drugbank_resource:DB00957_136]
p6461
sa(dp6462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00675
p6464
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00675_136
p6465
sg16
VTamoxifen [drugbank:DB00675]
p6466
sg18
Vdrug-target interaction Tamoxifen and Estrogen receptor [drugbank_resource:DB00675_136]
p6467
sa(dp6468
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6469
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00882
p6470
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00882_136
p6471
sg16
VClomifene [drugbank:DB00882]
p6472
sg18
Vdrug-target interaction Clomifene and Estrogen receptor [drugbank_resource:DB00882_136]
p6473
sa(dp6474
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6475
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00947
p6476
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00947_136
p6477
sg16
VFulvestrant [drugbank:DB00947]
p6478
sg18
Vdrug-target interaction Fulvestrant and Estrogen receptor [drugbank_resource:DB00947_136]
p6479
sa(dp6480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00890
p6482
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00890_136
p6483
sg16
VDienestrol [drugbank:DB00890]
p6484
sg18
Vdrug-target interaction Dienestrol and Estrogen receptor [drugbank_resource:DB00890_136]
p6485
sa(dp6486
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6487
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00977
p6488
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00977_136
p6489
sg16
VEthinyl Estradiol [drugbank:DB00977]
p6490
sg18
Vdrug-target interaction Ethinyl Estradiol and Estrogen receptor [drugbank_resource:DB00977_136]
p6491
sa(dp6492
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6493
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01065
p6494
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01065_136
p6495
sg16
VMelatonin [drugbank:DB01065]
p6496
sg18
Vdrug-target interaction Melatonin and Estrogen receptor [drugbank_resource:DB01065_136]
p6497
sa(dp6498
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6499
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01108
p6500
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01108_136
p6501
sg16
VTrilostane [drugbank:DB01108]
p6502
sg18
Vdrug-target interaction Trilostane and Estrogen receptor [drugbank_resource:DB01108_136]
p6503
sa(dp6504
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6505
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01431
p6506
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01431_136
p6507
sg16
VAllylestrenol [drugbank:DB01431]
p6508
sg18
Vdrug-target interaction Allylestrenol and Estrogen receptor [drugbank_resource:DB01431_136]
p6509
sa(dp6510
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6511
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p6512
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_136
p6513
sg16
VGenistein [drugbank:DB01645]
p6514
sg18
Vdrug-target interaction Genistein and Estrogen receptor [drugbank_resource:DB01645_136]
p6515
sa(dp6516
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6517
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01196
p6518
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01196_136
p6519
sg16
VEstramustine [drugbank:DB01196]
p6520
sg18
Vdrug-target interaction Estramustine and Estrogen receptor [drugbank_resource:DB01196_136]
p6521
sa(dp6522
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6523
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p6524
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_136
p6525
sg16
VDanazol [drugbank:DB01406]
p6526
sg18
Vdrug-target interaction Danazol and Estrogen receptor [drugbank_resource:DB01406_136]
p6527
sa(dp6528
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6529
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01183
p6530
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01183_136
p6531
sg16
VNaloxone [drugbank:DB01183]
p6532
sg18
Vdrug-target interaction Naloxone and Estrogen receptor [drugbank_resource:DB01183_136]
p6533
sa(dp6534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p6536
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_136
p6537
sg16
VFluoxymesterone [drugbank:DB01185]
p6538
sg18
Vdrug-target interaction Fluoxymesterone and Estrogen receptor [drugbank_resource:DB01185_136]
p6539
sa(dp6540
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6541
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01357
p6542
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01357_136
p6543
sg16
VMestranol [drugbank:DB01357]
p6544
sg18
Vdrug-target interaction Mestranol and Estrogen receptor [drugbank_resource:DB01357_136]
p6545
sa(dp6546
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6547
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02715
p6548
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02715_136
p6549
sg16
VCompound 18 [drugbank:DB02715]
p6550
sg18
Vdrug-target interaction Compound 18 and Estrogen receptor [drugbank_resource:DB02715_136]
p6551
sa(dp6552
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6553
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02615
p6554
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02615_136
p6555
sg16
VCompound 19 [drugbank:DB02615]
p6556
sg18
Vdrug-target interaction Compound 19 and Estrogen receptor [drugbank_resource:DB02615_136]
p6557
sa(dp6558
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6559
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03742
p6560
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03742_136
p6561
sg16
VCompound 4-D [drugbank:DB03742]
p6562
sg18
Vdrug-target interaction Compound 4-D and Estrogen receptor [drugbank_resource:DB03742_136]
p6563
sa(dp6564
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6565
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03802
p6566
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03802_136
p6567
sg16
V1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol [drugbank:DB03802]
p6568
sg18
Vdrug-target interaction 1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol and Estrogen receptor [drugbank_resource:DB03802_136]
p6569
sa(dp6570
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6571
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04471
p6572
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04471_136
p6573
sg16
V2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol [drugbank:DB04471]
p6574
sg18
Vdrug-target interaction 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol and Estrogen receptor [drugbank_resource:DB04471_136]
p6575
sa(dp6576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04574
p6578
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04574_136
p6579
sg16
VEstropipate [drugbank:DB04574]
p6580
sg18
Vdrug-target interaction Estropipate and Estrogen receptor [drugbank_resource:DB04574_136]
p6581
sa(dp6582
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6583
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06713
p6584
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06713_136
p6585
sg16
VNorelgestromin [drugbank:DB06713]
p6586
sg18
Vdrug-target interaction Norelgestromin and Estrogen receptor [drugbank_resource:DB06713_136]
p6587
sa(dp6588
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6589
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06927
p6590
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06927_136
p6591
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p6592
sg18
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Estrogen receptor [drugbank_resource:DB06927_136]
p6593
sa(dp6594
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6595
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07087
p6596
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07087_136
p6597
sg16
V4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07087]
p6598
sg18
Vdrug-target interaction 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07087_136]
p6599
sa(dp6600
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6601
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07195
p6602
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07195_136
p6603
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07195]
p6604
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07195_136]
p6605
sa(dp6606
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6607
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04573
p6608
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04573_136
p6609
sg16
VEstriol [drugbank:DB04573]
p6610
sg18
Vdrug-target interaction Estriol and Estrogen receptor [drugbank_resource:DB04573_136]
p6611
sa(dp6612
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6613
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04575
p6614
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04575_136
p6615
sg16
VQuinestrol [drugbank:DB04575]
p6616
sg18
Vdrug-target interaction Quinestrol and Estrogen receptor [drugbank_resource:DB04575_136]
p6617
sa(dp6618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06898
p6620
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06898_136
p6621
sg16
V4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol [drugbank:DB06898]
p6622
sg18
Vdrug-target interaction 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol and Estrogen receptor [drugbank_resource:DB06898_136]
p6623
sa(dp6624
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6625
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06871
p6626
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06871_136
p6627
sg16
V17-METHYL-17-ALPHA-DIHYDROEQUILENIN [drugbank:DB06871]
p6628
sg18
Vdrug-target interaction 17-METHYL-17-ALPHA-DIHYDROEQUILENIN and Estrogen receptor [drugbank_resource:DB06871_136]
p6629
sa(dp6630
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6631
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07086
p6632
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07086_136
p6633
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07086]
p6634
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07086_136]
p6635
sa(dp6636
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6637
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07567
p6638
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07567_136
p6639
sg16
V(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL [drugbank:DB07567]
p6640
sg18
Vdrug-target interaction (2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL and Estrogen receptor [drugbank_resource:DB07567_136]
p6641
sa(dp6642
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6643
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07638
p6644
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07638_136
p6645
sg16
V(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07638]
p6646
sg18
Vdrug-target interaction (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB07638_136]
p6647
sa(dp6648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07712
p6650
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07712_136
p6651
sg16
V3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07712]
p6652
sg18
Vdrug-target interaction 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Estrogen receptor [drugbank_resource:DB07712_136]
p6653
sa(dp6654
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6655
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07991
p6656
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07991_136
p6657
sg16
VN-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE [drugbank:DB07991]
p6658
sg18
Vdrug-target interaction N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE and Estrogen receptor [drugbank_resource:DB07991_136]
p6659
sa(dp6660
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6661
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08020
p6662
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08020_136
p6663
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB08020]
p6664
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB08020_136]
p6665
sa(dp6666
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6667
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08048
p6668
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08048_136
p6669
sg16
V4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB08048]
p6670
sg18
Vdrug-target interaction 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL and Estrogen receptor [drugbank_resource:DB08048_136]
p6671
sa(dp6672
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6673
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07678
p6674
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07678_136
p6675
sg16
V(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL [drugbank:DB07678]
p6676
sg18
Vdrug-target interaction (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL and Estrogen receptor [drugbank_resource:DB07678_136]
p6677
sa(dp6678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07708
p6680
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07708_136
p6681
sg16
V3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07708]
p6682
sg18
Vdrug-target interaction 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Estrogen receptor [drugbank_resource:DB07708_136]
p6683
sa(dp6684
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6685
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07707
p6686
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07707_136
p6687
sg16
V(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL [drugbank:DB07707]
p6688
sg18
Vdrug-target interaction (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL and Estrogen receptor [drugbank_resource:DB07707_136]
p6689
sa(dp6690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07932
p6692
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07932_136
p6693
sg16
Vdimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate [drugbank:DB07932]
p6694
sg18
Vdrug-target interaction dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate and Estrogen receptor [drugbank_resource:DB07932_136]
p6695
sa(dp6696
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6697
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07933
p6698
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07933_136
p6699
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07933]
p6700
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB07933_136]
p6701
sa(dp6702
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6703
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08047
p6704
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08047_136
p6705
sg16
V4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol [drugbank:DB08047]
p6706
sg18
Vdrug-target interaction 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol and Estrogen receptor [drugbank_resource:DB08047_136]
p6707
sa(dp6708
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6709
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08320
p6710
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08320_136
p6711
sg16
VDIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE [drugbank:DB08320]
p6712
sg18
Vdrug-target interaction DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE and Estrogen receptor [drugbank_resource:DB08320_136]
p6713
sa(dp6714
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6715
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08398
p6716
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08398_136
p6717
sg16
V2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE [drugbank:DB08398]
p6718
sg18
Vdrug-target interaction 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE and Estrogen receptor [drugbank_resource:DB08398_136]
p6719
sa(dp6720
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6721
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08595
p6722
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08595_136
p6723
sg16
V4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB08595]
p6724
sg18
Vdrug-target interaction 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB08595_136]
p6725
sa(dp6726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08737
p6728
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08737_136
p6729
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL [drugbank:DB08737]
p6730
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL and Estrogen receptor [drugbank_resource:DB08737_136]
p6731
sa(dp6732
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p6733
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08773
p6734
sg11
g6375
sg12
g6380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08773_136
p6735
sg16
VRALOXIFENE CORE [drugbank:DB08773]
p6736
sg18
Vdrug-target interaction RALOXIFENE CORE and Estrogen receptor [drugbank_resource:DB08773_136]
p6737
sasS'TCN1'
p6738
(lp6739
(dp6740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:265
p6741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00200
p6742
sg11
g6738
sg12
S'transcobalamin I (vitamin B12 binding protein, R binder family)'
p6743
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00200_265
p6744
sg16
VHydroxocobalamin [drugbank:DB00200]
p6745
sg18
Vdrug-target interaction Hydroxocobalamin and Transcobalamin-1 [drugbank_resource:DB00200_265]
p6746
sasS'MAOB'
p6747
(lp6748
(dp6749
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6750
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00191
p6751
sg11
g6747
sg12
S'monoamine oxidase B'
p6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00191_3939
p6753
sg16
VPhentermine [drugbank:DB00191]
p6754
sg18
Vdrug-target interaction Phentermine and Amine oxidase [flavin-containing] B [drugbank_resource:DB00191_3939]
p6755
sa(dp6756
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6757
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00191
p6758
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00191_3939
p6759
sg16
VPhentermine [drugbank:DB00191]
p6760
sg18
Vdrug-enzyme interaction Phentermine and Amine oxidase [flavin-containing] B [drugbank_resource:DB00191_3939]
p6761
sa(dp6762
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6763
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00780
p6764
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00780_3939
p6765
sg16
VPhenelzine [drugbank:DB00780]
p6766
sg18
Vdrug-target interaction Phenelzine and Amine oxidase [flavin-containing] B [drugbank_resource:DB00780_3939]
p6767
sa(dp6768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00780
p6770
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00780_3939
p6771
sg16
VPhenelzine [drugbank:DB00780]
p6772
sg18
Vdrug-enzyme interaction Phenelzine and Amine oxidase [flavin-containing] B [drugbank_resource:DB00780_3939]
p6773
sa(dp6774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00752
p6776
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00752_3939
p6777
sg16
VTranylcypromine [drugbank:DB00752]
p6778
sg18
Vdrug-target interaction Tranylcypromine and Amine oxidase [flavin-containing] B [drugbank_resource:DB00752_3939]
p6779
sa(dp6780
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6781
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p6782
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_3939
p6783
sg16
VZonisamide [drugbank:DB00909]
p6784
sg18
Vdrug-target interaction Zonisamide and Amine oxidase [flavin-containing] B [drugbank_resource:DB00909_3939]
p6785
sa(dp6786
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6787
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01037
p6788
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01037_3939
p6789
sg16
VSelegiline [drugbank:DB01037]
p6790
sg18
Vdrug-target interaction Selegiline and Amine oxidase [flavin-containing] B [drugbank_resource:DB01037_3939]
p6791
sa(dp6792
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6793
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01247
p6794
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01247_3939
p6795
sg16
VIsocarboxazid [drugbank:DB01247]
p6796
sg18
Vdrug-target interaction Isocarboxazid and Amine oxidase [flavin-containing] B [drugbank_resource:DB01247_3939]
p6797
sa(dp6798
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6799
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01363
p6800
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01363_3939
p6801
sg16
VEphedra [drugbank:DB01363]
p6802
sg18
Vdrug-target interaction Ephedra and Amine oxidase [flavin-containing] B [drugbank_resource:DB01363_3939]
p6803
sa(dp6804
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6805
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01367
p6806
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01367_3939
p6807
sg16
VRasagiline [drugbank:DB01367]
p6808
sg18
Vdrug-target interaction Rasagiline and Amine oxidase [flavin-containing] B [drugbank_resource:DB01367_3939]
p6809
sa(dp6810
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6811
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01442
p6812
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01442_3939
p6813
sg16
VMMDA [drugbank:DB01442]
p6814
sg18
Vdrug-target interaction MMDA and Amine oxidase [flavin-containing] B [drugbank_resource:DB01442_3939]
p6815
sa(dp6816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01472
p6818
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01472_3939
p6819
sg16
V4-Methoxyamphetamine [drugbank:DB01472]
p6820
sg18
Vdrug-target interaction 4-Methoxyamphetamine and Amine oxidase [flavin-containing] B [drugbank_resource:DB01472_3939]
p6821
sa(dp6822
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6823
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01577
p6824
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01577_3939
p6825
sg16
VMethamphetamine [drugbank:DB01577]
p6826
sg18
Vdrug-target interaction Methamphetamine and Amine oxidase [flavin-containing] B [drugbank_resource:DB01577_3939]
p6827
sa(dp6828
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6829
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01626
p6830
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01626_3939
p6831
sg16
VPargyline [drugbank:DB01626]
p6832
sg18
Vdrug-target interaction Pargyline and Amine oxidase [flavin-containing] B [drugbank_resource:DB01626_3939]
p6833
sa(dp6834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02095
p6836
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02095_3939
p6837
sg16
VIsatin [drugbank:DB02095]
p6838
sg18
Vdrug-target interaction Isatin and Amine oxidase [flavin-containing] B [drugbank_resource:DB02095_3939]
p6839
sa(dp6840
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6841
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02095
p6842
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02095_3939
p6843
sg16
VIsatin [drugbank:DB02095]
p6844
sg18
Vdrug-enzyme interaction Isatin and Amine oxidase [flavin-containing] B [drugbank_resource:DB02095_3939]
p6845
sa(dp6846
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6847
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02211
p6848
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02211_3939
p6849
sg16
VN-Methyl-N-Propargyl-1(R)-Aminoindan [drugbank:DB02211]
p6850
sg18
Vdrug-target interaction N-Methyl-N-Propargyl-1(R)-Aminoindan and Amine oxidase [flavin-containing] B [drugbank_resource:DB02211_3939]
p6851
sa(dp6852
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6853
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02211
p6854
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02211_3939
p6855
sg16
VN-Methyl-N-Propargyl-1(R)-Aminoindan [drugbank:DB02211]
p6856
sg18
Vdrug-enzyme interaction N-Methyl-N-Propargyl-1(R)-Aminoindan and Amine oxidase [flavin-containing] B [drugbank_resource:DB02211_3939]
p6857
sa(dp6858
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6859
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02509
p6860
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02509_3939
p6861
sg16
VFarnesol [drugbank:DB02509]
p6862
sg18
Vdrug-target interaction Farnesol and Amine oxidase [flavin-containing] B [drugbank_resource:DB02509_3939]
p6863
sa(dp6864
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6865
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02509
p6866
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02509_3939
p6867
sg16
VFarnesol [drugbank:DB02509]
p6868
sg18
Vdrug-enzyme interaction Farnesol and Amine oxidase [flavin-containing] B [drugbank_resource:DB02509_3939]
p6869
sa(dp6870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02939
p6872
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02939_3939
p6873
sg16
V[(1e)-4-Phenylbut-1-Enyl]Benzene [drugbank:DB02939]
p6874
sg18
Vdrug-target interaction [(1e)-4-Phenylbut-1-Enyl]Benzene and Amine oxidase [flavin-containing] B [drugbank_resource:DB02939_3939]
p6875
sa(dp6876
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6877
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02939
p6878
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02939_3939
p6879
sg16
V[(1e)-4-Phenylbut-1-Enyl]Benzene [drugbank:DB02939]
p6880
sg18
Vdrug-enzyme interaction [(1e)-4-Phenylbut-1-Enyl]Benzene and Amine oxidase [flavin-containing] B [drugbank_resource:DB02939_3939]
p6881
sa(dp6882
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6883
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03147
p6884
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03147_3939
p6885
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p6886
sg18
Vdrug-target interaction Flavin-Adenine Dinucleotide and Amine oxidase [flavin-containing] B [drugbank_resource:DB03147_3939]
p6887
sa(dp6888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03147
p6890
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03147_3939
p6891
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p6892
sg18
Vdrug-enzyme interaction Flavin-Adenine Dinucleotide and Amine oxidase [flavin-containing] B [drugbank_resource:DB03147_3939]
p6893
sa(dp6894
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6895
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02643
p6896
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02643_3939
p6897
sg16
VN-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate [drugbank:DB02643]
p6898
sg18
Vdrug-target interaction N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate and Amine oxidase [flavin-containing] B [drugbank_resource:DB02643_3939]
p6899
sa(dp6900
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6901
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03894
p6902
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03894_3939
p6903
sg16
VN-Propargyl-1(S)-Aminoindan [drugbank:DB03894]
p6904
sg18
Vdrug-target interaction N-Propargyl-1(S)-Aminoindan and Amine oxidase [flavin-containing] B [drugbank_resource:DB03894_3939]
p6905
sa(dp6906
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6907
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03894
p6908
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03894_3939
p6909
sg16
VN-Propargyl-1(S)-Aminoindan [drugbank:DB03894]
p6910
sg18
Vdrug-enzyme interaction N-Propargyl-1(S)-Aminoindan and Amine oxidase [flavin-containing] B [drugbank_resource:DB03894_3939]
p6911
sa(dp6912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04147
p6914
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04147_3939
p6915
sg16
VLauryl Dimethylamine-N-Oxide [drugbank:DB04147]
p6916
sg18
Vdrug-target interaction Lauryl Dimethylamine-N-Oxide and Amine oxidase [flavin-containing] B [drugbank_resource:DB04147_3939]
p6917
sa(dp6918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04147
p6920
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04147_3939
p6921
sg16
VLauryl Dimethylamine-N-Oxide [drugbank:DB04147]
p6922
sg18
Vdrug-enzyme interaction Lauryl Dimethylamine-N-Oxide and Amine oxidase [flavin-containing] B [drugbank_resource:DB04147_3939]
p6923
sa(dp6924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04307
p6926
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04307_3939
p6927
sg16
V5-Hydroxy-N-Propargyl-1(R)-Aminoindan [drugbank:DB04307]
p6928
sg18
Vdrug-target interaction 5-Hydroxy-N-Propargyl-1(R)-Aminoindan and Amine oxidase [flavin-containing] B [drugbank_resource:DB04307_3939]
p6929
sa(dp6930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04307
p6932
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04307_3939
p6933
sg16
V5-Hydroxy-N-Propargyl-1(R)-Aminoindan [drugbank:DB04307]
p6934
sg18
Vdrug-enzyme interaction 5-Hydroxy-N-Propargyl-1(R)-Aminoindan and Amine oxidase [flavin-containing] B [drugbank_resource:DB04307_3939]
p6935
sa(dp6936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04820
p6938
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04820_3939
p6939
sg16
VNialamide [drugbank:DB04820]
p6940
sg18
Vdrug-target interaction Nialamide and Amine oxidase [flavin-containing] B [drugbank_resource:DB04820_3939]
p6941
sa(dp6942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04821
p6944
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04821_3939
p6945
sg16
VNomifensine [drugbank:DB04821]
p6946
sg18
Vdrug-target interaction Nomifensine and Amine oxidase [flavin-containing] B [drugbank_resource:DB04821_3939]
p6947
sa(dp6948
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6949
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04677
p6950
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04677_3939
p6951
sg16
VN-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE [drugbank:DB04677]
p6952
sg18
Vdrug-target interaction N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE and Amine oxidase [flavin-containing] B [drugbank_resource:DB04677_3939]
p6953
sa(dp6954
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6955
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04832
p6956
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04832_3939
p6957
sg16
VZimelidine [drugbank:DB04832]
p6958
sg18
Vdrug-target interaction Zimelidine and Amine oxidase [flavin-containing] B [drugbank_resource:DB04832_3939]
p6959
sa(dp6960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07512
p6962
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07512_3939
p6963
sg16
V7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE [drugbank:DB07512]
p6964
sg18
Vdrug-target interaction 7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE and Amine oxidase [flavin-containing] B [drugbank_resource:DB07512_3939]
p6965
sa(dp6966
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6967
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08082
p6968
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08082_3939
p6969
sg16
VN-(2-AMINOETHYL)-P-CHLOROBENZAMIDE [drugbank:DB08082]
p6970
sg18
Vdrug-target interaction N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE and Amine oxidase [flavin-containing] B [drugbank_resource:DB08082_3939]
p6971
sa(dp6972
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6973
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07513
p6974
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07513_3939
p6975
sg16
V7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE [drugbank:DB07513]
p6976
sg18
Vdrug-target interaction 7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE and Amine oxidase [flavin-containing] B [drugbank_resource:DB07513_3939]
p6977
sa(dp6978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08176
p6980
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08176_3939
p6981
sg16
V(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE [drugbank:DB08176]
p6982
sg18
Vdrug-target interaction (1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE and Amine oxidase [flavin-containing] B [drugbank_resource:DB08176_3939]
p6983
sa(dp6984
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6985
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08480
p6986
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08480_3939
p6987
sg16
V4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN [drugbank:DB08480]
p6988
sg18
Vdrug-target interaction 4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN and Amine oxidase [flavin-containing] B [drugbank_resource:DB08480_3939]
p6989
sa(dp6990
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3939
p6991
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08516
p6992
sg11
g6747
sg12
g6752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08516_3939
p6993
sg16
V(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE] [drugbank:DB08516]
p6994
sg18
Vdrug-target interaction (S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE] and Amine oxidase [flavin-containing] B [drugbank_resource:DB08516_3939]
p6995
sasS'GPX3'
p6996
(lp6997
(dp6998
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:911
p6999
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p7000
sg11
g6996
sg12
S'glutathione peroxidase 3 (plasma)'
p7001
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_911
p7002
sg16
VGlutathione [drugbank:DB00143]
p7003
sg18
Vdrug-target interaction Glutathione and Glutathione peroxidase 3 [drugbank_resource:DB00143_911]
p7004
sasS'AR'
p7005
(lp7006
(dp7007
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7008
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00421
p7009
sg11
g7005
sg12
S'androgen receptor'
p7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00421_146
p7011
sg16
VSpironolactone [drugbank:DB00421]
p7012
sg18
Vdrug-target interaction Spironolactone and Androgen receptor [drugbank_resource:DB00421_146]
p7013
sa(dp7014
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7015
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00621
p7016
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00621_146
p7017
sg16
VOxandrolone [drugbank:DB00621]
p7018
sg18
Vdrug-target interaction Oxandrolone and Androgen receptor [drugbank_resource:DB00621_146]
p7019
sa(dp7020
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7021
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00367
p7022
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00367_146
p7023
sg16
VLevonorgestrel [drugbank:DB00367]
p7024
sg18
Vdrug-target interaction Levonorgestrel and Androgen receptor [drugbank_resource:DB00367_146]
p7025
sa(dp7026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00499
p7028
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00499_146
p7029
sg16
VFlutamide [drugbank:DB00499]
p7030
sg18
Vdrug-target interaction Flutamide and Androgen receptor [drugbank_resource:DB00499_146]
p7031
sa(dp7032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00624
p7034
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00624_146
p7035
sg16
VTestosterone [drugbank:DB00624]
p7036
sg18
Vdrug-target interaction Testosterone and Androgen receptor [drugbank_resource:DB00624_146]
p7037
sa(dp7038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00687
p7040
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00687_146
p7041
sg16
VFludrocortisone [drugbank:DB00687]
p7042
sg18
Vdrug-target interaction Fludrocortisone and Androgen receptor [drugbank_resource:DB00687_146]
p7043
sa(dp7044
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7045
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00984
p7046
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00984_146
p7047
sg16
VNandrolone phenpropionate [drugbank:DB00984]
p7048
sg18
Vdrug-target interaction Nandrolone phenpropionate and Androgen receptor [drugbank_resource:DB00984_146]
p7049
sa(dp7050
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7051
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00665
p7052
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00665_146
p7053
sg16
VNilutamide [drugbank:DB00665]
p7054
sg18
Vdrug-target interaction Nilutamide and Androgen receptor [drugbank_resource:DB00665_146]
p7055
sa(dp7056
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7057
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01128
p7058
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01128_146
p7059
sg16
VBicalutamide [drugbank:DB01128]
p7060
sg18
Vdrug-target interaction Bicalutamide and Androgen receptor [drugbank_resource:DB01128_146]
p7061
sa(dp7062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00858
p7064
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00858_146
p7065
sg16
VDrostanolone [drugbank:DB00858]
p7066
sg18
Vdrug-target interaction Drostanolone and Androgen receptor [drugbank_resource:DB00858_146]
p7067
sa(dp7068
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7069
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p7070
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_146
p7071
sg16
VDanazol [drugbank:DB01406]
p7072
sg18
Vdrug-target interaction Danazol and Androgen receptor [drugbank_resource:DB01406_146]
p7073
sa(dp7074
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7075
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p7076
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_146
p7077
sg16
VFluoxymesterone [drugbank:DB01185]
p7078
sg18
Vdrug-target interaction Fluoxymesterone and Androgen receptor [drugbank_resource:DB01185_146]
p7079
sa(dp7080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01420
p7082
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01420_146
p7083
sg16
VTestosterone Propionate [drugbank:DB01420]
p7084
sg18
Vdrug-target interaction Testosterone Propionate and Androgen receptor [drugbank_resource:DB01420_146]
p7085
sa(dp7086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01481
p7088
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01481_146
p7089
sg16
VDelta1-dihydrotestosterone [drugbank:DB01481]
p7090
sg18
Vdrug-target interaction Delta1-dihydrotestosterone and Androgen receptor [drugbank_resource:DB01481_146]
p7091
sa(dp7092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01395
p7094
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01395_146
p7095
sg16
VDrospirenone [drugbank:DB01395]
p7096
sg18
Vdrug-target interaction Drospirenone and Androgen receptor [drugbank_resource:DB01395_146]
p7097
sa(dp7098
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7099
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01541
p7100
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01541_146
p7101
sg16
VBoldenone [drugbank:DB01541]
p7102
sg18
Vdrug-target interaction Boldenone and Androgen receptor [drugbank_resource:DB01541_146]
p7103
sa(dp7104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01564
p7106
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01564_146
p7107
sg16
VCalusterone [drugbank:DB01564]
p7108
sg18
Vdrug-target interaction Calusterone and Androgen receptor [drugbank_resource:DB01564_146]
p7109
sa(dp7110
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7111
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02266
p7112
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02266_146
p7113
sg16
VFlufenamic Acid [drugbank:DB02266]
p7114
sg18
Vdrug-target interaction Flufenamic Acid and Androgen receptor [drugbank_resource:DB02266_146]
p7115
sa(dp7116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02932
p7118
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02932_146
p7119
sg16
V(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide [drugbank:DB02932]
p7120
sg18
Vdrug-target interaction (2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide and Androgen receptor [drugbank_resource:DB02932_146]
p7121
sa(dp7122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02998
p7124
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02998_146
p7125
sg16
VMethyltrienolone [drugbank:DB02998]
p7126
sg18
Vdrug-target interaction Methyltrienolone and Androgen receptor [drugbank_resource:DB02998_146]
p7127
sa(dp7128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02901
p7130
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02901_146
p7131
sg16
VDihydrotestosterone [drugbank:DB02901]
p7132
sg18
Vdrug-target interaction Dihydrotestosterone and Androgen receptor [drugbank_resource:DB02901_146]
p7133
sa(dp7134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07286
p7136
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07286_146
p7137
sg16
V2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE [drugbank:DB07286]
p7138
sg18
Vdrug-target interaction 2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE and Androgen receptor [drugbank_resource:DB07286_146]
p7139
sa(dp7140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06710
p7142
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06710_146
p7143
sg16
VMethyltestosterone [drugbank:DB06710]
p7144
sg18
Vdrug-target interaction Methyltestosterone and Androgen receptor [drugbank_resource:DB06710_146]
p7145
sa(dp7146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07419
p7148
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07419_146
p7149
sg16
V(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide [drugbank:DB07419]
p7150
sg18
Vdrug-target interaction (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide and Androgen receptor [drugbank_resource:DB07419_146]
p7151
sa(dp7152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04709
p7154
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04709_146
p7155
sg16
V(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE [drugbank:DB04709]
p7156
sg18
Vdrug-target interaction (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE and Androgen receptor [drugbank_resource:DB04709_146]
p7157
sa(dp7158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04839
p7160
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04839_146
p7161
sg16
VCyproterone [drugbank:DB04839]
p7162
sg18
Vdrug-target interaction Cyproterone and Androgen receptor [drugbank_resource:DB04839_146]
p7163
sa(dp7164
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7165
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06870
p7166
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06870_146
p7167
sg16
V17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE [drugbank:DB06870]
p7168
sg18
Vdrug-target interaction 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE and Androgen receptor [drugbank_resource:DB06870_146]
p7169
sa(dp7170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07039
p7172
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07039_146
p7173
sg16
V(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide [drugbank:DB07039]
p7174
sg18
Vdrug-target interaction (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and Androgen receptor [drugbank_resource:DB07039_146]
p7175
sa(dp7176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07422
p7178
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07422_146
p7179
sg16
V(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide [drugbank:DB07422]
p7180
sg18
Vdrug-target interaction (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide and Androgen receptor [drugbank_resource:DB07422_146]
p7181
sa(dp7182
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7183
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07454
p7184
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07454_146
p7185
sg16
V(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE [drugbank:DB07454]
p7186
sg18
Vdrug-target interaction (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE and Androgen receptor [drugbank_resource:DB07454_146]
p7187
sa(dp7188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07421
p7190
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07421_146
p7191
sg16
V4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile [drugbank:DB07421]
p7192
sg18
Vdrug-target interaction 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile and Androgen receptor [drugbank_resource:DB07421_146]
p7193
sa(dp7194
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7195
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07423
p7196
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07423_146
p7197
sg16
V(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide [drugbank:DB07423]
p7198
sg18
Vdrug-target interaction (2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide and Androgen receptor [drugbank_resource:DB07423_146]
p7199
sa(dp7200
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7201
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07769
p7202
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07769_146
p7203
sg16
VS-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE [drugbank:DB07769]
p7204
sg18
Vdrug-target interaction S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE and Androgen receptor [drugbank_resource:DB07769_146]
p7205
sa(dp7206
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7207
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08035
p7208
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08035_146
p7209
sg16
V1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE [drugbank:DB08035]
p7210
sg18
Vdrug-target interaction 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE and Androgen receptor [drugbank_resource:DB08035_146]
p7211
sa(dp7212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08089
p7214
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08089_146
p7215
sg16
V6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE [drugbank:DB08089]
p7216
sg18
Vdrug-target interaction 6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE and Androgen receptor [drugbank_resource:DB08089_146]
p7217
sa(dp7218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07717
p7220
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07717_146
p7221
sg16
V(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE [drugbank:DB07717]
p7222
sg18
Vdrug-target interaction (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE and Androgen receptor [drugbank_resource:DB07717_146]
p7223
sa(dp7224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08087
p7226
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08087_146
p7227
sg16
V4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE [drugbank:DB08087]
p7228
sg18
Vdrug-target interaction 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE and Androgen receptor [drugbank_resource:DB08087_146]
p7229
sa(dp7230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08088
p7232
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08088_146
p7233
sg16
V2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile [drugbank:DB08088]
p7234
sg18
Vdrug-target interaction 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile and Androgen receptor [drugbank_resource:DB08088_146]
p7235
sa(dp7236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08461
p7238
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08461_146
p7239
sg16
V3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL [drugbank:DB08461]
p7240
sg18
Vdrug-target interaction 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL and Androgen receptor [drugbank_resource:DB08461_146]
p7241
sa(dp7242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p7243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08804
p7244
sg11
g7005
sg12
g7010
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08804_146
p7245
sg16
VNandrolone decanoate [drugbank:DB08804]
p7246
sg18
Vdrug-target interaction Nandrolone decanoate and Androgen receptor [drugbank_resource:DB08804_146]
p7247
sasS'ITGAL'
p7248
(lp7249
(dp7250
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7251
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00095
p7252
sg11
g7248
sg12
S'integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)'
p7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00095_572
p7254
sg16
VEfalizumab [drugbank:DB00095]
p7255
sg18
Vdrug-target interaction Efalizumab and Integrin alpha-L [drugbank_resource:DB00095_572]
p7256
sa(dp7257
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7258
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p7259
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_572
p7260
sg16
VAntithymocyte globulin [drugbank:DB00098]
p7261
sg18
Vdrug-target interaction Antithymocyte globulin and Integrin alpha-L [drugbank_resource:DB00098_572]
p7262
sa(dp7263
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7264
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00227
p7265
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00227_572
p7266
sg16
VLovastatin [drugbank:DB00227]
p7267
sg18
Vdrug-target interaction Lovastatin and Integrin alpha-L [drugbank_resource:DB00227_572]
p7268
sa(dp7269
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7270
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02177
p7271
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02177_572
p7272
sg16
V1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine [drugbank:DB02177]
p7273
sg18
Vdrug-target interaction 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine and Integrin alpha-L [drugbank_resource:DB02177_572]
p7274
sa(dp7275
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7276
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03932
p7277
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03932_572
p7278
sg16
VLFA703 [drugbank:DB03932]
p7279
sg18
Vdrug-target interaction LFA703 and Integrin alpha-L [drugbank_resource:DB03932_572]
p7280
sa(dp7281
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7282
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04724
p7283
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04724_572
p7284
sg16
V(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE [drugbank:DB04724]
p7285
sg18
Vdrug-target interaction (S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE and Integrin alpha-L [drugbank_resource:DB04724_572]
p7286
sa(dp7287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06972
p7289
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06972_572
p7290
sg16
V7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile [drugbank:DB06972]
p7291
sg18
Vdrug-target interaction 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile and Integrin alpha-L [drugbank_resource:DB06972_572]
p7292
sa(dp7293
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:572
p7294
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07486
p7295
sg11
g7248
sg12
g7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07486_572
p7296
sg16
V3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline [drugbank:DB07486]
p7297
sg18
Vdrug-target interaction 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline and Integrin alpha-L [drugbank_resource:DB07486_572]
p7298
sasS'GABRE'
p7299
(lp7300
(dp7301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p7303
sg11
g7299
sg12
S'gamma-aminobutyric acid (GABA) A receptor, epsilon'
p7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_6089
p7305
sg16
VTemazepam [drugbank:DB00231]
p7306
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00231_6089]
p7307
sa(dp7308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p7310
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_6089
p7311
sg16
VLorazepam [drugbank:DB00186]
p7312
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00186_6089]
p7313
sa(dp7314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p7316
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_6089
p7317
sg16
VClorazepate [drugbank:DB00628]
p7318
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00628_6089]
p7319
sa(dp7320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p7322
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_6089
p7323
sg16
VAlprazolam [drugbank:DB00404]
p7324
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00404_6089]
p7325
sa(dp7326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p7328
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_6089
p7329
sg16
VClobazam [drugbank:DB00349]
p7330
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00349_6089]
p7331
sa(dp7332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p7334
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_6089
p7335
sg16
VChlordiazepoxide [drugbank:DB00475]
p7336
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00475_6089]
p7337
sa(dp7338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p7340
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_6089
p7341
sg16
VAdinazolam [drugbank:DB00546]
p7342
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00546_6089]
p7343
sa(dp7344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p7346
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_6089
p7347
sg16
VMidazolam [drugbank:DB00683]
p7348
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00683_6089]
p7349
sa(dp7350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p7352
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_6089
p7353
sg16
VDiazepam [drugbank:DB00829]
p7354
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00829_6089]
p7355
sa(dp7356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p7358
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_6089
p7359
sg16
VFlurazepam [drugbank:DB00690]
p7360
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00690_6089]
p7361
sa(dp7362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p7364
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_6089
p7365
sg16
VHalazepam [drugbank:DB00801]
p7366
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00801_6089]
p7367
sa(dp7368
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7369
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p7370
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_6089
p7371
sg16
VOxazepam [drugbank:DB00842]
p7372
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00842_6089]
p7373
sa(dp7374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p7376
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_6089
p7377
sg16
VTriazolam [drugbank:DB00897]
p7378
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB00897_6089]
p7379
sa(dp7380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p7382
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_6089
p7383
sg16
VClonazepam [drugbank:DB01068]
p7384
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01068_6089]
p7385
sa(dp7386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p7388
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_6089
p7389
sg16
VBromazepam [drugbank:DB01558]
p7390
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01558_6089]
p7391
sa(dp7392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p7394
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_6089
p7395
sg16
VCinolazepam [drugbank:DB01594]
p7396
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01594_6089]
p7397
sa(dp7398
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7399
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p7400
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_6089
p7401
sg16
VClotiazepam [drugbank:DB01559]
p7402
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01559_6089]
p7403
sa(dp7404
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7405
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p7406
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_6089
p7407
sg16
VPrazepam [drugbank:DB01588]
p7408
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01588_6089]
p7409
sa(dp7410
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7411
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p7412
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_6089
p7413
sg16
VQuazepam [drugbank:DB01589]
p7414
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01589_6089]
p7415
sa(dp7416
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7417
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p7418
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_6089
p7419
sg16
VEstazolam [drugbank:DB01215]
p7420
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01215_6089]
p7421
sa(dp7422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p7424
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_6089
p7425
sg16
VFludiazepam [drugbank:DB01567]
p7426
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01567_6089]
p7427
sa(dp7428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01587
p7430
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01587_6089
p7431
sg16
VKetazolam [drugbank:DB01587]
p7432
sg18
Vdrug-target interaction Ketazolam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01587_6089]
p7433
sa(dp7434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6089
p7435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p7436
sg11
g7299
sg12
g7304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_6089
p7437
sg16
VNitrazepam [drugbank:DB01595]
p7438
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric acid receptor subunit epsilon [drugbank_resource:DB01595_6089]
p7439
sasS'AGTR1'
p7440
(lp7441
(dp7442
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7443
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00177
p7444
sg11
g7440
sg12
S'angiotensin II receptor, type 1'
p7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00177_70
p7446
sg16
VValsartan [drugbank:DB00177]
p7447
sg18
Vdrug-target interaction Valsartan and Type-1 angiotensin II receptor [drugbank_resource:DB00177_70]
p7448
sa(dp7449
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7450
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00275
p7451
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00275_70
p7452
sg16
VOlmesartan [drugbank:DB00275]
p7453
sg18
Vdrug-target interaction Olmesartan and Type-1 angiotensin II receptor [drugbank_resource:DB00275_70]
p7454
sa(dp7455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00678
p7457
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00678_70
p7458
sg16
VLosartan [drugbank:DB00678]
p7459
sg18
Vdrug-target interaction Losartan and Type-1 angiotensin II receptor [drugbank_resource:DB00678_70]
p7460
sa(dp7461
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7462
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00876
p7463
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00876_70
p7464
sg16
VEprosartan [drugbank:DB00876]
p7465
sg18
Vdrug-target interaction Eprosartan and Type-1 angiotensin II receptor [drugbank_resource:DB00876_70]
p7466
sa(dp7467
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7468
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00966
p7469
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00966_70
p7470
sg16
VTelmisartan [drugbank:DB00966]
p7471
sg18
Vdrug-target interaction Telmisartan and Type-1 angiotensin II receptor [drugbank_resource:DB00966_70]
p7472
sa(dp7473
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7474
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00796
p7475
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00796_70
p7476
sg16
VCandesartan [drugbank:DB00796]
p7477
sg18
Vdrug-target interaction Candesartan and Type-1 angiotensin II receptor [drugbank_resource:DB00796_70]
p7478
sa(dp7479
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7480
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01029
p7481
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01029_70
p7482
sg16
VIrbesartan [drugbank:DB01029]
p7483
sg18
Vdrug-target interaction Irbesartan and Type-1 angiotensin II receptor [drugbank_resource:DB01029_70]
p7484
sa(dp7485
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7486
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01347
p7487
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01347_70
p7488
sg16
VSaprisartan [drugbank:DB01347]
p7489
sg18
Vdrug-target interaction Saprisartan and Type-1 angiotensin II receptor [drugbank_resource:DB01347_70]
p7490
sa(dp7491
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7492
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01342
p7493
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01342_70
p7494
sg16
VForasartan [drugbank:DB01342]
p7495
sg18
Vdrug-target interaction Forasartan and Type-1 angiotensin II receptor [drugbank_resource:DB01342_70]
p7496
sa(dp7497
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:70
p7498
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01349
p7499
sg11
g7440
sg12
g7445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01349_70
p7500
sg16
VTasosartan [drugbank:DB01349]
p7501
sg18
Vdrug-target interaction Tasosartan and Type-1 angiotensin II receptor [drugbank_resource:DB01349_70]
p7502
sasS'LCK'
p7503
(lp7504
(dp7505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p7507
sg11
g7503
sg12
S'lymphocyte-specific protein tyrosine kinase'
p7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_937
p7509
sg16
VDasatinib [drugbank:DB01254]
p7510
sg18
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB01254_937]
p7511
sa(dp7512
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7513
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01830
p7514
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01830_937
p7515
sg16
V{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid [drugbank:DB01830]
p7516
sg18
Vdrug-target interaction {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB01830_937]
p7517
sa(dp7518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p7520
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_937
p7521
sg16
VStaurosporine [drugbank:DB02010]
p7522
sg18
Vdrug-target interaction Staurosporine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB02010_937]
p7523
sa(dp7524
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7525
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03023
p7526
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03023_937
p7527
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p7528
sg18
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB03023_937]
p7529
sa(dp7530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p7532
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_937
p7533
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p7534
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB04395_937]
p7535
sa(dp7536
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7537
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04003
p7538
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04003_937
p7539
sg16
V(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid [drugbank:DB04003]
p7540
sg18
Vdrug-target interaction (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB04003_937]
p7541
sa(dp7542
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7543
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07146
p7544
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07146_937
p7545
sg16
V2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE [drugbank:DB07146]
p7546
sg18
Vdrug-target interaction 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB07146_937]
p7547
sa(dp7548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06925
p7550
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06925_937
p7551
sg16
V3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE [drugbank:DB06925]
p7552
sg18
Vdrug-target interaction 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB06925_937]
p7553
sa(dp7554
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7555
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07297
p7556
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07297_937
p7557
sg16
V5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE [drugbank:DB07297]
p7558
sg18
Vdrug-target interaction 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB07297_937]
p7559
sa(dp7560
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7561
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08055
p7562
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08055_937
p7563
sg16
VN-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine [drugbank:DB08055]
p7564
sg18
Vdrug-target interaction N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08055_937]
p7565
sa(dp7566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08056
p7568
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08056_937
p7569
sg16
VN-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine [drugbank:DB08056]
p7570
sg18
Vdrug-target interaction N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08056_937]
p7571
sa(dp7572
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p7573
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08057
p7574
sg11
g7503
sg12
g7508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08057_937
p7575
sg16
VN-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine [drugbank:DB08057]
p7576
sg18
Vdrug-target interaction N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08057_937]
p7577
sasS'BTK'
p7578
(lp7579
(dp7580
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2355
p7581
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p7582
sg11
g7578
sg12
S'Bruton agammaglobulinemia tyrosine kinase'
p7583
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2355
p7584
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p7585
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and Tyrosine-protein kinase BTK [drugbank_resource:DB01863_2355]
p7586
sasS'HDAC1'
p7587
(lp7588
(dp7589
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4121
p7590
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p7591
sg11
g7587
sg12
S'histone deacetylase 1'
p7592
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4121
p7593
sg16
VVorinostat [drugbank:DB02546]
p7594
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 1 [drugbank_resource:DB02546_4121]
p7595
sasS'PDGFRA'
p7596
(lp7597
(dp7598
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:950
p7599
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00102
p7600
sg11
g7596
sg12
S'platelet-derived growth factor receptor, alpha polypeptide'
p7601
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00102_950
p7602
sg16
VBecaplermin [drugbank:DB00102]
p7603
sg18
Vdrug-target interaction Becaplermin and Alpha platelet-derived growth factor receptor [drugbank_resource:DB00102_950]
p7604
sa(dp7605
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:950
p7606
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p7607
sg11
g7596
sg12
g7601
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_950
p7608
sg16
VImatinib [drugbank:DB00619]
p7609
sg18
Vdrug-target interaction Imatinib and Alpha platelet-derived growth factor receptor [drugbank_resource:DB00619_950]
p7610
sa(dp7611
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:950
p7612
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01268
p7613
sg11
g7596
sg12
g7601
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01268_950
p7614
sg16
VSunitinib [drugbank:DB01268]
p7615
sg18
Vdrug-target interaction Sunitinib and Alpha platelet-derived growth factor receptor [drugbank_resource:DB01268_950]
p7616
sasS'DNMT1'
p7617
(lp7618
(dp7619
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p7620
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01035
p7621
sg11
g7617
sg12
S'DNA (cytosine-5-)-methyltransferase 1'
p7622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01035_1064
p7623
sg16
VProcainamide [drugbank:DB01035]
p7624
sg18
Vdrug-target interaction Procainamide and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01035_1064]
p7625
sa(dp7626
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p7627
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00928
p7628
sg11
g7617
sg12
g7622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00928_1064
p7629
sg16
VAzacitidine [drugbank:DB00928]
p7630
sg18
Vdrug-target interaction Azacitidine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB00928_1064]
p7631
sa(dp7632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p7633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01099
p7634
sg11
g7617
sg12
g7622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01099_1064
p7635
sg16
VFlucytosine [drugbank:DB01099]
p7636
sg18
Vdrug-target interaction Flucytosine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01099_1064]
p7637
sa(dp7638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p7639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01262
p7640
sg11
g7617
sg12
g7622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01262_1064
p7641
sg16
VDecitabine [drugbank:DB01262]
p7642
sg18
Vdrug-target interaction Decitabine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01262_1064]
p7643
sasS'ABCC8'
p7644
(lp7645
(dp7646
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7647
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p7648
sg11
g7644
sg12
S'ATP-binding cassette, sub-family C (CFTR/MRP), member 8'
p7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_230
p7650
sg16
VAdenosine triphosphate [drugbank:DB00171]
p7651
sg18
Vdrug-target interaction Adenosine triphosphate and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB00171_230]
p7652
sa(dp7653
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7654
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00222
p7655
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00222_230
p7656
sg16
VGlimepiride [drugbank:DB00222]
p7657
sg18
Vdrug-target interaction Glimepiride and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB00222_230]
p7658
sa(dp7659
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7660
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00672
p7661
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00672_230
p7662
sg16
VChlorpropamide [drugbank:DB00672]
p7663
sg18
Vdrug-target interaction Chlorpropamide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB00672_230]
p7664
sa(dp7665
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7666
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01016
p7667
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01016_230
p7668
sg16
VGlyburide [drugbank:DB01016]
p7669
sg18
Vdrug-target interaction Glyburide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01016_230]
p7670
sa(dp7671
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7672
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00731
p7673
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00731_230
p7674
sg16
VNateglinide [drugbank:DB00731]
p7675
sg18
Vdrug-target interaction Nateglinide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB00731_230]
p7676
sa(dp7677
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7678
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00912
p7679
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00912_230
p7680
sg16
VRepaglinide [drugbank:DB00912]
p7681
sg18
Vdrug-target interaction Repaglinide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB00912_230]
p7682
sa(dp7683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01067
p7685
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01067_230
p7686
sg16
VGlipizide [drugbank:DB01067]
p7687
sg18
Vdrug-target interaction Glipizide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01067_230]
p7688
sa(dp7689
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7690
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01124
p7691
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01124_230
p7692
sg16
VTolbutamide [drugbank:DB01124]
p7693
sg18
Vdrug-target interaction Tolbutamide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01124_230]
p7694
sa(dp7695
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7696
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01120
p7697
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01120_230
p7698
sg16
VGliclazide [drugbank:DB01120]
p7699
sg18
Vdrug-target interaction Gliclazide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01120_230]
p7700
sa(dp7701
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7702
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01252
p7703
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01252_230
p7704
sg16
VMitiglinide [drugbank:DB01252]
p7705
sg18
Vdrug-target interaction Mitiglinide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01252_230]
p7706
sa(dp7707
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7708
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01289
p7709
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01289_230
p7710
sg16
VGlisoxepide [drugbank:DB01289]
p7711
sg18
Vdrug-target interaction Glisoxepide and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01289_230]
p7712
sa(dp7713
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7714
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01382
p7715
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01382_230
p7716
sg16
VGlycodiazine [drugbank:DB01382]
p7717
sg18
Vdrug-target interaction Glycodiazine and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01382_230]
p7718
sa(dp7719
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:230
p7720
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01251
p7721
sg11
g7644
sg12
g7649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01251_230
p7722
sg16
VGliquidone [drugbank:DB01251]
p7723
sg18
Vdrug-target interaction Gliquidone and ATP-binding cassette transporter sub-family C member 8 [drugbank_resource:DB01251_230]
p7724
sasS'HDAC4'
p7725
(lp7726
(dp7727
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6003
p7728
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07879
p7729
sg11
g7725
sg12
S'histone deacetylase 4'
p7730
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07879_6003
p7731
sg16
VN-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide [drugbank:DB07879]
p7732
sg18
Vdrug-target interaction N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide and Histone deacetylase 4 [drugbank_resource:DB07879_6003]
p7733
sa(dp7734
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6003
p7735
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08613
p7736
sg11
g7725
sg12
g7730
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08613_6003
p7737
sg16
V2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL [drugbank:DB08613]
p7738
sg18
Vdrug-target interaction 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL and Histone deacetylase 4 [drugbank_resource:DB08613_6003]
p7739
sasS'HDAC7'
p7740
(lp7741
(dp7742
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6005
p7743
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04297
p7744
sg11
g7740
sg12
S'histone deacetylase 7'
p7745
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04297_6005
p7746
sg16
V7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide [drugbank:DB04297]
p7747
sg18
Vdrug-target interaction 7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide and Histone deacetylase 7a [drugbank_resource:DB04297_6005]
p7748
sasS'HDAC9'
p7749
(lp7750
(dp7751
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1039
p7752
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00313
p7753
sg11
g7749
sg12
S'histone deacetylase 9'
p7754
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00313_1039
p7755
sg16
VValproic Acid [drugbank:DB00313]
p7756
sg18
Vdrug-target interaction Valproic Acid and Histone deacetylase 9 [drugbank_resource:DB00313_1039]
p7757
sasS'PRNP'
p7758
(lp7759
(dp7760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1867
p7761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00759
p7762
sg11
g7758
sg12
S'prion protein'
p7763
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00759_1867
p7764
sg16
VTetracycline [drugbank:DB00759]
p7765
sg18
Vdrug-target interaction Tetracycline and Major prion protein [drugbank_resource:DB00759_1867]
p7766
sasS'EPHA2'
p7767
(lp7768
(dp7769
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:936
p7770
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p7771
sg11
g7767
sg12
S'EPH receptor A2'
p7772
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_936
p7773
sg16
VDasatinib [drugbank:DB01254]
p7774
sg18
Vdrug-target interaction Dasatinib and Ephrin type-A receptor 2 [drugbank_resource:DB01254_936]
p7775
sa(dp7776
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:936
p7777
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p7778
sg11
g7767
sg12
g7772
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_936
p7779
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p7780
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Ephrin type-A receptor 2 [drugbank_resource:DB04395_936]
p7781
sasS'SMAD2'
p7782
(lp7783
(dp7784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6955
p7785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p7786
sg11
g7782
sg12
S'SMAD family member 2'
p7787
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_6955
p7788
sg16
VPhosphonoserine [drugbank:DB04522]
p7789
sg18
Vdrug-target interaction Phosphonoserine and Mothers against decapentaplegic homolog 2 [drugbank_resource:DB04522_6955]
p7790
sasS'ADRA2A'
p7791
(lp7792
(dp7793
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7794
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00248
p7795
sg11
g7791
sg12
S'adrenoceptor alpha 2A'
p7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00248_318
p7797
sg16
VCabergoline [drugbank:DB00248]
p7798
sg18
Vdrug-target interaction Cabergoline and Alpha-2A adrenergic receptor [drugbank_resource:DB00248_318]
p7799
sa(dp7800
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7801
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00217
p7802
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00217_318
p7803
sg16
VBethanidine [drugbank:DB00217]
p7804
sg18
Vdrug-target interaction Bethanidine and Alpha-2A adrenergic receptor [drugbank_resource:DB00217_318]
p7805
sa(dp7806
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7807
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p7808
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_318
p7809
sg16
VZiprasidone [drugbank:DB00246]
p7810
sg18
Vdrug-target interaction Ziprasidone and Alpha-2A adrenergic receptor [drugbank_resource:DB00246_318]
p7811
sa(dp7812
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7813
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00268
p7814
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00268_318
p7815
sg16
VRopinirole [drugbank:DB00268]
p7816
sg18
Vdrug-target interaction Ropinirole and Alpha-2A adrenergic receptor [drugbank_resource:DB00268_318]
p7817
sa(dp7818
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7819
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p7820
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_318
p7821
sg16
VOlanzapine [drugbank:DB00334]
p7822
sg18
Vdrug-target interaction Olanzapine and Alpha-2A adrenergic receptor [drugbank_resource:DB00334_318]
p7823
sa(dp7824
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7825
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00543
p7826
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00543_318
p7827
sg16
VAmoxapine [drugbank:DB00543]
p7828
sg18
Vdrug-target interaction Amoxapine and Alpha-2A adrenergic receptor [drugbank_resource:DB00543_318]
p7829
sa(dp7830
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7831
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00589
p7832
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00589_318
p7833
sg16
VLisuride [drugbank:DB00589]
p7834
sg18
Vdrug-target interaction Lisuride and Alpha-2A adrenergic receptor [drugbank_resource:DB00589_318]
p7835
sa(dp7836
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7837
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00629
p7838
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00629_318
p7839
sg16
VGuanabenz [drugbank:DB00629]
p7840
sg18
Vdrug-target interaction Guanabenz and Alpha-2A adrenergic receptor [drugbank_resource:DB00629_318]
p7841
sa(dp7842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00320
p7844
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00320_318
p7845
sg16
VDihydroergotamine [drugbank:DB00320]
p7846
sg18
Vdrug-target interaction Dihydroergotamine and Alpha-2A adrenergic receptor [drugbank_resource:DB00320_318]
p7847
sa(dp7848
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7849
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00363
p7850
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00363_318
p7851
sg16
VClozapine [drugbank:DB00363]
p7852
sg18
Vdrug-target interaction Clozapine and Alpha-2A adrenergic receptor [drugbank_resource:DB00363_318]
p7853
sa(dp7854
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7855
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00370
p7856
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00370_318
p7857
sg16
VMirtazapine [drugbank:DB00370]
p7858
sg18
Vdrug-target interaction Mirtazapine and Alpha-2A adrenergic receptor [drugbank_resource:DB00370_318]
p7859
sa(dp7860
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7861
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00413
p7862
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00413_318
p7863
sg16
VPramipexole [drugbank:DB00413]
p7864
sg18
Vdrug-target interaction Pramipexole and Alpha-2A adrenergic receptor [drugbank_resource:DB00413_318]
p7865
sa(dp7866
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7867
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00484
p7868
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00484_318
p7869
sg16
VBrimonidine [drugbank:DB00484]
p7870
sg18
Vdrug-target interaction Brimonidine and Alpha-2A adrenergic receptor [drugbank_resource:DB00484_318]
p7871
sa(dp7872
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7873
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00575
p7874
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00575_318
p7875
sg16
VClonidine [drugbank:DB00575]
p7876
sg18
Vdrug-target interaction Clonidine and Alpha-2A adrenergic receptor [drugbank_resource:DB00575_318]
p7877
sa(dp7878
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7879
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00633
p7880
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00633_318
p7881
sg16
VDexmedetomidine [drugbank:DB00633]
p7882
sg18
Vdrug-target interaction Dexmedetomidine and Alpha-2A adrenergic receptor [drugbank_resource:DB00633_318]
p7883
sa(dp7884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00656
p7886
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00656_318
p7887
sg16
VTrazodone [drugbank:DB00656]
p7888
sg18
Vdrug-target interaction Trazodone and Alpha-2A adrenergic receptor [drugbank_resource:DB00656_318]
p7889
sa(dp7890
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7891
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p7892
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_318
p7893
sg16
VAmitriptyline [drugbank:DB00321]
p7894
sg18
Vdrug-target interaction Amitriptyline and Alpha-2A adrenergic receptor [drugbank_resource:DB00321_318]
p7895
sa(dp7896
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7897
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00368
p7898
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00368_318
p7899
sg16
VNorepinephrine [drugbank:DB00368]
p7900
sg18
Vdrug-target interaction Norepinephrine and Alpha-2A adrenergic receptor [drugbank_resource:DB00368_318]
p7901
sa(dp7902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00397
p7904
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00397_318
p7905
sg16
VPhenylpropanolamine [drugbank:DB00397]
p7906
sg18
Vdrug-target interaction Phenylpropanolamine and Alpha-2A adrenergic receptor [drugbank_resource:DB00397_318]
p7907
sa(dp7908
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7909
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00449
p7910
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00449_318
p7911
sg16
VDipivefrin [drugbank:DB00449]
p7912
sg18
Vdrug-target interaction Dipivefrin and Alpha-2A adrenergic receptor [drugbank_resource:DB00449_318]
p7913
sa(dp7914
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7915
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00668
p7916
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00668_318
p7917
sg16
VEpinephrine [drugbank:DB00668]
p7918
sg18
Vdrug-target interaction Epinephrine and Alpha-2A adrenergic receptor [drugbank_resource:DB00668_318]
p7919
sa(dp7920
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7921
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00692
p7922
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00692_318
p7923
sg16
VPhentolamine [drugbank:DB00692]
p7924
sg18
Vdrug-target interaction Phentolamine and Alpha-2A adrenergic receptor [drugbank_resource:DB00692_318]
p7925
sa(dp7926
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7927
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00696
p7928
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00696_318
p7929
sg16
VErgotamine [drugbank:DB00696]
p7930
sg18
Vdrug-target interaction Ergotamine and Alpha-2A adrenergic receptor [drugbank_resource:DB00696_318]
p7931
sa(dp7932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00697
p7934
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00697_318
p7935
sg16
VTizanidine [drugbank:DB00697]
p7936
sg18
Vdrug-target interaction Tizanidine and Alpha-2A adrenergic receptor [drugbank_resource:DB00697_318]
p7937
sa(dp7938
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7939
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00714
p7940
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00714_318
p7941
sg16
VApomorphine [drugbank:DB00714]
p7942
sg18
Vdrug-target interaction Apomorphine and Alpha-2A adrenergic receptor [drugbank_resource:DB00714_318]
p7943
sa(dp7944
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7945
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00800
p7946
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00800_318
p7947
sg16
VFenoldopam [drugbank:DB00800]
p7948
sg18
Vdrug-target interaction Fenoldopam and Alpha-2A adrenergic receptor [drugbank_resource:DB00800_318]
p7949
sa(dp7950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00852
p7952
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00852_318
p7953
sg16
VPseudoephedrine [drugbank:DB00852]
p7954
sg18
Vdrug-target interaction Pseudoephedrine and Alpha-2A adrenergic receptor [drugbank_resource:DB00852_318]
p7955
sa(dp7956
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7957
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00935
p7958
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00935_318
p7959
sg16
VOxymetazoline [drugbank:DB00935]
p7960
sg18
Vdrug-target interaction Oxymetazoline and Alpha-2A adrenergic receptor [drugbank_resource:DB00935_318]
p7961
sa(dp7962
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7963
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00968
p7964
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00968_318
p7965
sg16
VMethyldopa [drugbank:DB00968]
p7966
sg18
Vdrug-target interaction Methyldopa and Alpha-2A adrenergic receptor [drugbank_resource:DB00968_318]
p7967
sa(dp7968
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7969
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00964
p7970
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00964_318
p7971
sg16
VApraclonidine [drugbank:DB00964]
p7972
sg18
Vdrug-target interaction Apraclonidine and Alpha-2A adrenergic receptor [drugbank_resource:DB00964_318]
p7973
sa(dp7974
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7975
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01149
p7976
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01149_318
p7977
sg16
VNefazodone [drugbank:DB01149]
p7978
sg18
Vdrug-target interaction Nefazodone and Alpha-2A adrenergic receptor [drugbank_resource:DB01149_318]
p7979
sa(dp7980
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7981
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00734
p7982
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00734_318
p7983
sg16
VRisperidone [drugbank:DB00734]
p7984
sg18
Vdrug-target interaction Risperidone and Alpha-2A adrenergic receptor [drugbank_resource:DB00734_318]
p7985
sa(dp7986
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7987
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00751
p7988
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00751_318
p7989
sg16
VEpinastine [drugbank:DB00751]
p7990
sg18
Vdrug-target interaction Epinastine and Alpha-2A adrenergic receptor [drugbank_resource:DB00751_318]
p7991
sa(dp7992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00797
p7994
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00797_318
p7995
sg16
VTolazoline [drugbank:DB00797]
p7996
sg18
Vdrug-target interaction Tolazoline and Alpha-2A adrenergic receptor [drugbank_resource:DB00797_318]
p7997
sa(dp7998
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p7999
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00865
p8000
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00865_318
p8001
sg16
VBenzphetamine [drugbank:DB00865]
p8002
sg18
Vdrug-target interaction Benzphetamine and Alpha-2A adrenergic receptor [drugbank_resource:DB00865_318]
p8003
sa(dp8004
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8005
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00925
p8006
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00925_318
p8007
sg16
VPhenoxybenzamine [drugbank:DB00925]
p8008
sg18
Vdrug-target interaction Phenoxybenzamine and Alpha-2A adrenergic receptor [drugbank_resource:DB00925_318]
p8009
sa(dp8010
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8011
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01018
p8012
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01018_318
p8013
sg16
VGuanfacine [drugbank:DB01018]
p8014
sg18
Vdrug-target interaction Guanfacine and Alpha-2A adrenergic receptor [drugbank_resource:DB01018_318]
p8015
sa(dp8016
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8017
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01049
p8018
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01049_318
p8019
sg16
VErgoloid mesylate [drugbank:DB01049]
p8020
sg18
Vdrug-target interaction Ergoloid mesylate and Alpha-2A adrenergic receptor [drugbank_resource:DB01049_318]
p8021
sa(dp8022
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8023
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01142
p8024
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01142_318
p8025
sg16
VDoxepin [drugbank:DB01142]
p8026
sg18
Vdrug-target interaction Doxepin and Alpha-2A adrenergic receptor [drugbank_resource:DB01142_318]
p8027
sa(dp8028
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8029
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01200
p8030
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01200_318
p8031
sg16
VBromocriptine [drugbank:DB01200]
p8032
sg18
Vdrug-target interaction Bromocriptine and Alpha-2A adrenergic receptor [drugbank_resource:DB01200_318]
p8033
sa(dp8034
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8035
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p8036
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_318
p8037
sg16
VAripiprazole [drugbank:DB01238]
p8038
sg18
Vdrug-target interaction Aripiprazole and Alpha-2A adrenergic receptor [drugbank_resource:DB01238_318]
p8039
sa(dp8040
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8041
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01363
p8042
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01363_318
p8043
sg16
VEphedra [drugbank:DB01363]
p8044
sg18
Vdrug-target interaction Ephedra and Alpha-2A adrenergic receptor [drugbank_resource:DB01363_318]
p8045
sa(dp8046
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8047
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01392
p8048
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01392_318
p8049
sg16
VYohimbine [drugbank:DB01392]
p8050
sg18
Vdrug-target interaction Yohimbine and Alpha-2A adrenergic receptor [drugbank_resource:DB01392_318]
p8051
sa(dp8052
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8053
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01577
p8054
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01577_318
p8055
sg16
VMethamphetamine [drugbank:DB01577]
p8056
sg18
Vdrug-target interaction Methamphetamine and Alpha-2A adrenergic receptor [drugbank_resource:DB01577_318]
p8057
sa(dp8058
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8059
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01186
p8060
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01186_318
p8061
sg16
VPergolide [drugbank:DB01186]
p8062
sg18
Vdrug-target interaction Pergolide and Alpha-2A adrenergic receptor [drugbank_resource:DB01186_318]
p8063
sa(dp8064
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8065
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01267
p8066
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01267_318
p8067
sg16
VPaliperidone [drugbank:DB01267]
p8068
sg18
Vdrug-target interaction Paliperidone and Alpha-2A adrenergic receptor [drugbank_resource:DB01267_318]
p8069
sa(dp8070
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8071
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01472
p8072
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01472_318
p8073
sg16
V4-Methoxyamphetamine [drugbank:DB01472]
p8074
sg18
Vdrug-target interaction 4-Methoxyamphetamine and Alpha-2A adrenergic receptor [drugbank_resource:DB01472_318]
p8075
sa(dp8076
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8077
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p8078
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_318
p8079
sg16
VQuetiapine [drugbank:DB01224]
p8080
sg18
Vdrug-target interaction Quetiapine and Alpha-2A adrenergic receptor [drugbank_resource:DB01224_318]
p8081
sa(dp8082
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8083
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01287
p8084
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01287_318
p8085
sg16
VDihydroergotoxine [drugbank:DB01287]
p8086
sg18
Vdrug-target interaction Dihydroergotoxine and Alpha-2A adrenergic receptor [drugbank_resource:DB01287_318]
p8087
sa(dp8088
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8089
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01403
p8090
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01403_318
p8091
sg16
VMethotrimeprazine [drugbank:DB01403]
p8092
sg18
Vdrug-target interaction Methotrimeprazine and Alpha-2A adrenergic receptor [drugbank_resource:DB01403_318]
p8093
sa(dp8094
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8095
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01608
p8096
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01608_318
p8097
sg16
VPropericiazine [drugbank:DB01608]
p8098
sg18
Vdrug-target interaction Propericiazine and Alpha-2A adrenergic receptor [drugbank_resource:DB01608_318]
p8099
sa(dp8100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01624
p8102
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01624_318
p8103
sg16
VZuclopenthixol [drugbank:DB01624]
p8104
sg18
Vdrug-target interaction Zuclopenthixol and Alpha-2A adrenergic receptor [drugbank_resource:DB01624_318]
p8105
sa(dp8106
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8107
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04948
p8108
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04948_318
p8109
sg16
VLofexidine [drugbank:DB04948]
p8110
sg18
Vdrug-target interaction Lofexidine and Alpha-2A adrenergic receptor [drugbank_resource:DB04948_318]
p8111
sa(dp8112
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8113
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06148
p8114
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06148_318
p8115
sg16
VMianserin [drugbank:DB06148]
p8116
sg18
Vdrug-target interaction Mianserin and Alpha-2A adrenergic receptor [drugbank_resource:DB06148_318]
p8117
sa(dp8118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06711
p8120
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06711_318
p8121
sg16
VNaphazoline [drugbank:DB06711]
p8122
sg18
Vdrug-target interaction Naphazoline and Alpha-2A adrenergic receptor [drugbank_resource:DB06711_318]
p8123
sa(dp8124
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8125
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06262
p8126
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06262_318
p8127
sg16
VDroxidopa [drugbank:DB06262]
p8128
sg18
Vdrug-target interaction Droxidopa and Alpha-2A adrenergic receptor [drugbank_resource:DB06262_318]
p8129
sa(dp8130
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:318
p8131
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06694
p8132
sg11
g7791
sg12
g7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06694_318
p8133
sg16
VXylometazoline [drugbank:DB06694]
p8134
sg18
Vdrug-target interaction Xylometazoline and Alpha-2A adrenergic receptor [drugbank_resource:DB06694_318]
p8135
sasS'ALDOA'
p8136
(lp8137
(dp8138
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3069
p8139
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02512
p8140
sg11
g8136
sg12
S'aldolase A, fructose-bisphosphate'
p8141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02512_3069
p8142
sg16
V1,6-Fructose Diphosphate (Linear Form) [drugbank:DB02512]
p8143
sg18
Vdrug-target interaction 1,6-Fructose Diphosphate (Linear Form) and Fructose-bisphosphate aldolase A [drugbank_resource:DB02512_3069]
p8144
sa(dp8145
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3069
p8146
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04326
p8147
sg11
g8136
sg12
g8141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04326_3069
p8148
sg16
V1,3-Dihydroxyacetonephosphate [drugbank:DB04326]
p8149
sg18
Vdrug-target interaction 1,3-Dihydroxyacetonephosphate and Fructose-bisphosphate aldolase A [drugbank_resource:DB04326_3069]
p8150
sa(dp8151
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3069
p8152
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04733
p8153
sg11
g8136
sg12
g8141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04733_3069
p8154
sg16
V1,6-DI-O-PHOSPHONO-D-MANNITOL [drugbank:DB04733]
p8155
sg18
Vdrug-target interaction 1,6-DI-O-PHOSPHONO-D-MANNITOL and Fructose-bisphosphate aldolase A [drugbank_resource:DB04733_3069]
p8156
sa(dp8157
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3069
p8158
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08240
p8159
sg11
g8136
sg12
g8141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08240_3069
p8160
sg16
VN-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE [drugbank:DB08240]
p8161
sg18
Vdrug-target interaction N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE and Fructose-bisphosphate aldolase A [drugbank_resource:DB08240_3069]
p8162
sasS'XIAP'
p8163
(lp8164
(dp8165
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2042
p8166
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02628
p8167
sg11
g8163
sg12
S'X-linked inhibitor of apoptosis'
p8168
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02628_2042
p8169
sg16
V1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide [drugbank:DB02628]
p8170
sg18
Vdrug-target interaction 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide and Baculoviral IAP repeat-containing protein 4 [drugbank_resource:DB02628_2042]
p8171
sa(dp8172
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2042
p8173
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04612
p8174
sg11
g8163
sg12
g8168
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04612_2042
p8175
sg16
VN-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE [drugbank:DB04612]
p8176
sg18
Vdrug-target interaction N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE and Baculoviral IAP repeat-containing protein 4 [drugbank_resource:DB04612_2042]
p8177
sasS'VDR'
p8178
(lp8179
(dp8180
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8181
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00136
p8182
sg11
g8178
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00136_856
p8184
sg16
VCalcitriol [drugbank:DB00136]
p8185
sg18
Vdrug-target interaction Calcitriol and Vitamin D3 receptor [drugbank_resource:DB00136_856]
p8186
sa(dp8187
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8188
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00169
p8189
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00169_856
p8190
sg16
VCholecalciferol [drugbank:DB00169]
p8191
sg18
Vdrug-target interaction Cholecalciferol and Vitamin D3 receptor [drugbank_resource:DB00169_856]
p8192
sa(dp8193
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8194
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00146
p8195
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00146_856
p8196
sg16
VCalcidiol [drugbank:DB00146]
p8197
sg18
Vdrug-target interaction Calcidiol and Vitamin D3 receptor [drugbank_resource:DB00146_856]
p8198
sa(dp8199
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8200
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00153
p8201
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00153_856
p8202
sg16
VErgocalciferol [drugbank:DB00153]
p8203
sg18
Vdrug-target interaction Ergocalciferol and Vitamin D3 receptor [drugbank_resource:DB00153_856]
p8204
sa(dp8205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01070
p8207
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01070_856
p8208
sg16
VDihydrotachysterol [drugbank:DB01070]
p8209
sg18
Vdrug-target interaction Dihydrotachysterol and Vitamin D3 receptor [drugbank_resource:DB01070_856]
p8210
sa(dp8211
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8212
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00910
p8213
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00910_856
p8214
sg16
VParicalcitol [drugbank:DB00910]
p8215
sg18
Vdrug-target interaction Paricalcitol and Vitamin D3 receptor [drugbank_resource:DB00910_856]
p8216
sa(dp8217
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8218
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01436
p8219
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01436_856
p8220
sg16
VAlfacalcidol [drugbank:DB01436]
p8221
sg18
Vdrug-target interaction Alfacalcidol and Vitamin D3 receptor [drugbank_resource:DB01436_856]
p8222
sa(dp8223
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8224
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02300
p8225
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02300_856
p8226
sg16
VCalcipotriol [drugbank:DB02300]
p8227
sg18
Vdrug-target interaction Calcipotriol and Vitamin D3 receptor [drugbank_resource:DB02300_856]
p8228
sa(dp8229
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8230
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03451
p8231
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03451_856
p8232
sg16
V1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3 [drugbank:DB03451]
p8233
sg18
Vdrug-target interaction 1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3 and Vitamin D3 receptor [drugbank_resource:DB03451_856]
p8234
sa(dp8235
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8236
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04258
p8237
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04258_856
p8238
sg16
VSeocalcitol [drugbank:DB04258]
p8239
sg18
Vdrug-target interaction Seocalcitol and Vitamin D3 receptor [drugbank_resource:DB04258_856]
p8240
sa(dp8241
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8242
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04796
p8243
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04796_856
p8244
sg16
VInecalcitol [drugbank:DB04796]
p8245
sg18
Vdrug-target interaction Inecalcitol and Vitamin D3 receptor [drugbank_resource:DB04796_856]
p8246
sa(dp8247
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8248
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07530
p8249
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07530_856
p8250
sg16
V(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol [drugbank:DB07530]
p8251
sg18
Vdrug-target interaction (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol and Vitamin D3 receptor [drugbank_resource:DB07530_856]
p8252
sa(dp8253
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8254
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08696
p8255
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08696_856
p8256
sg16
V5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL [drugbank:DB08696]
p8257
sg18
Vdrug-target interaction 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL and Vitamin D3 receptor [drugbank_resource:DB08696_856]
p8258
sa(dp8259
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p8260
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08742
p8261
sg11
g8178
sg12
g8183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08742_856
p8262
sg16
V1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) [drugbank:DB08742]
p8263
sg18
Vdrug-target interaction 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) and Vitamin D3 receptor [drugbank_resource:DB08742_856]
p8264
sasS'MAPK10'
p8265
(lp8266
(dp8267
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8268
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01782
p8269
sg11
g8265
sg12
S'mitogen-activated protein kinase 10'
p8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01782_1836
p8271
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p8272
sg18
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Mitogen-activated protein kinase 10 [drugbank_resource:DB01782_1836]
p8273
sa(dp8274
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8275
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02388
p8276
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02388_1836
p8277
sg16
VCyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine [drugbank:DB02388]
p8278
sg18
Vdrug-target interaction Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine and Mitogen-activated protein kinase 10 [drugbank_resource:DB02388_1836]
p8279
sa(dp8280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03084
p8282
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03084_1836
p8283
sg16
VCyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine [drugbank:DB03084]
p8284
sg18
Vdrug-target interaction Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine and Mitogen-activated protein kinase 10 [drugbank_resource:DB03084_1836]
p8285
sa(dp8286
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8287
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03623
p8288
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03623_1836
p8289
sg16
V9-(4-Hydroxyphenyl)-2,7-Phenanthroline [drugbank:DB03623]
p8290
sg18
Vdrug-target interaction 9-(4-Hydroxyphenyl)-2,7-Phenanthroline and Mitogen-activated protein kinase 10 [drugbank_resource:DB03623_1836]
p8291
sa(dp8292
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8293
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p8294
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_1836
p8295
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p8296
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Mitogen-activated protein kinase 10 [drugbank_resource:DB04395_1836]
p8297
sa(dp8298
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8299
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06933
p8300
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06933_1836
p8301
sg16
VN-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide [drugbank:DB06933]
p8302
sg18
Vdrug-target interaction N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide and Mitogen-activated protein kinase 10 [drugbank_resource:DB06933_1836]
p8303
sa(dp8304
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8305
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07217
p8306
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07217_1836
p8307
sg16
VN-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide [drugbank:DB07217]
p8308
sg18
Vdrug-target interaction N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide and Mitogen-activated protein kinase 10 [drugbank_resource:DB07217_1836]
p8309
sa(dp8310
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8311
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07010
p8312
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07010_1836
p8313
sg16
VN-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07010]
p8314
sg18
Vdrug-target interaction N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 10 [drugbank_resource:DB07010_1836]
p8315
sa(dp8316
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8317
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08005
p8318
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08005_1836
p8319
sg16
V4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide [drugbank:DB08005]
p8320
sg18
Vdrug-target interaction 4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide and Mitogen-activated protein kinase 10 [drugbank_resource:DB08005_1836]
p8321
sa(dp8322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08010
p8324
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08010_1836
p8325
sg16
V(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime [drugbank:DB08010]
p8326
sg18
Vdrug-target interaction (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime and Mitogen-activated protein kinase 10 [drugbank_resource:DB08010_1836]
p8327
sa(dp8328
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8329
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08011
p8330
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08011_1836
p8331
sg16
V(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime [drugbank:DB08011]
p8332
sg18
Vdrug-target interaction (3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime and Mitogen-activated protein kinase 10 [drugbank_resource:DB08011_1836]
p8333
sa(dp8334
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8335
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08015
p8336
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08015_1836
p8337
sg16
V(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime [drugbank:DB08015]
p8338
sg18
Vdrug-target interaction (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime and Mitogen-activated protein kinase 10 [drugbank_resource:DB08015_1836]
p8339
sa(dp8340
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8341
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08021
p8342
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08021_1836
p8343
sg16
V5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide [drugbank:DB08021]
p8344
sg18
Vdrug-target interaction 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide and Mitogen-activated protein kinase 10 [drugbank_resource:DB08021_1836]
p8345
sa(dp8346
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8347
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08026
p8348
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08026_1836
p8349
sg16
V2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide [drugbank:DB08026]
p8350
sg18
Vdrug-target interaction 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide and Mitogen-activated protein kinase 10 [drugbank_resource:DB08026_1836]
p8351
sa(dp8352
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8353
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08023
p8354
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08023_1836
p8355
sg16
VN-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine [drugbank:DB08023]
p8356
sg18
Vdrug-target interaction N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine and Mitogen-activated protein kinase 10 [drugbank_resource:DB08023_1836]
p8357
sa(dp8358
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8359
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08555
p8360
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08555_1836
p8361
sg16
V1-(3-BROMOPHENYL)-7-CHLORO-6-METHOXY-3,4-DIHYDROISOQUINOLINE [drugbank:DB08555]
p8362
sg18
Vdrug-target interaction 1-(3-BROMOPHENYL)-7-CHLORO-6-METHOXY-3,4-DIHYDROISOQUINOLINE and Mitogen-activated protein kinase 10 [drugbank_resource:DB08555_1836]
p8363
sa(dp8364
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1836
p8365
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08025
p8366
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08025_1836
p8367
sg16
VN-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE [drugbank:DB08025]
p8368
sg18
Vdrug-target interaction N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE and Mitogen-activated protein kinase 10 [drugbank_resource:DB08025_1836]
p8369
sa(dp8370
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6653
p8371
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08023
p8372
sg11
g8265
sg12
g8270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08023_6653
p8373
sg16
VN-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine [drugbank:DB08023]
p8374
sg18
Vdrug-target interaction N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine and cDNA FLJ42801 fis, clone BRCAN2001223, highly similar to Mitogen-activated protein kinase 10 (EC 2.7.11.24) [drugbank_resource:DB08023_6653]
p8375
sasS'LYZ'
p8376
(lp8377
(dp8378
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8379
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00128
p8380
sg11
g8376
sg12
S'lysozyme'
p8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00128_6252
p8382
sg16
VL-Aspartic Acid [drugbank:DB00128]
p8383
sg18
Vdrug-target interaction L-Aspartic Acid and Lysozyme C [drugbank_resource:DB00128_6252]
p8384
sa(dp8385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02250
p8387
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02250_6252
p8388
sg16
VCu-Bicyclam [drugbank:DB02250]
p8389
sg18
Vdrug-target interaction Cu-Bicyclam and Lysozyme C [drugbank_resource:DB02250_6252]
p8390
sa(dp8391
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8392
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02759
p8393
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02759_6252
p8394
sg16
V4-Methylumbelliferyl Chitobiose [drugbank:DB02759]
p8395
sg18
Vdrug-target interaction 4-Methylumbelliferyl Chitobiose and Lysozyme C [drugbank_resource:DB02759_6252]
p8396
sa(dp8397
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8398
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02772
p8399
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02772_6252
p8400
sg16
VSucrose [drugbank:DB02772]
p8401
sg18
Vdrug-target interaction Sucrose and Lysozyme C [drugbank_resource:DB02772_6252]
p8402
sa(dp8403
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8404
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03006
p8405
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03006_6252
p8406
sg16
V4-Aminophenylarsonic Acid [drugbank:DB03006]
p8407
sg18
Vdrug-target interaction 4-Aminophenylarsonic Acid and Lysozyme C [drugbank_resource:DB03006_6252]
p8408
sa(dp8409
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8410
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03175
p8411
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03175_6252
p8412
sg16
V1-Proponol [drugbank:DB03175]
p8413
sg18
Vdrug-target interaction 1-Proponol and Lysozyme C [drugbank_resource:DB03175_6252]
p8414
sa(dp8415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p8417
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_6252
p8418
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p8419
sg18
Vdrug-target interaction Alpha-D-Mannose and Lysozyme C [drugbank_resource:DB02944_6252]
p8420
sa(dp8421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03013
p8423
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03013_6252
p8424
sg16
VDi(N-Acetyl-D-Glucosamine) [drugbank:DB03013]
p8425
sg18
Vdrug-target interaction Di(N-Acetyl-D-Glucosamine) and Lysozyme C [drugbank_resource:DB03013_6252]
p8426
sa(dp8427
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8428
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03189
p8429
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03189_6252
p8430
sg16
VCu-Cyclam [drugbank:DB03189]
p8431
sg18
Vdrug-target interaction Cu-Cyclam and Lysozyme C [drugbank_resource:DB03189_6252]
p8432
sa(dp8433
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8434
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03120
p8435
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03120_6252
p8436
sg16
VPara-Toluene Sulfonate [drugbank:DB03120]
p8437
sg18
Vdrug-target interaction Para-Toluene Sulfonate and Lysozyme C [drugbank_resource:DB03120_6252]
p8438
sa(dp8439
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8440
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03967
p8441
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03967_6252
p8442
sg16
VDodecyl Sulfate [drugbank:DB03967]
p8443
sg18
Vdrug-target interaction Dodecyl Sulfate and Lysozyme C [drugbank_resource:DB03967_6252]
p8444
sa(dp8445
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8446
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03487
p8447
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03487_6252
p8448
sg16
V3-Aminosuccinimide [drugbank:DB03487]
p8449
sg18
Vdrug-target interaction 3-Aminosuccinimide and Lysozyme C [drugbank_resource:DB03487_6252]
p8450
sa(dp8451
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8452
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04194
p8453
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04194_6252
p8454
sg16
VChitotriose [drugbank:DB04194]
p8455
sg18
Vdrug-target interaction Chitotriose and Lysozyme C [drugbank_resource:DB04194_6252]
p8456
sa(dp8457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04268
p8459
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04268_6252
p8460
sg16
VMethylumbelliferyl Chitotriose [drugbank:DB04268]
p8461
sg18
Vdrug-target interaction Methylumbelliferyl Chitotriose and Lysozyme C [drugbank_resource:DB04268_6252]
p8462
sa(dp8463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6252
p8464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06912
p8465
sg11
g8376
sg12
g8381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06912_6252
p8466
sg16
VUNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE [drugbank:DB06912]
p8467
sg18
Vdrug-target interaction UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE and Lysozyme C [drugbank_resource:DB06912_6252]
p8468
sasS'CD2'
p8469
(lp8470
(dp8471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:793
p8472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00092
p8473
sg11
g8469
sg12
S'CD2 molecule'
p8474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00092_793
p8475
sg16
VAlefacept [drugbank:DB00092]
p8476
sg18
Vdrug-target interaction Alefacept and T-cell surface antigen CD2 [drugbank_resource:DB00092_793]
p8477
sa(dp8478
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:793
p8479
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p8480
sg11
g8469
sg12
g8474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_793
p8481
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p8482
sg18
Vdrug-target interaction Alpha-D-Mannose and T-cell surface antigen CD2 [drugbank_resource:DB02944_793]
p8483
sasS'ABL1'
p8484
(lp8485
(dp8486
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8487
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p8488
sg11
g8484
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_17
p8490
sg16
VAdenosine triphosphate [drugbank:DB00171]
p8491
sg18
Vdrug-target interaction Adenosine triphosphate and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB00171_17]
p8492
sa(dp8493
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8494
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p8495
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_17
p8496
sg16
VImatinib [drugbank:DB00619]
p8497
sg18
Vdrug-target interaction Imatinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB00619_17]
p8498
sa(dp8499
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8500
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p8501
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_17
p8502
sg16
VDasatinib [drugbank:DB01254]
p8503
sg18
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB01254_17]
p8504
sa(dp8505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03878
p8507
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03878_17
p8508
sg16
VN-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide [drugbank:DB03878]
p8509
sg18
Vdrug-target interaction N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB03878_17]
p8510
sa(dp8511
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8512
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04868
p8513
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04868_17
p8514
sg16
VNilotinib [drugbank:DB04868]
p8515
sg18
Vdrug-target interaction Nilotinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB04868_17]
p8516
sa(dp8517
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8518
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07831
p8519
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07831_17
p8520
sg16
V2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE [drugbank:DB07831]
p8521
sg18
Vdrug-target interaction 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB07831_17]
p8522
sa(dp8523
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8524
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08043
p8525
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08043_17
p8526
sg16
V1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA [drugbank:DB08043]
p8527
sg18
Vdrug-target interaction 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08043_17]
p8528
sa(dp8529
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8530
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08339
p8531
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08339_17
p8532
sg16
V6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE [drugbank:DB08339]
p8533
sg18
Vdrug-target interaction 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08339_17]
p8534
sa(dp8535
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8536
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08350
p8537
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08350_17
p8538
sg16
V5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE [drugbank:DB08350]
p8539
sg18
Vdrug-target interaction 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08350_17]
p8540
sa(dp8541
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8542
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08583
p8543
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08583_17
p8544
sg16
V2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide [drugbank:DB08583]
p8545
sg18
Vdrug-target interaction 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08583_17]
p8546
sa(dp8547
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p8548
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p8549
sg11
g8484
sg12
g8489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_17
p8550
sg16
VMYRISTIC ACID [drugbank:DB08231]
p8551
sg18
Vdrug-target interaction MYRISTIC ACID and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08231_17]
p8552
sasS'VDAC2'
p8553
(lp8554
(dp8555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4246
p8556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01375
p8557
sg11
g8553
sg12
S'voltage-dependent anion channel 2'
p8558
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01375_4246
p8559
sg16
VDihydroxyaluminium [drugbank:DB01375]
p8560
sg18
Vdrug-target interaction Dihydroxyaluminium and Voltage-dependent anion-selective channel protein 2 [drugbank_resource:DB01375_4246]
p8561
sasS'THRA'
p8562
(lp8563
(dp8564
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:758
p8565
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00279
p8566
sg11
g8562
sg12
S'thyroid hormone receptor, alpha'
p8567
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00279_758
p8568
sg16
VLiothyronine [drugbank:DB00279]
p8569
sg18
Vdrug-target interaction Liothyronine and Thyroid hormone receptor alpha [drugbank_resource:DB00279_758]
p8570
sa(dp8571
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:758
p8572
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00509
p8573
sg11
g8562
sg12
g8567
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00509_758
p8574
sg16
VDextrothyroxine [drugbank:DB00509]
p8575
sg18
Vdrug-target interaction Dextrothyroxine and Thyroid hormone receptor alpha [drugbank_resource:DB00509_758]
p8576
sa(dp8577
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:758
p8578
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00451
p8579
sg11
g8562
sg12
g8567
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00451_758
p8580
sg16
VLevothyroxine [drugbank:DB00451]
p8581
sg18
Vdrug-target interaction Levothyroxine and Thyroid hormone receptor alpha [drugbank_resource:DB00451_758]
p8582
sa(dp8583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:758
p8584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01583
p8585
sg11
g8562
sg12
g8567
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01583_758
p8586
sg16
VLiotrix [drugbank:DB01583]
p8587
sg18
Vdrug-target interaction Liotrix and Thyroid hormone receptor alpha [drugbank_resource:DB01583_758]
p8588
sa(dp8589
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:758
p8590
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03176
p8591
sg11
g8562
sg12
g8567
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03176_758
p8592
sg16
V3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid [drugbank:DB03176]
p8593
sg18
Vdrug-target interaction 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid and Thyroid hormone receptor alpha [drugbank_resource:DB03176_758]
p8594
sasS'RAF1'
p8595
(lp8596
(dp8597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:40
p8598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00398
p8599
sg11
g8595
sg12
S'v-raf-1 murine leukemia viral oncogene homolog 1'
p8600
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00398_40
p8601
sg16
VSorafenib [drugbank:DB00398]
p8602
sg18
Vdrug-target interaction Sorafenib and RAF proto-oncogene serine/threonine-protein kinase [drugbank_resource:DB00398_40]
p8603
sasS'F10'
p8604
(lp8605
(dp8606
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8607
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00025
p8608
sg11
g8604
sg12
S'coagulation factor X'
p8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00025_239
p8610
sg16
VAntihemophilic Factor [drugbank:DB00025]
p8611
sg18
Vdrug-target interaction Antihemophilic Factor and Coagulation factor X [drugbank_resource:DB00025_239]
p8612
sa(dp8613
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8614
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00036
p8615
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00036_239
p8616
sg16
VCoagulation factor VIIa [drugbank:DB00036]
p8617
sg18
Vdrug-target interaction Coagulation factor VIIa and Coagulation factor X [drugbank_resource:DB00036_239]
p8618
sa(dp8619
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8620
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00100
p8621
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00100_239
p8622
sg16
VCoagulation Factor IX [drugbank:DB00100]
p8623
sg18
Vdrug-target interaction Coagulation Factor IX and Coagulation factor X [drugbank_resource:DB00100_239]
p8624
sa(dp8625
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8626
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00170
p8627
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00170_239
p8628
sg16
VMenadione [drugbank:DB00170]
p8629
sg18
Vdrug-target interaction Menadione and Coagulation factor X [drugbank_resource:DB00170_239]
p8630
sa(dp8631
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8632
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00569
p8633
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00569_239
p8634
sg16
VFondaparinux sodium [drugbank:DB00569]
p8635
sg18
Vdrug-target interaction Fondaparinux sodium and Coagulation factor X [drugbank_resource:DB00569_239]
p8636
sa(dp8637
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8638
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01109
p8639
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01109_239
p8640
sg16
VHeparin [drugbank:DB01109]
p8641
sg18
Vdrug-target interaction Heparin and Coagulation factor X [drugbank_resource:DB01109_239]
p8642
sa(dp8643
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8644
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01225
p8645
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01225_239
p8646
sg16
VEnoxaparin [drugbank:DB01225]
p8647
sg18
Vdrug-target interaction Enoxaparin and Coagulation factor X [drugbank_resource:DB01225_239]
p8648
sa(dp8649
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8650
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03847
p8651
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03847_239
p8652
sg16
VGamma-Carboxy-Glutamic Acid [drugbank:DB03847]
p8653
sg18
Vdrug-target interaction Gamma-Carboxy-Glutamic Acid and Coagulation factor X [drugbank_resource:DB03847_239]
p8654
sa(dp8655
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8656
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06920
p8657
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06920_239
p8658
sg16
V(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE [drugbank:DB06920]
p8659
sg18
Vdrug-target interaction (2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE and Coagulation factor X [drugbank_resource:DB06920_239]
p8660
sa(dp8661
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8662
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04673
p8663
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04673_239
p8664
sg16
V4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE [drugbank:DB04673]
p8665
sg18
Vdrug-target interaction 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE and Coagulation factor X [drugbank_resource:DB04673_239]
p8666
sa(dp8667
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8668
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06228
p8669
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06228_239
p8670
sg16
VRivaroxaban [drugbank:DB06228]
p8671
sg18
Vdrug-target interaction Rivaroxaban and Coagulation factor X [drugbank_resource:DB06228_239]
p8672
sa(dp8673
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8674
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07211
p8675
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07211_239
p8676
sg16
V(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE [drugbank:DB07211]
p8677
sg18
Vdrug-target interaction (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE and Coagulation factor X [drugbank_resource:DB07211_239]
p8678
sa(dp8679
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8680
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07261
p8681
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07261_239
p8682
sg16
VTHIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE [drugbank:DB07261]
p8683
sg18
Vdrug-target interaction THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE and Coagulation factor X [drugbank_resource:DB07261_239]
p8684
sa(dp8685
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8686
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07277
p8687
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07277_239
p8688
sg16
V2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE [drugbank:DB07277]
p8689
sg18
Vdrug-target interaction 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE and Coagulation factor X [drugbank_resource:DB07277_239]
p8690
sa(dp8691
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8692
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07278
p8693
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07278_239
p8694
sg16
V2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE [drugbank:DB07278]
p8695
sg18
Vdrug-target interaction 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE and Coagulation factor X [drugbank_resource:DB07278_239]
p8696
sa(dp8697
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8698
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07605
p8699
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07605_239
p8700
sg16
V2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE [drugbank:DB07605]
p8701
sg18
Vdrug-target interaction 2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE and Coagulation factor X [drugbank_resource:DB07605_239]
p8702
sa(dp8703
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8704
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07800
p8705
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07800_239
p8706
sg16
VN-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE [drugbank:DB07800]
p8707
sg18
Vdrug-target interaction N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE and Coagulation factor X [drugbank_resource:DB07800_239]
p8708
sa(dp8709
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8710
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07847
p8711
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07847_239
p8712
sg16
V6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE [drugbank:DB07847]
p8713
sg18
Vdrug-target interaction 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE and Coagulation factor X [drugbank_resource:DB07847_239]
p8714
sa(dp8715
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8716
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07872
p8717
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07872_239
p8718
sg16
V5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide [drugbank:DB07872]
p8719
sg18
Vdrug-target interaction 5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide and Coagulation factor X [drugbank_resource:DB07872_239]
p8720
sa(dp8721
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8722
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08173
p8723
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08173_239
p8724
sg16
V5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE [drugbank:DB08173]
p8725
sg18
Vdrug-target interaction 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE and Coagulation factor X [drugbank_resource:DB08173_239]
p8726
sa(dp8727
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8728
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08174
p8729
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08174_239
p8730
sg16
V5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE [drugbank:DB08174]
p8731
sg18
Vdrug-target interaction 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE and Coagulation factor X [drugbank_resource:DB08174_239]
p8732
sa(dp8733
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8734
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08426
p8735
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08426_239
p8736
sg16
VTHIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE [drugbank:DB08426]
p8737
sg18
Vdrug-target interaction THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE and Coagulation factor X [drugbank_resource:DB08426_239]
p8738
sa(dp8739
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8740
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08487
p8741
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08487_239
p8742
sg16
V3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE [drugbank:DB08487]
p8743
sg18
Vdrug-target interaction 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE and Coagulation factor X [drugbank_resource:DB08487_239]
p8744
sa(dp8745
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8746
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08488
p8747
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08488_239
p8748
sg16
V4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE [drugbank:DB08488]
p8749
sg18
Vdrug-target interaction 4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE and Coagulation factor X [drugbank_resource:DB08488_239]
p8750
sa(dp8751
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8752
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07630
p8753
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07630_239
p8754
sg16
VN-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE [drugbank:DB07630]
p8755
sg18
Vdrug-target interaction N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE and Coagulation factor X [drugbank_resource:DB07630_239]
p8756
sa(dp8757
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8758
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07804
p8759
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07804_239
p8760
sg16
V5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE [drugbank:DB07804]
p8761
sg18
Vdrug-target interaction 5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE and Coagulation factor X [drugbank_resource:DB07804_239]
p8762
sa(dp8763
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8764
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07973
p8765
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07973_239
p8766
sg16
VN-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE [drugbank:DB07973]
p8767
sg18
Vdrug-target interaction N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE and Coagulation factor X [drugbank_resource:DB07973_239]
p8768
sa(dp8769
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8770
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07974
p8771
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07974_239
p8772
sg16
V1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE [drugbank:DB07974]
p8773
sg18
Vdrug-target interaction 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE and Coagulation factor X [drugbank_resource:DB07974_239]
p8774
sa(dp8775
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8776
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08477
p8777
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08477_239
p8778
sg16
V5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide [drugbank:DB08477]
p8779
sg18
Vdrug-target interaction 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide and Coagulation factor X [drugbank_resource:DB08477_239]
p8780
sa(dp8781
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8782
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08745
p8783
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08745_239
p8784
sg16
V4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE [drugbank:DB08745]
p8785
sg18
Vdrug-target interaction 4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE and Coagulation factor X [drugbank_resource:DB08745_239]
p8786
sa(dp8787
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8788
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07629
p8789
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07629_239
p8790
sg16
VN-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE [drugbank:DB07629]
p8791
sg18
Vdrug-target interaction N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE and Coagulation factor X [drugbank_resource:DB07629_239]
p8792
sa(dp8793
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8794
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07843
p8795
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07843_239
p8796
sg16
V5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE [drugbank:DB07843]
p8797
sg18
Vdrug-target interaction 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE and Coagulation factor X [drugbank_resource:DB07843_239]
p8798
sa(dp8799
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8800
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07844
p8801
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07844_239
p8802
sg16
V6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE [drugbank:DB07844]
p8803
sg18
Vdrug-target interaction 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE and Coagulation factor X [drugbank_resource:DB07844_239]
p8804
sa(dp8805
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8806
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07848
p8807
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07848_239
p8808
sg16
V5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE [drugbank:DB07848]
p8809
sg18
Vdrug-target interaction 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE and Coagulation factor X [drugbank_resource:DB07848_239]
p8810
sa(dp8811
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8812
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07875
p8813
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07875_239
p8814
sg16
V5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide [drugbank:DB07875]
p8815
sg18
Vdrug-target interaction 5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide and Coagulation factor X [drugbank_resource:DB07875_239]
p8816
sa(dp8817
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8818
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08143
p8819
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08143_239
p8820
sg16
V5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE [drugbank:DB08143]
p8821
sg18
Vdrug-target interaction 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE and Coagulation factor X [drugbank_resource:DB08143_239]
p8822
sa(dp8823
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8824
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08495
p8825
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08495_239
p8826
sg16
V4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE [drugbank:DB08495]
p8827
sg18
Vdrug-target interaction 4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE and Coagulation factor X [drugbank_resource:DB08495_239]
p8828
sa(dp8829
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:239
p8830
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08746
p8831
sg11
g8604
sg12
g8609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08746_239
p8832
sg16
V1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE [drugbank:DB08746]
p8833
sg18
Vdrug-target interaction 1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE and Coagulation factor X [drugbank_resource:DB08746_239]
p8834
sasS'GNAI1'
p8835
(lp8836
(dp8837
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7001
p8838
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04444
p8839
sg11
g8835
sg12
S'guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1'
p8840
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04444_7001
p8841
sg16
VTetrafluoroaluminate Ion [drugbank:DB04444]
p8842
sg18
Vdrug-target interaction Tetrafluoroaluminate Ion and Guanine nucleotide-binding protein G(i) subunit alpha-1 [drugbank_resource:DB04444_7001]
p8843
sa(dp8844
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7001
p8845
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p8846
sg11
g8835
sg12
g8840
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_7001
p8847
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p8848
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Guanine nucleotide-binding protein G(i) subunit alpha-1 [drugbank_resource:DB04315_7001]
p8849
sasS'NCOA2'
p8850
(lp8851
(dp8852
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8853
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p8854
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_6241
p8855
sg16
VGenistein [drugbank:DB01645]
p8856
sg18
Vdrug-target interaction Genistein and Nuclear receptor coactivator 2 [drugbank_resource:DB01645_6241]
p8857
sa(dp8858
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8859
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02998
p8860
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02998_6241
p8861
sg16
VMethyltrienolone [drugbank:DB02998]
p8862
sg18
Vdrug-target interaction Methyltrienolone and Nuclear receptor coactivator 2 [drugbank_resource:DB02998_6241]
p8863
sa(dp8864
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8865
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06871
p8866
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06871_6241
p8867
sg16
V17-METHYL-17-ALPHA-DIHYDROEQUILENIN [drugbank:DB06871]
p8868
sg18
Vdrug-target interaction 17-METHYL-17-ALPHA-DIHYDROEQUILENIN and Nuclear receptor coactivator 2 [drugbank_resource:DB06871_6241]
p8869
sa(dp8870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06898
p8872
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06898_6241
p8873
sg16
V4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol [drugbank:DB06898]
p8874
sg18
Vdrug-target interaction 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol and Nuclear receptor coactivator 2 [drugbank_resource:DB06898_6241]
p8875
sa(dp8876
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8877
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07086
p8878
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07086_6241
p8879
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07086]
p8880
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07086_6241]
p8881
sa(dp8882
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8883
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07080
p8884
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07080_6241
p8885
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p8886
sg18
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Nuclear receptor coactivator 2 [drugbank_resource:DB07080_6241]
p8887
sa(dp8888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07087
p8890
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07087_6241
p8891
sg16
V4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07087]
p8892
sg18
Vdrug-target interaction 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07087_6241]
p8893
sa(dp8894
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8895
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07195
p8896
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07195_6241
p8897
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07195]
p8898
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07195_6241]
p8899
sa(dp8900
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8901
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07708
p8902
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07708_6241
p8903
sg16
V3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07708]
p8904
sg18
Vdrug-target interaction 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Nuclear receptor coactivator 2 [drugbank_resource:DB07708_6241]
p8905
sa(dp8906
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8907
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07863
p8908
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07863_6241
p8909
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p8910
sg18
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Nuclear receptor coactivator 2 [drugbank_resource:DB07863_6241]
p8911
sa(dp8912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07932
p8914
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07932_6241
p8915
sg16
Vdimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate [drugbank:DB07932]
p8916
sg18
Vdrug-target interaction dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate and Nuclear receptor coactivator 2 [drugbank_resource:DB07932_6241]
p8917
sa(dp8918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08175
p8920
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08175_6241
p8921
sg16
V(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID [drugbank:DB08175]
p8922
sg18
Vdrug-target interaction (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID and Nuclear receptor coactivator 2 [drugbank_resource:DB08175_6241]
p8923
sa(dp8924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08402
p8926
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08402_6241
p8927
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p8928
sg18
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Nuclear receptor coactivator 2 [drugbank_resource:DB08402_6241]
p8929
sa(dp8930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08601
p8932
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08601_6241
p8933
sg16
Vtributylstannanyl [drugbank:DB08601]
p8934
sg18
Vdrug-target interaction tributylstannanyl and Nuclear receptor coactivator 2 [drugbank_resource:DB08601_6241]
p8935
sa(dp8936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07678
p8938
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07678_6241
p8939
sg16
V(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL [drugbank:DB07678]
p8940
sg18
Vdrug-target interaction (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07678_6241]
p8941
sa(dp8942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07707
p8944
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07707_6241
p8945
sg16
V(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL [drugbank:DB07707]
p8946
sg18
Vdrug-target interaction (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL and Nuclear receptor coactivator 2 [drugbank_resource:DB07707_6241]
p8947
sa(dp8948
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8949
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08047
p8950
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08047_6241
p8951
sg16
V4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol [drugbank:DB08047]
p8952
sg18
Vdrug-target interaction 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol and Nuclear receptor coactivator 2 [drugbank_resource:DB08047_6241]
p8953
sa(dp8954
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8955
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08048
p8956
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08048_6241
p8957
sg16
V4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB08048]
p8958
sg18
Vdrug-target interaction 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL and Nuclear receptor coactivator 2 [drugbank_resource:DB08048_6241]
p8959
sa(dp8960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08320
p8962
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08320_6241
p8963
sg16
VDIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE [drugbank:DB08320]
p8964
sg18
Vdrug-target interaction DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE and Nuclear receptor coactivator 2 [drugbank_resource:DB08320_6241]
p8965
sa(dp8966
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8967
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08398
p8968
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08398_6241
p8969
sg16
V2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE [drugbank:DB08398]
p8970
sg18
Vdrug-target interaction 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE and Nuclear receptor coactivator 2 [drugbank_resource:DB08398_6241]
p8971
sa(dp8972
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8973
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07712
p8974
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07712_6241
p8975
sg16
V3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07712]
p8976
sg18
Vdrug-target interaction 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Nuclear receptor coactivator 2 [drugbank_resource:DB07712_6241]
p8977
sa(dp8978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08595
p8980
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08595_6241
p8981
sg16
V4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB08595]
p8982
sg18
Vdrug-target interaction 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Nuclear receptor coactivator 2 [drugbank_resource:DB08595_6241]
p8983
sa(dp8984
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6241
p8985
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08773
p8986
sg11
g8850
sg12
g2731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08773_6241
p8987
sg16
VRALOXIFENE CORE [drugbank:DB08773]
p8988
sg18
Vdrug-target interaction RALOXIFENE CORE and Nuclear receptor coactivator 2 [drugbank_resource:DB08773_6241]
p8989
sasS'CREBBP'
p8990
(lp8991
(dp8992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6876
p8993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08655
p8994
sg11
g8990
sg12
S'CREB binding protein'
p8995
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08655_6876
p8996
sg16
V9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE [drugbank:DB08655]
p8997
sg18
Vdrug-target interaction 9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE and CREB-binding protein [drugbank_resource:DB08655_6876]
p8998
sasS'NDUFV1'
p8999
(lp9000
(dp9001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:539
p9002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p9003
sg11
g8999
sg12
S'NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa'
p9004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_539
p9005
sg16
VNADH [drugbank:DB00157]
p9006
sg18
Vdrug-target interaction NADH and NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial [drugbank_resource:DB00157_539]
p9007
sasS'TEK'
p9008
(lp9009
(dp9010
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5787
p9011
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08221
p9012
sg11
g9008
sg12
S'TEK tyrosine kinase, endothelial'
p9013
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08221_5787
p9014
sg16
VN-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE [drugbank:DB08221]
p9015
sg18
Vdrug-target interaction N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE and Angiopoietin-1 receptor [drugbank_resource:DB08221_5787]
p9016
sasS'FCER1A'
p9017
(lp9018
(dp9019
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:18
p9020
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00043
p9021
sg11
g9017
sg12
S'Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide'
p9022
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00043_18
p9023
sg16
VOmalizumab [drugbank:DB00043]
p9024
sg18
Vdrug-target interaction Omalizumab and High affinity immunoglobulin epsilon receptor subunit alpha [drugbank_resource:DB00043_18]
p9025
sa(dp9026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:18
p9027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00895
p9028
sg11
g9017
sg12
g9022
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00895_18
p9029
sg16
VBenzylpenicilloyl Polylysine [drugbank:DB00895]
p9030
sg18
Vdrug-target interaction Benzylpenicilloyl Polylysine and High affinity immunoglobulin epsilon receptor subunit alpha [drugbank_resource:DB00895_18]
p9031
sa(dp9032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:18
p9033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p9034
sg11
g9017
sg12
g9022
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_18
p9035
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p9036
sg18
Vdrug-target interaction Alpha-D-Mannose and High affinity immunoglobulin epsilon receptor subunit alpha [drugbank_resource:DB02944_18]
p9037
sasS'ASPA'
p9038
(lp9039
(dp9040
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:209
p9041
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00128
p9042
sg11
g9038
sg12
S'aspartoacylase'
p9043
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00128_209
p9044
sg16
VL-Aspartic Acid [drugbank:DB00128]
p9045
sg18
Vdrug-target interaction L-Aspartic Acid and Aspartoacylase [drugbank_resource:DB00128_209]
p9046
sasS'A2M'
p9047
(lp9048
(dp9049
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1128
p9050
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00102
p9051
sg11
g9047
sg12
S'alpha-2-macroglobulin'
p9052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00102_1128
p9053
sg16
VBecaplermin [drugbank:DB00102]
p9054
sg18
Vdrug-target interaction Becaplermin and Alpha-2-macroglobulin [drugbank_resource:DB00102_1128]
p9055
sa(dp9056
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1128
p9057
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00626
p9058
sg11
g9047
sg12
g9052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00626_1128
p9059
sg16
VBacitracin [drugbank:DB00626]
p9060
sg18
Vdrug-target interaction Bacitracin and Alpha-2-macroglobulin [drugbank_resource:DB00626_1128]
p9061
sasS'CKS1B'
p9062
(lp9063
(dp9064
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7062
p9065
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02681
p9066
sg11
g9062
sg12
S'CDC28 protein kinase regulatory subunit 1B'
p9067
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02681_7062
p9068
sg16
VMeta Vanadate [drugbank:DB02681]
p9069
sg18
Vdrug-target interaction Meta Vanadate and Cyclin-dependent kinases regulatory subunit 1 [drugbank_resource:DB02681_7062]
p9070
sasS'P2RY12'
p9071
(lp9072
(dp9073
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:122
p9074
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00208
p9075
sg11
g9071
sg12
S'purinergic receptor P2Y, G-protein coupled, 12'
p9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00208_122
p9077
sg16
VTiclopidine [drugbank:DB00208]
p9078
sg18
Vdrug-target interaction Ticlopidine and P2Y purinoceptor 12 [drugbank_resource:DB00208_122]
p9079
sa(dp9080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:122
p9081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00374
p9082
sg11
g9071
sg12
g9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00374_122
p9083
sg16
VTreprostinil [drugbank:DB00374]
p9084
sg18
Vdrug-target interaction Treprostinil and P2Y purinoceptor 12 [drugbank_resource:DB00374_122]
p9085
sa(dp9086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:122
p9087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00758
p9088
sg11
g9071
sg12
g9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00758_122
p9089
sg16
VClopidogrel [drugbank:DB00758]
p9090
sg18
Vdrug-target interaction Clopidogrel and P2Y purinoceptor 12 [drugbank_resource:DB00758_122]
p9091
sa(dp9092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:122
p9093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01240
p9094
sg11
g9071
sg12
g9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01240_122
p9095
sg16
VEpoprostenol [drugbank:DB01240]
p9096
sg18
Vdrug-target interaction Epoprostenol and P2Y purinoceptor 12 [drugbank_resource:DB01240_122]
p9097
sa(dp9098
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:122
p9099
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06209
p9100
sg11
g9071
sg12
g9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06209_122
p9101
sg16
VPrasugrel [drugbank:DB06209]
p9102
sg18
Vdrug-target interaction Prasugrel and P2Y purinoceptor 12 [drugbank_resource:DB06209_122]
p9103
sa(dp9104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:122
p9105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08816
p9106
sg11
g9071
sg12
g9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08816_122
p9107
sg16
VTicagrelor [drugbank:DB08816]
p9108
sg18
Vdrug-target interaction Ticagrelor and P2Y purinoceptor 12 [drugbank_resource:DB08816_122]
p9109
sasS'PDE3B'
p9110
(lp9111
(dp9112
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2256
p9113
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01970
p9114
sg11
g9110
sg12
S'phosphodiesterase 3B, cGMP-inhibited'
p9115
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01970_2256
p9116
sg16
VHg9a-9, Nonanoyl-N-Hydroxyethylglucamide [drugbank:DB01970]
p9117
sg18
Vdrug-target interaction Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide and cGMP-inhibited 3',5'-cyclic phosphodiesterase B [drugbank_resource:DB01970_2256]
p9118
sa(dp9119
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2256
p9120
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01640
p9121
sg11
g9110
sg12
g9115
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01640_2256
p9122
sg16
V(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One [drugbank:DB01640]
p9123
sg18
Vdrug-target interaction (5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One and cGMP-inhibited 3',5'-cyclic phosphodiesterase B [drugbank_resource:DB01640_2256]
p9124
sa(dp9125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2256
p9126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07954
p9127
sg11
g9110
sg12
g9115
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07954_2256
p9128
sg16
V3-ISOBUTYL-1-METHYLXANTHINE [drugbank:DB07954]
p9129
sg18
Vdrug-target interaction 3-ISOBUTYL-1-METHYLXANTHINE and cGMP-inhibited 3',5'-cyclic phosphodiesterase B [drugbank_resource:DB07954_2256]
p9130
sasS'ESRRG'
p9131
(lp9132
(dp9133
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9134
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00255
p9135
sg11
g9131
sg12
S'estrogen-related receptor gamma'
p9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00255_3809
p9137
sg16
VDiethylstilbestrol [drugbank:DB00255]
p9138
sg18
Vdrug-target interaction Diethylstilbestrol and Estrogen-related receptor gamma [drugbank_resource:DB00255_3809]
p9139
sa(dp9140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00197
p9142
sg11
g9131
sg12
g9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00197_3809
p9143
sg16
VTroglitazone [drugbank:DB00197]
p9144
sg18
Vdrug-target interaction Troglitazone and Estrogen-related receptor gamma [drugbank_resource:DB00197_3809]
p9145
sa(dp9146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02659
p9148
sg11
g9131
sg12
g9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02659_3809
p9149
sg16
VCholic Acid [drugbank:DB02659]
p9150
sg18
Vdrug-target interaction Cholic Acid and Estrogen-related receptor gamma [drugbank_resource:DB02659_3809]
p9151
sa(dp9152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06884
p9154
sg11
g9131
sg12
g9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06884_3809
p9155
sg16
V4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE [drugbank:DB06884]
p9156
sg18
Vdrug-target interaction 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE and Estrogen-related receptor gamma [drugbank_resource:DB06884_3809]
p9157
sa(dp9158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06902
p9160
sg11
g9131
sg12
g9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06902_3809
p9161
sg16
V4-(1-methyl-1-phenylethyl)phenol [drugbank:DB06902]
p9162
sg18
Vdrug-target interaction 4-(1-methyl-1-phenylethyl)phenol and Estrogen-related receptor gamma [drugbank_resource:DB06902_3809]
p9163
sa(dp9164
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9165
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06973
p9166
sg11
g9131
sg12
g9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06973_3809
p9167
sg16
V4,4'-PROPANE-2,2-DIYLDIPHENOL [drugbank:DB06973]
p9168
sg18
Vdrug-target interaction 4,4'-PROPANE-2,2-DIYLDIPHENOL and Estrogen-related receptor gamma [drugbank_resource:DB06973_3809]
p9169
sa(dp9170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3809
p9171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07485
p9172
sg11
g9131
sg12
g9136
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07485_3809
p9173
sg16
V4,4'-cyclohexane-1,1-diyldiphenol [drugbank:DB07485]
p9174
sg18
Vdrug-target interaction 4,4'-cyclohexane-1,1-diyldiphenol and Estrogen-related receptor gamma [drugbank_resource:DB07485_3809]
p9175
sasS'MAPK3'
p9176
(lp9177
(dp9178
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p9179
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00605
p9180
sg11
g9176
sg12
S'mitogen-activated protein kinase 3'
p9181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00605_1714
p9182
sg16
VSulindac [drugbank:DB00605]
p9183
sg18
Vdrug-target interaction Sulindac and Mitogen-activated protein kinase 3 [drugbank_resource:DB00605_1714]
p9184
sa(dp9185
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p9186
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p9187
sg11
g9176
sg12
g9181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1714
p9188
sg16
VArsenic trioxide [drugbank:DB01169]
p9189
sg18
Vdrug-target interaction Arsenic trioxide and Mitogen-activated protein kinase 3 [drugbank_resource:DB01169_1714]
p9190
sa(dp9191
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p9192
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p9193
sg11
g9176
sg12
g9181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_1714
p9194
sg16
VPurvalanol [drugbank:DB02733]
p9195
sg18
Vdrug-target interaction Purvalanol and Mitogen-activated protein kinase 3 [drugbank_resource:DB02733_1714]
p9196
sa(dp9197
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p9198
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04604
p9199
sg11
g9176
sg12
g9181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04604_1714
p9200
sg16
V5-iodotubercidin [drugbank:DB04604]
p9201
sg18
Vdrug-target interaction 5-iodotubercidin and Mitogen-activated protein kinase 3 [drugbank_resource:DB04604_1714]
p9202
sasS'MAPK1'
p9203
(lp9204
(dp9205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01064
p9207
sg11
g9203
sg12
S'mitogen-activated protein kinase 1'
p9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01064_1176
p9209
sg16
VIsoproterenol [drugbank:DB01064]
p9210
sg18
Vdrug-target interaction Isoproterenol and Mitogen-activated protein kinase 1 [drugbank_resource:DB01064_1176]
p9211
sa(dp9212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02116
p9214
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02116_1176
p9215
sg16
VOlomoucine [drugbank:DB02116]
p9216
sg18
Vdrug-target interaction Olomoucine and Mitogen-activated protein kinase 1 [drugbank_resource:DB02116_1176]
p9217
sa(dp9218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p9220
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1176
p9221
sg16
VArsenic trioxide [drugbank:DB01169]
p9222
sg18
Vdrug-target interaction Arsenic trioxide and Mitogen-activated protein kinase 1 [drugbank_resource:DB01169_1176]
p9223
sa(dp9224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p9226
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_1176
p9227
sg16
VPhosphonothreonine [drugbank:DB02482]
p9228
sg18
Vdrug-target interaction Phosphonothreonine and Mitogen-activated protein kinase 1 [drugbank_resource:DB02482_1176]
p9229
sa(dp9230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p9232
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_1176
p9233
sg16
VPurvalanol [drugbank:DB02733]
p9234
sg18
Vdrug-target interaction Purvalanol and Mitogen-activated protein kinase 1 [drugbank_resource:DB02733_1176]
p9235
sa(dp9236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04338
p9238
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04338_1176
p9239
sg16
VSB220025 [drugbank:DB04338]
p9240
sg18
Vdrug-target interaction SB220025 and Mitogen-activated protein kinase 1 [drugbank_resource:DB04338_1176]
p9241
sa(dp9242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06877
p9244
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06877_1176
p9245
sg16
VN,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB06877]
p9246
sg18
Vdrug-target interaction N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB06877_1176]
p9247
sa(dp9248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07010
p9250
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07010_1176
p9251
sg16
VN-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07010]
p9252
sg18
Vdrug-target interaction N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07010_1176]
p9253
sa(dp9254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07264
p9256
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07264_1176
p9257
sg16
V(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07264]
p9258
sg18
Vdrug-target interaction (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07264_1176]
p9259
sa(dp9260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07788
p9262
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07788_1176
p9263
sg16
V(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE [drugbank:DB07788]
p9264
sg18
Vdrug-target interaction (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07788_1176]
p9265
sa(dp9266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07794
p9268
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07794_1176
p9269
sg16
V5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE [drugbank:DB07794]
p9270
sg18
Vdrug-target interaction 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07794_1176]
p9271
sa(dp9272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08513
p9274
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08513_1176
p9275
sg16
V[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID [drugbank:DB08513]
p9276
sg18
Vdrug-target interaction [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID and Mitogen-activated protein kinase 1 [drugbank_resource:DB08513_1176]
p9277
sa(dp9278
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9279
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07905
p9280
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07905_1176
p9281
sg16
V(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione [drugbank:DB07905]
p9282
sg18
Vdrug-target interaction (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione and Mitogen-activated protein kinase 1 [drugbank_resource:DB07905_1176]
p9283
sa(dp9284
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p9285
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08521
p9286
sg11
g9203
sg12
g9208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08521_1176
p9287
sg16
V4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB08521]
p9288
sg18
Vdrug-target interaction 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 1 [drugbank_resource:DB08521_1176]
p9289
sasS'HLA-B'
p9290
(lp9291
(dp9292
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6585
p9293
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04464
p9294
sg11
g9290
sg12
S'major histocompatibility complex, class I, B'
p9295
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6585
p9296
sg16
VN-Formylmethionine [drugbank:DB04464]
p9297
sg18
Vdrug-target interaction N-Formylmethionine and HLA class I histocompatibility antigen, B-27 alpha chain [drugbank_resource:DB04464_6585]
p9298
sasS'C3'
p9299
(lp9300
(dp9301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2683
p9302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p9303
sg11
g9299
sg12
S'complement component 3'
p9304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_2683
p9305
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p9306
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB01907_2683]
p9307
sa(dp9308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2683
p9309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02147
p9310
sg11
g9299
sg12
g9304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02147_2683
p9311
sg16
VCyclo-Tetrametavanadate [drugbank:DB02147]
p9312
sg18
Vdrug-target interaction Cyclo-Tetrametavanadate and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB02147_2683]
p9313
sa(dp9314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2683
p9315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p9316
sg11
g9299
sg12
g9304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2683
p9317
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p9318
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB03431_2683]
p9319
sa(dp9320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5898
p9321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00028
p9322
sg11
g9299
sg12
g9304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00028_5898
p9323
sg16
VIntravenous Immunoglobulin [drugbank:DB00028]
p9324
sg18
Vdrug-target interaction Intravenous Immunoglobulin and Complement C3 [drugbank_resource:DB00028_5898]
p9325
sa(dp9326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5898
p9327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01915
p9328
sg11
g9299
sg12
g9304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01915_5898
p9329
sg16
VS-Hydroxycysteine [drugbank:DB01915]
p9330
sg18
Vdrug-target interaction S-Hydroxycysteine and Complement C3 [drugbank_resource:DB01915_5898]
p9331
sasS'NFKB1'
p9332
(lp9333
(dp9334
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1787
p9335
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01041
p9336
sg11
g9332
sg12
S'nuclear factor of kappa light polypeptide gene enhancer in B-cells 1'
p9337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01041_1787
p9338
sg16
VThalidomide [drugbank:DB01041]
p9339
sg18
Vdrug-target interaction Thalidomide and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB01041_1787]
p9340
sa(dp9341
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1787
p9342
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01411
p9343
sg11
g9332
sg12
g9337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01411_1787
p9344
sg16
VPranlukast [drugbank:DB01411]
p9345
sg18
Vdrug-target interaction Pranlukast and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB01411_1787]
p9346
sa(dp9347
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1787
p9348
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08814
p9349
sg11
g9332
sg12
g9337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08814_1787
p9350
sg16
VTriflusal [drugbank:DB08814]
p9351
sg18
Vdrug-target interaction Triflusal and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB08814_1787]
p9352
sasS'MAPK8'
p9353
(lp9354
(dp9355
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9356
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01782
p9357
sg11
g9353
sg12
S'mitogen-activated protein kinase 8'
p9358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01782_6292
p9359
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p9360
sg18
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Mitogen-activated protein kinase 8 [drugbank_resource:DB01782_6292]
p9361
sa(dp9362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07268
p9364
sg11
g9353
sg12
g9358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07268_6292
p9365
sg16
V2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE [drugbank:DB07268]
p9366
sg18
Vdrug-target interaction 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07268_6292]
p9367
sa(dp9368
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9369
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07218
p9370
sg11
g9353
sg12
g9358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07218_6292
p9371
sg16
V6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE [drugbank:DB07218]
p9372
sg18
Vdrug-target interaction 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07218_6292]
p9373
sa(dp9374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07272
p9376
sg11
g9353
sg12
g9358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07272_6292
p9377
sg16
VN-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE [drugbank:DB07272]
p9378
sg18
Vdrug-target interaction N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07272_6292]
p9379
sa(dp9380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07276
p9382
sg11
g9353
sg12
g9358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07276_6292
p9383
sg16
V5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE [drugbank:DB07276]
p9384
sg18
Vdrug-target interaction 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07276_6292]
p9385
sa(dp9386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07845
p9388
sg11
g9353
sg12
g9358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07845_6292
p9389
sg16
V2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide [drugbank:DB07845]
p9390
sg18
Vdrug-target interaction 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide and Mitogen-activated protein kinase 8 [drugbank_resource:DB07845_6292]
p9391
sasS'FTH1'
p9392
(lp9393
(dp9394
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:443
p9395
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00893
p9396
sg11
g9392
sg12
S'ferritin, heavy polypeptide 1'
p9397
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00893_443
p9398
sg16
VIron Dextran [drugbank:DB00893]
p9399
sg18
Vdrug-target interaction Iron Dextran and Ferritin heavy chain [drugbank_resource:DB00893_443]
p9400
sasS'C7'
p9401
(lp9402
(dp9403
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1209
p9404
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04487
p9405
sg11
S'CXCL10'
p9406
sg12
g2088
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04487_1209
p9407
sg16
VN-Methylleucine [drugbank:DB04487]
p9408
sg18
Vdrug-target interaction N-Methylleucine and Small inducible cytokine B10 [drugbank_resource:DB04487_1209]
p9409
sasS'C6'
p9410
(lp9411
(dp9412
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6418
p9413
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07475
p9414
sg11
S'PSMA7'
p9415
sg12
S'proteasome (prosome, macropain) subunit, alpha type, 7'
p9416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07475_6418
p9417
sg16
VN-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE [drugbank:DB07475]
p9418
sg18
Vdrug-target interaction N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE and Proteasome subunit alpha type-7 [drugbank_resource:DB07475_6418]
p9419
sa(dp9420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6418
p9421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07558
p9422
sg11
g9415
sg12
g9416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07558_6418
p9423
sg16
V2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE [drugbank:DB07558]
p9424
sg18
Vdrug-target interaction 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE and Proteasome subunit alpha type-7 [drugbank_resource:DB07558_6418]
p9425
sa(dp9426
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6418
p9427
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08515
p9428
sg11
g9415
sg12
g9416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08515_6418
p9429
sg16
V(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE [drugbank:DB08515]
p9430
sg18
Vdrug-target interaction (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE and Proteasome subunit alpha type-7 [drugbank_resource:DB08515_6418]
p9431
sasS'TGFBR2'
p9432
(lp9433
(dp9434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3393
p9435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04077
p9436
sg11
g9432
sg12
S'transforming growth factor, beta receptor II (70/80kDa)'
p9437
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04077_3393
p9438
sg16
VGlycerol [drugbank:DB04077]
p9439
sg18
Vdrug-target interaction Glycerol and TGF-beta receptor type-2 [drugbank_resource:DB04077_3393]
p9440
sasS'AKR1C1'
p9441
(lp9442
(dp9443
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9444
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p9445
sg11
g9441
sg12
S'aldo-keto reductase family 1, member C1'
p9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_139
p9447
sg16
VNADH [drugbank:DB00157]
p9448
sg18
Vdrug-target interaction NADH and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB00157_139]
p9449
sa(dp9450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00936
p9452
sg11
g9441
sg12
g9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00936_139
p9453
sg16
VSalicyclic acid [drugbank:DB00936]
p9454
sg18
Vdrug-target interaction Salicyclic acid and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB00936_139]
p9455
sa(dp9456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00945
p9458
sg11
g9441
sg12
g9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00945_139
p9459
sg16
VAcetylsalicylic acid [drugbank:DB00945]
p9460
sg18
Vdrug-target interaction Acetylsalicylic acid and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB00945_139]
p9461
sa(dp9462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03461
p9464
sg11
g9441
sg12
g9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03461_139
p9465
sg16
V2'-Monophosphoadenosine 5'-Diphosphoribose [drugbank:DB03461]
p9466
sg18
Vdrug-target interaction 2'-Monophosphoadenosine 5'-Diphosphoribose and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB03461_139]
p9467
sa(dp9468
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9469
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04674
p9470
sg11
g9441
sg12
g9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04674_139
p9471
sg16
V2-HYDROXY-3,5-DIIODOBENZOIC ACID [drugbank:DB04674]
p9472
sg18
Vdrug-target interaction 2-HYDROXY-3,5-DIIODOBENZOIC ACID and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB04674_139]
p9473
sa(dp9474
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9475
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07768
p9476
sg11
g9441
sg12
g9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07768_139
p9477
sg16
V(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE [drugbank:DB07768]
p9478
sg18
Vdrug-target interaction (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB07768_139]
p9479
sa(dp9480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:139
p9481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07931
p9482
sg11
g9441
sg12
g9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07931_139
p9483
sg16
V4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol [drugbank:DB07931]
p9484
sg18
Vdrug-target interaction 4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol and Aldo-keto reductase family 1 member C1 [drugbank_resource:DB07931_139]
p9485
sasS'ACACB'
p9486
(lp9487
(dp9488
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:775
p9489
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00121
p9490
sg11
g9486
sg12
S'acetyl-CoA carboxylase beta'
p9491
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00121_775
p9492
sg16
VBiotin [drugbank:DB00121]
p9493
sg18
Vdrug-target interaction Biotin and Acetyl-CoA carboxylase 2 [drugbank_resource:DB00121_775]
p9494
sa(dp9495
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:775
p9496
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00173
p9497
sg11
g9486
sg12
g9491
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00173_775
p9498
sg16
VAdenine [drugbank:DB00173]
p9499
sg18
Vdrug-target interaction Adenine and Acetyl-CoA carboxylase 2 [drugbank_resource:DB00173_775]
p9500
sa(dp9501
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:775
p9502
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02859
p9503
sg11
g9486
sg12
g9491
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02859_775
p9504
sg16
VSoraphen A [drugbank:DB02859]
p9505
sg18
Vdrug-target interaction Soraphen A and Acetyl-CoA carboxylase 2 [drugbank_resource:DB02859_775]
p9506
sa(dp9507
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:775
p9508
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03781
p9509
sg11
g9486
sg12
g9491
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03781_775
p9510
sg16
V2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid [drugbank:DB03781]
p9511
sg18
Vdrug-target interaction 2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid and Acetyl-CoA carboxylase 2 [drugbank_resource:DB03781_775]
p9512
sa(dp9513
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:775
p9514
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07870
p9515
sg11
g9486
sg12
g9491
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07870_775
p9516
sg16
V(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID [drugbank:DB07870]
p9517
sg18
Vdrug-target interaction (2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID and Acetyl-CoA carboxylase 2 [drugbank_resource:DB07870_775]
p9518
sasS'PROS1'
p9519
(lp9520
(dp9521
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1245
p9522
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00055
p9523
sg11
g9519
sg12
S'protein S (alpha)'
p9524
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00055_1245
p9525
sg16
VDrotrecogin alfa [drugbank:DB00055]
p9526
sg18
Vdrug-target interaction Drotrecogin alfa and Vitamin K-dependent protein S [drugbank_resource:DB00055_1245]
p9527
sa(dp9528
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1245
p9529
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00170
p9530
sg11
g9519
sg12
g9524
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00170_1245
p9531
sg16
VMenadione [drugbank:DB00170]
p9532
sg18
Vdrug-target interaction Menadione and Vitamin K-dependent protein S [drugbank_resource:DB00170_1245]
p9533
sa(dp9534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1245
p9535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00464
p9536
sg11
g9519
sg12
g9524
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00464_1245
p9537
sg16
VSodium Tetradecyl Sulfate [drugbank:DB00464]
p9538
sg18
Vdrug-target interaction Sodium Tetradecyl Sulfate and Vitamin K-dependent protein S [drugbank_resource:DB00464_1245]
p9539
sasS'HSP90AA1'
p9540
(lp9541
(dp9542
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9543
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00615
p9544
sg11
g9540
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00615_1939
p9546
sg16
VRifabutin [drugbank:DB00615]
p9547
sg18
Vdrug-target interaction Rifabutin and Heat shock protein HSP 90-alpha [drugbank_resource:DB00615_1939]
p9548
sa(dp9549
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9550
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00716
p9551
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00716_1939
p9552
sg16
VNedocromil [drugbank:DB00716]
p9553
sg18
Vdrug-target interaction Nedocromil and Heat shock protein HSP 90-alpha [drugbank_resource:DB00716_1939]
p9554
sa(dp9555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02359
p9557
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02359_1939
p9558
sg16
V9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine [drugbank:DB02359]
p9559
sg18
Vdrug-target interaction 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02359_1939]
p9560
sa(dp9561
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9562
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02754
p9563
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02754_1939
p9564
sg16
V9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine [drugbank:DB02754]
p9565
sg18
Vdrug-target interaction 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02754_1939]
p9566
sa(dp9567
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9568
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02424
p9569
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02424_1939
p9570
sg16
VGeldanamycin [drugbank:DB02424]
p9571
sg18
Vdrug-target interaction Geldanamycin and Heat shock protein HSP 90-alpha [drugbank_resource:DB02424_1939]
p9572
sa(dp9573
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9574
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02550
p9575
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02550_1939
p9576
sg16
V8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine [drugbank:DB02550]
p9577
sg18
Vdrug-target interaction 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02550_1939]
p9578
sa(dp9579
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9580
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02840
p9581
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02840_1939
p9582
sg16
V4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid [drugbank:DB02840]
p9583
sg18
Vdrug-target interaction 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid and Heat shock protein HSP 90-alpha [drugbank_resource:DB02840_1939]
p9584
sa(dp9585
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9586
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03137
p9587
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03137_1939
p9588
sg16
V8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine [drugbank:DB03137]
p9589
sg18
Vdrug-target interaction 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03137_1939]
p9590
sa(dp9591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03080
p9593
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03080_1939
p9594
sg16
V17-Dmag [drugbank:DB03080]
p9595
sg18
Vdrug-target interaction 17-Dmag and Heat shock protein HSP 90-alpha [drugbank_resource:DB03080_1939]
p9596
sa(dp9597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03093
p9599
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03093_1939
p9600
sg16
V8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB03093]
p9601
sg18
Vdrug-target interaction 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03093_1939]
p9602
sa(dp9603
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9604
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03504
p9605
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03504_1939
p9606
sg16
V9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine [drugbank:DB03504]
p9607
sg18
Vdrug-target interaction 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03504_1939]
p9608
sa(dp9609
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9610
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03749
p9611
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03749_1939
p9612
sg16
V4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole [drugbank:DB03749]
p9613
sg18
Vdrug-target interaction 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole and Heat shock protein HSP 90-alpha [drugbank_resource:DB03749_1939]
p9614
sa(dp9615
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9616
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03809
p9617
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03809_1939
p9618
sg16
V9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine [drugbank:DB03809]
p9619
sg18
Vdrug-target interaction 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03809_1939]
p9620
sa(dp9621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03899
p9623
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03899_1939
p9624
sg16
V9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine [drugbank:DB03899]
p9625
sg18
Vdrug-target interaction 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03899_1939]
p9626
sa(dp9627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04054
p9629
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04054_1939
p9630
sg16
V9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB04054]
p9631
sg18
Vdrug-target interaction 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04054_1939]
p9632
sa(dp9633
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9634
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p9635
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1939
p9636
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p9637
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Heat shock protein HSP 90-alpha [drugbank_resource:DB03431_1939]
p9638
sa(dp9639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04254
p9641
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04254_1939
p9642
sg16
V8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB04254]
p9643
sg18
Vdrug-target interaction 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04254_1939]
p9644
sa(dp9645
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9646
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04588
p9647
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04588_1939
p9648
sg16
VN-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE [drugbank:DB04588]
p9649
sg18
Vdrug-target interaction N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB04588_1939]
p9650
sa(dp9651
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9652
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06956
p9653
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06956_1939
p9654
sg16
VN-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE [drugbank:DB06956]
p9655
sg18
Vdrug-target interaction N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06956_1939]
p9656
sa(dp9657
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9658
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06958
p9659
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06958_1939
p9660
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE [drugbank:DB06958]
p9661
sg18
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06958_1939]
p9662
sa(dp9663
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9664
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06961
p9665
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06961_1939
p9666
sg16
V5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide [drugbank:DB06961]
p9667
sg18
Vdrug-target interaction 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB06961_1939]
p9668
sa(dp9669
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9670
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06969
p9671
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06969_1939
p9672
sg16
V2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide [drugbank:DB06969]
p9673
sg18
Vdrug-target interaction 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB06969_1939]
p9674
sa(dp9675
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9676
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04505
p9677
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04505_1939
p9678
sg16
V8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine [drugbank:DB04505]
p9679
sg18
Vdrug-target interaction 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04505_1939]
p9680
sa(dp9681
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9682
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07324
p9683
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07324_1939
p9684
sg16
V3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE [drugbank:DB07324]
p9685
sg18
Vdrug-target interaction 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07324_1939]
p9686
sa(dp9687
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9688
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07325
p9689
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07325_1939
p9690
sg16
VN-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE [drugbank:DB07325]
p9691
sg18
Vdrug-target interaction N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07325_1939]
p9692
sa(dp9693
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9694
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06957
p9695
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06957_1939
p9696
sg16
V4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL [drugbank:DB06957]
p9697
sg18
Vdrug-target interaction 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB06957_1939]
p9698
sa(dp9699
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9700
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06964
p9701
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06964_1939
p9702
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE [drugbank:DB06964]
p9703
sg18
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06964_1939]
p9704
sa(dp9705
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9706
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07100
p9707
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07100_1939
p9708
sg16
V4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL [drugbank:DB07100]
p9709
sg18
Vdrug-target interaction 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB07100_1939]
p9710
sa(dp9711
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9712
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07317
p9713
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07317_1939
p9714
sg16
V(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one [drugbank:DB07317]
p9715
sg18
Vdrug-target interaction (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one and Heat shock protein HSP 90-alpha [drugbank_resource:DB07317_1939]
p9716
sa(dp9717
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9718
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07319
p9719
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07319_1939
p9720
sg16
V6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE [drugbank:DB07319]
p9721
sg18
Vdrug-target interaction 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07319_1939]
p9722
sa(dp9723
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9724
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07495
p9725
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07495_1939
p9726
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE [drugbank:DB07495]
p9727
sg18
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07495_1939]
p9728
sa(dp9729
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9730
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07502
p9731
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07502_1939
p9732
sg16
V4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol [drugbank:DB07502]
p9733
sg18
Vdrug-target interaction 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB07502_1939]
p9734
sa(dp9735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08197
p9737
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08197_1939
p9738
sg16
V(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime [drugbank:DB08197]
p9739
sg18
Vdrug-target interaction (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime and Heat shock protein HSP 90-alpha [drugbank_resource:DB08197_1939]
p9740
sa(dp9741
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9742
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08442
p9743
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08442_1939
p9744
sg16
V4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol [drugbank:DB08442]
p9745
sg18
Vdrug-target interaction 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB08442_1939]
p9746
sa(dp9747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07594
p9749
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07594_1939
p9750
sg16
V4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL [drugbank:DB07594]
p9751
sg18
Vdrug-target interaction 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB07594_1939]
p9752
sa(dp9753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07877
p9755
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07877_1939
p9756
sg16
V8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE [drugbank:DB07877]
p9757
sg18
Vdrug-target interaction 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07877_1939]
p9758
sa(dp9759
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9760
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08194
p9761
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08194_1939
p9762
sg16
V4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine [drugbank:DB08194]
p9763
sg18
Vdrug-target interaction 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08194_1939]
p9764
sa(dp9765
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9766
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08436
p9767
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08436_1939
p9768
sg16
V8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- [drugbank:DB08436]
p9769
sg18
Vdrug-target interaction 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- and Heat shock protein HSP 90-alpha [drugbank_resource:DB08436_1939]
p9770
sa(dp9771
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9772
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08443
p9773
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08443_1939
p9774
sg16
V2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol [drugbank:DB08443]
p9775
sg18
Vdrug-target interaction 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol and Heat shock protein HSP 90-alpha [drugbank_resource:DB08443_1939]
p9776
sa(dp9777
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9778
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08786
p9779
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08786_1939
p9780
sg16
V4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine [drugbank:DB08786]
p9781
sg18
Vdrug-target interaction 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08786_1939]
p9782
sa(dp9783
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9784
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08787
p9785
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08787_1939
p9786
sg16
V4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine [drugbank:DB08787]
p9787
sg18
Vdrug-target interaction 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08787_1939]
p9788
sa(dp9789
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9790
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08789
p9791
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08789_1939
p9792
sg16
V2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE [drugbank:DB08789]
p9793
sg18
Vdrug-target interaction 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB08789_1939]
p9794
sa(dp9795
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9796
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07601
p9797
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07601_1939
p9798
sg16
V4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol [drugbank:DB07601]
p9799
sg18
Vdrug-target interaction 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB07601_1939]
p9800
sa(dp9801
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9802
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08557
p9803
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08557_1939
p9804
sg16
V2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide [drugbank:DB08557]
p9805
sg18
Vdrug-target interaction 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB08557_1939]
p9806
sa(dp9807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08788
p9809
sg11
g9540
sg12
g9545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08788_1939
p9810
sg16
V3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE [drugbank:DB08788]
p9811
sg18
Vdrug-target interaction 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB08788_1939]
p9812
sasS'RXRB'
p9813
(lp9814
(dp9815
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9816
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00210
p9817
sg11
g9813
sg12
S'retinoid X receptor, beta'
p9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00210_88
p9819
sg16
VAdapalene [drugbank:DB00210]
p9820
sg18
Vdrug-target interaction Adapalene and Retinoic acid receptor RXR-beta [drugbank_resource:DB00210_88]
p9821
sa(dp9822
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9823
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00307
p9824
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00307_88
p9825
sg16
VBexarotene [drugbank:DB00307]
p9826
sg18
Vdrug-target interaction Bexarotene and Retinoic acid receptor RXR-beta [drugbank_resource:DB00307_88]
p9827
sa(dp9828
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9829
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00459
p9830
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00459_88
p9831
sg16
VAcitretin [drugbank:DB00459]
p9832
sg18
Vdrug-target interaction Acitretin and Retinoic acid receptor RXR-beta [drugbank_resource:DB00459_88]
p9833
sa(dp9834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00523
p9836
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00523_88
p9837
sg16
VAlitretinoin [drugbank:DB00523]
p9838
sg18
Vdrug-target interaction Alitretinoin and Retinoic acid receptor RXR-beta [drugbank_resource:DB00523_88]
p9839
sa(dp9840
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9841
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00755
p9842
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00755_88
p9843
sg16
VTretinoin [drugbank:DB00755]
p9844
sg18
Vdrug-target interaction Tretinoin and Retinoic acid receptor RXR-beta [drugbank_resource:DB00755_88]
p9845
sa(dp9846
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9847
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00799
p9848
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00799_88
p9849
sg16
VTazarotene [drugbank:DB00799]
p9850
sg18
Vdrug-target interaction Tazarotene and Retinoic acid receptor RXR-beta [drugbank_resource:DB00799_88]
p9851
sa(dp9852
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9853
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00926
p9854
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00926_88
p9855
sg16
VEtretinate [drugbank:DB00926]
p9856
sg18
Vdrug-target interaction Etretinate and Retinoic acid receptor RXR-beta [drugbank_resource:DB00926_88]
p9857
sa(dp9858
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9859
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01941
p9860
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01941_88
p9861
sg16
V6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid [drugbank:DB01941]
p9862
sg18
Vdrug-target interaction 6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid and Retinoic acid receptor RXR-beta [drugbank_resource:DB01941_88]
p9863
sa(dp9864
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9865
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07080
p9866
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07080_88
p9867
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p9868
sg18
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Retinoic acid receptor RXR-beta [drugbank_resource:DB07080_88]
p9869
sa(dp9870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08175
p9872
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08175_88
p9873
sg16
V(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID [drugbank:DB08175]
p9874
sg18
Vdrug-target interaction (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID and Retinoic acid receptor RXR-beta [drugbank_resource:DB08175_88]
p9875
sa(dp9876
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:88
p9877
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07929
p9878
sg11
g9813
sg12
g9818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07929_88
p9879
sg16
VN-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE [drugbank:DB07929]
p9880
sg18
Vdrug-target interaction N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE and Retinoic acid receptor RXR-beta [drugbank_resource:DB07929_88]
p9881
sasS'KAT2B'
p9882
(lp9883
(dp9884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4573
p9885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01992
p9886
sg11
g9882
sg12
S'K(lysine) acetyltransferase 2B'
p9887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01992_4573
p9888
sg16
VCoenzyme A [drugbank:DB01992]
p9889
sg18
Vdrug-target interaction Coenzyme A and Histone acetyltransferase PCAF [drugbank_resource:DB01992_4573]
p9890
sa(dp9891
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4573
p9892
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08186
p9893
sg11
g9882
sg12
g9887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08186_4573
p9894
sg16
V(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE [drugbank:DB08186]
p9895
sg18
Vdrug-target interaction (3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE and Histone acetyltransferase PCAF [drugbank_resource:DB08186_4573]
p9896
sa(dp9897
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4573
p9898
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08291
p9899
sg11
g9882
sg12
g9887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08291_4573
p9900
sg16
VN-(3-AMINOPROPYL)-2-NITROBENZENAMINE [drugbank:DB08291]
p9901
sg18
Vdrug-target interaction N-(3-AMINOPROPYL)-2-NITROBENZENAMINE and Histone acetyltransferase PCAF [drugbank_resource:DB08291_4573]
p9902
sasS'PLA2G2A'
p9903
(lp9904
(dp9905
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9906
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00328
p9907
sg11
g9903
sg12
S'phospholipase A2, group IIA (platelets, synovial fluid)'
p9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00328_2981
p9909
sg16
VIndomethacin [drugbank:DB00328]
p9910
sg18
Vdrug-target interaction Indomethacin and Phospholipase A2, membrane associated [drugbank_resource:DB00328_2981]
p9911
sa(dp9912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00586
p9914
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00586_2981
p9915
sg16
VDiclofenac [drugbank:DB00586]
p9916
sg18
Vdrug-target interaction Diclofenac and Phospholipase A2, membrane associated [drugbank_resource:DB00586_2981]
p9917
sa(dp9918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01381
p9920
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01381_2981
p9921
sg16
VGinkgo biloba [drugbank:DB01381]
p9922
sg18
Vdrug-target interaction Ginkgo biloba and Phospholipase A2, membrane associated [drugbank_resource:DB01381_2981]
p9923
sa(dp9924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01955
p9926
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01955_2981
p9927
sg16
V1,4-Butanediol [drugbank:DB01955]
p9928
sg18
Vdrug-target interaction 1,4-Butanediol and Phospholipase A2, membrane associated [drugbank_resource:DB01955_2981]
p9929
sa(dp9930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02080
p9932
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02080_2981
p9933
sg16
V1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene [drugbank:DB02080]
p9934
sg18
Vdrug-target interaction 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene and Phospholipase A2, membrane associated [drugbank_resource:DB02080_2981]
p9935
sa(dp9936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02504
p9938
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02504_2981
p9939
sg16
V[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid [drugbank:DB02504]
p9940
sg18
Vdrug-target interaction [3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid and Phospholipase A2, membrane associated [drugbank_resource:DB02504_2981]
p9941
sa(dp9942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02936
p9944
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02936_2981
p9945
sg16
V4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid [drugbank:DB02936]
p9946
sg18
Vdrug-target interaction 4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid and Phospholipase A2, membrane associated [drugbank_resource:DB02936_2981]
p9947
sa(dp9948
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9949
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02448
p9950
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02448_2981
p9951
sg16
VN-Tridecanoic Acid [drugbank:DB02448]
p9952
sg18
Vdrug-target interaction N-Tridecanoic Acid and Phospholipase A2, membrane associated [drugbank_resource:DB02448_2981]
p9953
sa(dp9954
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9955
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03121
p9956
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03121_2981
p9957
sg16
V1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid [drugbank:DB03121]
p9958
sg18
Vdrug-target interaction 1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid and Phospholipase A2, membrane associated [drugbank_resource:DB03121_2981]
p9959
sa(dp9960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03471
p9962
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03471_2981
p9963
sg16
V6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid [drugbank:DB03471]
p9964
sg18
Vdrug-target interaction 6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid and Phospholipase A2, membrane associated [drugbank_resource:DB03471_2981]
p9965
sa(dp9966
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9967
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03784
p9968
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03784_2981
p9969
sg16
VElaidoylamide [drugbank:DB03784]
p9970
sg18
Vdrug-target interaction Elaidoylamide and Phospholipase A2, membrane associated [drugbank_resource:DB03784_2981]
p9971
sa(dp9972
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9973
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04112
p9974
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04112_2981
p9975
sg16
V1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide [drugbank:DB04112]
p9976
sg18
Vdrug-target interaction 1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide and Phospholipase A2, membrane associated [drugbank_resource:DB04112_2981]
p9977
sa(dp9978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04287
p9980
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04287_2981
p9981
sg16
V(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid [drugbank:DB04287]
p9982
sg18
Vdrug-target interaction (S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid and Phospholipase A2, membrane associated [drugbank_resource:DB04287_2981]
p9983
sa(dp9984
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2981
p9985
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04786
p9986
sg11
g9903
sg12
g9908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04786_2981
p9987
sg16
VSuramin [drugbank:DB04786]
p9988
sg18
Vdrug-target interaction Suramin and Phospholipase A2, membrane associated [drugbank_resource:DB04786_2981]
p9989
sasS'NPY2R'
p9990
(lp9991
(dp9992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4186
p9993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00847
p9994
sg11
g9990
sg12
S'neuropeptide Y receptor Y2'
p9995
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00847_4186
p9996
sg16
VCysteamine [drugbank:DB00847]
p9997
sg18
Vdrug-target interaction Cysteamine and Neuropeptide Y receptor type 2 [drugbank_resource:DB00847_4186]
p9998
sasS'PRKAR1A'
p9999
(lp10000
(dp10001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5849
p10002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01790
p10003
sg11
g9999
sg12
S'protein kinase, cAMP-dependent, regulatory, type I, alpha'
p10004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01790_5849
p10005
sg16
VSp-Adenosine-3',5'-Cyclic-Monophosphorothioate [drugbank:DB01790]
p10006
sg18
Vdrug-target interaction Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate and cAMP-dependent protein kinase type I-alpha regulatory subunit [drugbank_resource:DB01790_5849]
p10007
sa(dp10008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5849
p10009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02315
p10010
sg11
g9999
sg12
g10004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02315_5849
p10011
sg16
VCyclic Guanosine Monophosphate [drugbank:DB02315]
p10012
sg18
Vdrug-target interaction Cyclic Guanosine Monophosphate and cAMP-dependent protein kinase type I-alpha regulatory subunit [drugbank_resource:DB02315_5849]
p10013
sa(dp10014
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5849
p10015
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02527
p10016
sg11
g9999
sg12
g10004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02527_5849
p10017
sg16
VCyclic Adenosine Monophosphate [drugbank:DB02527]
p10018
sg18
Vdrug-target interaction Cyclic Adenosine Monophosphate and cAMP-dependent protein kinase type I-alpha regulatory subunit [drugbank_resource:DB02527_5849]
p10019
sasS'FDPS'
p10020
(lp10021
(dp10022
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10023
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00282
p10024
sg11
g10020
sg12
S'farnesyl diphosphate synthase'
p10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00282_853
p10026
sg16
VPamidronate [drugbank:DB00282]
p10027
sg18
Vdrug-target interaction Pamidronate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB00282_853]
p10028
sa(dp10029
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10030
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00630
p10031
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00630_853
p10032
sg16
VAlendronate [drugbank:DB00630]
p10033
sg18
Vdrug-target interaction Alendronate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB00630_853]
p10034
sa(dp10035
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10036
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00399
p10037
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00399_853
p10038
sg16
VZoledronate [drugbank:DB00399]
p10039
sg18
Vdrug-target interaction Zoledronate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB00399_853]
p10040
sa(dp10041
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10042
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00710
p10043
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00710_853
p10044
sg16
VIbandronate [drugbank:DB00710]
p10045
sg18
Vdrug-target interaction Ibandronate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB00710_853]
p10046
sa(dp10047
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10048
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00884
p10049
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00884_853
p10050
sg16
VRisedronate [drugbank:DB00884]
p10051
sg18
Vdrug-target interaction Risedronate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB00884_853]
p10052
sa(dp10053
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10054
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01785
p10055
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01785_853
p10056
sg16
VDimethylallyl Diphosphate [drugbank:DB01785]
p10057
sg18
Vdrug-target interaction Dimethylallyl Diphosphate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB01785_853]
p10058
sa(dp10059
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10060
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02508
p10061
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02508_853
p10062
sg16
VIsopentyl Pyrophosphate [drugbank:DB02508]
p10063
sg18
Vdrug-target interaction Isopentyl Pyrophosphate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB02508_853]
p10064
sa(dp10065
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10066
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02552
p10067
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02552_853
p10068
sg16
VGeranyl Diphosphate [drugbank:DB02552]
p10069
sg18
Vdrug-target interaction Geranyl Diphosphate and Farnesyl pyrophosphate synthetase [drugbank_resource:DB02552_853]
p10070
sa(dp10071
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10072
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04714
p10073
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04714_853
p10074
sg16
VISOPENTENYL PYROPHOSPHATE [drugbank:DB04714]
p10075
sg18
Vdrug-target interaction ISOPENTENYL PYROPHOSPHATE and Farnesyl pyrophosphate synthetase [drugbank_resource:DB04714_853]
p10076
sa(dp10077
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10078
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07841
p10079
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07841_853
p10080
sg16
VGERANYLGERANYL DIPHOSPHATE [drugbank:DB07841]
p10081
sg18
Vdrug-target interaction GERANYLGERANYL DIPHOSPHATE and Farnesyl pyrophosphate synthetase [drugbank_resource:DB07841_853]
p10082
sa(dp10083
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:853
p10084
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07780
p10085
sg11
g10020
sg12
g10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07780_853
p10086
sg16
VFARNESYL DIPHOSPHATE [drugbank:DB07780]
p10087
sg18
Vdrug-target interaction FARNESYL DIPHOSPHATE and Farnesyl pyrophosphate synthetase [drugbank_resource:DB07780_853]
p10088
sasS'LGALS3'
p10089
(lp10090
(dp10091
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2467
p10092
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01827
p10093
sg11
g10089
sg12
S'lectin, galactoside-binding, soluble, 3'
p10094
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01827_2467
p10095
sg16
V2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide [drugbank:DB01827]
p10096
sg18
Vdrug-target interaction 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide and Galectin-3 [drugbank_resource:DB01827_2467]
p10097
sasS'HAP1'
p10098
(lp10099
(dp10100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4180
p10101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04967
p10102
sg11
S'APEX1'
p10103
sg12
S'APEX nuclease (multifunctional DNA repair enzyme) 1'
p10104
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04967_4180
p10105
sg16
VLucanthone [drugbank:DB04967]
p10106
sg18
Vdrug-target interaction Lucanthone and DNA-(apurinic or apyrimidinic site) lyase [drugbank_resource:DB04967_4180]
p10107
sasS'CAT'
p10108
(lp10109
(dp10110
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2230
p10111
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01213
p10112
sg11
g10108
sg12
S'catalase'
p10113
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01213_2230
p10114
sg16
VFomepizole [drugbank:DB01213]
p10115
sg18
Vdrug-target interaction Fomepizole and Catalase [drugbank_resource:DB01213_2230]
p10116
sa(dp10117
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2230
p10118
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03014
p10119
sg11
g10108
sg12
g10113
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03014_2230
p10120
sg16
VHeme [drugbank:DB03014]
p10121
sg18
Vdrug-target interaction Heme and Catalase [drugbank_resource:DB03014_2230]
p10122
sasS'CSNK2A2'
p10123
(lp10124
(dp10125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6487
p10126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07546
p10127
sg11
g10123
sg12
S'casein kinase 2, alpha prime polypeptide'
p10128
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07546_6487
p10129
sg16
V[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid [drugbank:DB07546]
p10130
sg18
Vdrug-target interaction [1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid and Casein kinase II subunit alpha' [drugbank_resource:DB07546_6487]
p10131
sasS'CASP1'
p10132
(lp10133
(dp10134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p10135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01017
p10136
sg11
g10132
sg12
S'caspase 1, apoptosis-related cysteine peptidase'
p10137
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01017_494
p10138
sg16
VMinocycline [drugbank:DB01017]
p10139
sg18
Vdrug-target interaction Minocycline and Caspase-1 [drugbank_resource:DB01017_494]
p10140
sa(dp10141
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p10142
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07744
p10143
sg11
g10132
sg12
g10137
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07744_494
p10144
sg16
V3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID [drugbank:DB07744]
p10145
sg18
Vdrug-target interaction 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID and Caspase-1 [drugbank_resource:DB07744_494]
p10146
sa(dp10147
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p10148
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07733
p10149
sg11
g10132
sg12
g10137
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07733_494
p10150
sg16
V1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE [drugbank:DB07733]
p10151
sg18
Vdrug-target interaction 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE and Caspase-1 [drugbank_resource:DB07733_494]
p10152
sa(dp10153
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p10154
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07916
p10155
sg11
g10132
sg12
g10137
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07916_494
p10156
sg16
V3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID [drugbank:DB07916]
p10157
sg18
Vdrug-target interaction 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID and Caspase-1 [drugbank_resource:DB07916_494]
p10158
sasS'LRP2'
p10159
(lp10160
(dp10161
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p10162
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p10163
sg11
g10159
sg12
S'low density lipoprotein receptor-related protein 2'
p10164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1244
p10165
sg16
VUrokinase [drugbank:DB00013]
p10166
sg18
Vdrug-target interaction Urokinase and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00013_1244]
p10167
sa(dp10168
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p10169
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p10170
sg11
g10159
sg12
g10164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_1244
p10171
sg16
VInsulin recombinant [drugbank:DB00030]
p10172
sg18
Vdrug-target interaction Insulin recombinant and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00030_1244]
p10173
sa(dp10174
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p10175
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p10176
sg11
g10159
sg12
g10164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_1244
p10177
sg16
VInsulin, porcine [drugbank:DB00071]
p10178
sg18
Vdrug-target interaction Insulin, porcine and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00071_1244]
p10179
sa(dp10180
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p10181
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00798
p10182
sg11
g10159
sg12
g10164
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00798_1244
p10183
sg16
VGentamicin [drugbank:DB00798]
p10184
sg18
Vdrug-target interaction Gentamicin and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00798_1244]
p10185
sasS'IL2RA'
p10186
(lp10187
(dp10188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:724
p10189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00004
p10190
sg11
g10186
sg12
S'interleukin 2 receptor, alpha'
p10191
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00004_724
p10192
sg16
VDenileukin diftitox [drugbank:DB00004]
p10193
sg18
Vdrug-target interaction Denileukin diftitox and Interleukin-2 receptor alpha chain [drugbank_resource:DB00004_724]
p10194
sa(dp10195
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:724
p10196
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00111
p10197
sg11
g10186
sg12
g10191
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00111_724
p10198
sg16
VDaclizumab [drugbank:DB00111]
p10199
sg18
Vdrug-target interaction Daclizumab and Interleukin-2 receptor alpha chain [drugbank_resource:DB00111_724]
p10200
sa(dp10201
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:724
p10202
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00041
p10203
sg11
g10186
sg12
g10191
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00041_724
p10204
sg16
VAldesleukin [drugbank:DB00041]
p10205
sg18
Vdrug-target interaction Aldesleukin and Interleukin-2 receptor alpha chain [drugbank_resource:DB00041_724]
p10206
sa(dp10207
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:724
p10208
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00074
p10209
sg11
g10186
sg12
g10191
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00074_724
p10210
sg16
VBasiliximab [drugbank:DB00074]
p10211
sg18
Vdrug-target interaction Basiliximab and Interleukin-2 receptor alpha chain [drugbank_resource:DB00074_724]
p10212
sasS'F3'
p10213
(lp10214
(dp10215
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2139
p10216
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00036
p10217
sg11
g10213
sg12
S'coagulation factor III (thromboplastin, tissue factor)'
p10218
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00036_2139
p10219
sg16
VCoagulation factor VIIa [drugbank:DB00036]
p10220
sg18
Vdrug-target interaction Coagulation factor VIIa and Tissue factor [drugbank_resource:DB00036_2139]
p10221
sa(dp10222
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2139
p10223
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07247
p10224
sg11
g10213
sg12
g10218
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07247_2139
p10225
sg16
V[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA [drugbank:DB07247]
p10226
sg18
Vdrug-target interaction [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA and Tissue factor [drugbank_resource:DB07247_2139]
p10227
sa(dp10228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2139
p10229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07207
p10230
sg11
g10213
sg12
g10218
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07207_2139
p10231
sg16
V2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB07207]
p10232
sg18
Vdrug-target interaction 2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Tissue factor [drugbank_resource:DB07207_2139]
p10233
sa(dp10234
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2139
p10235
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08232
p10236
sg11
g10213
sg12
g10218
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08232_2139
p10237
sg16
V{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID [drugbank:DB08232]
p10238
sg18
Vdrug-target interaction {5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID and Tissue factor [drugbank_resource:DB08232_2139]
p10239
sasS'ITK'
p10240
(lp10241
(dp10242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2450
p10243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p10244
sg11
g10240
sg12
S'IL2-inducible T-cell kinase'
p10245
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2450
p10246
sg16
VStaurosporine [drugbank:DB02010]
p10247
sg18
Vdrug-target interaction Staurosporine and Tyrosine-protein kinase ITK/TSK [drugbank_resource:DB02010_2450]
p10248
sasS'RAD51'
p10249
(lp10250
(dp10251
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4178
p10252
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p10253
sg11
g10249
sg12
S'RAD51 homolog (S. cerevisiae)'
p10254
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_4178
p10255
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p10256
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and DNA repair protein RAD51 homolog 1 [drugbank_resource:DB04395_4178]
p10257
sasS'ADH4'
p10258
(lp10259
(dp10260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:396
p10261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p10262
sg11
g10258
sg12
S'alcohol dehydrogenase 4 (class II), pi polypeptide'
p10263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_396
p10264
sg16
VNADH [drugbank:DB00157]
p10265
sg18
Vdrug-target interaction NADH and Alcohol dehydrogenase 4 [drugbank_resource:DB00157_396]
p10266
sa(dp10267
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:396
p10268
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p10269
sg11
g10258
sg12
g10263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_396
p10270
sg16
VNADH [drugbank:DB00157]
p10271
sg18
Vdrug-enzyme interaction NADH and Alcohol dehydrogenase 4 [drugbank_resource:DB00157_396]
p10272
sa(dp10273
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:396
p10274
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p10275
sg11
g10258
sg12
g10263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_396
p10276
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p10277
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Alcohol dehydrogenase 4 [drugbank_resource:DB01907_396]
p10278
sa(dp10279
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:396
p10280
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03559
p10281
sg11
g10258
sg12
g10263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03559_396
p10282
sg16
VCyclohexylformamide [drugbank:DB03559]
p10283
sg18
Vdrug-target interaction Cyclohexylformamide and Alcohol dehydrogenase 4 [drugbank_resource:DB03559_396]
p10284
sasS'CKMT2'
p10285
(lp10286
(dp10287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:456
p10288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00148
p10289
sg11
g10285
sg12
S'creatine kinase, mitochondrial 2 (sarcomeric)'
p10290
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00148_456
p10291
sg16
VCreatine [drugbank:DB00148]
p10292
sg18
Vdrug-target interaction Creatine and Creatine kinase, sarcomeric mitochondrial [drugbank_resource:DB00148_456]
p10293
sasS'GRIK1'
p10294
(lp10295
(dp10296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:382
p10297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p10298
sg11
g10294
sg12
S'glutamate receptor, ionotropic, kainate 1'
p10299
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_382
p10300
sg16
VL-Glutamic Acid [drugbank:DB00142]
p10301
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate receptor, ionotropic kainate 1 [drugbank_resource:DB00142_382]
p10302
sa(dp10303
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:382
p10304
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00273
p10305
sg11
g10294
sg12
g10299
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00273_382
p10306
sg16
VTopiramate [drugbank:DB00273]
p10307
sg18
Vdrug-target interaction Topiramate and Glutamate receptor, ionotropic kainate 1 [drugbank_resource:DB00273_382]
p10308
sasS'GRIK3'
p10309
(lp10310
(dp10311
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:924
p10312
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p10313
sg11
g10309
sg12
S'glutamate receptor, ionotropic, kainate 3'
p10314
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_924
p10315
sg16
VL-Glutamic Acid [drugbank:DB00142]
p10316
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate receptor, ionotropic kainate 3 [drugbank_resource:DB00142_924]
p10317
sasS'GSTM5'
p10318
(lp10319
(dp10320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4035
p10321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p10322
sg11
g10318
sg12
S'glutathione S-transferase mu 5'
p10323
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_4035
p10324
sg16
VGlutathione [drugbank:DB00143]
p10325
sg18
Vdrug-target interaction Glutathione and Glutathione S-transferase Mu 5 [drugbank_resource:DB00143_4035]
p10326
sasS'ISG20'
p10327
(lp10328
(dp10329
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3529
p10330
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03685
p10331
sg11
g10327
sg12
S'interferon stimulated exonuclease gene 20kDa'
p10332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03685_3529
p10333
sg16
VUridine-5'-Monophosphate [drugbank:DB03685]
p10334
sg18
Vdrug-target interaction Uridine-5'-Monophosphate and Interferon-stimulated gene 20 kDa protein [drugbank_resource:DB03685_3529]
p10335
sasS'IL6'
p10336
(lp10337
(dp10338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1159
p10339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01404
p10340
sg11
g10336
sg12
S'interleukin 6 (interferon, beta 2)'
p10341
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01404_1159
p10342
sg16
VGinseng [drugbank:DB01404]
p10343
sg18
Vdrug-target interaction Ginseng and Interleukin-6 [drugbank_resource:DB01404_1159]
p10344
sasS'CDK1'
p10345
(lp10346
(dp10347
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1771
p10348
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02116
p10349
sg11
g10345
sg12
S'cyclin-dependent kinase 1'
p10350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02116_1771
p10351
sg16
VOlomoucine [drugbank:DB02116]
p10352
sg18
Vdrug-target interaction Olomoucine and Cell division control protein 2 homolog [drugbank_resource:DB02116_1771]
p10353
sa(dp10354
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1771
p10355
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p10356
sg11
g10345
sg12
g10350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_1771
p10357
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p10358
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Cell division control protein 2 homolog [drugbank_resource:DB02052_1771]
p10359
sa(dp10360
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1771
p10361
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02950
p10362
sg11
g10345
sg12
g10350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02950_1771
p10363
sg16
VHymenialdisine [drugbank:DB02950]
p10364
sg18
Vdrug-target interaction Hymenialdisine and Cell division control protein 2 homolog [drugbank_resource:DB02950_1771]
p10365
sa(dp10366
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1771
p10367
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p10368
sg11
g10345
sg12
g10350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_1771
p10369
sg16
VFlavopiridol [drugbank:DB03496]
p10370
sg18
Vdrug-target interaction Flavopiridol and Cell division control protein 2 homolog [drugbank_resource:DB03496_1771]
p10371
sa(dp10372
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1771
p10373
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03428
p10374
sg11
g10345
sg12
g10350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03428_1771
p10375
sg16
VSU9516 [drugbank:DB03428]
p10376
sg18
Vdrug-target interaction SU9516 and Cell division control protein 2 homolog [drugbank_resource:DB03428_1771]
p10377
sa(dp10378
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1771
p10379
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04014
p10380
sg11
g10345
sg12
g10350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04014_1771
p10381
sg16
VAlsterpaullone [drugbank:DB04014]
p10382
sg18
Vdrug-target interaction Alsterpaullone and Cell division control protein 2 homolog [drugbank_resource:DB04014_1771]
p10383
sasS'ADRB2'
p10384
(lp10385
(dp10386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00195
p10388
sg11
g10384
sg12
S'adrenoceptor beta 2, surface'
p10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00195_766
p10390
sg16
VBetaxolol [drugbank:DB00195]
p10391
sg18
Vdrug-target interaction Betaxolol and Beta-2 adrenergic receptor [drugbank_resource:DB00195_766]
p10392
sa(dp10393
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10394
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00264
p10395
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00264_766
p10396
sg16
VMetoprolol [drugbank:DB00264]
p10397
sg18
Vdrug-target interaction Metoprolol and Beta-2 adrenergic receptor [drugbank_resource:DB00264_766]
p10398
sa(dp10399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00449
p10401
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00449_766
p10402
sg16
VDipivefrin [drugbank:DB00449]
p10403
sg18
Vdrug-target interaction Dipivefrin and Beta-2 adrenergic receptor [drugbank_resource:DB00449_766]
p10404
sa(dp10405
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10406
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00489
p10407
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00489_766
p10408
sg16
VSotalol [drugbank:DB00489]
p10409
sg18
Vdrug-target interaction Sotalol and Beta-2 adrenergic receptor [drugbank_resource:DB00489_766]
p10410
sa(dp10411
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10412
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00521
p10413
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00521_766
p10414
sg16
VCarteolol [drugbank:DB00521]
p10415
sg18
Vdrug-target interaction Carteolol and Beta-2 adrenergic receptor [drugbank_resource:DB00521_766]
p10416
sa(dp10417
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10418
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00571
p10419
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00571_766
p10420
sg16
VPropranolol [drugbank:DB00571]
p10421
sg18
Vdrug-target interaction Propranolol and Beta-2 adrenergic receptor [drugbank_resource:DB00571_766]
p10422
sa(dp10423
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10424
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00368
p10425
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00368_766
p10426
sg16
VNorepinephrine [drugbank:DB00368]
p10427
sg18
Vdrug-target interaction Norepinephrine and Beta-2 adrenergic receptor [drugbank_resource:DB00368_766]
p10428
sa(dp10429
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10430
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00373
p10431
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00373_766
p10432
sg16
VTimolol [drugbank:DB00373]
p10433
sg18
Vdrug-target interaction Timolol and Beta-2 adrenergic receptor [drugbank_resource:DB00373_766]
p10434
sa(dp10435
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10436
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00598
p10437
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00598_766
p10438
sg16
VLabetalol [drugbank:DB00598]
p10439
sg18
Vdrug-target interaction Labetalol and Beta-2 adrenergic receptor [drugbank_resource:DB00598_766]
p10440
sa(dp10441
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10442
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00612
p10443
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00612_766
p10444
sg16
VBisoprolol [drugbank:DB00612]
p10445
sg18
Vdrug-target interaction Bisoprolol and Beta-2 adrenergic receptor [drugbank_resource:DB00612_766]
p10446
sa(dp10447
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10448
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00668
p10449
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00668_766
p10450
sg16
VEpinephrine [drugbank:DB00668]
p10451
sg18
Vdrug-target interaction Epinephrine and Beta-2 adrenergic receptor [drugbank_resource:DB00668_766]
p10452
sa(dp10453
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10454
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00816
p10455
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00816_766
p10456
sg16
VOrciprenaline [drugbank:DB00816]
p10457
sg18
Vdrug-target interaction Orciprenaline and Beta-2 adrenergic receptor [drugbank_resource:DB00816_766]
p10458
sa(dp10459
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10460
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00841
p10461
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00841_766
p10462
sg16
VDobutamine [drugbank:DB00841]
p10463
sg18
Vdrug-target interaction Dobutamine and Beta-2 adrenergic receptor [drugbank_resource:DB00841_766]
p10464
sa(dp10465
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10466
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00852
p10467
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00852_766
p10468
sg16
VPseudoephedrine [drugbank:DB00852]
p10469
sg18
Vdrug-target interaction Pseudoephedrine and Beta-2 adrenergic receptor [drugbank_resource:DB00852_766]
p10470
sa(dp10471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00871
p10473
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00871_766
p10474
sg16
VTerbutaline [drugbank:DB00871]
p10475
sg18
Vdrug-target interaction Terbutaline and Beta-2 adrenergic receptor [drugbank_resource:DB00871_766]
p10476
sa(dp10477
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10478
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00925
p10479
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00925_766
p10480
sg16
VPhenoxybenzamine [drugbank:DB00925]
p10481
sg18
Vdrug-target interaction Phenoxybenzamine and Beta-2 adrenergic receptor [drugbank_resource:DB00925_766]
p10482
sa(dp10483
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10484
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00866
p10485
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00866_766
p10486
sg16
VAlprenolol [drugbank:DB00866]
p10487
sg18
Vdrug-target interaction Alprenolol and Beta-2 adrenergic receptor [drugbank_resource:DB00866_766]
p10488
sa(dp10489
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10490
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00867
p10491
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00867_766
p10492
sg16
VRitodrine [drugbank:DB00867]
p10493
sg18
Vdrug-target interaction Ritodrine and Beta-2 adrenergic receptor [drugbank_resource:DB00867_766]
p10494
sa(dp10495
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10496
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00901
p10497
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00901_766
p10498
sg16
VBitolterol [drugbank:DB00901]
p10499
sg18
Vdrug-target interaction Bitolterol and Beta-2 adrenergic receptor [drugbank_resource:DB00901_766]
p10500
sa(dp10501
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10502
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01001
p10503
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01001_766
p10504
sg16
VSalbutamol [drugbank:DB01001]
p10505
sg18
Vdrug-target interaction Salbutamol and Beta-2 adrenergic receptor [drugbank_resource:DB01001_766]
p10506
sa(dp10507
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10508
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01064
p10509
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01064_766
p10510
sg16
VIsoproterenol [drugbank:DB01064]
p10511
sg18
Vdrug-target interaction Isoproterenol and Beta-2 adrenergic receptor [drugbank_resource:DB01064_766]
p10512
sa(dp10513
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10514
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01136
p10515
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01136_766
p10516
sg16
VCarvedilol [drugbank:DB01136]
p10517
sg18
Vdrug-target interaction Carvedilol and Beta-2 adrenergic receptor [drugbank_resource:DB01136_766]
p10518
sa(dp10519
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10520
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00938
p10521
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00938_766
p10522
sg16
VSalmeterol [drugbank:DB00938]
p10523
sg18
Vdrug-target interaction Salmeterol and Beta-2 adrenergic receptor [drugbank_resource:DB00938_766]
p10524
sa(dp10525
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10526
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00960
p10527
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00960_766
p10528
sg16
VPindolol [drugbank:DB00960]
p10529
sg18
Vdrug-target interaction Pindolol and Beta-2 adrenergic receptor [drugbank_resource:DB00960_766]
p10530
sa(dp10531
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10532
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00983
p10533
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00983_766
p10534
sg16
VFormoterol [drugbank:DB00983]
p10535
sg18
Vdrug-target interaction Formoterol and Beta-2 adrenergic receptor [drugbank_resource:DB00983_766]
p10536
sa(dp10537
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10538
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01102
p10539
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01102_766
p10540
sg16
VArbutamine [drugbank:DB01102]
p10541
sg18
Vdrug-target interaction Arbutamine and Beta-2 adrenergic receptor [drugbank_resource:DB01102_766]
p10542
sa(dp10543
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10544
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01151
p10545
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01151_766
p10546
sg16
VDesipramine [drugbank:DB01151]
p10547
sg18
Vdrug-target interaction Desipramine and Beta-2 adrenergic receptor [drugbank_resource:DB01151_766]
p10548
sa(dp10549
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10550
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01210
p10551
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01210_766
p10552
sg16
VLevobunolol [drugbank:DB01210]
p10553
sg18
Vdrug-target interaction Levobunolol and Beta-2 adrenergic receptor [drugbank_resource:DB01210_766]
p10554
sa(dp10555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01359
p10557
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01359_766
p10558
sg16
VPenbutolol [drugbank:DB01359]
p10559
sg18
Vdrug-target interaction Penbutolol and Beta-2 adrenergic receptor [drugbank_resource:DB01359_766]
p10560
sa(dp10561
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10562
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01363
p10563
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01363_766
p10564
sg16
VEphedra [drugbank:DB01363]
p10565
sg18
Vdrug-target interaction Ephedra and Beta-2 adrenergic receptor [drugbank_resource:DB01363_766]
p10566
sa(dp10567
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10568
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01366
p10569
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01366_766
p10570
sg16
VProcaterol [drugbank:DB01366]
p10571
sg18
Vdrug-target interaction Procaterol and Beta-2 adrenergic receptor [drugbank_resource:DB01366_766]
p10572
sa(dp10573
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10574
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01408
p10575
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01408_766
p10576
sg16
VBambuterol [drugbank:DB01408]
p10577
sg18
Vdrug-target interaction Bambuterol and Beta-2 adrenergic receptor [drugbank_resource:DB01408_766]
p10578
sa(dp10579
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10580
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01291
p10581
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01291_766
p10582
sg16
VPirbuterol [drugbank:DB01291]
p10583
sg18
Vdrug-target interaction Pirbuterol and Beta-2 adrenergic receptor [drugbank_resource:DB01291_766]
p10584
sa(dp10585
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10586
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01580
p10587
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01580_766
p10588
sg16
VOxprenolol [drugbank:DB01580]
p10589
sg18
Vdrug-target interaction Oxprenolol and Beta-2 adrenergic receptor [drugbank_resource:DB01580_766]
p10590
sa(dp10591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01193
p10593
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01193_766
p10594
sg16
VAcebutolol [drugbank:DB01193]
p10595
sg18
Vdrug-target interaction Acebutolol and Beta-2 adrenergic receptor [drugbank_resource:DB01193_766]
p10596
sa(dp10597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01203
p10599
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01203_766
p10600
sg16
VNadolol [drugbank:DB01203]
p10601
sg18
Vdrug-target interaction Nadolol and Beta-2 adrenergic receptor [drugbank_resource:DB01203_766]
p10602
sa(dp10603
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10604
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01214
p10605
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01214_766
p10606
sg16
VMetipranolol [drugbank:DB01214]
p10607
sg18
Vdrug-target interaction Metipranolol and Beta-2 adrenergic receptor [drugbank_resource:DB01214_766]
p10608
sa(dp10609
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10610
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01274
p10611
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01274_766
p10612
sg16
VArformoterol [drugbank:DB01274]
p10613
sg18
Vdrug-target interaction Arformoterol and Beta-2 adrenergic receptor [drugbank_resource:DB01274_766]
p10614
sa(dp10615
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10616
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01288
p10617
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01288_766
p10618
sg16
VFenoterol [drugbank:DB01288]
p10619
sg18
Vdrug-target interaction Fenoterol and Beta-2 adrenergic receptor [drugbank_resource:DB01288_766]
p10620
sa(dp10621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01295
p10623
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01295_766
p10624
sg16
VBevantolol [drugbank:DB01295]
p10625
sg18
Vdrug-target interaction Bevantolol and Beta-2 adrenergic receptor [drugbank_resource:DB01295_766]
p10626
sa(dp10627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01407
p10629
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01407_766
p10630
sg16
VClenbuterol [drugbank:DB01407]
p10631
sg18
Vdrug-target interaction Clenbuterol and Beta-2 adrenergic receptor [drugbank_resource:DB01407_766]
p10632
sa(dp10633
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10634
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB05039
p10635
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB05039_766
p10636
sg16
VIndacaterol [drugbank:DB05039]
p10637
sg18
Vdrug-target interaction Indacaterol and Beta-2 adrenergic receptor [drugbank_resource:DB05039_766]
p10638
sa(dp10639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04861
p10641
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04861_766
p10642
sg16
VNebivolol [drugbank:DB04861]
p10643
sg18
Vdrug-target interaction Nebivolol and Beta-2 adrenergic receptor [drugbank_resource:DB04861_766]
p10644
sa(dp10645
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10646
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06262
p10647
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06262_766
p10648
sg16
VDroxidopa [drugbank:DB06262]
p10649
sg18
Vdrug-target interaction Droxidopa and Beta-2 adrenergic receptor [drugbank_resource:DB06262_766]
p10650
sa(dp10651
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10652
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07543
p10653
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07543_766
p10654
sg16
V(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol [drugbank:DB07543]
p10655
sg18
Vdrug-target interaction (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol and Beta-2 adrenergic receptor [drugbank_resource:DB07543_766]
p10656
sa(dp10657
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10658
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08808
p10659
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08808_766
p10660
sg16
VBupranolol [drugbank:DB08808]
p10661
sg18
Vdrug-target interaction Bupranolol and Beta-2 adrenergic receptor [drugbank_resource:DB08808_766]
p10662
sa(dp10663
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:766
p10664
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08807
p10665
sg11
g10384
sg12
g10389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08807_766
p10666
sg16
VBopindolol [drugbank:DB08807]
p10667
sg18
Vdrug-target interaction Bopindolol and Beta-2 adrenergic receptor [drugbank_resource:DB08807_766]
p10668
sasS'CDK4'
p10669
(lp10670
(dp10671
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3959
p10672
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p10673
sg11
g10669
sg12
S'cyclin-dependent kinase 4'
p10674
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_3959
p10675
sg16
VPurvalanol [drugbank:DB02733]
p10676
sg18
Vdrug-target interaction Purvalanol and Cell division protein kinase 4 [drugbank_resource:DB02733_3959]
p10677
sa(dp10678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3959
p10679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p10680
sg11
g10669
sg12
g10674
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3959
p10681
sg16
VFlavopiridol [drugbank:DB03496]
p10682
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 4 [drugbank_resource:DB03496_3959]
p10683
sasS'CDK6'
p10684
(lp10685
(dp10686
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3955
p10687
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p10688
sg11
g10684
sg12
S'cyclin-dependent kinase 6'
p10689
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3955
p10690
sg16
VFlavopiridol [drugbank:DB03496]
p10691
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 6 [drugbank_resource:DB03496_3955]
p10692
sa(dp10693
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3955
p10694
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07379
p10695
sg11
g10684
sg12
g10689
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07379_3955
p10696
sg16
V(2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL [drugbank:DB07379]
p10697
sg18
Vdrug-target interaction (2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL and Cell division protein kinase 6 [drugbank_resource:DB07379_3955]
p10698
sa(dp10699
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3955
p10700
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07795
p10701
sg11
g10684
sg12
g10689
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07795_3955
p10702
sg16
V3,7,3',4'-TETRAHYDROXYFLAVONE [drugbank:DB07795]
p10703
sg18
Vdrug-target interaction 3,7,3',4'-TETRAHYDROXYFLAVONE and Cell division protein kinase 6 [drugbank_resource:DB07795_3955]
p10704
sasS'OXTR'
p10705
(lp10706
(dp10707
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:940
p10708
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00107
p10709
sg11
g10705
sg12
S'oxytocin receptor'
p10710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00107_940
p10711
sg16
VOxytocin [drugbank:DB00107]
p10712
sg18
Vdrug-target interaction Oxytocin and Oxytocin receptor [drugbank_resource:DB00107_940]
p10713
sa(dp10714
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:940
p10715
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01282
p10716
sg11
g10705
sg12
g10710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01282_940
p10717
sg16
VCarbetocin [drugbank:DB01282]
p10718
sg18
Vdrug-target interaction Carbetocin and Oxytocin receptor [drugbank_resource:DB01282_940]
p10719
sasS'MME'
p10720
(lp10721
(dp10722
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10723
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00616
p10724
sg11
g10720
sg12
S'membrane metallo-endopeptidase'
p10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00616_294
p10726
sg16
VCandoxatril [drugbank:DB00616]
p10727
sg18
Vdrug-target interaction Candoxatril and Neprilysin [drugbank_resource:DB00616_294]
p10728
sa(dp10729
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10730
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02062
p10731
sg11
g10720
sg12
g10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02062_294
p10732
sg16
VN-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine [drugbank:DB02062]
p10733
sg18
Vdrug-target interaction N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine and Neprilysin [drugbank_resource:DB02062_294]
p10734
sa(dp10735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02558
p10737
sg11
g10720
sg12
g10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02558_294
p10738
sg16
VN-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine [drugbank:DB02558]
p10739
sg18
Vdrug-target interaction N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine and Neprilysin [drugbank_resource:DB02558_294]
p10740
sa(dp10741
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10742
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02557
p10743
sg11
g10720
sg12
g10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02557_294
p10744
sg16
VPhosphoramidon [drugbank:DB02557]
p10745
sg18
Vdrug-target interaction Phosphoramidon and Neprilysin [drugbank_resource:DB02557_294]
p10746
sa(dp10747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02597
p10749
sg11
g10720
sg12
g10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02597_294
p10750
sg16
V[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala [drugbank:DB02597]
p10751
sg18
Vdrug-target interaction [2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala and Neprilysin [drugbank_resource:DB02597_294]
p10752
sa(dp10753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08575
p10755
sg11
g10720
sg12
g10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08575_294
p10756
sg16
V2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM [drugbank:DB08575]
p10757
sg18
Vdrug-target interaction 2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM and Neprilysin [drugbank_resource:DB08575_294]
p10758
sa(dp10759
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:294
p10760
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08626
p10761
sg11
g10720
sg12
g10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08626_294
p10762
sg16
VThiorphan [drugbank:DB08626]
p10763
sg18
Vdrug-target interaction Thiorphan and Neprilysin [drugbank_resource:DB08626_294]
p10764
sasS'PSMB6'
p10765
(lp10766
(dp10767
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6421
p10768
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07475
p10769
sg11
g10765
sg12
S'proteasome (prosome, macropain) subunit, beta type, 6'
p10770
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07475_6421
p10771
sg16
VN-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE [drugbank:DB07475]
p10772
sg18
Vdrug-target interaction N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE and Proteasome subunit beta type-6 [drugbank_resource:DB07475_6421]
p10773
sa(dp10774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6421
p10775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08515
p10776
sg11
g10765
sg12
g10770
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08515_6421
p10777
sg16
V(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE [drugbank:DB08515]
p10778
sg18
Vdrug-target interaction (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE and Proteasome subunit beta type-6 [drugbank_resource:DB08515_6421]
p10779
sasS'PTPRB'
p10780
(lp10781
(dp10782
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6271
p10783
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06989
p10784
sg11
g10780
sg12
S'protein tyrosine phosphatase, receptor type, B'
p10785
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06989_6271
p10786
sg16
V{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID [drugbank:DB06989]
p10787
sg18
Vdrug-target interaction {4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID and Receptor-type tyrosine-protein phosphatase beta [drugbank_resource:DB06989_6271]
p10788
sa(dp10789
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6271
p10790
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07127
p10791
sg11
g10780
sg12
g10785
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07127_6271
p10792
sg16
V{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID [drugbank:DB07127]
p10793
sg18
Vdrug-target interaction {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID and Receptor-type tyrosine-protein phosphatase beta [drugbank_resource:DB07127_6271]
p10794
sa(dp10795
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6271
p10796
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07068
p10797
sg11
g10780
sg12
g10785
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07068_6271
p10798
sg16
V(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID [drugbank:DB07068]
p10799
sg18
Vdrug-target interaction (4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID and Receptor-type tyrosine-protein phosphatase beta [drugbank_resource:DB07068_6271]
p10800
sa(dp10801
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6271
p10802
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08678
p10803
sg11
g10780
sg12
g10785
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08678_6271
p10804
sg16
V(4-ETHYLPHENYL)SULFAMIC ACID [drugbank:DB08678]
p10805
sg18
Vdrug-target interaction (4-ETHYLPHENYL)SULFAMIC ACID and Receptor-type tyrosine-protein phosphatase beta [drugbank_resource:DB08678_6271]
p10806
sasS'CDC42'
p10807
(lp10808
(dp10809
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7128
p10810
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02623
p10811
sg11
g10807
sg12
S'cell division cycle 42'
p10812
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02623_7128
p10813
sg16
VAminophosphonic Acid-Guanylate Ester [drugbank:DB02623]
p10814
sg18
Vdrug-target interaction Aminophosphonic Acid-Guanylate Ester and Cell division control protein 42 homolog [drugbank_resource:DB02623_7128]
p10815
sa(dp10816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7128
p10817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p10818
sg11
g10807
sg12
g10812
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_7128
p10819
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p10820
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Cell division control protein 42 homolog [drugbank_resource:DB04315_7128]
p10821
sasS'FAS'
p10822
(lp10823
(dp10824
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1295
p10825
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01034
p10826
sg11
S'FASN'
p10827
sg12
S'fatty acid synthase'
p10828
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01034_1295
p10829
sg16
VCerulenin [drugbank:DB01034]
p10830
sg18
Vdrug-target interaction Cerulenin and Fatty acid synthase [drugbank_resource:DB01034_1295]
p10831
sa(dp10832
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1295
p10833
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01083
p10834
sg11
g10827
sg12
g10828
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01083_1295
p10835
sg16
VOrlistat [drugbank:DB01083]
p10836
sg18
Vdrug-target interaction Orlistat and Fatty acid synthase [drugbank_resource:DB01083_1295]
p10837
sasS'POLA1'
p10838
(lp10839
(dp10840
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p10841
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00242
p10842
sg11
g10838
sg12
S'polymerase (DNA directed), alpha 1, catalytic subunit'
p10843
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00242_603
p10844
sg16
VCladribine [drugbank:DB00242]
p10845
sg18
Vdrug-target interaction Cladribine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB00242_603]
p10846
sa(dp10847
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p10848
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00631
p10849
sg11
g10838
sg12
g10843
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00631_603
p10850
sg16
VClofarabine [drugbank:DB00631]
p10851
sg18
Vdrug-target interaction Clofarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB00631_603]
p10852
sa(dp10853
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p10854
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01073
p10855
sg11
g10838
sg12
g10843
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01073_603
p10856
sg16
VFludarabine [drugbank:DB01073]
p10857
sg18
Vdrug-target interaction Fludarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB01073_603]
p10858
sa(dp10859
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p10860
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01280
p10861
sg11
g10838
sg12
g10843
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01280_603
p10862
sg16
VNelarabine [drugbank:DB01280]
p10863
sg18
Vdrug-target interaction Nelarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB01280_603]
p10864
sasS'PTK2'
p10865
(lp10866
(dp10867
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5271
p10868
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p10869
sg11
g10865
sg12
S'protein tyrosine kinase 2'
p10870
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_5271
p10871
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p10872
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Focal adhesion kinase 1 [drugbank_resource:DB03431_5271]
p10873
sa(dp10874
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5271
p10875
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07248
p10876
sg11
g10865
sg12
g10870
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07248_5271
p10877
sg16
V7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE [drugbank:DB07248]
p10878
sg18
Vdrug-target interaction 7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE and Focal adhesion kinase 1 [drugbank_resource:DB07248_5271]
p10879
sa(dp10880
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5271
p10881
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07460
p10882
sg11
g10865
sg12
g10870
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07460_5271
p10883
sg16
V2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE [drugbank:DB07460]
p10884
sg18
Vdrug-target interaction 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE and Focal adhesion kinase 1 [drugbank_resource:DB07460_5271]
p10885
sasS'PSAP'
p10886
(lp10887
(dp10888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2126
p10889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01966
p10890
sg11
g10886
sg12
S'prosaposin'
p10891
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01966_2126
p10892
sg16
VDi-Stearoyl-3-Sn-Phosphatidylethanolamine [drugbank:DB01966]
p10893
sg18
Vdrug-target interaction Di-Stearoyl-3-Sn-Phosphatidylethanolamine and Proactivator polypeptide [drugbank_resource:DB01966_2126]
p10894
sasS'PCBD1'
p10895
(lp10896
(dp10897
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7065
p10898
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04400
p10899
sg11
g10895
sg12
S'pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha'
p10900
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04400_7065
p10901
sg16
V7,8-Dihydrobiopterin [drugbank:DB04400]
p10902
sg18
Vdrug-target interaction 7,8-Dihydrobiopterin and Pterin-4-alpha-carbinolamine dehydratase [drugbank_resource:DB04400_7065]
p10903
sasS'EGFR'
p10904
(lp10905
(dp10906
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10907
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p10908
sg11
g10904
sg12
S'epidermal growth factor receptor'
p10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_844
p10910
sg16
VTrastuzumab [drugbank:DB00072]
p10911
sg18
Vdrug-target interaction Trastuzumab and Epidermal growth factor receptor [drugbank_resource:DB00072_844]
p10912
sa(dp10913
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10914
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00002
p10915
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00002_844
p10916
sg16
VCetuximab [drugbank:DB00002]
p10917
sg18
Vdrug-target interaction Cetuximab and Epidermal growth factor receptor [drugbank_resource:DB00002_844]
p10918
sa(dp10919
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10920
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00281
p10921
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00281_844
p10922
sg16
VLidocaine [drugbank:DB00281]
p10923
sg18
Vdrug-target interaction Lidocaine and Epidermal growth factor receptor [drugbank_resource:DB00281_844]
p10924
sa(dp10925
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10926
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00317
p10927
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00317_844
p10928
sg16
VGefitinib [drugbank:DB00317]
p10929
sg18
Vdrug-target interaction Gefitinib and Epidermal growth factor receptor [drugbank_resource:DB00317_844]
p10930
sa(dp10931
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10932
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00530
p10933
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00530_844
p10934
sg16
VErlotinib [drugbank:DB00530]
p10935
sg18
Vdrug-target interaction Erlotinib and Epidermal growth factor receptor [drugbank_resource:DB00530_844]
p10936
sa(dp10937
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10938
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01259
p10939
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01259_844
p10940
sg16
VLapatinib [drugbank:DB01259]
p10941
sg18
Vdrug-target interaction Lapatinib and Epidermal growth factor receptor [drugbank_resource:DB01259_844]
p10942
sa(dp10943
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10944
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01269
p10945
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01269_844
p10946
sg16
VPanitumumab [drugbank:DB01269]
p10947
sg18
Vdrug-target interaction Panitumumab and Epidermal growth factor receptor [drugbank_resource:DB01269_844]
p10948
sa(dp10949
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10950
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p10951
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_844
p10952
sg16
VFlavopiridol [drugbank:DB03496]
p10953
sg18
Vdrug-target interaction Flavopiridol and Epidermal growth factor receptor [drugbank_resource:DB03496_844]
p10954
sa(dp10955
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10956
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07602
p10957
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07602_844
p10958
sg16
VS-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE [drugbank:DB07602]
p10959
sg18
Vdrug-target interaction S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE and Epidermal growth factor receptor [drugbank_resource:DB07602_844]
p10960
sa(dp10961
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p10962
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07662
p10963
sg11
g10904
sg12
g10909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07662_844
p10964
sg16
VN-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE [drugbank:DB07662]
p10965
sg18
Vdrug-target interaction N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE and Epidermal growth factor receptor [drugbank_resource:DB07662_844]
p10966
sasS'CDK9'
p10967
(lp10968
(dp10969
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3950
p10970
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p10971
sg11
g10967
sg12
S'cyclin-dependent kinase 9'
p10972
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3950
p10973
sg16
VFlavopiridol [drugbank:DB03496]
p10974
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 9 [drugbank_resource:DB03496_3950]
p10975
sasS'CTNNB1'
p10976
(lp10977
(dp10978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1392
p10979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03904
p10980
sg11
g10976
sg12
S'catenin (cadherin-associated protein), beta 1, 88kDa'
p10981
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03904_1392
p10982
sg16
VUrea [drugbank:DB03904]
p10983
sg18
Vdrug-target interaction Urea and Catenin beta-1 [drugbank_resource:DB03904_1392]
p10984
sasS'IARS'
p10985
(lp10986
(dp10987
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:701
p10988
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00167
p10989
sg11
g10985
sg12
S'isoleucyl-tRNA synthetase'
p10990
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00167_701
p10991
sg16
VL-Isoleucine [drugbank:DB00167]
p10992
sg18
Vdrug-target interaction L-Isoleucine and Isoleucine-tRNA synthetase [drugbank_resource:DB00167_701]
p10993
sa(dp10994
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:546
p10995
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00167
p10996
sg11
g10985
sg12
g10990
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00167_546
p10997
sg16
VL-Isoleucine [drugbank:DB00167]
p10998
sg18
Vdrug-target interaction L-Isoleucine and Isoleucyl-tRNA synthetase, cytoplasmic [drugbank_resource:DB00167_546]
p10999
sasS'GPD1'
p11000
(lp11001
(dp11002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:231
p11003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p11004
sg11
g11000
sg12
S'glycerol-3-phosphate dehydrogenase 1 (soluble)'
p11005
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_231
p11006
sg16
VNADH [drugbank:DB00157]
p11007
sg18
Vdrug-target interaction NADH and Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic [drugbank_resource:DB00157_231]
p11008
sasS'RRM2'
p11009
(lp11010
(dp11011
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4218
p11012
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00242
p11013
sg11
g11009
sg12
S'ribonucleotide reductase M2'
p11014
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00242_4218
p11015
sg16
VCladribine [drugbank:DB00242]
p11016
sg18
Vdrug-target interaction Cladribine and Ribonucleoside-diphosphate reductase M2 subunit [drugbank_resource:DB00242_4218]
p11017
sa(dp11018
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4218
p11019
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB05260
p11020
sg11
g11009
sg12
g11014
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB05260_4218
p11021
sg16
VGallium nitrate [drugbank:DB05260]
p11022
sg18
Vdrug-target interaction Gallium nitrate and Ribonucleoside-diphosphate reductase M2 subunit [drugbank_resource:DB05260_4218]
p11023
sasS'LEPREL1'
p11024
(lp11025
(dp11026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3949
p11027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p11028
sg11
g11024
sg12
S'leprecan-like 1'
p11029
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3949
p11030
sg16
VVitamin C [drugbank:DB00126]
p11031
sg18
Vdrug-target interaction Vitamin C and Prolyl 3-hydroxylase 2 [drugbank_resource:DB00126_3949]
p11032
sa(dp11033
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3949
p11034
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00139
p11035
sg11
g11024
sg12
g11029
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00139_3949
p11036
sg16
VSuccinic acid [drugbank:DB00139]
p11037
sg18
Vdrug-target interaction Succinic acid and Prolyl 3-hydroxylase 2 [drugbank_resource:DB00139_3949]
p11038
sa(dp11039
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3949
p11040
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p11041
sg11
g11024
sg12
g11029
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_3949
p11042
sg16
VL-Proline [drugbank:DB00172]
p11043
sg18
Vdrug-target interaction L-Proline and Prolyl 3-hydroxylase 2 [drugbank_resource:DB00172_3949]
p11044
sasS'PIN1'
p11045
(lp11046
(dp11047
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6240
p11048
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01766
p11049
sg11
g11045
sg12
S'peptidylprolyl cis/trans isomerase, NIMA-interacting 1'
p11050
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01766_6240
p11051
sg16
VBeta-(2-Naphthyl)-Alanine [drugbank:DB01766]
p11052
sg18
Vdrug-target interaction Beta-(2-Naphthyl)-Alanine and Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [drugbank_resource:DB01766_6240]
p11053
sa(dp11054
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6240
p11055
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06867
p11056
sg11
g11045
sg12
g11050
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06867_6240
p11057
sg16
V3,6,9,12,15,18-HEXAOXAICOSANE [drugbank:DB06867]
p11058
sg18
Vdrug-target interaction 3,6,9,12,15,18-HEXAOXAICOSANE and Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [drugbank_resource:DB06867_6240]
p11059
sasS'PDE2A'
p11060
(lp11061
(dp11062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3806
p11063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02315
p11064
sg11
g11060
sg12
S'phosphodiesterase 2A, cGMP-stimulated'
p11065
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02315_3806
p11066
sg16
VCyclic Guanosine Monophosphate [drugbank:DB02315]
p11067
sg18
Vdrug-target interaction Cyclic Guanosine Monophosphate and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB02315_3806]
p11068
sa(dp11069
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3806
p11070
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07954
p11071
sg11
g11060
sg12
g11065
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07954_3806
p11072
sg16
V3-ISOBUTYL-1-METHYLXANTHINE [drugbank:DB07954]
p11073
sg18
Vdrug-target interaction 3-ISOBUTYL-1-METHYLXANTHINE and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB07954_3806]
p11074
sa(dp11075
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3806
p11076
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08811
p11077
sg11
g11060
sg12
g11065
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08811_3806
p11078
sg16
VTofisopam [drugbank:DB08811]
p11079
sg18
Vdrug-target interaction Tofisopam and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB08811_3806]
p11080
sasS'ALDH1A1'
p11081
(lp11082
(dp11083
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:611
p11084
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00162
p11085
sg11
g11081
sg12
S'aldehyde dehydrogenase 1 family, member A1'
p11086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00162_611
p11087
sg16
VVitamin A [drugbank:DB00162]
p11088
sg18
Vdrug-target interaction Vitamin A and Retinal dehydrogenase 1 [drugbank_resource:DB00162_611]
p11089
sa(dp11090
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:611
p11091
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p11092
sg11
g11081
sg12
g11086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_611
p11093
sg16
VNADH [drugbank:DB00157]
p11094
sg18
Vdrug-target interaction NADH and Retinal dehydrogenase 1 [drugbank_resource:DB00157_611]
p11095
sa(dp11096
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:611
p11097
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00755
p11098
sg11
g11081
sg12
g11086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00755_611
p11099
sg16
VTretinoin [drugbank:DB00755]
p11100
sg18
Vdrug-target interaction Tretinoin and Retinal dehydrogenase 1 [drugbank_resource:DB00755_611]
p11101
sa(dp11102
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:611
p11103
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p11104
sg11
g11081
sg12
g11086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_611
p11105
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p11106
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Retinal dehydrogenase 1 [drugbank_resource:DB01907_611]
p11107
sa(dp11108
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:611
p11109
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04447
p11110
sg11
g11081
sg12
g11086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04447_611
p11111
sg16
V1,4-Dithiothreitol [drugbank:DB04447]
p11112
sg18
Vdrug-target interaction 1,4-Dithiothreitol and Retinal dehydrogenase 1 [drugbank_resource:DB04447_611]
p11113
sasS'ALDH1A3'
p11114
(lp11115
(dp11116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:640
p11117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00162
p11118
sg11
g11114
sg12
S'aldehyde dehydrogenase 1 family, member A3'
p11119
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00162_640
p11120
sg16
VVitamin A [drugbank:DB00162]
p11121
sg18
Vdrug-target interaction Vitamin A and Aldehyde dehydrogenase 1A3 [drugbank_resource:DB00162_640]
p11122
sa(dp11123
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:640
p11124
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p11125
sg11
g11114
sg12
g11119
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_640
p11126
sg16
VNADH [drugbank:DB00157]
p11127
sg18
Vdrug-target interaction NADH and Aldehyde dehydrogenase 1A3 [drugbank_resource:DB00157_640]
p11128
sasS'CDK8'
p11129
(lp11130
(dp11131
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3968
p11132
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p11133
sg11
g11129
sg12
S'cyclin-dependent kinase 8'
p11134
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3968
p11135
sg16
VFlavopiridol [drugbank:DB03496]
p11136
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 8 [drugbank_resource:DB03496_3968]
p11137
sasS'HDAC3'
p11138
(lp11139
(dp11140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4123
p11141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p11142
sg11
g11138
sg12
S'histone deacetylase 3'
p11143
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4123
p11144
sg16
VVorinostat [drugbank:DB02546]
p11145
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 3 [drugbank_resource:DB02546_4123]
p11146
sasS'CCNA2'
p11147
(lp11148
(dp11149
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11150
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02091
p11151
sg11
g11147
sg12
S'cyclin A2'
p11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02091_6235
p11153
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [drugbank:DB02091]
p11154
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine and Cyclin-A2 [drugbank_resource:DB02091_6235]
p11155
sa(dp11156
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11157
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02407
p11158
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02407_6235
p11159
sg16
V6-O-Cyclohexylmethyl Guanine [drugbank:DB02407]
p11160
sg18
Vdrug-target interaction 6-O-Cyclohexylmethyl Guanine and Cyclin-A2 [drugbank_resource:DB02407_6235]
p11161
sa(dp11162
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11163
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02915
p11164
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02915_6235
p11165
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine [drugbank:DB02915]
p11166
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine and Cyclin-A2 [drugbank_resource:DB02915_6235]
p11167
sa(dp11168
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11169
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02833
p11170
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02833_6235
p11171
sg16
V[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine [drugbank:DB02833]
p11172
sg18
Vdrug-target interaction [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine and Cyclin-A2 [drugbank_resource:DB02833_6235]
p11173
sa(dp11174
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11175
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06844
p11176
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06844_6235
p11177
sg16
V4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE [drugbank:DB06844]
p11178
sg18
Vdrug-target interaction 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB06844_6235]
p11179
sa(dp11180
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11181
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06944
p11182
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06944_6235
p11183
sg16
VN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE [drugbank:DB06944]
p11184
sg18
Vdrug-target interaction N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE and Cyclin-A2 [drugbank_resource:DB06944_6235]
p11185
sa(dp11186
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11187
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07126
p11188
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07126_6235
p11189
sg16
VO6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE [drugbank:DB07126]
p11190
sg18
Vdrug-target interaction O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE and Cyclin-A2 [drugbank_resource:DB07126_6235]
p11191
sa(dp11192
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11193
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07137
p11194
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07137_6235
p11195
sg16
V(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE [drugbank:DB07137]
p11196
sg18
Vdrug-target interaction (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE and Cyclin-A2 [drugbank_resource:DB07137_6235]
p11197
sa(dp11198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07164
p11200
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07164_6235
p11201
sg16
VN-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine [drugbank:DB07164]
p11202
sg18
Vdrug-target interaction N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB07164_6235]
p11203
sa(dp11204
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11205
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07203
p11206
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07203_6235
p11207
sg16
V6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE [drugbank:DB07203]
p11208
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE and Cyclin-A2 [drugbank_resource:DB07203_6235]
p11209
sa(dp11210
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11211
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06948
p11212
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06948_6235
p11213
sg16
V2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE [drugbank:DB06948]
p11214
sg18
Vdrug-target interaction 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE and Cyclin-A2 [drugbank_resource:DB06948_6235]
p11215
sa(dp11216
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11217
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07538
p11218
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07538_6235
p11219
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE [drugbank:DB07538]
p11220
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07538_6235]
p11221
sa(dp11222
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11223
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07471
p11224
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07471_6235
p11225
sg16
V5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE [drugbank:DB07471]
p11226
sg18
Vdrug-target interaction 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE and Cyclin-A2 [drugbank_resource:DB07471_6235]
p11227
sa(dp11228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07533
p11230
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07533_6235
p11231
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07533]
p11232
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07533_6235]
p11233
sa(dp11234
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11235
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07534
p11236
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07534_6235
p11237
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07534]
p11238
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07534_6235]
p11239
sa(dp11240
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11241
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07539
p11242
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07539_6235
p11243
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID [drugbank:DB07539]
p11244
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID and Cyclin-A2 [drugbank_resource:DB07539_6235]
p11245
sa(dp11246
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11247
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07688
p11248
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07688_6235
p11249
sg16
V4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07688]
p11250
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07688_6235]
p11251
sa(dp11252
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11253
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07852
p11254
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07852_6235
p11255
sg16
V1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID [drugbank:DB07852]
p11256
sg18
Vdrug-target interaction 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID and Cyclin-A2 [drugbank_resource:DB07852_6235]
p11257
sa(dp11258
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11259
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08182
p11260
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08182_6235
p11261
sg16
V4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08182]
p11262
sg18
Vdrug-target interaction 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB08182_6235]
p11263
sa(dp11264
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11265
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08241
p11266
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08241_6235
p11267
sg16
V4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE [drugbank:DB08241]
p11268
sg18
Vdrug-target interaction 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE and Cyclin-A2 [drugbank_resource:DB08241_6235]
p11269
sa(dp11270
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11271
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08248
p11272
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08248_6235
p11273
sg16
V3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE [drugbank:DB08248]
p11274
sg18
Vdrug-target interaction 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB08248_6235]
p11275
sa(dp11276
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11277
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08285
p11278
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08285_6235
p11279
sg16
V(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol [drugbank:DB08285]
p11280
sg18
Vdrug-target interaction (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol and Cyclin-A2 [drugbank_resource:DB08285_6235]
p11281
sa(dp11282
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11283
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08463
p11284
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08463_6235
p11285
sg16
V(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol [drugbank:DB08463]
p11286
sg18
Vdrug-target interaction (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol and Cyclin-A2 [drugbank_resource:DB08463_6235]
p11287
sa(dp11288
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11289
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08218
p11290
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08218_6235
p11291
sg16
VHYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM [drugbank:DB08218]
p11292
sg18
Vdrug-target interaction HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM and Cyclin-A2 [drugbank_resource:DB08218_6235]
p11293
sa(dp11294
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11295
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08219
p11296
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08219_6235
p11297
sg16
V4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE [drugbank:DB08219]
p11298
sg18
Vdrug-target interaction 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE and Cyclin-A2 [drugbank_resource:DB08219_6235]
p11299
sa(dp11300
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11301
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08233
p11302
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08233_6235
p11303
sg16
V6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE [drugbank:DB08233]
p11304
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE and Cyclin-A2 [drugbank_resource:DB08233_6235]
p11305
sa(dp11306
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11307
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07562
p11308
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07562_6235
p11309
sg16
VN-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE [drugbank:DB07562]
p11310
sg18
Vdrug-target interaction N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE and Cyclin-A2 [drugbank_resource:DB07562_6235]
p11311
sa(dp11312
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11313
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08178
p11314
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08178_6235
p11315
sg16
V4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08178]
p11316
sg18
Vdrug-target interaction 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB08178_6235]
p11317
sa(dp11318
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11319
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08309
p11320
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08309_6235
p11321
sg16
V3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL [drugbank:DB08309]
p11322
sg18
Vdrug-target interaction 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL and Cyclin-A2 [drugbank_resource:DB08309_6235]
p11323
sa(dp11324
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11325
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08355
p11326
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08355_6235
p11327
sg16
V1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid [drugbank:DB08355]
p11328
sg18
Vdrug-target interaction 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid and Cyclin-A2 [drugbank_resource:DB08355_6235]
p11329
sa(dp11330
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11331
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08527
p11332
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08527_6235
p11333
sg16
V1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE [drugbank:DB08527]
p11334
sg18
Vdrug-target interaction 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE and Cyclin-A2 [drugbank_resource:DB08527_6235]
p11335
sa(dp11336
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11337
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08572
p11338
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08572_6235
p11339
sg16
V4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE [drugbank:DB08572]
p11340
sg18
Vdrug-target interaction 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE and Cyclin-A2 [drugbank_resource:DB08572_6235]
p11341
sa(dp11342
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p11343
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08694
p11344
sg11
g11147
sg12
g11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08694_6235
p11345
sg16
V9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol [drugbank:DB08694]
p11346
sg18
Vdrug-target interaction 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol and Cyclin-A2 [drugbank_resource:DB08694_6235]
p11347
sasS'AASS'
p11348
(lp11349
(dp11350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:83
p11351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p11352
sg11
g11348
sg12
S'aminoadipate-semialdehyde synthase'
p11353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_83
p11354
sg16
VL-Glutamic Acid [drugbank:DB00142]
p11355
sg18
Vdrug-target interaction L-Glutamic Acid and Alpha-aminoadipic semialdehyde synthase, mitochondrial [drugbank_resource:DB00142_83]
p11356
sa(dp11357
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:83
p11358
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p11359
sg11
g11348
sg12
g11353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_83
p11360
sg16
VNADH [drugbank:DB00157]
p11361
sg18
Vdrug-target interaction NADH and Alpha-aminoadipic semialdehyde synthase, mitochondrial [drugbank_resource:DB00157_83]
p11362
sa(dp11363
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:83
p11364
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02338
p11365
sg11
g11348
sg12
g11353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02338_83
p11366
sg16
VNadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate [drugbank:DB02338]
p11367
sg18
Vdrug-target interaction Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate and Alpha-aminoadipic semialdehyde synthase, mitochondrial [drugbank_resource:DB02338_83]
p11368
sa(dp11369
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:83
p11370
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04207
p11371
sg11
g11348
sg12
g11353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04207_83
p11372
sg16
VN-(5-Amino-5-Carboxypentyl)Glutamic Acid [drugbank:DB04207]
p11373
sg18
Vdrug-target interaction N-(5-Amino-5-Carboxypentyl)Glutamic Acid and Alpha-aminoadipic semialdehyde synthase, mitochondrial [drugbank_resource:DB04207_83]
p11374
sasS'PLOD3'
p11375
(lp11376
(dp11377
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3938
p11378
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p11379
sg11
g11375
sg12
S'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3'
p11380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3938
p11381
sg16
VVitamin C [drugbank:DB00126]
p11382
sg18
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 [drugbank_resource:DB00126_3938]
p11383
sa(dp11384
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3938
p11385
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00139
p11386
sg11
g11375
sg12
g11380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00139_3938
p11387
sg16
VSuccinic acid [drugbank:DB00139]
p11388
sg18
Vdrug-target interaction Succinic acid and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 [drugbank_resource:DB00139_3938]
p11389
sasS'RDH5'
p11390
(lp11391
(dp11392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:627
p11393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p11394
sg11
g11390
sg12
S'retinol dehydrogenase 5 (11-cis/9-cis)'
p11395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_627
p11396
sg16
VNADH [drugbank:DB00157]
p11397
sg18
Vdrug-target interaction NADH and 11-cis retinol dehydrogenase [drugbank_resource:DB00157_627]
p11398
sa(dp11399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:627
p11400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00162
p11401
sg11
g11390
sg12
g11395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00162_627
p11402
sg16
VVitamin A [drugbank:DB00162]
p11403
sg18
Vdrug-target interaction Vitamin A and 11-cis retinol dehydrogenase [drugbank_resource:DB00162_627]
p11404
sasS'MAOA'
p11405
(lp11406
(dp11407
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11408
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00191
p11409
sg11
g11405
sg12
S'monoamine oxidase A'
p11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00191_3941
p11411
sg16
VPhentermine [drugbank:DB00191]
p11412
sg18
Vdrug-target interaction Phentermine and Amine oxidase [flavin-containing] A [drugbank_resource:DB00191_3941]
p11413
sa(dp11414
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11415
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00191
p11416
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00191_3941
p11417
sg16
VPhentermine [drugbank:DB00191]
p11418
sg18
Vdrug-enzyme interaction Phentermine and Amine oxidase [flavin-containing] A [drugbank_resource:DB00191_3941]
p11419
sa(dp11420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00752
p11422
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00752_3941
p11423
sg16
VTranylcypromine [drugbank:DB00752]
p11424
sg18
Vdrug-target interaction Tranylcypromine and Amine oxidase [flavin-containing] A [drugbank_resource:DB00752_3941]
p11425
sa(dp11426
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11427
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00780
p11428
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00780_3941
p11429
sg16
VPhenelzine [drugbank:DB00780]
p11430
sg18
Vdrug-target interaction Phenelzine and Amine oxidase [flavin-containing] A [drugbank_resource:DB00780_3941]
p11431
sa(dp11432
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11433
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00780
p11434
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00780_3941
p11435
sg16
VPhenelzine [drugbank:DB00780]
p11436
sg18
Vdrug-enzyme interaction Phenelzine and Amine oxidase [flavin-containing] A [drugbank_resource:DB00780_3941]
p11437
sa(dp11438
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11439
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p11440
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_3941
p11441
sg16
VZonisamide [drugbank:DB00909]
p11442
sg18
Vdrug-target interaction Zonisamide and Amine oxidase [flavin-containing] A [drugbank_resource:DB00909_3941]
p11443
sa(dp11444
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11445
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00805
p11446
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00805_3941
p11447
sg16
VMinaprine [drugbank:DB00805]
p11448
sg18
Vdrug-target interaction Minaprine and Amine oxidase [flavin-containing] A [drugbank_resource:DB00805_3941]
p11449
sa(dp11450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01037
p11452
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01037_3941
p11453
sg16
VSelegiline [drugbank:DB01037]
p11454
sg18
Vdrug-target interaction Selegiline and Amine oxidase [flavin-containing] A [drugbank_resource:DB01037_3941]
p11455
sa(dp11456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01577
p11458
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01577_3941
p11459
sg16
VMethamphetamine [drugbank:DB01577]
p11460
sg18
Vdrug-target interaction Methamphetamine and Amine oxidase [flavin-containing] A [drugbank_resource:DB01577_3941]
p11461
sa(dp11462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01171
p11464
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01171_3941
p11465
sg16
VMoclobemide [drugbank:DB01171]
p11466
sg18
Vdrug-target interaction Moclobemide and Amine oxidase [flavin-containing] A [drugbank_resource:DB01171_3941]
p11467
sa(dp11468
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11469
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01171
p11470
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01171_3941
p11471
sg16
VMoclobemide [drugbank:DB01171]
p11472
sg18
Vdrug-enzyme interaction Moclobemide and Amine oxidase [flavin-containing] A [drugbank_resource:DB01171_3941]
p11473
sa(dp11474
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11475
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01442
p11476
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01442_3941
p11477
sg16
VMMDA [drugbank:DB01442]
p11478
sg18
Vdrug-target interaction MMDA and Amine oxidase [flavin-containing] A [drugbank_resource:DB01442_3941]
p11479
sa(dp11480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01472
p11482
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01472_3941
p11483
sg16
V4-Methoxyamphetamine [drugbank:DB01472]
p11484
sg18
Vdrug-target interaction 4-Methoxyamphetamine and Amine oxidase [flavin-containing] A [drugbank_resource:DB01472_3941]
p11485
sa(dp11486
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11487
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01247
p11488
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01247_3941
p11489
sg16
VIsocarboxazid [drugbank:DB01247]
p11490
sg18
Vdrug-target interaction Isocarboxazid and Amine oxidase [flavin-containing] A [drugbank_resource:DB01247_3941]
p11491
sa(dp11492
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11493
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01363
p11494
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01363_3941
p11495
sg16
VEphedra [drugbank:DB01363]
p11496
sg18
Vdrug-target interaction Ephedra and Amine oxidase [flavin-containing] A [drugbank_resource:DB01363_3941]
p11497
sa(dp11498
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11499
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01626
p11500
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01626_3941
p11501
sg16
VPargyline [drugbank:DB01626]
p11502
sg18
Vdrug-target interaction Pargyline and Amine oxidase [flavin-containing] A [drugbank_resource:DB01626_3941]
p11503
sa(dp11504
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11505
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03147
p11506
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03147_3941
p11507
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p11508
sg18
Vdrug-target interaction Flavin-Adenine Dinucleotide and Amine oxidase [flavin-containing] A [drugbank_resource:DB03147_3941]
p11509
sa(dp11510
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11511
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04017
p11512
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04017_3941
p11513
sg16
VN-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine [drugbank:DB04017]
p11514
sg18
Vdrug-target interaction N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine and Amine oxidase [flavin-containing] A [drugbank_resource:DB04017_3941]
p11515
sa(dp11516
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11517
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04821
p11518
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04821_3941
p11519
sg16
VNomifensine [drugbank:DB04821]
p11520
sg18
Vdrug-target interaction Nomifensine and Amine oxidase [flavin-containing] A [drugbank_resource:DB04821_3941]
p11521
sa(dp11522
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11523
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04820
p11524
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04820_3941
p11525
sg16
VNialamide [drugbank:DB04820]
p11526
sg18
Vdrug-target interaction Nialamide and Amine oxidase [flavin-containing] A [drugbank_resource:DB04820_3941]
p11527
sa(dp11528
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11529
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04832
p11530
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04832_3941
p11531
sg16
VZimelidine [drugbank:DB04832]
p11532
sg18
Vdrug-target interaction Zimelidine and Amine oxidase [flavin-containing] A [drugbank_resource:DB04832_3941]
p11533
sa(dp11534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07641
p11536
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07641_3941
p11537
sg16
VDECYL(DIMETHYL)PHOSPHINE OXIDE [drugbank:DB07641]
p11538
sg18
Vdrug-target interaction DECYL(DIMETHYL)PHOSPHINE OXIDE and Amine oxidase [flavin-containing] A [drugbank_resource:DB07641_3941]
p11539
sa(dp11540
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3941
p11541
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07919
p11542
sg11
g11405
sg12
g11410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07919_3941
p11543
sg16
V7-METHOXY-1-METHYL-9H-BETA-CARBOLINE [drugbank:DB07919]
p11544
sg18
Vdrug-target interaction 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE and Amine oxidase [flavin-containing] A [drugbank_resource:DB07919_3941]
p11545
sasS'NSF'
p11546
(lp11547
(dp11548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7018
p11549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01902
p11550
sg11
g11546
sg12
S'N-ethylmaleimide-sensitive factor'
p11551
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01902_7018
p11552
sg16
V1-Ethyl-Pyrrolidine-2,5-Dione [drugbank:DB01902]
p11553
sg18
Vdrug-target interaction 1-Ethyl-Pyrrolidine-2,5-Dione and Vesicle-fusing ATPase [drugbank_resource:DB01902_7018]
p11554
sasS'TPO'
p11555
(lp11556
(dp11557
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:563
p11558
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00509
p11559
sg11
g11555
sg12
S'thyroid peroxidase'
p11560
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00509_563
p11561
sg16
VDextrothyroxine [drugbank:DB00509]
p11562
sg18
Vdrug-target interaction Dextrothyroxine and Thyroid peroxidase [drugbank_resource:DB00509_563]
p11563
sa(dp11564
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:563
p11565
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00550
p11566
sg11
g11555
sg12
g11560
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00550_563
p11567
sg16
VPropylthiouracil [drugbank:DB00550]
p11568
sg18
Vdrug-target interaction Propylthiouracil and Thyroid peroxidase [drugbank_resource:DB00550_563]
p11569
sa(dp11570
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:563
p11571
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00389
p11572
sg11
g11555
sg12
g11560
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00389_563
p11573
sg16
VCarbimazole [drugbank:DB00389]
p11574
sg18
Vdrug-target interaction Carbimazole and Thyroid peroxidase [drugbank_resource:DB00389_563]
p11575
sa(dp11576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:563
p11577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00763
p11578
sg11
g11555
sg12
g11560
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00763_563
p11579
sg16
VMethimazole [drugbank:DB00763]
p11580
sg18
Vdrug-target interaction Methimazole and Thyroid peroxidase [drugbank_resource:DB00763_563]
p11581
sasS'ABCB1'
p11582
(lp11583
(dp11584
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1588
p11585
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p11586
sg11
g11582
sg12
S'ATP-binding cassette, sub-family B (MDR/TAP), member 1'
p11587
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_1588
p11588
sg16
VAdenosine triphosphate [drugbank:DB00171]
p11589
sg18
Vdrug-target interaction Adenosine triphosphate and Multidrug resistance protein 1 [drugbank_resource:DB00171_1588]
p11590
sa(dp11591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1588
p11592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00778
p11593
sg11
g11582
sg12
g11587
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00778_1588
p11594
sg16
VRoxithromycin [drugbank:DB00778]
p11595
sg18
Vdrug-target interaction Roxithromycin and Multidrug resistance protein 1 [drugbank_resource:DB00778_1588]
p11596
sa(dp11597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1588
p11598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04877
p11599
sg11
g11582
sg12
g11587
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04877_1588
p11600
sg16
VVoacamine [drugbank:DB04877]
p11601
sg18
Vdrug-target interaction Voacamine and Multidrug resistance protein 1 [drugbank_resource:DB04877_1588]
p11602
sasS'PGR'
p11603
(lp11604
(dp11605
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11606
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00294
p11607
sg11
g11603
sg12
S'progesterone receptor'
p11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00294_614
p11609
sg16
VEtonogestrel [drugbank:DB00294]
p11610
sg18
Vdrug-target interaction Etonogestrel and Progesterone receptor [drugbank_resource:DB00294_614]
p11611
sa(dp11612
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11613
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00351
p11614
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00351_614
p11615
sg16
VMegestrol [drugbank:DB00351]
p11616
sg18
Vdrug-target interaction Megestrol and Progesterone receptor [drugbank_resource:DB00351_614]
p11617
sa(dp11618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00378
p11620
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00378_614
p11621
sg16
VDydrogesterone [drugbank:DB00378]
p11622
sg18
Vdrug-target interaction Dydrogesterone and Progesterone receptor [drugbank_resource:DB00378_614]
p11623
sa(dp11624
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11625
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00304
p11626
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00304_614
p11627
sg16
VDesogestrel [drugbank:DB00304]
p11628
sg18
Vdrug-target interaction Desogestrel and Progesterone receptor [drugbank_resource:DB00304_614]
p11629
sa(dp11630
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11631
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00588
p11632
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00588_614
p11633
sg16
VFluticasone Propionate [drugbank:DB00588]
p11634
sg18
Vdrug-target interaction Fluticasone Propionate and Progesterone receptor [drugbank_resource:DB00588_614]
p11635
sa(dp11636
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11637
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00367
p11638
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00367_614
p11639
sg16
VLevonorgestrel [drugbank:DB00367]
p11640
sg18
Vdrug-target interaction Levonorgestrel and Progesterone receptor [drugbank_resource:DB00367_614]
p11641
sa(dp11642
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11643
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00396
p11644
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00396_614
p11645
sg16
VProgesterone [drugbank:DB00396]
p11646
sg18
Vdrug-target interaction Progesterone and Progesterone receptor [drugbank_resource:DB00396_614]
p11647
sa(dp11648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00603
p11650
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00603_614
p11651
sg16
VMedroxyprogesterone [drugbank:DB00603]
p11652
sg18
Vdrug-target interaction Medroxyprogesterone and Progesterone receptor [drugbank_resource:DB00603_614]
p11653
sa(dp11654
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11655
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00823
p11656
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00823_614
p11657
sg16
VEthynodiol Diacetate [drugbank:DB00823]
p11658
sg18
Vdrug-target interaction Ethynodiol Diacetate and Progesterone receptor [drugbank_resource:DB00823_614]
p11659
sa(dp11660
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11661
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00717
p11662
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00717_614
p11663
sg16
VNorethindrone [drugbank:DB00717]
p11664
sg18
Vdrug-target interaction Norethindrone and Progesterone receptor [drugbank_resource:DB00717_614]
p11665
sa(dp11666
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11667
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00834
p11668
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00834_614
p11669
sg16
VMifepristone [drugbank:DB00834]
p11670
sg18
Vdrug-target interaction Mifepristone and Progesterone receptor [drugbank_resource:DB00834_614]
p11671
sa(dp11672
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11673
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00957
p11674
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00957_614
p11675
sg16
VNorgestimate [drugbank:DB00957]
p11676
sg18
Vdrug-target interaction Norgestimate and Progesterone receptor [drugbank_resource:DB00957_614]
p11677
sa(dp11678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p11680
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_614
p11681
sg16
VDanazol [drugbank:DB01406]
p11682
sg18
Vdrug-target interaction Danazol and Progesterone receptor [drugbank_resource:DB01406_614]
p11683
sa(dp11684
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11685
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01431
p11686
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01431_614
p11687
sg16
VAllylestrenol [drugbank:DB01431]
p11688
sg18
Vdrug-target interaction Allylestrenol and Progesterone receptor [drugbank_resource:DB01431_614]
p11689
sa(dp11690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01395
p11692
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01395_614
p11693
sg16
VDrospirenone [drugbank:DB01395]
p11694
sg18
Vdrug-target interaction Drospirenone and Progesterone receptor [drugbank_resource:DB01395_614]
p11695
sa(dp11696
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11697
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02998
p11698
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02998_614
p11699
sg16
VMethyltrienolone [drugbank:DB02998]
p11700
sg18
Vdrug-target interaction Methyltrienolone and Progesterone receptor [drugbank_resource:DB02998_614]
p11701
sa(dp11702
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11703
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04787
p11704
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04787_614
p11705
sg16
VTanaproget [drugbank:DB04787]
p11706
sg18
Vdrug-target interaction Tanaproget and Progesterone receptor [drugbank_resource:DB04787_614]
p11707
sa(dp11708
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p11709
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06713
p11710
sg11
g11603
sg12
g11608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06713_614
p11711
sg16
VNorelgestromin [drugbank:DB06713]
p11712
sg18
Vdrug-target interaction Norelgestromin and Progesterone receptor [drugbank_resource:DB06713_614]
p11713
sasS'AURKA'
p11714
(lp11715
(dp11716
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11717
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p11718
sg11
g11714
sg12
S'aurora kinase A'
p11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_1422
p11720
sg16
VPhosphonothreonine [drugbank:DB02482]
p11721
sg18
Vdrug-target interaction Phosphonothreonine and Serine/threonine-protein kinase 6 [drugbank_resource:DB02482_1422]
p11722
sa(dp11723
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11724
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p11725
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1422
p11726
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p11727
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Serine/threonine-protein kinase 6 [drugbank_resource:DB03431_1422]
p11728
sa(dp11729
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11730
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07186
p11731
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07186_1422
p11732
sg16
V4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE [drugbank:DB07186]
p11733
sg18
Vdrug-target interaction 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB07186_1422]
p11734
sa(dp11735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07266
p11737
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07266_1422
p11738
sg16
V8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one [drugbank:DB07266]
p11739
sg18
Vdrug-target interaction 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one and Serine/threonine-protein kinase 6 [drugbank_resource:DB07266_1422]
p11740
sa(dp11741
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11742
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07361
p11743
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07361_1422
p11744
sg16
V1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea [drugbank:DB07361]
p11745
sg18
Vdrug-target interaction 1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07361_1422]
p11746
sa(dp11747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07360
p11749
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07360_1422
p11750
sg16
V1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea [drugbank:DB07360]
p11751
sg18
Vdrug-target interaction 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07360_1422]
p11752
sa(dp11753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07362
p11755
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07362_1422
p11756
sg16
V1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea [drugbank:DB07362]
p11757
sg18
Vdrug-target interaction 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07362_1422]
p11758
sa(dp11759
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11760
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07545
p11761
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07545_1422
p11762
sg16
VN-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE [drugbank:DB07545]
p11763
sg18
Vdrug-target interaction N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB07545_1422]
p11764
sa(dp11765
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11766
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08066
p11767
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08066_1422
p11768
sg16
VN-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE [drugbank:DB08066]
p11769
sg18
Vdrug-target interaction N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB08066_1422]
p11770
sa(dp11771
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11772
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07801
p11773
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07801_1422
p11774
sg16
VN-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide [drugbank:DB07801]
p11775
sg18
Vdrug-target interaction N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide and Serine/threonine-protein kinase 6 [drugbank_resource:DB07801_1422]
p11776
sa(dp11777
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p11778
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08065
p11779
sg11
g11714
sg12
g11719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08065_1422
p11780
sg16
V2-(1H-pyrazol-3-yl)-1H-benzimidazole [drugbank:DB08065]
p11781
sg18
Vdrug-target interaction 2-(1H-pyrazol-3-yl)-1H-benzimidazole and Serine/threonine-protein kinase 6 [drugbank_resource:DB08065_1422]
p11782
sasS'TF'
p11783
(lp11784
(dp11785
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:566
p11786
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01370
p11787
sg11
g11783
sg12
S'transferrin'
p11788
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01370_566
p11789
sg16
VAluminium [drugbank:DB01370]
p11790
sg18
Vdrug-target interaction Aluminium and Serotransferrin [drugbank_resource:DB01370_566]
p11791
sasS'ADH1C'
p11792
(lp11793
(dp11794
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11795
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p11796
sg11
g11792
sg12
S'alcohol dehydrogenase 1C (class I), gamma polypeptide'
p11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_517
p11798
sg16
VNADH [drugbank:DB00157]
p11799
sg18
Vdrug-target interaction NADH and Alcohol dehydrogenase 1C [drugbank_resource:DB00157_517]
p11800
sa(dp11801
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11802
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00898
p11803
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00898_517
p11804
sg16
VEthanol [drugbank:DB00898]
p11805
sg18
Vdrug-target interaction Ethanol and Alcohol dehydrogenase 1C [drugbank_resource:DB00898_517]
p11806
sa(dp11807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p11809
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_517
p11810
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p11811
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Alcohol dehydrogenase 1C [drugbank_resource:DB01907_517]
p11812
sa(dp11813
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11814
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02131
p11815
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02131_517
p11816
sg16
VN-1-Methylheptylformamide [drugbank:DB02131]
p11817
sg18
Vdrug-target interaction N-1-Methylheptylformamide and Alcohol dehydrogenase 1C [drugbank_resource:DB02131_517]
p11818
sa(dp11819
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11820
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01213
p11821
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01213_517
p11822
sg16
VFomepizole [drugbank:DB01213]
p11823
sg18
Vdrug-target interaction Fomepizole and Alcohol dehydrogenase 1C [drugbank_resource:DB01213_517]
p11824
sa(dp11825
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11826
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01711
p11827
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01711_517
p11828
sg16
V2,3,4,5,6-Pentafluorobenzyl Alcohol [drugbank:DB01711]
p11829
sg18
Vdrug-target interaction 2,3,4,5,6-Pentafluorobenzyl Alcohol and Alcohol dehydrogenase 1C [drugbank_resource:DB01711_517]
p11830
sa(dp11831
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11832
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02659
p11833
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02659_517
p11834
sg16
VCholic Acid [drugbank:DB02659]
p11835
sg18
Vdrug-target interaction Cholic Acid and Alcohol dehydrogenase 1C [drugbank_resource:DB02659_517]
p11836
sa(dp11837
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11838
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02249
p11839
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02249_517
p11840
sg16
V2-Ethoxyethanol [drugbank:DB02249]
p11841
sg18
Vdrug-target interaction 2-Ethoxyethanol and Alcohol dehydrogenase 1C [drugbank_resource:DB02249_517]
p11842
sa(dp11843
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11844
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02757
p11845
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02757_517
p11846
sg16
VPyrazole [drugbank:DB02757]
p11847
sg18
Vdrug-target interaction Pyrazole and Alcohol dehydrogenase 1C [drugbank_resource:DB02757_517]
p11848
sa(dp11849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02822
p11851
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02822_517
p11852
sg16
VPara-Bromobenzyl Alcohol [drugbank:DB02822]
p11853
sg18
Vdrug-target interaction Para-Bromobenzyl Alcohol and Alcohol dehydrogenase 1C [drugbank_resource:DB02822_517]
p11854
sa(dp11855
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11856
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02871
p11857
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02871_517
p11858
sg16
V3-Butylthiolane 1-Oxide [drugbank:DB02871]
p11859
sg18
Vdrug-target interaction 3-Butylthiolane 1-Oxide and Alcohol dehydrogenase 1C [drugbank_resource:DB02871_517]
p11860
sa(dp11861
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11862
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03061
p11863
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03061_517
p11864
sg16
V(R)-N-(1-Methyl-Hexyl)-Formamide [drugbank:DB03061]
p11865
sg18
Vdrug-target interaction (R)-N-(1-Methyl-Hexyl)-Formamide and Alcohol dehydrogenase 1C [drugbank_resource:DB03061_517]
p11866
sa(dp11867
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11868
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03226
p11869
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03226_517
p11870
sg16
VTrifluoroethanol [drugbank:DB03226]
p11871
sg18
Vdrug-target interaction Trifluoroethanol and Alcohol dehydrogenase 1C [drugbank_resource:DB03226_517]
p11872
sa(dp11873
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11874
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02721
p11875
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02721_517
p11876
sg16
V4-Iodopyrazole [drugbank:DB02721]
p11877
sg18
Vdrug-target interaction 4-Iodopyrazole and Alcohol dehydrogenase 1C [drugbank_resource:DB02721_517]
p11878
sa(dp11879
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11880
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03020
p11881
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03020_517
p11882
sg16
V5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide [drugbank:DB03020]
p11883
sg18
Vdrug-target interaction 5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide and Alcohol dehydrogenase 1C [drugbank_resource:DB03020_517]
p11884
sa(dp11885
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11886
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04113
p11887
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04113_517
p11888
sg16
VN-Formylpiperidine [drugbank:DB04113]
p11889
sg18
Vdrug-target interaction N-Formylpiperidine and Alcohol dehydrogenase 1C [drugbank_resource:DB04113_517]
p11890
sa(dp11891
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11892
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04312
p11893
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04312_517
p11894
sg16
V2,3-Difluorobenzyl Alcohol [drugbank:DB04312]
p11895
sg18
Vdrug-target interaction 2,3-Difluorobenzyl Alcohol and Alcohol dehydrogenase 1C [drugbank_resource:DB04312_517]
p11896
sa(dp11897
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11898
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03559
p11899
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03559_517
p11900
sg16
VCyclohexylformamide [drugbank:DB03559]
p11901
sg18
Vdrug-target interaction Cyclohexylformamide and Alcohol dehydrogenase 1C [drugbank_resource:DB03559_517]
p11902
sa(dp11903
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11904
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04071
p11905
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04071_517
p11906
sg16
VCpad [drugbank:DB04071]
p11907
sg18
Vdrug-target interaction Cpad and Alcohol dehydrogenase 1C [drugbank_resource:DB04071_517]
p11908
sa(dp11909
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:517
p11910
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04448
p11911
sg11
g11792
sg12
g11797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04448_517
p11912
sg16
V2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene [drugbank:DB04448]
p11913
sg18
Vdrug-target interaction 2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene and Alcohol dehydrogenase 1C [drugbank_resource:DB04448_517]
p11914
sasS'EPRS'
p11915
(lp11916
(dp11917
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p11918
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p11919
sg11
g11915
sg12
S'glutamyl-prolyl-tRNA synthetase'
p11920
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_210
p11921
sg16
VL-Glutamic Acid [drugbank:DB00142]
p11922
sg18
Vdrug-target interaction L-Glutamic Acid and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB00142_210]
p11923
sa(dp11924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p11925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p11926
sg11
g11915
sg12
g11920
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_210
p11927
sg16
VL-Proline [drugbank:DB00172]
p11928
sg18
Vdrug-target interaction L-Proline and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB00172_210]
p11929
sa(dp11930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p11931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02510
p11932
sg11
g11915
sg12
g11920
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02510_210
p11933
sg16
V'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine [drugbank:DB02510]
p11934
sg18
Vdrug-target interaction '5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB02510_210]
p11935
sa(dp11936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p11937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02684
p11938
sg11
g11915
sg12
g11920
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02684_210
p11939
sg16
V5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine [drugbank:DB02684]
p11940
sg18
Vdrug-target interaction 5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB02684_210]
p11941
sa(dp11942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p11943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03376
p11944
sg11
g11915
sg12
g11920
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03376_210
p11945
sg16
V'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine [drugbank:DB03376]
p11946
sg18
Vdrug-target interaction '5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB03376_210]
p11947
sasS'S100B'
p11948
(lp11949
(dp11950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2132
p11951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00768
p11952
sg11
g11948
sg12
S'S100 calcium binding protein B'
p11953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00768_2132
p11954
sg16
VOlopatadine [drugbank:DB00768]
p11955
sg18
Vdrug-target interaction Olopatadine and Protein S100-B [drugbank_resource:DB00768_2132]
p11956
sa(dp11957
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2132
p11958
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01373
p11959
sg11
g11948
sg12
g11953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01373_2132
p11960
sg16
VCalcium [drugbank:DB01373]
p11961
sg18
Vdrug-target interaction Calcium and Protein S100-B [drugbank_resource:DB01373_2132]
p11962
sa(dp11963
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2132
p11964
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04464
p11965
sg11
g11948
sg12
g11953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04464_2132
p11966
sg16
VN-Formylmethionine [drugbank:DB04464]
p11967
sg18
Vdrug-target interaction N-Formylmethionine and Protein S100-B [drugbank_resource:DB04464_2132]
p11968
sa(dp11969
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2132
p11970
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07004
p11971
sg11
g11948
sg12
g11953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07004_2132
p11972
sg16
V2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide [drugbank:DB07004]
p11973
sg18
Vdrug-target interaction 2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide and Protein S100-B [drugbank_resource:DB07004_2132]
p11974
sa(dp11975
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2132
p11976
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06941
p11977
sg11
g11948
sg12
g11953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06941_2132
p11978
sg16
V(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide [drugbank:DB06941]
p11979
sg18
Vdrug-target interaction (Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide and Protein S100-B [drugbank_resource:DB06941_2132]
p11980
sasS'DPP4'
p11981
(lp11982
(dp11983
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p11984
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01076
p11985
sg11
g11981
sg12
S'dipeptidyl-peptidase 4'
p11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01076_952
p11987
sg16
VAtorvastatin [drugbank:DB01076]
p11988
sg18
Vdrug-target interaction Atorvastatin and Dipeptidyl peptidase 4 [drugbank_resource:DB01076_952]
p11989
sa(dp11990
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p11991
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01261
p11992
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01261_952
p11993
sg16
VSitagliptin [drugbank:DB01261]
p11994
sg18
Vdrug-target interaction Sitagliptin and Dipeptidyl peptidase 4 [drugbank_resource:DB01261_952]
p11995
sa(dp11996
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p11997
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02004
p11998
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02004_952
p11999
sg16
V5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine [drugbank:DB02004]
p12000
sg18
Vdrug-target interaction 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine and Dipeptidyl peptidase 4 [drugbank_resource:DB02004_952]
p12001
sa(dp12002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01884
p12004
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01884_952
p12005
sg16
V2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One [drugbank:DB01884]
p12006
sg18
Vdrug-target interaction 2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One and Dipeptidyl peptidase 4 [drugbank_resource:DB01884_952]
p12007
sa(dp12008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p12010
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_952
p12011
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p12012
sg18
Vdrug-target interaction Alpha-D-Mannose and Dipeptidyl peptidase 4 [drugbank_resource:DB02944_952]
p12013
sa(dp12014
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12015
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03253
p12016
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03253_952
p12017
sg16
V(2s)-Pyrrolidin-2-Ylmethylamine [drugbank:DB03253]
p12018
sg18
Vdrug-target interaction (2s)-Pyrrolidin-2-Ylmethylamine and Dipeptidyl peptidase 4 [drugbank_resource:DB03253_952]
p12019
sa(dp12020
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12021
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03660
p12022
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03660_952
p12023
sg16
VIodo-Phenylalanine [drugbank:DB03660]
p12024
sg18
Vdrug-target interaction Iodo-Phenylalanine and Dipeptidyl peptidase 4 [drugbank_resource:DB03660_952]
p12025
sa(dp12026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04876
p12028
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04876_952
p12029
sg16
VVildagliptin [drugbank:DB04876]
p12030
sg18
Vdrug-target interaction Vildagliptin and Dipeptidyl peptidase 4 [drugbank_resource:DB04876_952]
p12031
sa(dp12032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06939
p12034
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06939_952
p12035
sg16
VN-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE [drugbank:DB06939]
p12036
sg18
Vdrug-target interaction N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE and Dipeptidyl peptidase 4 [drugbank_resource:DB06939_952]
p12037
sa(dp12038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07015
p12040
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07015_952
p12041
sg16
V(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine [drugbank:DB07015]
p12042
sg18
Vdrug-target interaction (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine and Dipeptidyl peptidase 4 [drugbank_resource:DB07015_952]
p12043
sa(dp12044
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12045
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07021
p12046
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07021_952
p12047
sg16
V(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine [drugbank:DB07021]
p12048
sg18
Vdrug-target interaction (7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine and Dipeptidyl peptidase 4 [drugbank_resource:DB07021_952]
p12049
sa(dp12050
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12051
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07072
p12052
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07072_952
p12053
sg16
V(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE [drugbank:DB07072]
p12054
sg18
Vdrug-target interaction (1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB07072_952]
p12055
sa(dp12056
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12057
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07081
p12058
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07081_952
p12059
sg16
V(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE [drugbank:DB07081]
p12060
sg18
Vdrug-target interaction (2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB07081_952]
p12061
sa(dp12062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07135
p12064
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07135_952
p12065
sg16
V(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE [drugbank:DB07135]
p12066
sg18
Vdrug-target interaction (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE and Dipeptidyl peptidase 4 [drugbank_resource:DB07135_952]
p12067
sa(dp12068
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12069
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07154
p12070
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07154_952
p12071
sg16
V(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE [drugbank:DB07154]
p12072
sg18
Vdrug-target interaction (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE and Dipeptidyl peptidase 4 [drugbank_resource:DB07154_952]
p12073
sa(dp12074
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12075
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07193
p12076
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07193_952
p12077
sg16
V(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine [drugbank:DB07193]
p12078
sg18
Vdrug-target interaction (2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine and Dipeptidyl peptidase 4 [drugbank_resource:DB07193_952]
p12079
sa(dp12080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07239
p12082
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07239_952
p12083
sg16
V7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile [drugbank:DB07239]
p12084
sg18
Vdrug-target interaction 7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile and Dipeptidyl peptidase 4 [drugbank_resource:DB07239_952]
p12085
sa(dp12086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04491
p12088
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04491_952
p12089
sg16
VDiisopropylphosphono Group [drugbank:DB04491]
p12090
sg18
Vdrug-target interaction Diisopropylphosphono Group and Dipeptidyl peptidase 4 [drugbank_resource:DB04491_952]
p12091
sa(dp12092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04577
p12094
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04577_952
p12095
sg16
V1-(1-phenylcyclopentyl)methylamine [drugbank:DB04577]
p12096
sg18
Vdrug-target interaction 1-(1-phenylcyclopentyl)methylamine and Dipeptidyl peptidase 4 [drugbank_resource:DB04577_952]
p12097
sa(dp12098
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12099
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04578
p12100
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04578_952
p12101
sg16
V(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide [drugbank:DB04578]
p12102
sg18
Vdrug-target interaction (S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide and Dipeptidyl peptidase 4 [drugbank_resource:DB04578_952]
p12103
sa(dp12104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06880
p12106
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06880_952
p12107
sg16
V(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE [drugbank:DB06880]
p12108
sg18
Vdrug-target interaction (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB06880_952]
p12109
sa(dp12110
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12111
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07181
p12112
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07181_952
p12113
sg16
V4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide [drugbank:DB07181]
p12114
sg18
Vdrug-target interaction 4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide and Dipeptidyl peptidase 4 [drugbank_resource:DB07181_952]
p12115
sa(dp12116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07328
p12118
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07328_952
p12119
sg16
VMETHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE [drugbank:DB07328]
p12120
sg18
Vdrug-target interaction METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE and Dipeptidyl peptidase 4 [drugbank_resource:DB07328_952]
p12121
sa(dp12122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07356
p12124
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07356_952
p12125
sg16
V(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE [drugbank:DB07356]
p12126
sg18
Vdrug-target interaction (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB07356_952]
p12127
sa(dp12128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07412
p12130
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07412_952
p12131
sg16
V1-biphenyl-2-ylmethanamine [drugbank:DB07412]
p12132
sg18
Vdrug-target interaction 1-biphenyl-2-ylmethanamine and Dipeptidyl peptidase 4 [drugbank_resource:DB07412_952]
p12133
sa(dp12134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07465
p12136
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07465_952
p12137
sg16
V(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile [drugbank:DB07465]
p12138
sg18
Vdrug-target interaction (1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile and Dipeptidyl peptidase 4 [drugbank_resource:DB07465_952]
p12139
sa(dp12140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06335
p12142
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06335_952
p12143
sg16
VSaxagliptin [drugbank:DB06335]
p12144
sg18
Vdrug-target interaction Saxagliptin and Dipeptidyl peptidase 4 [drugbank_resource:DB06335_952]
p12145
sa(dp12146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06993
p12148
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06993_952
p12149
sg16
V(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine [drugbank:DB06993]
p12150
sg18
Vdrug-target interaction (2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine and Dipeptidyl peptidase 4 [drugbank_resource:DB06993_952]
p12151
sa(dp12152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06994
p12154
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06994_952
p12155
sg16
V(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine [drugbank:DB06994]
p12156
sg18
Vdrug-target interaction (2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine and Dipeptidyl peptidase 4 [drugbank_resource:DB06994_952]
p12157
sa(dp12158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07067
p12160
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07067_952
p12161
sg16
V(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE [drugbank:DB07067]
p12162
sg18
Vdrug-target interaction (2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB07067_952]
p12163
sa(dp12164
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12165
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07092
p12166
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07092_952
p12167
sg16
V(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE [drugbank:DB07092]
p12168
sg18
Vdrug-target interaction (2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE and Dipeptidyl peptidase 4 [drugbank_resource:DB07092_952]
p12169
sa(dp12170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07271
p12172
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07271_952
p12173
sg16
V(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE [drugbank:DB07271]
p12174
sg18
Vdrug-target interaction (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE and Dipeptidyl peptidase 4 [drugbank_resource:DB07271_952]
p12175
sa(dp12176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07482
p12178
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07482_952
p12179
sg16
V(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE [drugbank:DB07482]
p12180
sg18
Vdrug-target interaction (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE and Dipeptidyl peptidase 4 [drugbank_resource:DB07482_952]
p12181
sa(dp12182
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12183
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07666
p12184
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07666_952
p12185
sg16
V(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE [drugbank:DB07666]
p12186
sg18
Vdrug-target interaction (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB07666_952]
p12187
sa(dp12188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08024
p12190
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08024_952
p12191
sg16
V1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE [drugbank:DB08024]
p12192
sg18
Vdrug-target interaction 1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE and Dipeptidyl peptidase 4 [drugbank_resource:DB08024_952]
p12193
sa(dp12194
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12195
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08044
p12196
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08044_952
p12197
sg16
V(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE [drugbank:DB08044]
p12198
sg18
Vdrug-target interaction (1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB08044_952]
p12199
sa(dp12200
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12201
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08164
p12202
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08164_952
p12203
sg16
V(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE [drugbank:DB08164]
p12204
sg18
Vdrug-target interaction (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB08164_952]
p12205
sa(dp12206
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12207
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08445
p12208
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08445_952
p12209
sg16
V(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE [drugbank:DB08445]
p12210
sg18
Vdrug-target interaction (3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB08445_952]
p12211
sa(dp12212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08504
p12214
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08504_952
p12215
sg16
V6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM [drugbank:DB08504]
p12216
sg18
Vdrug-target interaction 6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM and Dipeptidyl peptidase 4 [drugbank_resource:DB08504_952]
p12217
sa(dp12218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08672
p12220
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08672_952
p12221
sg16
V4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE [drugbank:DB08672]
p12222
sg18
Vdrug-target interaction 4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE and Dipeptidyl peptidase 4 [drugbank_resource:DB08672_952]
p12223
sa(dp12224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07830
p12226
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07830_952
p12227
sg16
V(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE [drugbank:DB07830]
p12228
sg18
Vdrug-target interaction (4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE and Dipeptidyl peptidase 4 [drugbank_resource:DB07830_952]
p12229
sa(dp12230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07851
p12232
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07851_952
p12233
sg16
V(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE [drugbank:DB07851]
p12234
sg18
Vdrug-target interaction (3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB07851_952]
p12235
sa(dp12236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08530
p12238
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08530_952
p12239
sg16
V7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE [drugbank:DB08530]
p12240
sg18
Vdrug-target interaction 7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE and Dipeptidyl peptidase 4 [drugbank_resource:DB08530_952]
p12241
sa(dp12242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08588
p12244
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08588_952
p12245
sg16
V2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE [drugbank:DB08588]
p12246
sg18
Vdrug-target interaction 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE and Dipeptidyl peptidase 4 [drugbank_resource:DB08588_952]
p12247
sa(dp12248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07779
p12250
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07779_952
p12251
sg16
VN-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE [drugbank:DB07779]
p12252
sg18
Vdrug-target interaction N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE and Dipeptidyl peptidase 4 [drugbank_resource:DB07779_952]
p12253
sa(dp12254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08051
p12256
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08051_952
p12257
sg16
V(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE [drugbank:DB08051]
p12258
sg18
Vdrug-target interaction (2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE and Dipeptidyl peptidase 4 [drugbank_resource:DB08051_952]
p12259
sa(dp12260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08382
p12262
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08382_952
p12263
sg16
V2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine [drugbank:DB08382]
p12264
sg18
Vdrug-target interaction 2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine and Dipeptidyl peptidase 4 [drugbank_resource:DB08382_952]
p12265
sa(dp12266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08429
p12268
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08429_952
p12269
sg16
VN-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide [drugbank:DB08429]
p12270
sg18
Vdrug-target interaction N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide and Dipeptidyl peptidase 4 [drugbank_resource:DB08429_952]
p12271
sa(dp12272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:952
p12273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08743
p12274
sg11
g11981
sg12
g11986
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08743_952
p12275
sg16
V2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE [drugbank:DB08743]
p12276
sg18
Vdrug-target interaction 2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE and Dipeptidyl peptidase 4 [drugbank_resource:DB08743_952]
p12277
sasS'DAPK1'
p12278
(lp12279
(dp12280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3231
p12281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04069
p12282
sg11
g12278
sg12
S'death-associated protein kinase 1'
p12283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04069_3231
p12284
sg16
V5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine [drugbank:DB04069]
p12285
sg18
Vdrug-target interaction 5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine and Death-associated protein kinase 1 [drugbank_resource:DB04069_3231]
p12286
sa(dp12287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3231
p12288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p12289
sg11
g12278
sg12
g12283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_3231
p12290
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p12291
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Death-associated protein kinase 1 [drugbank_resource:DB04395_3231]
p12292
sa(dp12293
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3231
p12294
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07444
p12295
sg11
g12278
sg12
g12283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07444_3231
p12296
sg16
V6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE [drugbank:DB07444]
p12297
sg18
Vdrug-target interaction 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE and Death-associated protein kinase 1 [drugbank_resource:DB07444_3231]
p12298
sasS'HSD11B1'
p12299
(lp12300
(dp12301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p12303
sg11
g12299
sg12
S'hydroxysteroid (11-beta) dehydrogenase 1'
p12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_364
p12305
sg16
VNADH [drugbank:DB00157]
p12306
sg18
Vdrug-target interaction NADH and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB00157_364]
p12307
sa(dp12308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02329
p12310
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02329_364
p12311
sg16
VCarbenoxolone [drugbank:DB02329]
p12312
sg18
Vdrug-target interaction Carbenoxolone and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB02329_364]
p12313
sa(dp12314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03461
p12316
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03461_364
p12317
sg16
V2'-Monophosphoadenosine 5'-Diphosphoribose [drugbank:DB03461]
p12318
sg18
Vdrug-target interaction 2'-Monophosphoadenosine 5'-Diphosphoribose and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB03461_364]
p12319
sa(dp12320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03814
p12322
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03814_364
p12323
sg16
V2-(N-Morpholino)-Ethanesulfonic Acid [drugbank:DB03814]
p12324
sg18
Vdrug-target interaction 2-(N-Morpholino)-Ethanesulfonic Acid and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB03814_364]
p12325
sa(dp12326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07017
p12328
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07017_364
p12329
sg16
V(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one [drugbank:DB07017]
p12330
sg18
Vdrug-target interaction (5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07017_364]
p12331
sa(dp12332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04652
p12334
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04652_364
p12335
sg16
V(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE [drugbank:DB04652]
p12336
sg18
Vdrug-target interaction (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB04652_364]
p12337
sa(dp12338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06992
p12340
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06992_364
p12341
sg16
V(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone [drugbank:DB06992]
p12342
sg18
Vdrug-target interaction (3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB06992_364]
p12343
sa(dp12344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07049
p12346
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07049_364
p12347
sg16
V(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine [drugbank:DB07049]
p12348
sg18
Vdrug-target interaction (2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07049_364]
p12349
sa(dp12350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07056
p12352
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07056_364
p12353
sg16
V2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide [drugbank:DB07056]
p12354
sg18
Vdrug-target interaction 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07056_364]
p12355
sa(dp12356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07310
p12358
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07310_364
p12359
sg16
V(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one [drugbank:DB07310]
p12360
sg18
Vdrug-target interaction (5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07310_364]
p12361
sa(dp12362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07316
p12364
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07316_364
p12365
sg16
VN-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide [drugbank:DB07316]
p12366
sg18
Vdrug-target interaction N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07316_364]
p12367
sa(dp12368
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12369
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07619
p12370
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07619_364
p12371
sg16
VN-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide [drugbank:DB07619]
p12372
sg18
Vdrug-target interaction N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07619_364]
p12373
sa(dp12374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07624
p12376
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07624_364
p12377
sg16
V1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide [drugbank:DB07624]
p12378
sg18
Vdrug-target interaction 1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07624_364]
p12379
sa(dp12380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08280
p12382
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08280_364
p12383
sg16
V(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE [drugbank:DB08280]
p12384
sg18
Vdrug-target interaction (1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB08280_364]
p12385
sa(dp12386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07866
p12388
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07866_364
p12389
sg16
V(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one [drugbank:DB07866]
p12390
sg18
Vdrug-target interaction (5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB07866_364]
p12391
sa(dp12392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08277
p12394
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08277_364
p12395
sg16
V2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE [drugbank:DB08277]
p12396
sg18
Vdrug-target interaction 2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB08277_364]
p12397
sa(dp12398
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:364
p12399
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08771
p12400
sg11
g12299
sg12
g12304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08771_364
p12401
sg16
V(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one [drugbank:DB08771]
p12402
sg18
Vdrug-target interaction (5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one and Corticosteroid 11-beta-dehydrogenase isozyme 1 [drugbank_resource:DB08771_364]
p12403
sasS'CPT1A'
p12404
(lp12405
(dp12406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:451
p12407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00583
p12408
sg11
g12404
sg12
S'carnitine palmitoyltransferase 1A (liver)'
p12409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00583_451
p12410
sg16
VL-Carnitine [drugbank:DB00583]
p12411
sg18
Vdrug-target interaction L-Carnitine and Carnitine O-palmitoyltransferase I, liver isoform [drugbank_resource:DB00583_451]
p12412
sa(dp12413
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:451
p12414
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01074
p12415
sg11
g12404
sg12
g12409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01074_451
p12416
sg16
VPerhexiline [drugbank:DB01074]
p12417
sg18
Vdrug-target interaction Perhexiline and Carnitine O-palmitoyltransferase I, liver isoform [drugbank_resource:DB01074_451]
p12418
sasS'ANXA3'
p12419
(lp12420
(dp12421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5483
p12422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03994
p12423
sg11
g12419
sg12
S'annexin A3'
p12424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03994_5483
p12425
sg16
VEthanolamine [drugbank:DB03994]
p12426
sg18
Vdrug-target interaction Ethanolamine and Annexin A3 [drugbank_resource:DB03994_5483]
p12427
sasS'ITGB2'
p12428
(lp12429
(dp12430
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1630
p12431
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00641
p12432
sg11
g12428
sg12
S'integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)'
p12433
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00641_1630
p12434
sg16
VSimvastatin [drugbank:DB00641]
p12435
sg18
Vdrug-target interaction Simvastatin and Integrin beta-2 [drugbank_resource:DB00641_1630]
p12436
sasS'RAC1'
p12437
(lp12438
(dp12439
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1882
p12440
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p12441
sg11
g12437
sg12
S'ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)'
p12442
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_1882
p12443
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p12444
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Ras-related C3 botulinum toxin substrate 1 [drugbank_resource:DB04315_1882]
p12445
sasS'PRKCB'
p12446
(lp12447
(dp12448
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:997
p12449
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00163
p12450
sg11
g12446
sg12
S'protein kinase C, beta'
p12451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00163_997
p12452
sg16
VVitamin E [drugbank:DB00163]
p12453
sg18
Vdrug-target interaction Vitamin E and Protein kinase C beta type [drugbank_resource:DB00163_997]
p12454
sa(dp12455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:997
p12456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01738
p12457
sg11
g12446
sg12
g12451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01738_997
p12458
sg16
VO-Phosphoethanolamine [drugbank:DB01738]
p12459
sg18
Vdrug-target interaction O-Phosphoethanolamine and Protein kinase C beta type [drugbank_resource:DB01738_997]
p12460
sasS'HGS'
p12461
(lp12462
(dp12463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7135
p12464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04272
p12465
sg11
g12461
sg12
S'hepatocyte growth factor-regulated tyrosine kinase substrate'
p12466
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04272_7135
p12467
sg16
VCitric Acid [drugbank:DB04272]
p12468
sg18
Vdrug-target interaction Citric Acid and Hepatocyte growth factor-regulated tyrosine kinase substrate [drugbank_resource:DB04272_7135]
p12469
sasS'PTGIS'
p12470
(lp12471
(dp12472
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:130
p12473
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00812
p12474
sg11
g12470
sg12
S'prostaglandin I2 (prostacyclin) synthase'
p12475
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00812_130
p12476
sg16
VPhenylbutazone [drugbank:DB00812]
p12477
sg18
Vdrug-target interaction Phenylbutazone and Prostacyclin synthase [drugbank_resource:DB00812_130]
p12478
sa(dp12479
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:130
p12480
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01240
p12481
sg11
g12470
sg12
g12475
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01240_130
p12482
sg16
VEpoprostenol [drugbank:DB01240]
p12483
sg18
Vdrug-target interaction Epoprostenol and Prostacyclin synthase [drugbank_resource:DB01240_130]
p12484
sa(dp12485
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:130
p12486
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08675
p12487
sg11
g12470
sg12
g12475
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08675_130
p12488
sg16
V(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID [drugbank:DB08675]
p12489
sg18
Vdrug-target interaction (6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID and Prostacyclin synthase [drugbank_resource:DB08675_130]
p12490
sasS'PLAT'
p12491
(lp12492
(dp12493
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p12494
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p12495
sg11
g12491
sg12
S'plasminogen activator, tissue'
p12496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1792
p12497
sg16
VUrokinase [drugbank:DB00013]
p12498
sg18
Vdrug-target interaction Urokinase and Tissue-type plasminogen activator [drugbank_resource:DB00013_1792]
p12499
sa(dp12500
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p12501
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00513
p12502
sg11
g12491
sg12
g12496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00513_1792
p12503
sg16
VAminocaproic Acid [drugbank:DB00513]
p12504
sg18
Vdrug-target interaction Aminocaproic Acid and Tissue-type plasminogen activator [drugbank_resource:DB00513_1792]
p12505
sa(dp12506
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p12507
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01088
p12508
sg11
g12491
sg12
g12496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01088_1792
p12509
sg16
VIloprost [drugbank:DB01088]
p12510
sg18
Vdrug-target interaction Iloprost and Tissue-type plasminogen activator [drugbank_resource:DB01088_1792]
p12511
sa(dp12512
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p12513
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04134
p12514
sg11
g12491
sg12
g12496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04134_1792
p12515
sg16
V6-Amino Hexanoic Acid [drugbank:DB04134]
p12516
sg18
Vdrug-target interaction 6-Amino Hexanoic Acid and Tissue-type plasminogen activator [drugbank_resource:DB04134_1792]
p12517
sa(dp12518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p12519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07684
p12520
sg11
g12491
sg12
g12496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07684_1792
p12521
sg16
V5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID [drugbank:DB07684]
p12522
sg18
Vdrug-target interaction 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID and Tissue-type plasminogen activator [drugbank_resource:DB07684_1792]
p12523
sasS'JUN'
p12524
(lp12525
(dp12526
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1629
p12527
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00570
p12528
sg11
g12524
sg12
S'jun proto-oncogene'
p12529
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00570_1629
p12530
sg16
VVinblastine [drugbank:DB00570]
p12531
sg18
Vdrug-target interaction Vinblastine and Transcription factor AP-1 [drugbank_resource:DB00570_1629]
p12532
sa(dp12533
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1629
p12534
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01029
p12535
sg11
g12524
sg12
g12529
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01029_1629
p12536
sg16
VIrbesartan [drugbank:DB01029]
p12537
sg18
Vdrug-target interaction Irbesartan and Transcription factor AP-1 [drugbank_resource:DB01029_1629]
p12538
sa(dp12539
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1629
p12540
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p12541
sg11
g12524
sg12
g12529
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1629
p12542
sg16
VArsenic trioxide [drugbank:DB01169]
p12543
sg18
Vdrug-target interaction Arsenic trioxide and Transcription factor AP-1 [drugbank_resource:DB01169_1629]
p12544
sasS'PADI4'
p12545
(lp12546
(dp12547
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1814
p12548
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00155
p12549
sg11
g12545
sg12
S'peptidyl arginine deiminase, type IV'
p12550
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00155_1814
p12551
sg16
VL-Citrulline [drugbank:DB00155]
p12552
sg18
Vdrug-target interaction L-Citrulline and Protein-arginine deiminase type-4 [drugbank_resource:DB00155_1814]
p12553
sa(dp12554
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1814
p12555
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07449
p12556
sg11
g12545
sg12
g12550
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07449_1814
p12557
sg16
VN-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE [drugbank:DB07449]
p12558
sg18
Vdrug-target interaction N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE and Protein-arginine deiminase type-4 [drugbank_resource:DB07449_1814]
p12559
sasS'PRKCQ'
p12560
(lp12561
(dp12562
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2530
p12563
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p12564
sg11
g12560
sg12
S'protein kinase C, theta'
p12565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2530
p12566
sg16
VStaurosporine [drugbank:DB02010]
p12567
sg18
Vdrug-target interaction Staurosporine and Protein kinase C theta type [drugbank_resource:DB02010_2530]
p12568
sa(dp12569
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2530
p12570
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p12571
sg11
g12560
sg12
g12565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_2530
p12572
sg16
VPhosphonothreonine [drugbank:DB02482]
p12573
sg18
Vdrug-target interaction Phosphonothreonine and Protein kinase C theta type [drugbank_resource:DB02482_2530]
p12574
sa(dp12575
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2530
p12576
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p12577
sg11
g12560
sg12
g12565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_2530
p12578
sg16
VPhosphonoserine [drugbank:DB04522]
p12579
sg18
Vdrug-target interaction Phosphonoserine and Protein kinase C theta type [drugbank_resource:DB04522_2530]
p12580
sasS'ADRA2C'
p12581
(lp12582
(dp12583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00217
p12585
sg11
g12581
sg12
S'adrenoceptor alpha 2C'
p12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00217_378
p12587
sg16
VBethanidine [drugbank:DB00217]
p12588
sg18
Vdrug-target interaction Bethanidine and Alpha-2C adrenergic receptor [drugbank_resource:DB00217_378]
p12589
sa(dp12590
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12591
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00248
p12592
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00248_378
p12593
sg16
VCabergoline [drugbank:DB00248]
p12594
sg18
Vdrug-target interaction Cabergoline and Alpha-2C adrenergic receptor [drugbank_resource:DB00248_378]
p12595
sa(dp12596
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12597
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00268
p12598
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00268_378
p12599
sg16
VRopinirole [drugbank:DB00268]
p12600
sg18
Vdrug-target interaction Ropinirole and Alpha-2C adrenergic receptor [drugbank_resource:DB00268_378]
p12601
sa(dp12602
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12603
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p12604
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_378
p12605
sg16
VZiprasidone [drugbank:DB00246]
p12606
sg18
Vdrug-target interaction Ziprasidone and Alpha-2C adrenergic receptor [drugbank_resource:DB00246_378]
p12607
sa(dp12608
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12609
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00363
p12610
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00363_378
p12611
sg16
VClozapine [drugbank:DB00363]
p12612
sg18
Vdrug-target interaction Clozapine and Alpha-2C adrenergic receptor [drugbank_resource:DB00363_378]
p12613
sa(dp12614
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12615
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00413
p12616
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00413_378
p12617
sg16
VPramipexole [drugbank:DB00413]
p12618
sg18
Vdrug-target interaction Pramipexole and Alpha-2C adrenergic receptor [drugbank_resource:DB00413_378]
p12619
sa(dp12620
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12621
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p12622
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_378
p12623
sg16
VOlanzapine [drugbank:DB00334]
p12624
sg18
Vdrug-target interaction Olanzapine and Alpha-2C adrenergic receptor [drugbank_resource:DB00334_378]
p12625
sa(dp12626
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12627
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00368
p12628
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00368_378
p12629
sg16
VNorepinephrine [drugbank:DB00368]
p12630
sg18
Vdrug-target interaction Norepinephrine and Alpha-2C adrenergic receptor [drugbank_resource:DB00368_378]
p12631
sa(dp12632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00589
p12634
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00589_378
p12635
sg16
VLisuride [drugbank:DB00589]
p12636
sg18
Vdrug-target interaction Lisuride and Alpha-2C adrenergic receptor [drugbank_resource:DB00589_378]
p12637
sa(dp12638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00484
p12640
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00484_378
p12641
sg16
VBrimonidine [drugbank:DB00484]
p12642
sg18
Vdrug-target interaction Brimonidine and Alpha-2C adrenergic receptor [drugbank_resource:DB00484_378]
p12643
sa(dp12644
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12645
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00575
p12646
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00575_378
p12647
sg16
VClonidine [drugbank:DB00575]
p12648
sg18
Vdrug-target interaction Clonidine and Alpha-2C adrenergic receptor [drugbank_resource:DB00575_378]
p12649
sa(dp12650
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12651
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00697
p12652
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00697_378
p12653
sg16
VTizanidine [drugbank:DB00697]
p12654
sg18
Vdrug-target interaction Tizanidine and Alpha-2C adrenergic receptor [drugbank_resource:DB00697_378]
p12655
sa(dp12656
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12657
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00714
p12658
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00714_378
p12659
sg16
VApomorphine [drugbank:DB00714]
p12660
sg18
Vdrug-target interaction Apomorphine and Alpha-2C adrenergic receptor [drugbank_resource:DB00714_378]
p12661
sa(dp12662
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12663
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00925
p12664
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00925_378
p12665
sg16
VPhenoxybenzamine [drugbank:DB00925]
p12666
sg18
Vdrug-target interaction Phenoxybenzamine and Alpha-2C adrenergic receptor [drugbank_resource:DB00925_378]
p12667
sa(dp12668
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12669
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00734
p12670
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00734_378
p12671
sg16
VRisperidone [drugbank:DB00734]
p12672
sg18
Vdrug-target interaction Risperidone and Alpha-2C adrenergic receptor [drugbank_resource:DB00734_378]
p12673
sa(dp12674
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12675
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00800
p12676
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00800_378
p12677
sg16
VFenoldopam [drugbank:DB00800]
p12678
sg18
Vdrug-target interaction Fenoldopam and Alpha-2C adrenergic receptor [drugbank_resource:DB00800_378]
p12679
sa(dp12680
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12681
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01142
p12682
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01142_378
p12683
sg16
VDoxepin [drugbank:DB01142]
p12684
sg18
Vdrug-target interaction Doxepin and Alpha-2C adrenergic receptor [drugbank_resource:DB01142_378]
p12685
sa(dp12686
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12687
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01200
p12688
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01200_378
p12689
sg16
VBromocriptine [drugbank:DB01200]
p12690
sg18
Vdrug-target interaction Bromocriptine and Alpha-2C adrenergic receptor [drugbank_resource:DB01200_378]
p12691
sa(dp12692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01267
p12694
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01267_378
p12695
sg16
VPaliperidone [drugbank:DB01267]
p12696
sg18
Vdrug-target interaction Paliperidone and Alpha-2C adrenergic receptor [drugbank_resource:DB01267_378]
p12697
sa(dp12698
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12699
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p12700
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_378
p12701
sg16
VQuetiapine [drugbank:DB01224]
p12702
sg18
Vdrug-target interaction Quetiapine and Alpha-2C adrenergic receptor [drugbank_resource:DB01224_378]
p12703
sa(dp12704
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12705
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01403
p12706
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01403_378
p12707
sg16
VMethotrimeprazine [drugbank:DB01403]
p12708
sg18
Vdrug-target interaction Methotrimeprazine and Alpha-2C adrenergic receptor [drugbank_resource:DB01403_378]
p12709
sa(dp12710
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12711
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01186
p12712
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01186_378
p12713
sg16
VPergolide [drugbank:DB01186]
p12714
sg18
Vdrug-target interaction Pergolide and Alpha-2C adrenergic receptor [drugbank_resource:DB01186_378]
p12715
sa(dp12716
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12717
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p12718
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_378
p12719
sg16
VAripiprazole [drugbank:DB01238]
p12720
sg18
Vdrug-target interaction Aripiprazole and Alpha-2C adrenergic receptor [drugbank_resource:DB01238_378]
p12721
sa(dp12722
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12723
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01363
p12724
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01363_378
p12725
sg16
VEphedra [drugbank:DB01363]
p12726
sg18
Vdrug-target interaction Ephedra and Alpha-2C adrenergic receptor [drugbank_resource:DB01363_378]
p12727
sa(dp12728
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12729
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01392
p12730
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01392_378
p12731
sg16
VYohimbine [drugbank:DB01392]
p12732
sg18
Vdrug-target interaction Yohimbine and Alpha-2C adrenergic receptor [drugbank_resource:DB01392_378]
p12733
sa(dp12734
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12735
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01577
p12736
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01577_378
p12737
sg16
VMethamphetamine [drugbank:DB01577]
p12738
sg18
Vdrug-target interaction Methamphetamine and Alpha-2C adrenergic receptor [drugbank_resource:DB01577_378]
p12739
sa(dp12740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06694
p12742
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06694_378
p12743
sg16
VXylometazoline [drugbank:DB06694]
p12744
sg18
Vdrug-target interaction Xylometazoline and Alpha-2C adrenergic receptor [drugbank_resource:DB06694_378]
p12745
sa(dp12746
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:378
p12747
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06262
p12748
sg11
g12581
sg12
g12586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06262_378
p12749
sg16
VDroxidopa [drugbank:DB06262]
p12750
sg18
Vdrug-target interaction Droxidopa and Alpha-2C adrenergic receptor [drugbank_resource:DB06262_378]
p12751
sasS'PLA2G4A'
p12752
(lp12753
(dp12754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:723
p12755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00588
p12756
sg11
g12752
sg12
S'phospholipase A2, group IVA (cytosolic, calcium-dependent)'
p12757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00588_723
p12758
sg16
VFluticasone Propionate [drugbank:DB00588]
p12759
sg18
Vdrug-target interaction Fluticasone Propionate and Cytosolic phospholipase A2 [drugbank_resource:DB00588_723]
p12760
sa(dp12761
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:723
p12762
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01103
p12763
sg11
g12752
sg12
g12757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01103_723
p12764
sg16
VQuinacrine [drugbank:DB01103]
p12765
sg18
Vdrug-target interaction Quinacrine and Cytosolic phospholipase A2 [drugbank_resource:DB01103_723]
p12766
sa(dp12767
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:723
p12768
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04552
p12769
sg11
g12752
sg12
g12757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04552_723
p12770
sg16
VNiflumic Acid [drugbank:DB04552]
p12771
sg18
Vdrug-target interaction Niflumic Acid and Cytosolic phospholipase A2 [drugbank_resource:DB04552_723]
p12772
sasS'CTSG'
p12773
(lp12774
(dp12775
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1514
p12776
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02360
p12777
sg11
g12773
sg12
S'cathepsin G'
p12778
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02360_1514
p12779
sg16
VBis-Napthyl Beta-Ketophosphonic Acid [drugbank:DB02360]
p12780
sg18
Vdrug-target interaction Bis-Napthyl Beta-Ketophosphonic Acid and Cathepsin G [drugbank_resource:DB02360_1514]
p12781
sa(dp12782
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1514
p12783
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04016
p12784
sg11
g12773
sg12
g12778
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04016_1514
p12785
sg16
V2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid [drugbank:DB04016]
p12786
sg18
Vdrug-target interaction 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid and Cathepsin G [drugbank_resource:DB04016_1514]
p12787
sasS'PTPRS'
p12788
(lp12789
(dp12790
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6055
p12791
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00630
p12792
sg11
g12788
sg12
S'protein tyrosine phosphatase, receptor type, S'
p12793
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00630_6055
p12794
sg16
VAlendronate [drugbank:DB00630]
p12795
sg18
Vdrug-target interaction Alendronate and Receptor-type tyrosine-protein phosphatase S [drugbank_resource:DB00630_6055]
p12796
sa(dp12797
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6055
p12798
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01077
p12799
sg11
g12788
sg12
g12793
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01077_6055
p12800
sg16
VEtidronic acid [drugbank:DB01077]
p12801
sg18
Vdrug-target interaction Etidronic acid and Receptor-type tyrosine-protein phosphatase S [drugbank_resource:DB01077_6055]
p12802
sasS'PPP1CA'
p12803
(lp12804
(dp12805
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6312
p12806
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02506
p12807
sg11
g12803
sg12
S'protein phosphatase 1, catalytic subunit, alpha isozyme'
p12808
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02506_6312
p12809
sg16
V2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid [drugbank:DB02506]
p12810
sg18
Vdrug-target interaction 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid and Serine/threonine-protein phosphatase PP1-alpha catalytic subunit [drugbank_resource:DB02506_6312]
p12811
sasS'GLRA3'
p12812
(lp12813
(dp12814
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:461
p12815
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00145
p12816
sg11
g12812
sg12
S'glycine receptor, alpha 3'
p12817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00145_461
p12818
sg16
VGlycine [drugbank:DB00145]
p12819
sg18
Vdrug-target interaction Glycine and Glycine receptor subunit alpha-3 [drugbank_resource:DB00145_461]
p12820
sa(dp12821
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:461
p12822
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00466
p12823
sg11
g12812
sg12
g12817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00466_461
p12824
sg16
VPicrotoxin [drugbank:DB00466]
p12825
sg18
Vdrug-target interaction Picrotoxin and Glycine receptor subunit alpha-3 [drugbank_resource:DB00466_461]
p12826
sa(dp12827
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:461
p12828
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00431
p12829
sg11
g12812
sg12
g12817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00431_461
p12830
sg16
VLindane [drugbank:DB00431]
p12831
sg18
Vdrug-target interaction Lindane and Glycine receptor subunit alpha-3 [drugbank_resource:DB00431_461]
p12832
sa(dp12833
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:461
p12834
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00602
p12835
sg11
g12812
sg12
g12817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00602_461
p12836
sg16
VIvermectin [drugbank:DB00602]
p12837
sg18
Vdrug-target interaction Ivermectin and Glycine receptor subunit alpha-3 [drugbank_resource:DB00602_461]
p12838
sasS'CFD'
p12839
(lp12840
(dp12841
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3346
p12842
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03058
p12843
sg11
g12839
sg12
S'complement factor D (adipsin)'
p12844
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03058_3346
p12845
sg16
VIsatoic Anhydride [drugbank:DB03058]
p12846
sg18
Vdrug-target interaction Isatoic Anhydride and Complement factor D [drugbank_resource:DB03058_3346]
p12847
sa(dp12848
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3346
p12849
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04459
p12850
sg11
g12839
sg12
g12844
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04459_3346
p12851
sg16
V3,4-Dichloroisocoumarin [drugbank:DB04459]
p12852
sg18
Vdrug-target interaction 3,4-Dichloroisocoumarin and Complement factor D [drugbank_resource:DB04459_3346]
p12853
sasS'PTPN11'
p12854
(lp12855
(dp12856
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1737
p12857
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02779
p12858
sg11
g12854
sg12
S'protein tyrosine phosphatase, non-receptor type 11'
p12859
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02779_1737
p12860
sg16
VDodecane-Trimethylamine [drugbank:DB02779]
p12861
sg18
Vdrug-target interaction Dodecane-Trimethylamine and Tyrosine-protein phosphatase non-receptor type 11 [drugbank_resource:DB02779_1737]
p12862
sasS'CFB'
p12863
(lp12864
(dp12865
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3095
p12866
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02459
p12867
sg11
g12863
sg12
S'complement factor B'
p12868
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02459_3095
p12869
sg16
V4-Guanidinobenzoic Acid [drugbank:DB02459]
p12870
sg18
Vdrug-target interaction 4-Guanidinobenzoic Acid and Complement factor B [drugbank_resource:DB02459_3095]
p12871
sa(dp12872
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3095
p12873
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04491
p12874
sg11
g12863
sg12
g12868
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04491_3095
p12875
sg16
VDiisopropylphosphono Group [drugbank:DB04491]
p12876
sg18
Vdrug-target interaction Diisopropylphosphono Group and Complement factor B [drugbank_resource:DB04491_3095]
p12877
sasS'NRIP1'
p12878
(lp12879
(dp12880
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6243
p12881
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06884
p12882
sg11
g12878
sg12
S'nuclear receptor interacting protein 1'
p12883
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06884_6243
p12884
sg16
V4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE [drugbank:DB06884]
p12885
sg18
Vdrug-target interaction 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE and Nuclear receptor-interacting protein 1 [drugbank_resource:DB06884_6243]
p12886
sasS'CA4'
p12887
(lp12888
(dp12889
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12890
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00232
p12891
sg11
g12887
sg12
S'carbonic anhydrase IV'
p12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00232_592
p12893
sg16
VMethyclothiazide [drugbank:DB00232]
p12894
sg18
Vdrug-target interaction Methyclothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00232_592]
p12895
sa(dp12896
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12897
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00273
p12898
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00273_592
p12899
sg16
VTopiramate [drugbank:DB00273]
p12900
sg18
Vdrug-target interaction Topiramate and Carbonic anhydrase 4 [drugbank_resource:DB00273_592]
p12901
sa(dp12902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00436
p12904
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00436_592
p12905
sg16
VBendroflumethiazide [drugbank:DB00436]
p12906
sg18
Vdrug-target interaction Bendroflumethiazide and Carbonic anhydrase 4 [drugbank_resource:DB00436_592]
p12907
sa(dp12908
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12909
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00606
p12910
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00606_592
p12911
sg16
VCyclothiazide [drugbank:DB00606]
p12912
sg18
Vdrug-target interaction Cyclothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00606_592]
p12913
sa(dp12914
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12915
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00311
p12916
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00311_592
p12917
sg16
VEthoxzolamide [drugbank:DB00311]
p12918
sg18
Vdrug-target interaction Ethoxzolamide and Carbonic anhydrase 4 [drugbank_resource:DB00311_592]
p12919
sa(dp12920
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12921
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00562
p12922
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00562_592
p12923
sg16
VBenzthiazide [drugbank:DB00562]
p12924
sg18
Vdrug-target interaction Benzthiazide and Carbonic anhydrase 4 [drugbank_resource:DB00562_592]
p12925
sa(dp12926
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12927
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00703
p12928
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00703_592
p12929
sg16
VMethazolamide [drugbank:DB00703]
p12930
sg18
Vdrug-target interaction Methazolamide and Carbonic anhydrase 4 [drugbank_resource:DB00703_592]
p12931
sa(dp12932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00819
p12934
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00819_592
p12935
sg16
VAcetazolamide [drugbank:DB00819]
p12936
sg18
Vdrug-target interaction Acetazolamide and Carbonic anhydrase 4 [drugbank_resource:DB00819_592]
p12937
sa(dp12938
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12939
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00880
p12940
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00880_592
p12941
sg16
VChlorothiazide [drugbank:DB00880]
p12942
sg18
Vdrug-target interaction Chlorothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00880_592]
p12943
sa(dp12944
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12945
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p12946
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_592
p12947
sg16
VZonisamide [drugbank:DB00909]
p12948
sg18
Vdrug-target interaction Zonisamide and Carbonic anhydrase 4 [drugbank_resource:DB00909_592]
p12949
sa(dp12950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00999
p12952
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00999_592
p12953
sg16
VHydrochlorothiazide [drugbank:DB00999]
p12954
sg18
Vdrug-target interaction Hydrochlorothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00999_592]
p12955
sa(dp12956
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12957
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00869
p12958
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00869_592
p12959
sg16
VDorzolamide [drugbank:DB00869]
p12960
sg18
Vdrug-target interaction Dorzolamide and Carbonic anhydrase 4 [drugbank_resource:DB00869_592]
p12961
sa(dp12962
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12963
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00774
p12964
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00774_592
p12965
sg16
VHydroflumethiazide [drugbank:DB00774]
p12966
sg18
Vdrug-target interaction Hydroflumethiazide and Carbonic anhydrase 4 [drugbank_resource:DB00774_592]
p12967
sa(dp12968
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12969
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01021
p12970
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01021_592
p12971
sg16
VTrichlormethiazide [drugbank:DB01021]
p12972
sg18
Vdrug-target interaction Trichlormethiazide and Carbonic anhydrase 4 [drugbank_resource:DB01021_592]
p12973
sa(dp12974
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12975
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01144
p12976
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01144_592
p12977
sg16
VDichlorphenamide [drugbank:DB01144]
p12978
sg18
Vdrug-target interaction Dichlorphenamide and Carbonic anhydrase 4 [drugbank_resource:DB01144_592]
p12979
sa(dp12980
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12981
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01194
p12982
sg11
g12887
sg12
g12892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01194_592
p12983
sg16
VBrinzolamide [drugbank:DB01194]
p12984
sg18
Vdrug-target interaction Brinzolamide and Carbonic anhydrase 4 [drugbank_resource:DB01194_592]
p12985
sasS'GRIN2B'
p12986
(lp12987
(dp12988
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p12989
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p12990
sg11
g12986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p12991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_464
p12992
sg16
VL-Glutamic Acid [drugbank:DB00142]
p12993
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00142_464]
p12994
sa(dp12995
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p12996
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00454
p12997
sg11
g12986
sg12
g12991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00454_464
p12998
sg16
VMeperidine [drugbank:DB00454]
p12999
sg18
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00454_464]
p13000
sa(dp13001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p13002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00502
p13003
sg11
g12986
sg12
g12991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00502_464
p13004
sg16
VHaloperidol [drugbank:DB00502]
p13005
sg18
Vdrug-target interaction Haloperidol and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00502_464]
p13006
sa(dp13007
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p13008
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00949
p13009
sg11
g12986
sg12
g12991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00949_464
p13010
sg16
VFelbamate [drugbank:DB00949]
p13011
sg18
Vdrug-target interaction Felbamate and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00949_464]
p13012
sa(dp13013
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p13014
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01043
p13015
sg11
g12986
sg12
g12991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01043_464
p13016
sg16
VMemantine [drugbank:DB01043]
p13017
sg18
Vdrug-target interaction Memantine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB01043_464]
p13018
sa(dp13019
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p13020
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01520
p13021
sg11
g12986
sg12
g12991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01520_464
p13022
sg16
VTenocyclidine [drugbank:DB01520]
p13023
sg18
Vdrug-target interaction Tenocyclidine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB01520_464]
p13024
sasS'TYMS'
p13025
(lp13026
(dp13027
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13028
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00293
p13029
sg11
g13025
sg12
S'thymidylate synthetase'
p13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00293_359
p13031
sg16
VRaltitrexed [drugbank:DB00293]
p13032
sg18
Vdrug-target interaction Raltitrexed and Thymidylate synthase [drugbank_resource:DB00293_359]
p13033
sa(dp13034
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13035
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00322
p13036
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00322_359
p13037
sg16
VFloxuridine [drugbank:DB00322]
p13038
sg18
Vdrug-target interaction Floxuridine and Thymidylate synthase [drugbank_resource:DB00322_359]
p13039
sa(dp13040
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13041
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00441
p13042
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00441_359
p13043
sg16
VGemcitabine [drugbank:DB00441]
p13044
sg18
Vdrug-target interaction Gemcitabine and Thymidylate synthase [drugbank_resource:DB00441_359]
p13045
sa(dp13046
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13047
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00642
p13048
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00642_359
p13049
sg16
VPemetrexed [drugbank:DB00642]
p13050
sg18
Vdrug-target interaction Pemetrexed and Thymidylate synthase [drugbank_resource:DB00642_359]
p13051
sa(dp13052
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13053
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00544
p13054
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00544_359
p13055
sg16
VFluorouracil [drugbank:DB00544]
p13056
sg18
Vdrug-target interaction Fluorouracil and Thymidylate synthase [drugbank_resource:DB00544_359]
p13057
sa(dp13058
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13059
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00544
p13060
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00544_359
p13061
sg16
VFluorouracil [drugbank:DB00544]
p13062
sg18
Vdrug-enzyme interaction Fluorouracil and Thymidylate synthase [drugbank_resource:DB00544_359]
p13063
sa(dp13064
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13065
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00432
p13066
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00432_359
p13067
sg16
VTrifluridine [drugbank:DB00432]
p13068
sg18
Vdrug-target interaction Trifluridine and Thymidylate synthase [drugbank_resource:DB00432_359]
p13069
sa(dp13070
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13071
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00440
p13072
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00440_359
p13073
sg16
VTrimethoprim [drugbank:DB00440]
p13074
sg18
Vdrug-target interaction Trimethoprim and Thymidylate synthase [drugbank_resource:DB00440_359]
p13075
sa(dp13076
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13077
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00650
p13078
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00650_359
p13079
sg16
VLeucovorin [drugbank:DB00650]
p13080
sg18
Vdrug-target interaction Leucovorin and Thymidylate synthase [drugbank_resource:DB00650_359]
p13081
sa(dp13082
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13083
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01101
p13084
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01101_359
p13085
sg16
VCapecitabine [drugbank:DB01101]
p13086
sg18
Vdrug-target interaction Capecitabine and Thymidylate synthase [drugbank_resource:DB01101_359]
p13087
sa(dp13088
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13089
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01643
p13090
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01643_359
p13091
sg16
VThymidine-5'-Phosphate [drugbank:DB01643]
p13092
sg18
Vdrug-target interaction Thymidine-5'-Phosphate and Thymidylate synthase [drugbank_resource:DB01643_359]
p13093
sa(dp13094
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13095
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03541
p13096
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03541_359
p13097
sg16
V10-Propargyl-5,8-Dideazafolic Acid [drugbank:DB03541]
p13098
sg18
Vdrug-target interaction 10-Propargyl-5,8-Dideazafolic Acid and Thymidylate synthase [drugbank_resource:DB03541_359]
p13099
sa(dp13100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03800
p13102
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03800_359
p13103
sg16
V2'-deoxyuridylic acid [drugbank:DB03800]
p13104
sg18
Vdrug-target interaction 2'-deoxyuridylic acid and Thymidylate synthase [drugbank_resource:DB03800_359]
p13105
sa(dp13106
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13107
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04530
p13108
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04530_359
p13109
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p13110
sg18
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and Thymidylate synthase [drugbank_resource:DB04530_359]
p13111
sa(dp13112
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13113
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07577
p13114
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07577_359
p13115
sg16
V6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE [drugbank:DB07577]
p13116
sg18
Vdrug-target interaction 6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE and Thymidylate synthase [drugbank_resource:DB07577_359]
p13117
sa(dp13118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08479
p13120
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08479_359
p13121
sg16
VN-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide [drugbank:DB08479]
p13122
sg18
Vdrug-target interaction N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide and Thymidylate synthase [drugbank_resource:DB08479_359]
p13123
sa(dp13124
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13125
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08478
p13126
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08478_359
p13127
sg16
VN-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide [drugbank:DB08478]
p13128
sg18
Vdrug-target interaction N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide and Thymidylate synthase [drugbank_resource:DB08478_359]
p13129
sa(dp13130
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p13131
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08734
p13132
sg11
g13025
sg12
g13030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08734_359
p13133
sg16
V6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE [drugbank:DB08734]
p13134
sg18
Vdrug-target interaction 6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE and Thymidylate synthase [drugbank_resource:DB08734_359]
p13135
sasS'GSTP1'
p13136
(lp13137
(dp13138
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13139
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00143
p13140
sg11
g13136
sg12
S'glutathione S-transferase pi 1'
p13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00143_904
p13142
sg16
VGlutathione [drugbank:DB00143]
p13143
sg18
Vdrug-target interaction Glutathione and Glutathione S-transferase P [drugbank_resource:DB00143_904]
p13144
sa(dp13145
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13146
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01242
p13147
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01242_904
p13148
sg16
VClomipramine [drugbank:DB01242]
p13149
sg18
Vdrug-target interaction Clomipramine and Glutathione S-transferase P [drugbank_resource:DB01242_904]
p13150
sa(dp13151
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13152
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01915
p13153
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01915_904
p13154
sg16
VS-Hydroxycysteine [drugbank:DB01915]
p13155
sg18
Vdrug-target interaction S-Hydroxycysteine and Glutathione S-transferase P [drugbank_resource:DB01915_904]
p13156
sa(dp13157
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13158
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01834
p13159
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01834_904
p13160
sg16
V(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene [drugbank:DB01834]
p13161
sg18
Vdrug-target interaction (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene and Glutathione S-transferase P [drugbank_resource:DB01834_904]
p13162
sa(dp13163
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13164
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02633
p13165
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02633_904
p13166
sg16
VCibacron Blue [drugbank:DB02633]
p13167
sg18
Vdrug-target interaction Cibacron Blue and Glutathione S-transferase P [drugbank_resource:DB02633_904]
p13168
sa(dp13169
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13170
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03003
p13171
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03003_904
p13172
sg16
VGlutathione Sulfonic Acid [drugbank:DB03003]
p13173
sg18
Vdrug-target interaction Glutathione Sulfonic Acid and Glutathione S-transferase P [drugbank_resource:DB03003_904]
p13174
sa(dp13175
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13176
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03686
p13177
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03686_904
p13178
sg16
VS-(P-Nitrobenzyl)Glutathione [drugbank:DB03686]
p13179
sg18
Vdrug-target interaction S-(P-Nitrobenzyl)Glutathione and Glutathione S-transferase P [drugbank_resource:DB03686_904]
p13180
sa(dp13181
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13182
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04132
p13183
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04132_904
p13184
sg16
VS-Hexylglutathione [drugbank:DB04132]
p13185
sg18
Vdrug-target interaction S-Hexylglutathione and Glutathione S-transferase P [drugbank_resource:DB04132_904]
p13186
sa(dp13187
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13188
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03814
p13189
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03814_904
p13190
sg16
V2-(N-Morpholino)-Ethanesulfonic Acid [drugbank:DB03814]
p13191
sg18
Vdrug-target interaction 2-(N-Morpholino)-Ethanesulfonic Acid and Glutathione S-transferase P [drugbank_resource:DB03814_904]
p13192
sa(dp13193
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13194
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04077
p13195
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04077_904
p13196
sg16
VGlycerol [drugbank:DB04077]
p13197
sg18
Vdrug-target interaction Glycerol and Glutathione S-transferase P [drugbank_resource:DB04077_904]
p13198
sa(dp13199
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13200
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04339
p13201
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04339_904
p13202
sg16
VCarboxymethylenecysteine [drugbank:DB04339]
p13203
sg18
Vdrug-target interaction Carboxymethylenecysteine and Glutathione S-transferase P [drugbank_resource:DB04339_904]
p13204
sa(dp13205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07849
p13207
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07849_904
p13208
sg16
VS-NONYL-CYSTEINE [drugbank:DB07849]
p13209
sg18
Vdrug-target interaction S-NONYL-CYSTEINE and Glutathione S-transferase P [drugbank_resource:DB07849_904]
p13210
sa(dp13211
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:904
p13212
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08370
p13213
sg11
g13136
sg12
g13141
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08370_904
p13214
sg16
VS-(4-BROMOBENZYL)CYSTEINE [drugbank:DB08370]
p13215
sg18
Vdrug-target interaction S-(4-BROMOBENZYL)CYSTEINE and Glutathione S-transferase P [drugbank_resource:DB08370_904]
p13216
sasS'RND3'
p13217
(lp13218
(dp13219
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7112
p13220
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04137
p13221
sg11
g13217
sg12
S'Rho family GTPase 3'
p13222
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04137_7112
p13223
sg16
VGuanosine-5'-Triphosphate [drugbank:DB04137]
p13224
sg18
Vdrug-target interaction Guanosine-5'-Triphosphate and Rho-related GTP-binding protein RhoE [drugbank_resource:DB04137_7112]
p13225
sasS'GLYAT'
p13226
(lp13227
(dp13228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4057
p13229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00145
p13230
sg11
g13226
sg12
S'glycine-N-acyltransferase'
p13231
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00145_4057
p13232
sg16
VGlycine [drugbank:DB00145]
p13233
sg18
Vdrug-target interaction Glycine and Glycine N-acyltransferase [drugbank_resource:DB00145_4057]
p13234
sasS'PDK4'
p13235
(lp13236
(dp13237
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6793
p13238
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08356
p13239
sg11
g13235
sg12
S'pyruvate dehydrogenase kinase, isozyme 4'
p13240
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08356_6793
p13241
sg16
V4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol [drugbank:DB08356]
p13242
sg18
Vdrug-target interaction 4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol and [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial [drugbank_resource:DB08356_6793]
p13243
sasS'CCT3'
p13244
(lp13245
(dp13246
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7064
p13247
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p13248
sg11
g13244
sg12
S'chaperonin containing TCP1, subunit 3 (gamma)'
p13249
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7064
p13250
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p13251
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and T-complex protein 1 subunit gamma [drugbank_resource:DB03431_7064]
p13252
sa(dp13253
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7064
p13254
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p13255
sg11
g13244
sg12
g13249
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_7064
p13256
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p13257
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and T-complex protein 1 subunit gamma [drugbank_resource:DB04395_7064]
p13258
sasS'C1S'
p13259
(lp13260
(dp13261
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13262
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00054
p13263
sg11
g13259
sg12
S'complement component 1, s subcomponent'
p13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00054_2782
p13265
sg16
VAbciximab [drugbank:DB00054]
p13266
sg18
Vdrug-target interaction Abciximab and Complement C1s subcomponent [drugbank_resource:DB00054_2782]
p13267
sa(dp13268
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13269
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p13270
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_2782
p13271
sg16
VTrastuzumab [drugbank:DB00072]
p13272
sg18
Vdrug-target interaction Trastuzumab and Complement C1s subcomponent [drugbank_resource:DB00072_2782]
p13273
sa(dp13274
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13275
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00073
p13276
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00073_2782
p13277
sg16
VRituximab [drugbank:DB00073]
p13278
sg18
Vdrug-target interaction Rituximab and Complement C1s subcomponent [drugbank_resource:DB00073_2782]
p13279
sa(dp13280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00075
p13282
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00075_2782
p13283
sg16
VMuromonab [drugbank:DB00075]
p13284
sg18
Vdrug-target interaction Muromonab and Complement C1s subcomponent [drugbank_resource:DB00075_2782]
p13285
sa(dp13286
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13287
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00051
p13288
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00051_2782
p13289
sg16
VAdalimumab [drugbank:DB00051]
p13290
sg18
Vdrug-target interaction Adalimumab and Complement C1s subcomponent [drugbank_resource:DB00051_2782]
p13291
sa(dp13292
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13293
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00056
p13294
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00056_2782
p13295
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p13296
sg18
Vdrug-target interaction Gemtuzumab ozogamicin and Complement C1s subcomponent [drugbank_resource:DB00056_2782]
p13297
sa(dp13298
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13299
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00074
p13300
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00074_2782
p13301
sg16
VBasiliximab [drugbank:DB00074]
p13302
sg18
Vdrug-target interaction Basiliximab and Complement C1s subcomponent [drugbank_resource:DB00074_2782]
p13303
sa(dp13304
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13305
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00078
p13306
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00078_2782
p13307
sg16
VIbritumomab [drugbank:DB00078]
p13308
sg18
Vdrug-target interaction Ibritumomab and Complement C1s subcomponent [drugbank_resource:DB00078_2782]
p13309
sa(dp13310
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13311
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00002
p13312
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00002_2782
p13313
sg16
VCetuximab [drugbank:DB00002]
p13314
sg18
Vdrug-target interaction Cetuximab and Complement C1s subcomponent [drugbank_resource:DB00002_2782]
p13315
sa(dp13316
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13317
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00005
p13318
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00005_2782
p13319
sg16
VEtanercept [drugbank:DB00005]
p13320
sg18
Vdrug-target interaction Etanercept and Complement C1s subcomponent [drugbank_resource:DB00005_2782]
p13321
sa(dp13322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p13323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02371
p13324
sg11
g13259
sg12
g13264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02371_2782
p13325
sg16
V2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid [drugbank:DB02371]
p13326
sg18
Vdrug-target interaction 2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid and Complement C1s subcomponent [drugbank_resource:DB02371_2782]
p13327
sasS'PDPK1'
p13328
(lp13329
(dp13330
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13331
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00482
p13332
sg11
g13328
sg12
S'3-phosphoinositide dependent protein kinase-1'
p13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00482_2180
p13334
sg16
VCelecoxib [drugbank:DB00482]
p13335
sg18
Vdrug-target interaction Celecoxib and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB00482_2180]
p13336
sa(dp13337
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13338
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p13339
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2180
p13340
sg16
VStaurosporine [drugbank:DB02010]
p13341
sg18
Vdrug-target interaction Staurosporine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB02010_2180]
p13342
sa(dp13343
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13344
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01933
p13345
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01933_2180
p13346
sg16
V7-Hydroxystaurosporine [drugbank:DB01933]
p13347
sg18
Vdrug-target interaction 7-Hydroxystaurosporine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01933_2180]
p13348
sa(dp13349
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13350
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p13351
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2180
p13352
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p13353
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01863_2180]
p13354
sa(dp13355
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13356
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01946
p13357
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01946_2180
p13358
sg16
V3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione [drugbank:DB01946]
p13359
sg18
Vdrug-target interaction 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01946_2180]
p13360
sa(dp13361
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13362
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03777
p13363
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03777_2180
p13364
sg16
VRbt205 Inhibitor [drugbank:DB03777]
p13365
sg18
Vdrug-target interaction Rbt205 Inhibitor and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB03777_2180]
p13366
sa(dp13367
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13368
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06932
p13369
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06932_2180
p13370
sg16
V10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine [drugbank:DB06932]
p13371
sg18
Vdrug-target interaction 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB06932_2180]
p13372
sa(dp13373
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13374
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07033
p13375
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07033_2180
p13376
sg16
V5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE [drugbank:DB07033]
p13377
sg18
Vdrug-target interaction 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07033_2180]
p13378
sa(dp13379
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13380
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07132
p13381
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07132_2180
p13382
sg16
V1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA [drugbank:DB07132]
p13383
sg18
Vdrug-target interaction 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07132_2180]
p13384
sa(dp13385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07457
p13387
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07457_2180
p13388
sg16
V3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE [drugbank:DB07457]
p13389
sg18
Vdrug-target interaction 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07457_2180]
p13390
sa(dp13391
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13392
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p13393
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_2180
p13394
sg16
VPhosphonoserine [drugbank:DB04522]
p13395
sg18
Vdrug-target interaction Phosphonoserine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB04522_2180]
p13396
sa(dp13397
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13398
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07300
p13399
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07300_2180
p13400
sg16
V2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine [drugbank:DB07300]
p13401
sg18
Vdrug-target interaction 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07300_2180]
p13402
sa(dp13403
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p13404
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07456
p13405
sg11
g13328
sg12
g13333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07456_2180
p13406
sg16
V3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE [drugbank:DB07456]
p13407
sg18
Vdrug-target interaction 3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07456_2180]
p13408
sasS'AQP1'
p13409
(lp13410
(dp13411
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1025
p13412
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00819
p13413
sg11
g13409
sg12
S'aquaporin 1 (Colton blood group)'
p13414
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00819_1025
p13415
sg16
VAcetazolamide [drugbank:DB00819]
p13416
sg18
Vdrug-target interaction Acetazolamide and Aquaporin-1 [drugbank_resource:DB00819_1025]
p13417
sasS'MMP1'
p13418
(lp13419
(dp13420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1167
p13421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00786
p13422
sg11
g13418
sg12
S'matrix metallopeptidase 1 (interstitial collagenase)'
p13423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00786_1167
p13424
sg16
VMarimastat [drugbank:DB00786]
p13425
sg18
Vdrug-target interaction Marimastat and Interstitial collagenase [drugbank_resource:DB00786_1167]
p13426
sa(dp13427
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1167
p13428
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08403
p13429
sg11
g13418
sg12
g13423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08403_1167
p13430
sg16
VMETHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID [drugbank:DB08403]
p13431
sg18
Vdrug-target interaction METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID and Interstitial collagenase [drugbank_resource:DB08403_1167]
p13432
sa(dp13433
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1167
p13434
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08491
p13435
sg11
g13418
sg12
g13423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08491_1167
p13436
sg16
VN-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE [drugbank:DB08491]
p13437
sg18
Vdrug-target interaction N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE and Interstitial collagenase [drugbank_resource:DB08491_1167]
p13438
sa(dp13439
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1167
p13440
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07556
p13441
sg11
g13418
sg12
g13423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07556_1167
p13442
sg16
VN-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE [drugbank:DB07556]
p13443
sg18
Vdrug-target interaction N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE and Interstitial collagenase [drugbank_resource:DB07556_1167]
p13444
sa(dp13445
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1167
p13446
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07926
p13447
sg11
g13418
sg12
g13423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07926_1167
p13448
sg16
VN-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE [drugbank:DB07926]
p13449
sg18
Vdrug-target interaction N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE and Interstitial collagenase [drugbank_resource:DB07926_1167]
p13450
sa(dp13451
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1167
p13452
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08482
p13453
sg11
g13418
sg12
g13423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08482_1167
p13454
sg16
V[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER [drugbank:DB08482]
p13455
sg18
Vdrug-target interaction [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER and Interstitial collagenase [drugbank_resource:DB08482_1167]
p13456
sasS'SELP'
p13457
(lp13458
(dp13459
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2058
p13460
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01109
p13461
sg11
g13457
sg12
S'selectin P (granule membrane protein 140kDa, antigen CD62)'
p13462
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01109_2058
p13463
sg16
VHeparin [drugbank:DB01109]
p13464
sg18
Vdrug-target interaction Heparin and P-selectin [drugbank_resource:DB01109_2058]
p13465
sa(dp13466
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2058
p13467
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03721
p13468
sg11
g13457
sg12
g13462
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03721_2058
p13469
sg16
VO-Sialic Acid [drugbank:DB03721]
p13470
sg18
Vdrug-target interaction O-Sialic Acid and P-selectin [drugbank_resource:DB03721_2058]
p13471
sa(dp13472
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2058
p13473
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06779
p13474
sg11
g13457
sg12
g13462
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06779_2058
p13475
sg16
VDalteparin [drugbank:DB06779]
p13476
sg18
Vdrug-target interaction Dalteparin and P-selectin [drugbank_resource:DB06779_2058]
p13477
sa(dp13478
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2058
p13479
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08813
p13480
sg11
g13457
sg12
g13462
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08813_2058
p13481
sg16
VNadroparin [drugbank:DB08813]
p13482
sg18
Vdrug-target interaction Nadroparin and P-selectin [drugbank_resource:DB08813_2058]
p13483
sasS'MMP3'
p13484
(lp13485
(dp13486
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13487
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00786
p13488
sg11
g13484
sg12
S'matrix metallopeptidase 3 (stromelysin 1, progelatinase)'
p13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00786_1926
p13490
sg16
VMarimastat [drugbank:DB00786]
p13491
sg18
Vdrug-target interaction Marimastat and Stromelysin-1 [drugbank_resource:DB00786_1926]
p13492
sa(dp13493
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13494
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01877
p13495
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01877_1926
p13496
sg16
VN-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide [drugbank:DB01877]
p13497
sg18
Vdrug-target interaction N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide and Stromelysin-1 [drugbank_resource:DB01877_1926]
p13498
sa(dp13499
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13500
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01996
p13501
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01996_1926
p13502
sg16
V3-Methylpyridine [drugbank:DB01996]
p13503
sg18
Vdrug-target interaction 3-Methylpyridine and Stromelysin-1 [drugbank_resource:DB01996_1926]
p13504
sa(dp13505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02090
p13507
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02090_1926
p13508
sg16
VA Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor [drugbank:DB02090]
p13509
sg18
Vdrug-target interaction A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor and Stromelysin-1 [drugbank_resource:DB02090_1926]
p13510
sa(dp13511
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13512
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02350
p13513
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02350_1926
p13514
sg16
VN-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide [drugbank:DB02350]
p13515
sg18
Vdrug-target interaction N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide and Stromelysin-1 [drugbank_resource:DB02350_1926]
p13516
sa(dp13517
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13518
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02367
p13519
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02367_1926
p13520
sg16
V(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine [drugbank:DB02367]
p13521
sg18
Vdrug-target interaction (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine and Stromelysin-1 [drugbank_resource:DB02367_1926]
p13522
sa(dp13523
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13524
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02449
p13525
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02449_1926
p13526
sg16
V3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid [drugbank:DB02449]
p13527
sg18
Vdrug-target interaction 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid and Stromelysin-1 [drugbank_resource:DB02449_1926]
p13528
sa(dp13529
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13530
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02697
p13531
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02697_1926
p13532
sg16
VHydroxyaminovaline [drugbank:DB02697]
p13533
sg18
Vdrug-target interaction Hydroxyaminovaline and Stromelysin-1 [drugbank_resource:DB02697_1926]
p13534
sa(dp13535
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13536
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03033
p13537
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03033_1926
p13538
sg16
V1-Methyloxy-4-Sulfone-Benzene [drugbank:DB03033]
p13539
sg18
Vdrug-target interaction 1-Methyloxy-4-Sulfone-Benzene and Stromelysin-1 [drugbank_resource:DB03033_1926]
p13540
sa(dp13541
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13542
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03368
p13543
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03368_1926
p13544
sg16
V5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione [drugbank:DB03368]
p13545
sg18
Vdrug-target interaction 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione and Stromelysin-1 [drugbank_resource:DB03368_1926]
p13546
sa(dp13547
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13548
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04232
p13549
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04232_1926
p13550
sg16
VN-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide [drugbank:DB04232]
p13551
sg18
Vdrug-target interaction N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide and Stromelysin-1 [drugbank_resource:DB04232_1926]
p13552
sa(dp13553
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13554
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04416
p13555
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04416_1926
p13556
sg16
VR-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid [drugbank:DB04416]
p13557
sg18
Vdrug-target interaction R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid and Stromelysin-1 [drugbank_resource:DB04416_1926]
p13558
sa(dp13559
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13560
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04140
p13561
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04140_1926
p13562
sg16
V1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide [drugbank:DB04140]
p13563
sg18
Vdrug-target interaction 1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide and Stromelysin-1 [drugbank_resource:DB04140_1926]
p13564
sa(dp13565
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13566
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07390
p13567
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07390_1926
p13568
sg16
V2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE [drugbank:DB07390]
p13569
sg18
Vdrug-target interaction 2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE and Stromelysin-1 [drugbank_resource:DB07390_1926]
p13570
sa(dp13571
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13572
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07986
p13573
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07986_1926
p13574
sg16
V[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID [drugbank:DB07986]
p13575
sg18
Vdrug-target interaction [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID and Stromelysin-1 [drugbank_resource:DB07986_1926]
p13576
sa(dp13577
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13578
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07987
p13579
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07987_1926
p13580
sg16
V[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER [drugbank:DB07987]
p13581
sg18
Vdrug-target interaction [2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER and Stromelysin-1 [drugbank_resource:DB07987_1926]
p13582
sa(dp13583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08029
p13585
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08029_1926
p13586
sg16
VN~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide [drugbank:DB08029]
p13587
sg18
Vdrug-target interaction N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide and Stromelysin-1 [drugbank_resource:DB08029_1926]
p13588
sa(dp13589
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13590
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08507
p13591
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08507_1926
p13592
sg16
VN-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID [drugbank:DB08507]
p13593
sg18
Vdrug-target interaction N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID and Stromelysin-1 [drugbank_resource:DB08507_1926]
p13594
sa(dp13595
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13596
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08643
p13597
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08643_1926
p13598
sg16
V2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER [drugbank:DB08643]
p13599
sg18
Vdrug-target interaction 2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER and Stromelysin-1 [drugbank_resource:DB08643_1926]
p13600
sa(dp13601
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13602
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08271
p13603
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08271_1926
p13604
sg16
VN-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID [drugbank:DB08271]
p13605
sg18
Vdrug-target interaction N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID and Stromelysin-1 [drugbank_resource:DB08271_1926]
p13606
sa(dp13607
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13608
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07988
p13609
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07988_1926
p13610
sg16
V2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE [drugbank:DB07988]
p13611
sg18
Vdrug-target interaction 2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE and Stromelysin-1 [drugbank_resource:DB07988_1926]
p13612
sa(dp13613
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1926
p13614
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08030
p13615
sg11
g13484
sg12
g13489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08030_1926
p13616
sg16
V3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide [drugbank:DB08030]
p13617
sg18
Vdrug-target interaction 3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide and Stromelysin-1 [drugbank_resource:DB08030_1926]
p13618
sasS'NR3C1'
p13619
(lp13620
(dp13621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00180
p13623
sg11
g13619
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00180_871
p13625
sg16
VFlunisolide [drugbank:DB00180]
p13626
sg18
Vdrug-target interaction Flunisolide and Glucocorticoid receptor [drugbank_resource:DB00180_871]
p13627
sa(dp13628
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13629
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00288
p13630
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00288_871
p13631
sg16
VAmcinonide [drugbank:DB00288]
p13632
sg18
Vdrug-target interaction Amcinonide and Glucocorticoid receptor [drugbank_resource:DB00288_871]
p13633
sa(dp13634
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13635
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00223
p13636
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00223_871
p13637
sg16
VDiflorasone [drugbank:DB00223]
p13638
sg18
Vdrug-target interaction Diflorasone and Glucocorticoid receptor [drugbank_resource:DB00223_871]
p13639
sa(dp13640
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13641
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00240
p13642
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00240_871
p13643
sg16
VAlclometasone [drugbank:DB00240]
p13644
sg18
Vdrug-target interaction Alclometasone and Glucocorticoid receptor [drugbank_resource:DB00240_871]
p13645
sa(dp13646
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13647
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00253
p13648
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00253_871
p13649
sg16
VMedrysone [drugbank:DB00253]
p13650
sg18
Vdrug-target interaction Medrysone and Glucocorticoid receptor [drugbank_resource:DB00253_871]
p13651
sa(dp13652
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13653
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00591
p13654
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00591_871
p13655
sg16
VFluocinolone Acetonide [drugbank:DB00591]
p13656
sg18
Vdrug-target interaction Fluocinolone Acetonide and Glucocorticoid receptor [drugbank_resource:DB00591_871]
p13657
sa(dp13658
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13659
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00351
p13660
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00351_871
p13661
sg16
VMegestrol [drugbank:DB00351]
p13662
sg18
Vdrug-target interaction Megestrol and Glucocorticoid receptor [drugbank_resource:DB00351_871]
p13663
sa(dp13664
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13665
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00394
p13666
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00394_871
p13667
sg16
VBeclometasone dipropionate [drugbank:DB00394]
p13668
sg18
Vdrug-target interaction Beclometasone dipropionate and Glucocorticoid receptor [drugbank_resource:DB00394_871]
p13669
sa(dp13670
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13671
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00443
p13672
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00443_871
p13673
sg16
VBetamethasone [drugbank:DB00443]
p13674
sg18
Vdrug-target interaction Betamethasone and Glucocorticoid receptor [drugbank_resource:DB00443_871]
p13675
sa(dp13676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00588
p13678
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00588_871
p13679
sg16
VFluticasone Propionate [drugbank:DB00588]
p13680
sg18
Vdrug-target interaction Fluticasone Propionate and Glucocorticoid receptor [drugbank_resource:DB00588_871]
p13681
sa(dp13682
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13683
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00620
p13684
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00620_871
p13685
sg16
VTriamcinolone [drugbank:DB00620]
p13686
sg18
Vdrug-target interaction Triamcinolone and Glucocorticoid receptor [drugbank_resource:DB00620_871]
p13687
sa(dp13688
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13689
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00635
p13690
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00635_871
p13691
sg16
VPrednisone [drugbank:DB00635]
p13692
sg18
Vdrug-target interaction Prednisone and Glucocorticoid receptor [drugbank_resource:DB00635_871]
p13693
sa(dp13694
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13695
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00324
p13696
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00324_871
p13697
sg16
VFluorometholone [drugbank:DB00324]
p13698
sg18
Vdrug-target interaction Fluorometholone and Glucocorticoid receptor [drugbank_resource:DB00324_871]
p13699
sa(dp13700
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13701
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00547
p13702
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00547_871
p13703
sg16
VDesoximetasone [drugbank:DB00547]
p13704
sg18
Vdrug-target interaction Desoximetasone and Glucocorticoid receptor [drugbank_resource:DB00547_871]
p13705
sa(dp13706
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13707
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00596
p13708
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00596_871
p13709
sg16
VHalobetasol Propionate [drugbank:DB00596]
p13710
sg18
Vdrug-target interaction Halobetasol Propionate and Glucocorticoid receptor [drugbank_resource:DB00596_871]
p13711
sa(dp13712
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13713
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00663
p13714
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00663_871
p13715
sg16
VFlumethasone Pivalate [drugbank:DB00663]
p13716
sg18
Vdrug-target interaction Flumethasone Pivalate and Glucocorticoid receptor [drugbank_resource:DB00663_871]
p13717
sa(dp13718
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13719
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00687
p13720
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00687_871
p13721
sg16
VFludrocortisone [drugbank:DB00687]
p13722
sg18
Vdrug-target interaction Fludrocortisone and Glucocorticoid receptor [drugbank_resource:DB00687_871]
p13723
sa(dp13724
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13725
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00741
p13726
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00741_871
p13727
sg16
VHydrocortisone [drugbank:DB00741]
p13728
sg18
Vdrug-target interaction Hydrocortisone and Glucocorticoid receptor [drugbank_resource:DB00741_871]
p13729
sa(dp13730
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13731
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00764
p13732
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00764_871
p13733
sg16
VMometasone [drugbank:DB00764]
p13734
sg18
Vdrug-target interaction Mometasone and Glucocorticoid receptor [drugbank_resource:DB00764_871]
p13735
sa(dp13736
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13737
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00834
p13738
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00834_871
p13739
sg16
VMifepristone [drugbank:DB00834]
p13740
sg18
Vdrug-target interaction Mifepristone and Glucocorticoid receptor [drugbank_resource:DB00834_871]
p13741
sa(dp13742
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13743
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00838
p13744
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00838_871
p13745
sg16
VClocortolone [drugbank:DB00838]
p13746
sg18
Vdrug-target interaction Clocortolone and Glucocorticoid receptor [drugbank_resource:DB00838_871]
p13747
sa(dp13748
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13749
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00860
p13750
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00860_871
p13751
sg16
VPrednisolone [drugbank:DB00860]
p13752
sg18
Vdrug-target interaction Prednisolone and Glucocorticoid receptor [drugbank_resource:DB00860_871]
p13753
sa(dp13754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00873
p13756
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00873_871
p13757
sg16
VLoteprednol [drugbank:DB00873]
p13758
sg18
Vdrug-target interaction Loteprednol and Glucocorticoid receptor [drugbank_resource:DB00873_871]
p13759
sa(dp13760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00769
p13762
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00769_871
p13763
sg16
VHydrocortamate [drugbank:DB00769]
p13764
sg18
Vdrug-target interaction Hydrocortamate and Glucocorticoid receptor [drugbank_resource:DB00769_871]
p13765
sa(dp13766
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13767
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00846
p13768
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00846_871
p13769
sg16
VFlurandrenolide [drugbank:DB00846]
p13770
sg18
Vdrug-target interaction Flurandrenolide and Glucocorticoid receptor [drugbank_resource:DB00846_871]
p13771
sa(dp13772
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13773
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00896
p13774
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00896_871
p13775
sg16
VRimexolone [drugbank:DB00896]
p13776
sg18
Vdrug-target interaction Rimexolone and Glucocorticoid receptor [drugbank_resource:DB00896_871]
p13777
sa(dp13778
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13779
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00959
p13780
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00959_871
p13781
sg16
VMethylprednisolone [drugbank:DB00959]
p13782
sg18
Vdrug-target interaction Methylprednisolone and Glucocorticoid receptor [drugbank_resource:DB00959_871]
p13783
sa(dp13784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01013
p13786
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01013_871
p13787
sg16
VClobetasol [drugbank:DB01013]
p13788
sg18
Vdrug-target interaction Clobetasol and Glucocorticoid receptor [drugbank_resource:DB01013_871]
p13789
sa(dp13790
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13791
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01130
p13792
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01130_871
p13793
sg16
VPrednicarbate [drugbank:DB01130]
p13794
sg18
Vdrug-target interaction Prednicarbate and Glucocorticoid receptor [drugbank_resource:DB01130_871]
p13795
sa(dp13796
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13797
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01047
p13798
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01047_871
p13799
sg16
VFluocinonide [drugbank:DB01047]
p13800
sg18
Vdrug-target interaction Fluocinonide and Glucocorticoid receptor [drugbank_resource:DB01047_871]
p13801
sa(dp13802
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13803
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01260
p13804
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01260_871
p13805
sg16
VDesonide [drugbank:DB01260]
p13806
sg18
Vdrug-target interaction Desonide and Glucocorticoid receptor [drugbank_resource:DB01260_871]
p13807
sa(dp13808
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13809
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01222
p13810
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01222_871
p13811
sg16
VBudesonide [drugbank:DB01222]
p13812
sg18
Vdrug-target interaction Budesonide and Glucocorticoid receptor [drugbank_resource:DB01222_871]
p13813
sa(dp13814
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13815
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01234
p13816
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01234_871
p13817
sg16
VDexamethasone [drugbank:DB01234]
p13818
sg18
Vdrug-target interaction Dexamethasone and Glucocorticoid receptor [drugbank_resource:DB01234_871]
p13819
sa(dp13820
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13821
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01380
p13822
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01380_871
p13823
sg16
VCortisone acetate [drugbank:DB01380]
p13824
sg18
Vdrug-target interaction Cortisone acetate and Glucocorticoid receptor [drugbank_resource:DB01380_871]
p13825
sa(dp13826
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13827
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01384
p13828
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01384_871
p13829
sg16
VParamethasone [drugbank:DB01384]
p13830
sg18
Vdrug-target interaction Paramethasone and Glucocorticoid receptor [drugbank_resource:DB01384_871]
p13831
sa(dp13832
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13833
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01410
p13834
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01410_871
p13835
sg16
VCiclesonide [drugbank:DB01410]
p13836
sg18
Vdrug-target interaction Ciclesonide and Glucocorticoid receptor [drugbank_resource:DB01410_871]
p13837
sa(dp13838
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13839
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p13840
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_871
p13841
sg16
VFluoxymesterone [drugbank:DB01185]
p13842
sg18
Vdrug-target interaction Fluoxymesterone and Glucocorticoid receptor [drugbank_resource:DB01185_871]
p13843
sa(dp13844
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13845
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02210
p13846
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02210_871
p13847
sg16
VHexane-1,6-Diol [drugbank:DB02210]
p13848
sg18
Vdrug-target interaction Hexane-1,6-Diol and Glucocorticoid receptor [drugbank_resource:DB02210_871]
p13849
sa(dp13850
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p13851
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06781
p13852
sg11
g13619
sg12
g13624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06781_871
p13853
sg16
VDifluprednate [drugbank:DB06781]
p13854
sg18
Vdrug-target interaction Difluprednate and Glucocorticoid receptor [drugbank_resource:DB06781_871]
p13855
sasS'BCL2'
p13856
(lp13857
(dp13858
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:273
p13859
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01367
p13860
sg11
g13856
sg12
S'B-cell CLL/lymphoma 2'
p13861
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01367_273
p13862
sg16
VRasagiline [drugbank:DB01367]
p13863
sg18
Vdrug-target interaction Rasagiline and Apoptosis regulator Bcl-2 [drugbank_resource:DB01367_273]
p13864
sa(dp13865
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:273
p13866
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01229
p13867
sg11
g13856
sg12
g13861
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01229_273
p13868
sg16
VPaclitaxel [drugbank:DB01229]
p13869
sg18
Vdrug-target interaction Paclitaxel and Apoptosis regulator Bcl-2 [drugbank_resource:DB01229_273]
p13870
sa(dp13871
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:273
p13872
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01248
p13873
sg11
g13856
sg12
g13861
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01248_273
p13874
sg16
VDocetaxel [drugbank:DB01248]
p13875
sg18
Vdrug-target interaction Docetaxel and Apoptosis regulator Bcl-2 [drugbank_resource:DB01248_273]
p13876
sas.